Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
NON RARE IN EUROPE: Obesity due to MC3R deficiency ORPHA:217031	62/101	2.5518303259586287E-33	8.400625433055806E-30	0	0	12.672793692631384	951.0741218590885	OR7G2;OR10J1;OR10J3;OR11H2;OR14J1;OR11H1;OR2M7;OR2M5;OR2M3;OR2M2;OR2T12;OR51L1;OR1S2;OR2Y1;OR4D9;OR4D6;OR8H2;OR4D2;OR51G1;TAAR8;TAAR9;OR11G2;OR2T7;OR5R1;OR2T4;MC3R;OR10A7;OR13C9;OR4K15;OR6C3;OR4C5;OR56A4;OR13C4;OR10H3;OR2G3;OR4K5;OR6K2;OR10H2;OR2G2;OR10H5;FAM47B;OR10H4;OR9Q2;OR1I1;OR2W5;OR13F1;OR7D4;OR10K1;OR1D2;OR2F2;OR2J2;OR2J1;MOS;OR2AJ1;OR2V2;OR4D11;OR10C1;OR2Z1;OR4D10;OR51A4;OR7C2;OR7G3
Short stature due to GHSR deficiency ORPHA:314811	56/101	5.013080946547635E-27	8.251531238017407E-24	0	0	9.890087929656275	598.9214409246908	TAS2R7;OR11H2;OR14J1;OR11H1;OR2M7;OR2M5;OR2M2;OR2T12;OR51L1;OR1S2;OR11H6;OR2Y1;OR52B4;OR4D6;OR4D2;TAAR8;OR11G2;OR2T7;OR5R1;OR10A7;OR13C9;OR4K15;OR6C3;OR4C5;OR56A4;OR13C4;OR10H3;OR4K5;OR6K2;OR10H2;OR2G2;OR10H5;FAM47B;OR10H4;OR9Q2;OR1I1;OR2W5;OR13F1;OR7D4;OR1D5;OR5AU1;OR1D4;OR1D2;OR2F2;OR10G3;OR2J2;OR2J1;ADAM30;OR1L1;OR2V2;OR4D11;OR10C1;OR2Z1;GPR148;OR2A5;OR7C2
Isolated follicle stimulating hormone deficiency ORPHA:52901	52/101	3.518370529629752E-23	2.8956189458852855E-20	0	0	8.416920089400213	435.16705037421946	OR7G2;OR10J3;OR51H1;OR11H2;OR14J1;OR2M7;OR51L1;OR1S2;OR10W1;OR2Y1;OR4D9;OR5AP2;OR8D4;OR8H2;OR51G1;TAAR8;OR6C76;TAAR9;OR6C75;OR11G2;OR2T7;OR5R1;OR10A7;OR13C9;OR5V1;OR6X1;OR52R1;OR4K15;OR13C3;OR6C3;OR4C5;OR13C4;OR51F2;OR10H3;OR2G3;OR4K5;OR6K2;OR10H4;OR4K2;OR9Q2;OR4K1;OR1I1;OR13F1;OR7D4;OR10K1;OR10G3;OR2J2;OR2J1;OR51V1;OR4D11;OR10C1;OR7C2
Severe autosomal recessive macrothrombocytopenia ORPHA:438207	52/101	3.518370529629752E-23	2.8956189458852855E-20	0	0	8.416920089400213	435.16705037421946	OR7G2;IFNA5;OR10J1;IFNA7;OR10J3;IFNA6;OR14J1;CETN1;OR2M7;OR51L1;OR1S2;PRKACG;OR2Y1;OR4D6;TAAR8;TAAR9;OR2T7;OR5R1;OR10Z1;OR10A7;OR5V1;OR4K15;KIF2B;OR6C3;ACTRT2;OR4C5;OR56A4;PRR23B;OR13C4;OR6K6;OR10H3;OR4K5;OR6K2;OR10H2;OR2G2;FAM47B;OR10H4;OR9Q2;OR1I1;OR2W5;DNAJB8;LELP1;OR7D4;PDHA2;OR2J2;OR2J1;MOS;OR51V1;OR2V2;OR10C1;OR7C2;OR51A7
Adult-onset autosomal recessive sideroblastic anemia ORPHA:255132	51/101	2.9165802609217657E-22	1.6002303698257421E-19	0	0	8.085868102288021	400.94957731712384	HIST2H2AB;HIST2H2AC;HIST1H2AE;HIST1H1D;HIST1H2AD;HIST1H1E;RIMBP3C;HIST1H2AG;HIST1H1B;HIST1H2AB;HIST1H1C;HIST1H2AM;HIST1H2AL;HIST1H2AI;HIST1H2AH;HIST1H2AK;HIST1H2AJ;HIST2H3A;HIST1H2BF;HIST1H2BE;HIST1H2BH;HIST1H2BB;HIST2H3D;HIST2H3C;HIST1H2BD;HIST1H2BC;HIST1H2BN;HIST1H2BM;HIST1H2BO;HIST1H3J;HIST1H2BJ;HIST1H2BI;HIST1H2BL;HIST1H2BK;HIST2H4A;HIST1H3A;HIST1H3F;HIST1H3G;HIST1H3H;HIST1H3I;HIST1H3B;HIST1H3C;HIST1H4L;HIST1H4A;HIST1H4B;HIST1H4H;HIST1H4J;HIST1H4C;HIST1H4D;HIST1H4E;HIST1H4F
Childhood-onset spasticity with hyperglycinemia ORPHA:401866	51/101	2.9165802609217657E-22	1.6002303698257421E-19	0	0	8.085868102288021	400.94957731712384	HIST2H2AB;HIST2H2AC;HIST1H2AE;HIST1H1D;HIST1H2AD;HIST1H1E;RIMBP3C;HIST1H2AG;HIST1H1B;HIST1H2AB;HIST1H1C;HIST1H2AM;HIST1H2AL;HIST1H2AI;HIST1H2AH;HIST1H2AK;HIST1H2AJ;HIST2H3A;HIST1H2BF;HIST1H2BE;HIST1H2BH;HIST1H2BB;HIST2H3D;HIST2H3C;HIST1H2BD;HIST1H2BC;HIST1H2BN;HIST1H2BM;HIST1H2BO;HIST1H3J;HIST1H2BJ;HIST1H2BI;HIST1H2BL;HIST1H2BK;HIST2H4A;HIST1H3A;HIST1H3F;HIST1H3G;HIST1H3H;HIST1H3I;HIST1H3B;HIST1H3C;HIST1H4L;HIST1H4A;HIST1H4B;HIST1H4H;HIST1H4J;HIST1H4C;HIST1H4D;HIST1H4E;HIST1H4F
Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation ORPHA:324530	49/101	1.7802835085797347E-20	7.325866637805608E-18	0	0	7.462434920525463	339.3536999225599	HIST2H2AB;HIST2H2AC;HIST1H2AE;HIST1H1D;HIST1H2AD;HIST1H1E;RIMBP3C;HIST1H2AG;HIST1H1B;HIST1H2AB;HIST1H1C;HIST1H2AM;HIST1H2AL;TAS2R50;HIST1H2AI;HIST1H2AH;HIST1H2AJ;TAS2R13;POU5F2;HIST2H3A;HIST4H4;HIST1H2BF;HIST1H2BG;HIST1H2BB;HIST2H3D;HIST2H3C;HIST1H2BD;HIST1H2BC;HIST1H2BN;HIST1H2BM;HIST1H2BO;HIST1H2BI;HIST1H2BL;HIST2H4A;HIST1H3A;HIST1H3F;HIST1H3I;HIST1H3B;HIST1H3C;TAS2R30;HIST1H4L;HIST1H4A;HIST1H4B;HIST1H4H;HIST1H4J;HIST1H4C;HIST1H4D;HIST1H4E;HIST1H4F
PLCG2-associated antibody deficiency and immune dysregulation ORPHA:300359	49/101	1.7802835085797347E-20	7.325866637805608E-18	0	0	7.462434920525463	339.3536999225599	HIST2H2AB;HIST2H2AC;HIST1H2AE;HIST1H1D;HIST1H2AD;HIST1H1E;RIMBP3C;HIST1H2AG;HIST1H1B;HIST1H2AB;HIST1H1C;HIST1H2AM;HIST1H2AL;TAS2R50;HIST1H2AI;HIST1H2AH;HIST1H2AJ;TAS2R13;POU5F2;HIST2H3A;HIST4H4;HIST1H2BF;HIST1H2BG;HIST1H2BB;HIST2H3D;HIST2H3C;HIST1H2BD;HIST1H2BC;HIST1H2BN;HIST1H2BM;HIST1H2BO;HIST1H2BI;HIST1H2BL;HIST2H4A;HIST1H3A;HIST1H3F;HIST1H3I;HIST1H3B;HIST1H3C;TAS2R30;HIST1H4L;HIST1H4A;HIST1H4B;HIST1H4H;HIST1H4J;HIST1H4C;HIST1H4D;HIST1H4E;HIST1H4F
Male infertility due to acephalic spermatozoa ORPHA:529970	47/102	1.5323825513198357E-18	5.605114843272109E-16	0	0	6.760208443594023	277.30177587928523	OR10J1;CCT8L2;OR11H2;OR14J1;OR10H3;OR2G3;OR4K5;OR11H1;OR6K2;CETN1;OR11H12;OR2M7;FAM47B;OR10H4;OR9Q2;OR1I1;CCER1;OR51L1;OR1S2;SPZ1;ZNRF4;OR13F1;DNAJB8;LELP1;OR7D4;OR4D6;PRR30;OR10K1;PDHA2;OR51G1;OR1D2;OR2H1;OR2J2;OR2J1;ADAM30;OR2T7;OR5R1;OR10A7;OR2V2;OR10C1;OR2Z1;OR4D10;KIF2B;OR6C3;OR7C2;ACTRT2;OR56A4
Familial hypoaldosteronism ORPHA:427	43/101	1.5656069760237564E-15	4.685434695518369E-13	0	0	5.853482959012224	199.5481772157007	OR7G2;OR11H2;OR14J1;OR10H3;OR4K5;OR11H1;OR6K2;OR10H2;OR2G2;OR2M7;OR10H5;OR51D1;FAM47B;OR10H4;OR2M5;OR9Q2;OR1I1;OR2M2;OR2T12;OR51L1;OR1S2;OR2W5;OR2Y1;OR7D4;OR4D6;OR4D2;OR10K1;OR2F2;OR11G2;OR2J2;OR2J1;OR2T7;OR5R1;OR10A7;OR2V2;OR4K15;OR4D11;OR10C1;OR2Z1;OR6C3;OR7C2;OR4C5;OR56A4
Isolated congenital sclerocornea ORPHA:91490	43/101	1.5656069760237564E-15	4.685434695518369E-13	0	0	5.853482959012224	199.5481772157007	OR7G2;OR10J3;OR10H3;OR2G3;OR4K5;OR2M7;FAM47B;OR10H4;OR4K2;OR9Q2;OR4K1;OR1I1;CCER1;ZNRF4;OR10W1;OR2Y1;OR4D9;OR5AP2;LELP1;OR7D4;OR4D5;OR2A25;OR8H2;PRR30;OR10K1;OR51G1;SLC35G4;OR6C75;OR11G2;OR2H1;OR10G3;TAAR5;OR2J1;OR10A7;OR51V1;OR52R1;OR4D11;OR10C1;KIF2B;OR7C2;OR4C5;PRR23B;OR7E24
Early-onset sutural cataract ORPHA:98985	42/106	6.764800837922968E-14	1.855810363203534E-11	0	0	5.177278820375335	156.9981766319855	OR2G6;DCAF4L1;OR10H3;OR10H4;OR2T34;OR2T35;ARIH2OS;OR6S1;TRAJ46;TRAJ23;OR1S2;TRAJ48;TRAJ26;TRAJ47;TRAJ25;OR7D4;TRAJ21;OR4D2;OR4D1;OR52I2;OR2J1;RHOH;OR2T7;OR2T5;TRAJ35;TRAJ13;OR2T3;TRAJ12;TRAJ56;OR2T2;TRAJ36;TRAJ14;TRAJ8;TRAJ17;TRAJ16;OR4D11;TLR10;TRAJ50;TRAJ30;TRAJ33;TRAJ11;TRAJ10
Pulverulent cataract ORPHA:98984	42/109	2.0949039972701258E-13	5.304941506933272E-11	0	0	4.94462006322276	144.3537250782903	OR7G2;OR10J1;IFNA7;OR10J3;OR11H2;OR14J1;OR10H3;OR4K5;OR2G2;OR2M7;FAM47B;OR10H4;OR9Q2;OR1I1;OR2T12;OR1S2;GJA3;ZNRF4;OR2Y1;OR4D9;OR5AP2;LELP1;OR7D4;OR8H2;OR4D2;SLC35G4;TAAR9;OR6C75;OR11G2;OR10G3;TAAR5;OR2J1;OR2T7;MOS;OR10A7;OR4D11;OR10C1;OR6C3;OR7C2;OR4C5;CHST2;OR7G3
Dentin dysplasia type II ORPHA:99791	40/101	2.7043132827481516E-13	5.564124579254322E-11	0	0	5.169496487119438	149.59880884847846	OR51F2;OR11H2;OR1E2;OR11H1;OR11H12;OR2M7;OR10H4;OR2M5;OR1I1;OR2M3;CCER1;OR2M2;USP17L20;USP17L22;USP17L7;OR1S2;USP17L4;OR8B3;OR8B2;OR13D1;OR4F21;OR4F4;PRR30;OR10K1;OR4F3;OR2J3;OR1L6;OR1L4;OR1L1;USP17L2;OR2T7;USP17L11;USP17L1;OR4F17;OR2A12;OR51A4;OR10A2;OR2A14;OR2A2;OR10A5
Dentinogenesis imperfecta type 2 ORPHA:166260	40/101	2.7043132827481516E-13	5.564124579254322E-11	0	0	5.169496487119438	149.59880884847846	OR51F2;OR11H2;OR1E2;OR11H1;OR11H12;OR2M7;OR10H4;OR2M5;OR1I1;OR2M3;CCER1;OR2M2;USP17L20;USP17L22;USP17L7;OR1S2;USP17L4;OR8B3;OR8B2;OR13D1;OR4F21;OR4F4;PRR30;OR10K1;OR4F3;OR2J3;OR1L6;OR1L4;OR1L1;USP17L2;OR2T7;USP17L11;USP17L1;OR4F17;OR2A12;OR51A4;OR10A2;OR2A14;OR2A2;OR10A5
Dentinogenesis imperfecta type 3 ORPHA:166265	40/101	2.7043132827481516E-13	5.564124579254322E-11	0	0	5.169496487119438	149.59880884847846	OR51F2;OR11H2;OR1E2;OR11H1;OR11H12;OR2M7;OR10H4;OR2M5;OR1I1;OR2M3;CCER1;OR2M2;USP17L20;USP17L22;USP17L7;OR1S2;USP17L4;OR8B3;OR8B2;OR13D1;OR4F21;OR4F4;PRR30;OR10K1;OR4F3;OR2J3;OR1L6;OR1L4;OR1L1;USP17L2;OR2T7;USP17L11;USP17L1;OR4F17;OR2A12;OR51A4;OR10A2;OR2A14;OR2A2;OR10A5
Familial hyperaldosteronism type I ORPHA:403	38/100	4.787827960227904E-12	9.271488026511919E-10	0	0	4.827227993439037	125.8214285808747	OR7G2;OR14J1;OR10H3;OR4K5;OR11H1;OR6K2;OR2M7;FAM47B;OR10H4;OR2M5;OR9Q2;OR1I1;CCER1;OR2M2;OR2T12;OR1S2;OR2W5;DNAJB8;OR7D4;PRR30;OR4D2;OR1D5;OR10K1;OR1D4;OR1D2;OR11G2;OR2J1;ADAM30;OR2T7;OR5R1;OR10A7;OR2V2;OR10C1;OR2Z1;KIF2B;OR6C3;OR7C2;OR4C5
Early-onset lamellar cataract ORPHA:441452	37/108	3.021049862186589E-10	5.525164525732361E-8	0	0	4.10047534426353	89.88343040560605	IFNA5;IFNA7;OR10J3;IFNA6;OR5K4;OR14J1;OR10H3;OR2G2;OR2M7;IFNA2;OR10H4;OR9Q2;OR2T12;OR6S1;OR51L1;OR1S2;PRKACG;GJA10;OR7D4;OR4D2;TAAR8;TAAR9;OR2F1;TAAR6;OR2J2;OR2J1;OR2T7;MOS;OR10A7;OR13C9;OR2V2;OR10C1;OR6C3;OR7C2;OR13C4;ERAS;OR7G3
Cataract-microcornea syndrome ORPHA:1377	35/105	2.0913206392513355E-9	3.6234881812712616E-7	0	0	3.930957683741648	78.56203719663255	IFNA7;OR10J3;OR14J1;OR10H3;OR2G2;OR2M7;FAM47B;OR10H4;OR9Q2;SOX3;ZNRF4;PRKACG;GJA10;OR2Y1;OR4D9;OR5AP2;OR7D4;OR8H2;TAAR8;SLC35G4;OR6C75;OR11G2;OR10G3;TAAR5;OR2J1;CABS1;MOS;OR10A7;OR4D11;OR10C1;OR52A1;OR7C2;ACTRT2;OR4C5;OR7G3
Peeling skin syndrome type B ORPHA:263553	33/101	1.0540622284329292E-8	1.7349864280006014E-6	0	0	3.8123772873635438	70.02585754659985	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;CRCT1;CALML3;LCE2D;LCE1A;LCE1B;LCE3D;LCE5A;RNASE7;SFN;SPRR2B;SPRR2D;FGFBP1;PSAPL1;C1ORF68;LCE1E;LCE1F;LCE3E;LCE1D;LCE2B;LCE2C;LCE2A;GJB4;GJB3;GJB5;LCE6A;SPRR1A;SPRR1B;IVL
Hypotrichosis simplex of the scalp ORPHA:90368	33/102	1.3890136920631767E-8	2.177444321081894E-6	0	0	3.7569125984404326	67.97038891639946	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;CRCT1;CALML3;LCE2D;LCE1A;LCE1B;LCE3D;LCE5A;RNASE7;SPRR2B;SPRR2D;FGFBP1;PSAPL1;C1ORF68;LCE1E;LCE1F;LCE3E;LCE1D;LCE2B;LCE2C;LCE2A;GJB4;GJB3;LCE4A;GJB5;LCE6A;SPRR1A;SPRR1B;IVL
Self-improving collodion baby ORPHA:281122	32/100	3.079636505855005E-8	4.608256080579398E-6	0	0	3.6952061963575464	63.9118029339571	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;CRCT1;CALML3;LCE2D;LCE1A;LCE1B;LCE3D;RNASE7;SFN;SPRR2A;SPRR2B;SPRR2D;FGFBP1;C1ORF68;LCE1E;LCE1F;LCE3E;LCE2B;LCE2C;RNF225;GJB4;GJB3;GJB5;LCE6A;SP6;SPRR1A;SPRR1B;IVL
Keratoderma hereditarium mutilans with ichthyosis ORPHA:79395	32/101	4.0190418105969737E-8	5.292274256194095E-6	0	0	3.6414461808241785	62.01250743491009	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;CRCT1;CALML3;LCE2D;LCE1A;LCE3C;LCE1B;LCE3D;LCE3A;LCE5A;RNASE7;SPRR2B;SPRR2D;PSAPL1;C1ORF68;LCE1E;LCE1F;ASPRV1;LCE3E;LCE1D;LCE2B;LCE2C;LCE2A;LCE4A;LCE6A;SPRR1A;SPRR1B;IVL
NON RARE IN EUROPE: Partial color blindness, deutan type ORPHA:319698	32/101	4.0190418105969737E-8	5.292274256194095E-6	0	0	3.6414461808241785	62.01250743491009	OR10J3;OR11H2;OR14J1;OR10H3;OR11H1;OR6K2;OR2M7;FAM47B;OR10H4;OR2M5;OR9Q2;OR1I1;OR2M3;OR2M2;OR2T12;OR1S2;GJA10;OR7D4;OR6B2;OR4D2;OR1D4;OR1D2;OR2J1;OR5P3;OR1L1;OR2T7;OR5R1;OR2T4;OR10A7;OR2V2;OR51A4;OR7C2
Resistance to thyrotropin-releasing hormone syndrome ORPHA:99832	32/101	4.0190418105969737E-8	5.292274256194095E-6	0	0	3.6414461808241785	62.01250743491009	TAS2R7;TAS2R9;TAS2R8;TAS2R43;GPR22;TAS2R46;ADAM20;USP17L7;OR2AG1;OR13D1;PAPOLB;TAS2R3;OR4F21;OR2D3;OR4F3;TAS2R50;OR2D2;TAS2R30;OR2L8;TAS2R31;SMIM18;TAS2R10;OR2L5;TAS2R13;GPR52;OR2L3;OR1L4;TAS2R19;OR10A2;OR6A2;OR10A4;OR10A5
Congenital non-bullous ichthyosiform erythroderma ORPHA:79394	32/105	1.1154480626002442E-7	1.250074964744328E-5	0	0	3.441134890069712	55.08857607348794	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;CRCT1;CALML3;LCE2D;LCE1A;LCE1B;LCE3D;LCE5A;CAPNS2;RNASE7;SFN;SPRR2A;SPRR2B;SPRR2D;FGFBP1;C1ORF68;LCE1E;LCE1F;LCE3E;LCE1D;LCE2B;LCE2C;GJB4;GJB5;LCE6A;SPRR1A;SPRR1B;IVL
Lamellar ichthyosis ORPHA:313	32/105	1.1154480626002442E-7	1.250074964744328E-5	0	0	3.441134890069712	55.08857607348794	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;CRCT1;CALML3;LCE2D;LCE1A;LCE1B;LCE3D;LCE5A;RNASE7;SFN;SPRR2A;SPRR2B;SPRR2D;C1ORF68;LCE1E;LCE1F;LCE3E;LCE1D;LCE2B;LCE2C;RNF225;GJB4;GJB3;GJB5;LCE6A;SPRR1A;SPRR1B;IVL
Annular epidermolytic ichthyosis ORPHA:281139	31/100	1.1391934672639685E-7	1.250074964744328E-5	0	0	3.526082445660229	56.37421320917189	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;CRCT1;CALML3;LTB4R;LCE2D;LCE1A;LCE1B;LCE3D;LCE5A;CAPNS2;RNASE7;SPRR2B;SPRR2D;C1ORF68;LCE1E;LCE1F;ASPRV1;LCE3E;LCE1D;LCE2B;LCE2C;LCE2A;LCE4A;LCE6A;SPRR1A;SPRR1B;IVL
Autosomal dominant epidermolytic ichthyosis ORPHA:312	31/100	1.1391934672639685E-7	1.250074964744328E-5	0	0	3.526082445660229	56.37421320917189	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;CRCT1;CALML3;LTB4R;LCE2D;LCE1A;LCE1B;LCE3D;LCE5A;CAPNS2;RNASE7;SPRR2B;SPRR2D;C1ORF68;LCE1E;LCE1F;ASPRV1;LCE3E;LCE1D;LCE2B;LCE2C;LCE2A;LCE4A;LCE6A;SPRR1A;SPRR1B;IVL
Congenital reticular ichthyosiform erythroderma ORPHA:281190	31/100	1.1391934672639685E-7	1.250074964744328E-5	0	0	3.526082445660229	56.37421320917189	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;CRCT1;CALML3;LTB4R;LCE2D;LCE1A;LCE1B;LCE3D;LCE5A;CAPNS2;RNASE7;SPRR2B;SPRR2D;C1ORF68;LCE1E;LCE1F;ASPRV1;LCE3E;LCE1D;LCE2B;LCE2C;LCE2A;LCE4A;LCE6A;SPRR1A;SPRR1B;IVL
Hereditary palmoplantar keratoderma, Gamborg-Nielsen type ORPHA:86923	31/101	1.4657099440384638E-7	1.4621567078104917E-5	0	0	3.475512926379978	54.68982311477407	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;CRCT1;CALML3;LCE2D;LCE1A;LCE1B;LCE3D;LCE5A;RNASE7;SPRR2A;SPRR2B;SPRR2D;PSAPL1;C1ORF68;LCE1E;LCE1F;LCE3E;LCE1D;LCE2B;LCE2C;RNF225;LCE2A;LCE4A;LCE6A;SPRR1A;SPRR1B;IVL
IL21-related infantile inflammatory bowel disease ORPHA:477661	31/101	1.4657099440384638E-7	1.4621567078104917E-5	0	0	3.475512926379978	54.68982311477407	TRAJ45;TRAJ48;TRAJ47;TRAJ28;TRAJ49;TRAJ27;GPR171;CCR8;TRAJ40;TRAJ42;TRAJ41;CCR4;TRAJ44;TRAJ43;TRAJ3;TRAJ5;TRAJ57;TRAJ34;TRAJ37;TRAJ58;TRAJ39;TRAJ8;TRAJ17;TRAJ38;TRAJ16;TRAJ9;TRAJ18;TRAJ53;TRAJ52;TRAJ32;TRAJ54
Mal de Meleda ORPHA:87503	31/101	1.4657099440384638E-7	1.4621567078104917E-5	0	0	3.475512926379978	54.68982311477407	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;CRCT1;CALML3;LCE2D;LCE1A;LCE1B;LCE3D;LCE5A;RNASE7;SPRR2A;SPRR2B;SPRR2D;PSAPL1;C1ORF68;LCE1E;LCE1F;LCE3E;LCE1D;LCE2B;LCE2C;RNF225;LCE2A;LCE4A;LCE6A;SPRR1A;SPRR1B;IVL
Striate palmoplantar keratoderma ORPHA:50942	31/102	1.8776965819788195E-7	1.766107756535507E-5	0	0	3.42636790060058	53.06775684094692	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;CRCT1;CALML3;LCE2D;LCE1A;LCE1B;LCE3D;LCE5A;RNASE7;SPRR2A;SPRR2B;SPRR2D;PSAPL1;C1ORF68;LCE1E;LCE1F;LCE3E;LCE1D;LCE2B;LCE2C;LCE2A;GJB4;GJB5;LCE6A;SPRR1A;SPRR1B;IVL
Woolly hair ORPHA:170	31/102	1.8776965819788195E-7	1.766107756535507E-5	0	0	3.42636790060058	53.06775684094692	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;CRCT1;CALML3;LCE2D;LCE1A;LCE1B;LCE3D;LCE5A;CAPNS2;RNASE7;SPRR2B;PSAPL1;C1ORF68;LCE1E;LCE1F;LCE3E;LCE1D;LCE2B;LCE2C;LCE2A;GJB4;LPAR6;LCE4A;LCE6A;SPRR1A;SPRR1B;IVL
Peeling skin syndrome type A ORPHA:263548	30/102	6.455885040690268E-7	5.903548209431211E-5	0	0	3.268148148148148	46.581253896258715	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;CRCT1;SOX21;LCE2D;LCE1A;LCE1B;NHLH2;LCE3D;LCE5A;SPTSSB;SPRR2B;PSAPL1;GPR12;C1ORF68;LCE1E;POU3F1;LCE1F;ASPRV1;LCE3E;LCE1D;LCE2B;LCE2C;LCE2A;LCE4A;LCE6A;PYDC1
Diffuse palmoplantar keratoderma with painful fissures ORPHA:369999	29/101	1.701289121023307E-6	1.4001609466021816E-4	0	0	3.157806407028975	41.948692787742694	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;CRCT1;CALML3;LCE2D;LCE1A;LCE1B;LCE3D;LCE5A;RNASE7;SPRR2A;SPRR2B;SPRR2D;PSAPL1;C1ORF68;LCE1E;LCE1F;LCE3E;LCE1D;LCE2B;LCE2C;LCE2A;LCE6A;SPRR1A;SPRR1B;IVL
Epidermolytic palmoplantar keratoderma ORPHA:2199	29/101	1.701289121023307E-6	1.4001609466021816E-4	0	0	3.157806407028975	41.948692787742694	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;CRCT1;CALML3;LCE2D;LCE1A;LCE1B;LCE3D;CAPNS2;RNASE7;SPRR2A;SPRR2B;SPRR2D;FGFBP1;C1ORF68;LCE1F;LCE3E;LCE2B;LCE2C;GJB4;GJB3;GJB5;LCE6A;SPRR1A;SPRR1B;IVL
Focal palmoplantar keratoderma with joint keratoses ORPHA:370002	29/101	1.701289121023307E-6	1.4001609466021816E-4	0	0	3.157806407028975	41.948692787742694	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;CRCT1;CALML3;LCE2D;LCE1A;LCE1B;LCE3D;LCE5A;RNASE7;SPRR2A;SPRR2B;SPRR2D;PSAPL1;C1ORF68;LCE1E;LCE1F;LCE3E;LCE1D;LCE2B;LCE2C;LCE2A;LCE6A;SPRR1A;SPRR1B;IVL
Superficial epidermolytic ichthyosis ORPHA:455	29/101	1.701289121023307E-6	1.4001609466021816E-4	0	0	3.157806407028975	41.948692787742694	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;CRCT1;CALML3;LCE2D;LCE1A;LCE1B;LCE3D;LCE5A;CAPNS2;SPRR2B;PSAPL1;C1ORF68;LCE1E;LCE1F;ASPRV1;LCE3E;LCE1D;LCE2B;LCE2C;LCE2A;LCE4A;LCE6A;SPRR1A;SPRR1B;IVL
Progressive symmetric erythrokeratodermia ORPHA:316	29/104	3.2577957448018685E-6	2.6157716077775003E-4	0	0	3.0309788242262696	38.29477993712002	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;CRCT1;CALML3;LCE2D;LCE1A;LCE1B;LCE3D;LCE5A;RNASE7;SFN;PSAPL1;C1ORF68;LCE1E;LCE1F;LCE3E;LCE1D;LCE2B;LCE2C;LCE2A;GJB4;GJB3;GJB5;LCE6A;SPRR1B;IVL
DITRA ORPHA:404546	28/101	5.407110562295704E-6	4.0455018116085123E-4	0	0	3.0056449062020976	36.451847368506215	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;CRCT1;CALML3;LCE2D;LCE1A;LCE1B;LCE3D;CAPNS2;RNASE7;SPRR2A;SPRR2B;SPRR2D;C1ORF68;LCE1F;LCE3E;LCE1D;LCE2B;LCE2C;GJB2;GJB4;LCE6A;SPRR1A;SPRR1B;IVL
Severe combined immunodeficiency due to FOXN1 deficiency ORPHA:169095	28/101	5.407110562295704E-6	4.0455018116085123E-4	0	0	3.0056449062020976	36.451847368506215	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;CRCT1;TACSTD2;CALML3;LCE2D;LCE1A;LCE1B;LCE3D;RNASE7;SFN;SPRR2A;FGFBP1;C1ORF68;LCE3E;LCE2B;LCE2C;RNF225;GJB4;GJB3;GJB5;LCE6A;SPRR1A;SPRR1B;IVL
Spinocerebellar ataxia type 35 ORPHA:276193	28/101	5.407110562295704E-6	4.0455018116085123E-4	0	0	3.0056449062020976	36.451847368506215	KPRP;SPRR2E;SPRR4;SPRR2G;OR10H3;CRCT1;OR10H4;OR1I1;LCE2D;LCE1A;LCE3C;LCE3D;OR1S2;LCE3A;OR4D9;OR7D4;SPRR2B;OR11G2;C1ORF68;OR2J1;LCE3E;LCE2B;LCE2C;LCE4A;LCE6A;OR4D11;CLDN17;SPRR1A
Autosomal recessive epidermolytic ichthyosis ORPHA:512103	27/101	1.6390234343854405E-5	0.0011990366991104155	0	0	2.857703242523482	31.488531552176056	KPRP;SPRR2E;SPRR4;SPRR2G;NXT1;CALML5;CRCT1;LCE2D;LCE1A;LCE1B;LCE3D;LCE5A;EMC6;SPRR2B;SPRR2D;C1ORF68;LCE1E;LCE1F;LCE3E;LCE1D;LCE2B;LCE2C;LCE2A;TMEM99;LCE6A;SPRR1B;IVL
KID syndrome ORPHA:477	26/100	3.937631057165217E-5	0.0028179742261278027	0	0	2.750641502194297	27.897958324113542	SPRR2E;SPRR4;SPRR3;SPRR2G;CALML5;CRCT1;TACSTD2;CALML3;FOXQ1;LCE3D;CAPNS2;RNASE7;SFN;SPRR2A;SPRR2B;SPRR2D;FGFBP1;LCE3E;GJB2;GJB4;GJB3;GJB6;GJB5;SPRR1A;SPRR1B;IVL
Ichthyosis-short stature-brachydactyly-microspherophakia syndrome ORPHA:363992	25/102	1.540636467854897E-4	0.01079101117484749	0	0	2.540242462637141	22.29861603742225	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;CRCT1;CALML3;LCE2D;LCE1A;LCE3D;CAPNS2;RNASE7;SPRR2A;SPRR2B;SPRR2D;C1ORF68;ASPRV1;LCE3E;LCE2B;LCE2C;GJB6;LCE6A;SPRR1A;SPRR1B;IVL
Blue cone monochromatism ORPHA:16	24/100	2.906232099140064E-4	0.019525134837487943	0	0	2.4697648376259798	20.112487823679714	OR1D4;OR1D2;OR11H2;FAM47C;OR10H3;OR11H1;OR2M7;FAM47B;OR10H4;OR2M5;OR9Q2;OR2J1;OR2M3;OR5P3;OR2M2;OR2T12;OR1L1;OR2T7;OR2T4;OR1S2;NEUROD4;GJA10;OR7D4;OR6B2
X-linked cone dysfunction syndrome with myopia ORPHA:90001	24/100	2.906232099140064E-4	0.019525134837487943	0	0	2.4697648376259798	20.112487823679714	OR1D4;OR1D2;OR11H2;FAM47C;OR10H3;OR11H1;OR2M7;FAM47B;OR10H4;OR2M5;OR9Q2;OR2J1;OR2M3;OR5P3;OR2M2;OR2T12;OR1L1;OR2T7;OR2T4;OR1S2;NEUROD4;GJA10;OR7D4;OR6B2
Acral self-healing collodion baby ORPHA:281127	24/101	3.406227346383896E-4	0.02076537115610331	0	0	2.4375518098922355	19.463205355993313	KPRP;SPRR2E;SPRR4;SPRR2G;FGFBP1;CALML5;CRCT1;C15ORF62;CALML3;LCE3E;LCE3D;RNF225;LTB4R2;GJB3;GJB5;RNASE7;KCTD11;SFN;SPRR2A;SPRR2B;SPRR1A;SPRR1B;IVL;SPRR2D
Autosomal dominant focal non-epidermolytic palmoplantar keratoderma with plantar blistering ORPHA:402003	24/101	3.406227346383896E-4	0.02076537115610331	0	0	2.4375518098922355	19.463205355993313	KPRP;SPRR2E;SPRR4;SPRR3;SPRR2G;FGFBP1;CALML5;CRCT1;C1ORF68;CALML3;LCE3E;LCE1B;LCE3D;GJB4;CAPNS2;GJB3;GJB5;RNASE7;SPRR2A;SPRR2B;SPRR1A;SPRR1B;IVL;SPRR2D
Bathing suit ichthyosis ORPHA:100976	24/101	3.406227346383896E-4	0.02076537115610331	0	0	2.4375518098922355	19.463205355993313	KPRP;SPRR2E;SPRR4;SPRR2G;FGFBP1;CALML5;CRCT1;C15ORF62;CALML3;LCE3E;LCE3D;RNF225;LTB4R2;GJB3;GJB5;RNASE7;KCTD11;SFN;SPRR2A;SPRR2B;SPRR1A;SPRR1B;IVL;SPRR2D
Hidrotic ectodermal dysplasia ORPHA:189	24/101	3.406227346383896E-4	0.02076537115610331	0	0	2.4375518098922355	19.463205355993313	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;CRCT1;C1ORF68;CALML3;LCE3E;LCE1A;LCE2B;LCE3D;GJB2;CAPNS2;GJB6;GJB5;LCE6A;RNASE7;SPRR2A;SPRR2B;SPRR1A;SPRR1B;IVL;SPRR2D
Neurofibromatosis type 2 ORPHA:637	24/101	3.406227346383896E-4	0.02076537115610331	0	0	2.4375518098922355	19.463205355993313	HIST1H2BM;FOXD1;HIST1H2AH;HIST1H2BL;HIST1H2AJ;HIST2H2AB;TOR1AIP2;HIST2H2AC;GJC1;HIST1H4A;HIST2H3A;HIST1H3A;HIST1H4B;HIST1H2AD;HIST1H1E;RIMBP3C;BLID;HIST2H3D;HIST1H3B;HIST1H4C;HIST2H3C;HIST1H4D;HIST1H4E;HIST1H2AB
Isolated focal non-epidermolytic palmoplantar keratoderma ORPHA:448264	24/102	3.9802569810251756E-4	0.02382364723915432	0	0	2.406164757228587	18.837849415273844	KPRP;SPRR2E;SPRR4;SPRR2G;FGFBP1;PSAPL1;CALML5;CRCT1;C1ORF68;CALML3;LCE3E;LCE1B;LCE3D;GJB4;GJB3;GJB5;RNASE7;SFN;SPRR2A;SPRR2B;SPRR1A;SPRR1B;IVL;SPRR2D
Autosomal dominant generalized epidermolysis bullosa simplex, intermediate form ORPHA:79399	23/100	7.31471211561299E-4	0.04081361404169146	0	0	2.3349521546242857	16.859411574351242	KPRP;SPRR2E;SPRR4;SPRR3;SPRR2G;FGFBP1;CALML5;CRCT1;TACSTD2;CALML3;LCE3E;LCE3D;GJB4;CAPNS2;GJB3;GJB5;RNASE7;SFN;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
Autosomal dominant generalized epidermolysis bullosa simplex, severe form ORPHA:79396	23/100	7.31471211561299E-4	0.04081361404169146	0	0	2.3349521546242857	16.859411574351242	KPRP;SPRR2E;SPRR4;SPRR3;SPRR2G;FGFBP1;CALML5;CRCT1;TACSTD2;CALML3;LCE3E;LCE3D;GJB4;CAPNS2;GJB3;GJB5;RNASE7;SFN;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
Epidermolysis bullosa simplex with mottled pigmentation ORPHA:79397	23/100	7.31471211561299E-4	0.04081361404169146	0	0	2.3349521546242857	16.859411574351242	KPRP;SPRR2E;SPRR4;SPRR3;SPRR2G;FGFBP1;CALML5;CRCT1;TACSTD2;CALML3;LCE3E;LCE3D;GJB4;CAPNS2;GJB3;GJB5;RNASE7;SFN;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
Localized epidermolysis bullosa simplex ORPHA:79400	23/100	7.31471211561299E-4	0.04081361404169146	0	0	2.3349521546242857	16.859411574351242	KPRP;SPRR2E;SPRR4;SPRR3;SPRR2G;FGFBP1;CALML5;CRCT1;TACSTD2;CALML3;LCE3E;LCE3D;GJB4;CAPNS2;GJB3;GJB5;RNASE7;SFN;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
45,X/46,XY mixed gonadal dysgenesis ORPHA:1772	23/101	8.467216926124338E-4	0.04288319710892511	0	0	2.3048862229190097	16.30508436180989	KPRP;SPRR4;MAGEL2;SPRR2G;OLIG3;GPR119;OR2F1;LCE1E;LCE1F;LCE2D;LCE3E;LCE1D;LCE1A;CLDN6;LCE3C;LCE2C;LCE3D;LCE3A;LCE4A;LCE6A;NANOGP8;OR52A1;SRY
Atrial septal defect, sinus venosus type ORPHA:99105	23/101	8.467216926124338E-4	0.04288319710892511	0	0	2.3048862229190097	16.30508436180989	TMEM185B;FZD1;JUN;CEBPB;FZD2;JUND;CEBPD;IER5L;HPS6;ZBTB22;VASN;SERTAD3;NFIL3;MARVELD1;ZNF319;MYADM;KCTD11;FAM43A;MGAT1;ZNF865;CHST14;MGAT2;CCDC71
Autosomal recessive generalized epidermolysis bullosa simplex ORPHA:89838	23/101	8.467216926124338E-4	0.04288319710892511	0	0	2.3048862229190097	16.30508436180989	KPRP;SPRR2E;SPRR4;SPRR2G;FGFBP1;CALML5;CRCT1;C1ORF68;CALML3;LCE3E;LCE1B;LCE3D;GJB4;CAPNS2;GJB3;GJB5;RNASE7;SFN;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
Dermatopathia pigmentosa reticularis ORPHA:86920	23/101	8.467216926124338E-4	0.04288319710892511	0	0	2.3048862229190097	16.30508436180989	KPRP;SPRR2E;SPRR4;SPRR2G;FGFBP1;CALML5;CRCT1;C1ORF68;CALML3;LCE3E;LCE1B;LCE3D;GJB4;CAPNS2;GJB3;GJB5;RNASE7;SFN;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
Lipoyl transferase 2 deficiency ORPHA:447795	23/101	8.467216926124338E-4	0.04288319710892511	0	0	2.3048862229190097	16.30508436180989	DDX28;POP7;NXT1;IMP3;PARS2;MARS2;KTI12;UFSP1;RPP25L;THAP11;TMEM187;BLOC1S4;ZBTB9;TMEM177;ZNHIT2;TMEM203;ZNF837;SDHAF1;C19ORF73;RRS1;EMC6;METTL18;C19ORF48
Naegeli-Franceschetti-Jadassohn syndrome ORPHA:69087	23/101	8.467216926124338E-4	0.04288319710892511	0	0	2.3048862229190097	16.30508436180989	KPRP;SPRR2E;SPRR4;SPRR2G;FGFBP1;CALML5;CRCT1;C1ORF68;CALML3;LCE3E;LCE1B;LCE3D;GJB4;CAPNS2;GJB3;GJB5;RNASE7;SFN;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
ADULT syndrome ORPHA:978	22/101	0.001997952787119598	0.0900994599342153	0	0	2.175679160453409	13.523221509906842	SPRR2E;SPRR4;SPRR3;SPRR2G;FGFBP1;CALML5;CRCT1;TACSTD2;CALML3;LCE3E;LCE1B;LCE3D;GJB4;CAPNS2;GJB3;GJB5;RNASE7;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome ORPHA:1071	22/101	0.001997952787119598	0.0900994599342153	0	0	2.175679160453409	13.523221509906842	SPRR2E;SPRR4;SPRR3;SPRR2G;FGFBP1;CALML5;CRCT1;TACSTD2;CALML3;LCE3E;LCE1B;LCE3D;GJB4;CAPNS2;GJB3;GJB5;RNASE7;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
EEC syndrome ORPHA:1896	22/101	0.001997952787119598	0.0900994599342153	0	0	2.175679160453409	13.523221509906842	SPRR2E;SPRR4;SPRR3;SPRR2G;FGFBP1;CALML5;CRCT1;TACSTD2;CALML3;LCE3E;LCE1B;LCE3D;GJB4;CAPNS2;GJB3;GJB5;RNASE7;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
Limb-mammary syndrome ORPHA:69085	22/101	0.001997952787119598	0.0900994599342153	0	0	2.175679160453409	13.523221509906842	SPRR2E;SPRR4;SPRR3;SPRR2G;FGFBP1;CALML5;CRCT1;TACSTD2;CALML3;LCE3E;LCE1B;LCE3D;GJB4;CAPNS2;GJB3;GJB5;RNASE7;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
Minimal pigment oculocutaneous albinism type 1 ORPHA:352734	22/101	0.001997952787119598	0.0900994599342153	0	0	2.175679160453409	13.523221509906842	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;C1ORF68;LCE1E;LCE1F;LCE2D;LCE3E;LCE1D;LCE1A;LCE2B;LCE1B;LCE2C;LCE3D;LCE2A;LCE5A;LCE4A;LCE6A;SPRR2B;SPRR2D
Oculocutaneous albinism type 1A ORPHA:79431	22/101	0.001997952787119598	0.0900994599342153	0	0	2.175679160453409	13.523221509906842	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;C1ORF68;LCE1E;LCE1F;LCE2D;LCE3E;LCE1D;LCE1A;LCE2B;LCE1B;LCE2C;LCE3D;LCE2A;LCE5A;LCE4A;LCE6A;SPRR2B;SPRR2D
Oculocutaneous albinism type 1B ORPHA:79434	22/101	0.001997952787119598	0.0900994599342153	0	0	2.175679160453409	13.523221509906842	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;C1ORF68;LCE1E;LCE1F;LCE2D;LCE3E;LCE1D;LCE1A;LCE2B;LCE1B;LCE2C;LCE3D;LCE2A;LCE5A;LCE4A;LCE6A;SPRR2B;SPRR2D
Temperature-sensitive oculocutaneous albinism type 1 ORPHA:352737	22/101	0.001997952787119598	0.0900994599342153	0	0	2.175679160453409	13.523221509906842	KPRP;SPRR2E;SPRR4;SPRR2G;CALML5;C1ORF68;LCE1E;LCE1F;LCE2D;LCE3E;LCE1D;LCE1A;LCE2B;LCE1B;LCE2C;LCE3D;LCE2A;LCE5A;LCE4A;LCE6A;SPRR2B;SPRR2D
Uncombable hair syndrome ORPHA:1410	22/102	0.002278617729250354	0.10136769682016439	0	0	2.1483613817537646	13.07103084112641	KPRP;SPRR2E;SPRR3;FGFBP1;CALML5;CRCT1;TACSTD2;CALML3;LCE3E;LCE3D;GJB4;CAPNS2;GJB3;GJB5;RNASE7;SFN;SPRR2A;SPRR2B;SPRR1A;SPRR1B;IVL;SPRR2D
Epidermolysis bullosa simplex with circinate migratory erythema ORPHA:158681	21/101	0.00447027001597359	0.18628011256436783	0	0	2.049800796812749	11.090050504850073	SPRR2E;SPRR4;SPRR3;FGFBP1;CALML5;CRCT1;TACSTD2;CALML3;LCE3E;LCE3D;GJB4;CAPNS2;GJB3;GJB5;RNASE7;SFN;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
FADD-related immunodeficiency ORPHA:306550	21/101	0.00447027001597359	0.18628011256436783	0	0	2.049800796812749	11.090050504850073	DDX28;POP7;NXT1;ZNF581;FKBPL;IMP3;CDCA4;KTI12;HPS6;UFSP1;RPP25L;THAP11;COMMD5;BLOC1S4;ZNHIT2;TMEM203;C6ORF47;SDHAF1;RRS1;EMC6;BORCS6
Ichthyosis hystrix of Curth-Macklin ORPHA:79503	21/101	0.00447027001597359	0.18628011256436783	0	0	2.049800796812749	11.090050504850073	KPRP;SPRR2E;SPRR4;SPRR2G;FGFBP2;C1ORF68;GIMAP7;ASPRV1;LCE2D;LCE3E;LCE1D;LCE1A;LCE2B;HCAR2;LCE2C;HCAR3;LCE5A;CXCR1;CAPNS2;LCE6A;CXCR2
KRT1-related diffuse nonepidermolytic keratoderma ORPHA:530838	21/101	0.00447027001597359	0.18628011256436783	0	0	2.049800796812749	11.090050504850073	KPRP;SPRR2E;SPRR4;SPRR2G;FGFBP2;C1ORF68;GIMAP7;ASPRV1;LCE2D;LCE3E;LCE1D;LCE1A;LCE2B;HCAR2;LCE2C;HCAR3;LCE5A;CXCR1;CAPNS2;LCE6A;CXCR2
Partial chromosome Y deletion ORPHA:1646	21/101	0.00447027001597359	0.18628011256436783	0	0	2.049800796812749	11.090050504850073	OR51F1;PDHA2;XKRY2;OR51H1;OR11H2;OR14J1;OR10H3;OR51D1;OR2J2;OR4N4;OR2J1;OR51L1;GK2;SPZ1;OR52R1;OR51S1;CDY2A;OR51A4;LELP1;SRY;OR51A7
Ectodermal dysplasia-skin fragility syndrome ORPHA:158668	20/101	0.009473267245113734	0.3668940678931107	0	0	1.9271277176881896	8.979030371386507	KPRP;SPRR2E;FGFBP1;CALML5;CRCT1;TACSTD2;CALML3;GRHL2;LCE3D;GJB4;GJB3;GJB5;RNASE7;FAM84A;SFN;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
Hereditary hypotrichosis with recurrent skin vesicles ORPHA:217407	20/101	0.009473267245113734	0.3668940678931107	0	0	1.9271277176881896	8.979030371386507	SPRR2E;SPRR4;SPRR2G;FGFBP1;CALML5;CRCT1;CALML3;LCE3E;LCE1B;LCE3D;GJB4;GJB3;GJB5;RNASE7;SFN;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
Limb-girdle muscular dystrophy due to POMK deficiency ORPHA:445110	20/101	0.009473267245113734	0.3668940678931107	0	0	1.9271277176881896	8.979030371386507	HIST1H2BN;TAS2R30;HIST1H2AH;HIST1H2BL;HIST2H2AB;HIST2H2AC;TMPPE;HIST1H4A;HIST2H3A;HIST1H4B;HIST4H4;RBM12B;HIST1H1E;RIMBP3C;HIST1H3B;ZBED6;HIST2H3C;HIST1H4D;HIST1H4E;HIST1H2AB
NON RARE IN EUROPE: Autosomal dominant ichthyosis vulgaris ORPHA:462	20/101	0.009473267245113734	0.3668940678931107	0	0	1.9271277176881896	8.979030371386507	KPRP;SPRR2E;SPRR4;SPRR2G;CRCT1;C1ORF68;CALML3;LCE1F;LCE2D;LCE3E;LCE1A;LCE2B;LCE1B;LCE2C;LCE3D;LCE2A;LCE5A;LCE6A;RNASE7;IVL
Netherton syndrome ORPHA:634	20/101	0.009473267245113734	0.3668940678931107	0	0	1.9271277176881896	8.979030371386507	SPRR2E;SPRR3;FGFBP1;CALML5;CRCT1;CALML3;GRHL2;FUT3;GJB4;RASSF10;GJB3;GJB5;RNASE7;FAM84A;SFN;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
Synovial sarcoma ORPHA:3273	20/101	0.009473267245113734	0.3668940678931107	0	0	1.9271277176881896	8.979030371386507	MAGEA12;OR51B2;MAGEB16;OR52D1;DCAF4L2;NAA11;MAGEA9B;MAGEA2B;ATXN3L;RFPL4B;MAGEA1;MAGEB2;MAGEA2;OR51B5;OR51B4;OR8A1;MAGEB1;MAGEC2;MAGEA6;MAGEA3
Acral peeling skin syndrome ORPHA:263534	20/102	0.010554924732867094	0.40403270023951715	0	0	1.9035182387222103	8.663221261383875	SPRR2E;CXORF21;CRCT1;PTAFR;GPR84;RNASE2;LCE3E;HCAR2;LCE1B;HCAR3;LCE3D;TIFAB;CAPNS2;RNASE7;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D;TLR2
Pachyonychia congenita ORPHA:2309	19/100	0.01720209319280035	0.6509113883988362	0	0	1.8299616142753399	7.434629345107157	SPRR2E;SPRR3;FGFBP1;CALML5;CRCT1;TACSTD2;CALML3;LCE3E;LCE3D;GJB4;GJB3;GJB5;RNASE7;SFN;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
Colobomatous microphthalmia-rhizomelic dysplasia syndrome ORPHA:424099	19/101	0.018992920489858844	0.7025246545237676	0	0	1.8075425292068046	7.164536394946283	CHRM2;ZNF660;TAS2R50;TAS2R30;TAS2R31;SMIM18;GPR22;TAS2R13;TAS2R46;HIST2H2AB;TAS2R19;HIST1H4B;B3GALT2;MAB21L1;MAB21L2;HIST1H1E;HIST1H4D;RNF152;HIST1H4E
Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome ORPHA:65288	19/101	0.018992920489858844	0.7025246545237676	0	0	1.8075425292068046	7.164536394946283	ZCCHC12;CCDC177;MAGEL2;OLIG3;TMEM200C;BHLHE23;FBLL1;SERTM1;POU3F3;SOX3;NHLH2;SOX1;NEUROD4;GPR148;RPRML;INSM1;NEUROG1;CDK5R2;NEUROG2
Isolated congenital anosmia ORPHA:88620	19/102	0.020924511701787923	0.7653721391365093	0	0	1.7856636630555838	6.904864962218403	OR1D5;OR10K1;OR10H3;SPPL2C;OR6K2;OR10H4;OR2M5;OR9Q2;OR2L3;OR1I1;OR2M3;OR2M2;OR10A7;OR1S2;SLITRK3;OR10C1;OR13F1;DNAJB8;KIF2B
Harlequin ichthyosis ORPHA:457	18/101	0.03598530876296756	0.9999961656375117	0	0	1.6909334952542265	5.621752768087621	FGFBP1;CALML5;TACSTD2;CALML3;GRHL2;LCE1B;CLDN4;GJB4;GJB3;GJB5;RNASE7;SLITRK6;SFN;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
Intellectual disability-developmental delay-contractures syndrome ORPHA:3454	18/101	0.03598530876296756	0.9999961656375117	0	0	1.6909334952542265	5.621752768087621	BEX4;MAGEL2;BEX1;MAGEE1;ZNF518B;PABPC5;NAP1L3;ZCCHC18;GSPT2;MLLT11;TCEAL8;TCEAL7;NDN;ZNF501;FGFBP3;CCDC184;ZNF883;RAB9B
Mullerian aplasia and hyperandrogenism ORPHA:247768	18/101	0.03598530876296756	0.9999961656375117	0	0	1.6909334952542265	5.621752768087621	TMEM184A;CALML5;SOWAHB;TMEM30B;STX19;TACSTD2;CALML3;FUT2;GRHL2;FUT3;CLDN4;TMEM125;GJB4;RASSF10;PRR15L;GJB3;FAM84A;SPRR1B
SERKAL syndrome ORPHA:139466	18/101	0.03598530876296756	0.9999961656375117	0	0	1.6909334952542265	5.621752768087621	TMEM184A;CALML5;SOWAHB;TMEM30B;STX19;TACSTD2;CALML3;FUT2;GRHL2;FUT3;CLDN4;TMEM125;GJB4;RASSF10;PRR15L;GJB3;FAM84A;SPRR1B
Lafora disease ORPHA:501	18/102	0.039212624619581624	0.9999961656375117	0	0	1.6707086017430846	5.411018389300197	MAP10;MOAP1;MAGEH1;ZNF491;ZFP3;AMIGO1;DEXI;NKAPL;FAM220A;ARMCX1;RRAGA;TCEAL3;TCEAL1;NHLRC1;GPRASP2;FAM50B;RAB9B;TSPYL5
Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) ORPHA:402023	18/102	0.039212624619581624	0.9999961656375117	0	0	1.6707086017430846	5.411018389300197	HIST1H2BN;HIST1H2AI;EXOC8;HIST1H2AH;HIST1H2BL;HIST2H2AB;HIST2H2AC;TMPPE;HIST1H4A;HIST2H3A;HIST1H4B;RBM12B;HIST1H2AD;HIST1H1E;HIST2H3D;HIST1H3B;HIST2H3C;HIST1H2AB
Pure hair and nail ectodermal dysplasia ORPHA:69084	18/102	0.039212624619581624	0.9999961656375117	0	0	1.6707086017430846	5.411018389300197	KPRP;SPRR4;FGFBP1;CALML5;C1ORF68;CALML3;LCE1E;LCE2D;LCE1A;LCE2B;LCE1B;GJB3;GJB5;LCE6A;SP6;SFN;SPRR1B;IVL
Hairy cell leukemia variant ORPHA:300878	13/69	0.04631979434736236	0.9999961656375117	0	0	1.8088096288360955	5.556999411359062	IGLC7;GPR174;IGLJ2;IGLJ3;IGKJ4;IGHJ4;IGKJ1;IGHJ5;IGKJ2;IGKC;IGHJ3;IGLC3;IGLC2
Acute myeloid leukemia with CEBPA somatic mutations ORPHA:319480	17/101	0.06436375504520293	0.9999961656375117	0	0	1.5771942007028177	4.326566408803579	CCR1;CEBPA;CEBPB;CEBPD;PTAFR;RNASE6;RNASE2;ASCL2;MPEG1;HCAR2;HCAR3;FRAT1;FRAT2;MAFB;TIFAB;P2RY2;OXER1
Keratoderma hereditarium mutilans ORPHA:494	17/101	0.06436375504520293	0.9999961656375117	0	0	1.5771942007028177	4.326566408803579	FGFBP1;SOWAHB;SOWAHC;TACSTD2;CALML3;FOXQ1;CLDN4;GJB2;GJB4;GJB3;GJB5;RNASE7;SFN;SPRR2A;SPRR1A;SPRR1B;IVL
Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome ORPHA:2698	17/101	0.06436375504520293	0.9999961656375117	0	0	1.5771942007028177	4.326566408803579	FGFBP1;SOWAHB;SOWAHC;TACSTD2;CALML3;FOXQ1;CLDN4;GJB2;GJB4;GJB3;GJB5;RNASE7;SFN;SPRR2A;SPRR1A;SPRR1B;IVL
Lissencephaly due to TUBA1A mutation ORPHA:171680	17/101	0.06436375504520293	0.9999961656375117	0	0	1.5771942007028177	4.326566408803579	BEX4;ZCCHC12;MAGEH1;MAGEL2;BEX1;NAP1L3;ZCCHC18;MLLT11;GPR173;TCEAL7;ARMCX1;SOX1;ARMCX2;PNMA1;NDN;CCDC184;TSPYL4
Oculocutaneous albinism type 6 ORPHA:370097	17/101	0.06436375504520293	0.9999961656375117	0	0	1.5771942007028177	4.326566408803579	KPRP;SPRR2G;C1ORF68;POU3F1;LCE1F;LCE2D;LCE1D;LCE1A;LCE2B;LCE1B;LCE2C;LCE2A;LCE5A;SLITRK2;LCE4A;LCE6A;CCDC140
Porokeratotic eccrine ostial and dermal duct nevus ORPHA:166286	17/101	0.06436375504520293	0.9999961656375117	0	0	1.5771942007028177	4.326566408803579	FGFBP1;SOWAHB;SOWAHC;TACSTD2;CALML3;FOXQ1;CLDN4;GJB2;GJB4;GJB3;GJB5;RNASE7;SFN;SPRR2A;SPRR1A;SPRR1B;IVL
Prader-Willi syndrome due to translocation ORPHA:177907	17/101	0.06436375504520293	0.9999961656375117	0	0	1.5771942007028177	4.326566408803579	BEX4;ZNF781;MAGEH1;MAGEL2;PABPC5;NAP1L3;NAP1L2;KCNA5;GSPT2;NAP1L5;ARMCX4;TCEAL7;C3ORF18;ARMCX2;TCEAL2;NDN;GPRASP1
Sebocystomatosis ORPHA:841	17/101	0.06436375504520293	0.9999961656375117	0	0	1.5771942007028177	4.326566408803579	SPRR3;FGFBP1;CALML5;CRCT1;TACSTD2;CALML3;FOXQ1;GJB4;GJB3;GJB5;RNASE7;SFN;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
Acrodermatitis continua of Hallopeau ORPHA:163931	17/102	0.06939398342607148	0.9999961656375117	0	0	1.5585505965532478	4.15814302729581	SPRR2E;TMEM184A;FGFBP1;CRCT1;LCE3E;RNF223;LCE3D;GJB2;GJB4;GJB3;RNASE7;SFN;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
Generalized pustular psoriasis ORPHA:247353	17/102	0.06939398342607148	0.9999961656375117	0	0	1.5585505965532478	4.15814302729581	SPRR2E;TMEM184A;FGFBP1;CRCT1;LCE3E;RNF223;LCE3D;GJB2;GJB4;GJB3;RNASE7;SFN;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
Palmoplantar keratoderma-deafness syndrome ORPHA:2202	17/102	0.06939398342607148	0.9999961656375117	0	0	1.5585505965532478	4.15814302729581	FGFBP1;SOWAHB;SOWAHC;TACSTD2;CALML3;FOXQ1;CLDN4;GJB2;GJB4;GJB3;GJB5;RNASE7;SFN;SPRR2A;SPRR1A;SPRR1B;IVL
Prader-Willi syndrome due to imprinting mutation ORPHA:177910	17/102	0.06939398342607148	0.9999961656375117	0	0	1.5585505965532478	4.15814302729581	MAGEL2;BEX1;TRIL;TMEM200C;PABPC5;NAP1L3;PCDHB15;TCEAL7;ARMCX1;ARMCX2;TCEAL5;LRRTM1;TCEAL2;NDN;PCDHB5;LRRN1;LRRC4C
Pustulosis palmaris et plantaris ORPHA:163927	17/102	0.06939398342607148	0.9999961656375117	0	0	1.5585505965532478	4.15814302729581	SPRR2E;TMEM184A;FGFBP1;CRCT1;LCE3E;RNF223;LCE3D;GJB2;GJB4;GJB3;RNASE7;SFN;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
Cerulean cataract ORPHA:98989	17/104	0.08022955085528412	0.9999961656375117	0	0	1.522549154057527	3.841183485908127	BEX4;ZCCHC12;CCDC177;FOXB1;MAGEL2;NAP1L3;FBLL1;SERTM1;ATOH7;MOS;SOX3;NHLH2;SLITRK3;INSM1;TMEM229A;BEX5;RPRM
B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome ORPHA:536467	16/101	0.10857603291948024	0.9999961656375117	0	0	1.4662232384119727	3.2554621820868537	TIGD5;POP7;B3GALT6;ADO;UFSP1;CENPB;BLOC1S4;EID2;ZNHIT2;MBLAC1;RBM15B;TMEM203;ZNF837;SDHAF1;CHST14;ZCCHC3
Bamforth-Lazarus syndrome ORPHA:1226	16/101	0.10857603291948024	0.9999961656375117	0	0	1.4662232384119727	3.2554621820868537	SPRR3;FGFBP1;FOXC1;FOXE1;TWIST2;CALML3;FOXL2;FOXQ1;GJB3;UCN2;IFNE;GJB5;SFN;SPRR2A;SPRR1A;SPRR1B
Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency ORPHA:90795	16/101	0.10857603291948024	0.9999961656375117	0	0	1.4662232384119727	3.2554621820868537	PRR30;OR4D2;TRAJ4;OR1I1;CCER1;TRAJ23;TRAJ26;TRAJ14;TRAJ17;TRAJ16;DNAJB8;KIF2B;TRAJ20;CCR4;PPIAL4G;TRAJ22
Hirschsprung disease-ganglioneuroblastoma syndrome ORPHA:2151	16/101	0.10857603291948024	0.9999961656375117	0	0	1.4662232384119727	3.2554621820868537	HTR1E;NPY2R;SOX11;FBLL1;ASCL1;NEUROD4;LRRTM1;MAB21L1;MAB21L2;INSM2;INSM1;TMEM229A;NEUROG1;CDK5R2;NEUROG2;SLC18A3
Hyper-IgM syndrome type 2 ORPHA:101089	16/101	0.10857603291948024	0.9999961656375117	0	0	1.4662232384119727	3.2554621820868537	KLLN;RHOH;GPR82;SPN;ADAM29;MAS1;CYSLTR1;PGBD4;CNR2;PCDHB1;TLR10;FFAR1;OR7D2;CCR4;PPIAL4G;GDPGP1
NON RARE IN EUROPE: Partial color blindness, protan type ORPHA:319691	16/101	0.10857603291948024	0.9999961656375117	0	0	1.4662232384119727	3.2554621820868537	OR11H2;FAM47C;OR10H3;OR11H1;OR2M5;OR5P3;OR2T12;OR1L1;OR2T7;OR2T4;OR1S2;NEUROD4;TRAJ49;TMEM215;GJA10;OR6B2
Postural orthostatic tachycardia syndrome due to NET deficiency ORPHA:443236	16/101	0.10857603291948024	0.9999961656375117	0	0	1.4662232384119727	3.2554621820868537	KPRP;SPRR2E;SPRR4;SPRR2G;PSAPL1;CALML5;CRCT1;C1ORF68;CALML3;LCE2D;CAPNS2;LCE6A;RNASE7;SPRR1B;IVL;SLC18A3
Tessier number 7 facial cleft ORPHA:141276	16/102	0.11586571845562456	0.9999961656375117	0	0	1.4490919549675405	3.123261738333031	TAS2R30;TAS2R31;HIST1H2AH;TAS2R13;HIST2H2AB;HIST2H2AC;HIST1H4A;HIST2H3A;HIST1H4B;HIST1H2AD;HIST1H1E;RIMBP3C;HIST2H3C;HIST1H4D;HIST1H4E;HIST1H2AB
Cleft lip and alveolus ORPHA:141291	16/104	0.13129623532610765	0.9999961656375117	0	0	1.4159974301317058	2.8748984076726396	FGFBP1;CALML5;TACSTD2;CALML3;GRHL2;CLDN4;TMEM125;GJB4;GJB3;GJB5;RNASE7;SP6;SFN;SPRR1A;SPRR1B;IVL
Isolated cleft lip ORPHA:199302	16/104	0.13129623532610765	0.9999961656375117	0	0	1.4159974301317058	2.8748984076726396	FGFBP1;CALML5;TACSTD2;CALML3;GRHL2;CLDN4;TMEM125;GJB4;GJB3;GJB5;RNASE7;SP6;SFN;SPRR1A;SPRR1B;IVL
Van der Woude syndrome ORPHA:888	15/100	0.16310775343645195	0.9999961656375117	0	0	1.373977405531749	2.4914940039813818	FGFBP1;SOWAHB;TMEM30B;TACSTD2;CALML3;GRHL2;CLDN4;TMEM125;GJB4;PRR15L;GJB3;GJB5;SFN;SPRR1B;IVL
White sponge nevus ORPHA:171723	15/100	0.16310775343645195	0.9999961656375117	0	0	1.373977405531749	2.4914940039813818	SPRR3;FGFBP1;TACSTD2;CALML3;CLDN4;GJB4;GJB3;GJB5;RNASE7;SFN;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
Autosomal dominant distal renal tubular acidosis ORPHA:93608	15/101	0.17261910112662213	0.9999961656375117	0	0	1.357923918065609	2.3854212752748185	ARL11;LINC00694;C5AR2;FPR1;KCNJ15;FPR2;SPN;GP9;CNR2;CXCR1;OR2W3;CXCR2;FFAR2;CCR4;C16ORF54
Autosomal recessive spastic paraplegia type 56 ORPHA:320411	15/101	0.17261910112662213	0.9999961656375117	0	0	1.357923918065609	2.3854212752748185	MAGEE1;ZNF491;AMIGO1;IGIP;NAP1L3;TCEAL7;ARMCX2;TCEAL3;GPRASP1;TRAM1L1;GPRASP2;TRIM32;RAB9B;SOCS5;PCDHB7
Blepharophimosis-ptosis-epicanthus inversus syndrome plus ORPHA:572333	15/101	0.17261910112662213	0.9999961656375117	0	0	1.357923918065609	2.3854212752748185	FOXC2;FZD2;FOXD1;TWIST2;FZD9;TWIST1;FOXL2;FOXL1;TMEM158;UCN2;FOXL2NB;PHLDA2;CTXN1;FJX1;TCEAL9
Blepharophimosis-ptosis-epicanthus inversus syndrome type 1 ORPHA:572354	15/101	0.17261910112662213	0.9999961656375117	0	0	1.357923918065609	2.3854212752748185	FOXC2;FZD2;FOXD1;TWIST2;FZD9;TWIST1;FOXL2;FOXL1;TMEM158;UCN2;FOXL2NB;PHLDA2;CTXN1;FJX1;TCEAL9
Blepharophimosis-ptosis-epicanthus inversus syndrome type 2 ORPHA:572361	15/101	0.17261910112662213	0.9999961656375117	0	0	1.357923918065609	2.3854212752748185	FOXC2;FZD2;FOXD1;TWIST2;FZD9;TWIST1;FOXL2;FOXL1;TMEM158;UCN2;FOXL2NB;PHLDA2;CTXN1;FJX1;TCEAL9
Distal renal tubular acidosis with anemia ORPHA:93610	15/101	0.17261910112662213	0.9999961656375117	0	0	1.357923918065609	2.3854212752748185	ARL11;LINC00694;C5AR2;FPR1;KCNJ15;FPR2;SPN;GP9;CNR2;CXCR1;OR2W3;CXCR2;FFAR2;CCR4;C16ORF54
Ectodermal dysplasia-syndactyly syndrome ORPHA:247820	15/101	0.17261910112662213	0.9999961656375117	0	0	1.357923918065609	2.3854212752748185	TMEM184A;CALML5;TACSTD2;GRHL2;FUT3;RNF223;CLDN4;GJB4;PRR15L;GJB3;CLDN8;GJB5;SFN;SPRR1B;IVL
Focal facial dermal dysplasia type IV ORPHA:398189	15/101	0.17261910112662213	0.9999961656375117	0	0	1.357923918065609	2.3854212752748185	CCDC177;MAGEL2;OLIG3;SKIDA1;TMEM200C;HTR1B;SOX21;POU3F4;SOX2;GPR173;SOX3;SOX1;NEUROD4;MAB21L2;NEUROG1
Hereditary cryohydrocytosis with normal stomatin ORPHA:398088	15/101	0.17261910112662213	0.9999961656375117	0	0	1.357923918065609	2.3854212752748185	ARL11;LINC00694;C5AR2;FPR1;KCNJ15;FPR2;SPN;GP9;CNR2;CXCR1;OR2W3;CXCR2;FFAR2;CCR4;C16ORF54
Hypohidrosis-electrolyte imbalance-lacrimal gland dysfunction-ichthyosis-xerostomia syndrome ORPHA:528105	15/101	0.17261910112662213	0.9999961656375117	0	0	1.357923918065609	2.3854212752748185	GPR27;TAS2R40;LINC00694;MFSD6L;LRRC4;KCNJ15;OLIG1;FPR2;CXCR1;UBXN10;C10ORF105;CXCR2;LRRN1;CSNK1A1L;TLR2
Isolated thyrotropin-releasing hormone deficiency ORPHA:238670	15/101	0.17261910112662213	0.9999961656375117	0	0	1.357923918065609	2.3854212752748185	ZCCHC12;CCDC177;MAGEL2;BEX1;TMEM200C;KCNA5;C1QTNF4;GPR173;SOX3;TCEAL7;SOX1;NEUROD4;TCEAL5;LRRTM1;NEUROG1
MAGEL2-related Prader-Willi-like syndrome ORPHA:398069	15/101	0.17261910112662213	0.9999961656375117	0	0	1.357923918065609	2.3854212752748185	SMIM10L2B;MAGEL2;DCAF12L2;TMEM200C;PABPC5;NAP1L3;PCDHB15;FBLL1;TCEAL7;TCEAL5;LRRTM1;TCEAL2;NDN;PCDHB5;CCDC184
Palmoplantar keratoderma, Nagashima type ORPHA:140966	15/101	0.17261910112662213	0.9999961656375117	0	0	1.357923918065609	2.3854212752748185	KPRP;SPRR2E;FGFBP1;CRCT1;LCE3D;HRH1;GJB4;GJB3;UCN2;IFNE;GJB5;RNASE7;SPRR1B;IVL;SPRR2D
Seborrhea-like dermatitis with psoriasiform elements ORPHA:168606	15/101	0.17261910112662213	0.9999961656375117	0	0	1.357923918065609	2.3854212752748185	SPRR2E;SPRR3;CALML5;CRCT1;TACSTD2;CALML3;GRHL2;GJB4;GJB5;RNASE7;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
Southeast Asian ovalocytosis ORPHA:98868	15/101	0.17261910112662213	0.9999961656375117	0	0	1.357923918065609	2.3854212752748185	ARL11;LINC00694;C5AR2;FPR1;KCNJ15;FPR2;SPN;GP9;CNR2;CXCR1;OR2W3;CXCR2;FFAR2;CCR4;C16ORF54
UMOD-related autosomal dominant tubulointerstitial kidney disease ORPHA:88950	15/101	0.17261910112662213	0.9999961656375117	0	0	1.357923918065609	2.3854212752748185	PRR30;OR10K1;OR10H3;OR2H1;FAM47B;OR1I1;EDDM3A;CCER1;OR2T10;NAT8;OR4D11;OR4D9;KIF2B;RNF186;PFN3
Bladder exstrophy ORPHA:93930	15/102	0.1824041680171523	0.9999961656375117	0	0	1.3422394762883458	2.283861206720693	SPRR2E;SPRR3;FGFBP1;CALML3;GJB4;GJB3;GJB5;RNASE7;SLITRK6;SFN;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
Oculootodental syndrome ORPHA:99806	15/102	0.1824041680171523	0.9999961656375117	0	0	1.3422394762883458	2.283861206720693	POP7;NXT1;ZNF581;FKBPL;CDCA4;H2AFX;UFSP1;RPP25L;THAP11;COMMD5;BLOC1S4;ZNHIT2;TMEM203;SDHAF1;EMC6
Severe dermatitis-multiple allergies-metabolic wasting syndrome ORPHA:369992	15/102	0.1824041680171523	0.9999961656375117	0	0	1.3422394762883458	2.283861206720693	KPRP;SPRR2E;SPRR2G;CALML5;SOWAHB;CRCT1;CALML3;GRHL2;GJB2;GJB3;RNASE7;SFN;SPRR1A;SPRR1B;IVL
Inherited acute myeloid leukemia ORPHA:319465	15/104	0.2027625520033304	0.9999961656375117	0	0	1.311927970831163	2.093469280658781	HIST1H2AM;CEBPA;HIST1H2BO;HIST1H2AI;RNASE2;HIST2H2BE;HIST2H2AC;MAFB;P2RY2;HIST1H2BF;HIST1H2AG;HIST1H3H;HIST1H2AC;HIST1H4E;HIST1H2BC
Craniodiaphyseal dysplasia ORPHA:1513	14/101	0.2585472358011731	0.9999961656375117	0	0	1.2522039950898338	1.6938273823760617	FOXC2;MAGEL2;OLIG3;FZD7;GPR1;CLDN6;MOS;FAM133A;GJA1;FOXS1;FLRT2;GJA5;CCDC8;MAGEB3
Gelatinous drop-like corneal dystrophy ORPHA:98957	14/101	0.2585472358011731	0.9999961656375117	0	0	1.2522039950898338	1.6938273823760617	ARHGEF35;FGFBP1;CALML5;TMEM30B;TACSTD2;GRHL2;CLDN4;TMEM125;GJB4;GJB3;GJB5;SFN;SPRR1B;IVL
Isolated thyroid-stimulating hormone deficiency ORPHA:90674	14/101	0.2585472358011731	0.9999961656375117	0	0	1.2522039950898338	1.6938273823760617	OR6K6;TAS2R40;FPR1;OR6N2;OR6N1;OR52K2;OR52K1;GP9;CXCR1;PTTG2;TRDJ4;CXCR2;OR52B4;CSNK1A1L
Kyphoscoliosis-lateral tongue atrophy-hereditary spastic paraplegia syndrome ORPHA:496689	14/101	0.2585472358011731	0.9999961656375117	0	0	1.2522039950898338	1.6938273823760617	TAS2R40;C5AR2;P2RY14;FPR1;LRRC4;KCNJ15;FPR2;OR52K2;CXCR1;C10ORF105;CXCR2;FFAR2;KCNJ2;CSNK1A1L
Kyphosis-lateral tongue atrophy-myofibrillar myopathy syndrome ORPHA:496686	14/101	0.2585472358011731	0.9999961656375117	0	0	1.2522039950898338	1.6938273823760617	TAS2R40;C5AR2;P2RY14;FPR1;LRRC4;KCNJ15;FPR2;OR52K2;CXCR1;C10ORF105;CXCR2;FFAR2;KCNJ2;CSNK1A1L
Metaphyseal chondrodysplasia, Schmid type ORPHA:174	14/101	0.2585472358011731	0.9999961656375117	0	0	1.2522039950898338	1.6938273823760617	TAS2R50;TAS2R30;TAS2R31;TAS2R43;GPR22;TAS2R13;TAS2R46;GPR52;ADAM20;TAS2R19;POU5F2;HIST1H1E;HIST1H4E;TIGD1
Non-acquired combined pituitary hormone deficiency-sensorineural hearing loss-spine abnormalities syndrome ORPHA:231720	14/101	0.2585472358011731	0.9999961656375117	0	0	1.2522039950898338	1.6938273823760617	FOXD4;CHRM4;MAFA;TEX19;ATOH7;NEUROD4;VGF;GPRIN1;NHLH1;INSM2;NEUROG1;FOXD4L1;CDK5R2;NEUROG2
Pontocerebellar hypoplasia type 10 ORPHA:411493	14/101	0.2585472358011731	0.9999961656375117	0	0	1.2522039950898338	1.6938273823760617	DDX28;NXT1;TRMT10C;ZNF581;FKBPL;CDCA4;KTI12;TBCC;ZBTB9;RNF113A;SERTAD3;GEMIN7;MGAT2;METTL18
Syndactyly type 8 ORPHA:2498	14/101	0.2585472358011731	0.9999961656375117	0	0	1.2522039950898338	1.6938273823760617	FOXC2;MAGEL2;PABPC5;DCAF12L1;HTR1B;CLEC14A;MOS;TCEAL7;GJA1;ARMCX1;GJA4;NANOGP8;OR52A1;SUPT20HL2
Bifid uvula ORPHA:99771	14/102	0.2706609049309973	0.9999961656375117	0	0	1.2379041964214075	1.6178027768693255	FGFBP1;CALML5;SOWAHB;TACSTD2;CLDN4;TMEM125;UBB;GJB4;GJB3;GJB5;SP6;SFN;SPRR1B;IVL
Cleft hard palate ORPHA:101023	14/102	0.2706609049309973	0.9999961656375117	0	0	1.2379041964214075	1.6178027768693255	FGFBP1;CALML5;SOWAHB;TACSTD2;CLDN4;TMEM125;UBB;GJB4;GJB3;GJB5;SP6;SFN;SPRR1B;IVL
Cleft velum ORPHA:99772	14/102	0.2706609049309973	0.9999961656375117	0	0	1.2379041964214075	1.6178027768693255	FGFBP1;CALML5;SOWAHB;TACSTD2;CLDN4;TMEM125;UBB;GJB4;GJB3;GJB5;SP6;SFN;SPRR1B;IVL
Meesmann corneal dystrophy ORPHA:98954	14/102	0.2706609049309973	0.9999961656375117	0	0	1.2379041964214075	1.6178027768693255	SPRR3;FGFBP1;CALML5;CALML3;FUT3;GJB4;GJB3;GJB5;SFN;SPRR2A;SPRR1A;SPRR1B;IVL;SPRR2D
Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 ORPHA:98754	14/102	0.2706609049309973	0.9999961656375117	0	0	1.2379041964214075	1.6178027768693255	SMIM10L2B;MAGEL2;TRIL;TMEM200C;PABPC5;NAP1L3;PCDHB15;TCEAL7;TCEAL5;LRRTM1;TCEAL2;NDN;PCDHB5;LRRC4C
Submucosal cleft palate ORPHA:155878	14/102	0.2706609049309973	0.9999961656375117	0	0	1.2379041964214075	1.6178027768693255	FGFBP1;CALML5;SOWAHB;TACSTD2;CLDN4;TMEM125;UBB;GJB4;GJB3;GJB5;SP6;SFN;SPRR1B;IVL
Angelman syndrome due to imprinting defect in 15q11-q13 ORPHA:411515	14/103	0.2829629705822936	0.9999961656375117	0	0	1.2239257415432827	1.5451318779509533	ZNF660;ZNF781;MAGEH1;LRRN3;ZNF518B;NAP1L3;GSPT2;NAP1L5;ARMCX4;EPM2AIP1;LPAR6;B3GALT2;NDN;GPRASP1
Multiple synostoses syndrome ORPHA:3237	14/103	0.2829629705822936	0.9999961656375117	0	0	1.2239257415432827	1.5451318779509533	CHRM2;LRRN3;NOG;NAP1L3;GPR1;PRSS35;ZCCHC18;GPR173;TCEAL7;FLRT2;DSEL;CDC42EP3;GAS1;CD248
Hypocalcified amelogenesis imperfecta ORPHA:100032	14/104	0.29543859002255407	0.9999961656375117	0	0	1.2102579189957832	1.4756605590642833	TMEM184A;FGFBP1;TACSTD2;GRHL2;RNF223;CLDN4;TMEM125;GJB4;PRR15L;GJB3;P2RY2;GJB5;SFN;SPRR1B
Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1 ORPHA:177901	14/104	0.29543859002255407	0.9999961656375117	0	0	1.2102579189957832	1.4756605590642833	SMIM10L2B;MAGEL2;TRIL;TMEM200C;PABPC5;NAP1L3;PCDHB15;TCEAL7;TCEAL5;LRRTM1;TCEAL2;NDN;PCDHB5;LRRC4C
Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2 ORPHA:177904	14/104	0.29543859002255407	0.9999961656375117	0	0	1.2102579189957832	1.4756605590642833	SMIM10L2B;MAGEL2;TRIL;TMEM200C;PABPC5;NAP1L3;PCDHB15;TCEAL7;TCEAL5;LRRTM1;TCEAL2;NDN;PCDHB5;LRRC4C
Craniorachischisis ORPHA:63260	13/101	0.3648771937878493	0.9999961656375117	0	0	1.1489754180534948	1.1583906251784755	MAGEL2;TMEM200A;TMEM200C;PABPC5;NAP1L3;PRSS35;TCEAL7;ARMCX1;ARMCX2;FIBIN;NDN;GAS1;CD248
Deafness with labyrinthine aplasia, microtia, and microdontia ORPHA:90024	13/101	0.3648771937878493	0.9999961656375117	0	0	1.1489754180534948	1.1583906251784755	BHLHA9;ZCCHC12;CCDC177;OLIG3;SPPL2C;MRGPRG;SOX14;FZD10;SOX3;SOX1;ZNRF4;LRRC3B;NEUROG1
Early-onset generalized limb-onset dystonia ORPHA:256	13/101	0.3648771937878493	0.9999961656375117	0	0	1.1489754180534948	1.1583906251784755	DDX28;NXT1;CDCA4;C14ORF119;KTI12;DOLK;COMMD5;TMEM60;LSM10;C1GALT1C1;RNF113A;GEMIN7;MGAT2
Early-onset parkinsonism-intellectual disability syndrome ORPHA:2379	13/101	0.3648771937878493	0.9999961656375117	0	0	1.1489754180534948	1.1583906251784755	BEX4;GPR27;MOAP1;MAGEE1;KCNA3;NAP1L3;NAP1L2;ZCCHC18;FNDC9;SSTR3;MLLT11;BEX5;CDK5R1
Epithelial recurrent erosion dystrophy ORPHA:293381	13/101	0.3648771937878493	0.9999961656375117	0	0	1.1489754180534948	1.1583906251784755	FGFBP1;ARL14;TACSTD2;CALML3;CLDN4;GJB4;GJB3;GJB5;RNASE7;SFN;SPRR1A;SPRR1B;IVL
Familial isolated hypoparathyroidism due to agenesis of parathyroid gland ORPHA:2239	13/101	0.3648771937878493	0.9999961656375117	0	0	1.1489754180534948	1.1583906251784755	USP17L26;STH;USP17L2;USP17L22;USP17L11;USP17L25;USP17L24;USP17L1;USP17L7;USP17L4;SLITRK1;SLITRK3;CDR1
Fowler vasculopaty ORPHA:221126	13/101	0.3648771937878493	0.9999961656375117	0	0	1.1489754180534948	1.1583906251784755	CCR1;CEBPA;PTAFR;FPR3;FPR2;GPR84;HCAR2;HCAR3;TIFAB;P2RY2;MGAT1;CCR5;TLR2
Glycerol kinase deficiency, adult form ORPHA:284414	13/101	0.3648771937878493	0.9999961656375117	0	0	1.1489754180534948	1.1583906251784755	CCR1;CXORF21;GPR65;PTAFR;RNASE6;FPR1;FPR2;TLR1;HCAR3;TNFAIP8L2;CCR5;GAPT;TLR2
Glycerol kinase deficiency, juvenile form ORPHA:284411	13/101	0.3648771937878493	0.9999961656375117	0	0	1.1489754180534948	1.1583906251784755	CCR1;CXORF21;GPR65;PTAFR;RNASE6;FPR1;FPR2;TLR1;HCAR3;TNFAIP8L2;CCR5;GAPT;TLR2
Gollop-Wolfgang complex ORPHA:1986	13/101	0.3648771937878493	0.9999961656375117	0	0	1.1489754180534948	1.1583906251784755	BHLHA9;KCNJ4;SPPL2C;OR14I1;HTR1A;SSTR4;MOS;TCEAL6;NEUROD6;NPBWR2;PABPC1L2B;RPRML;PFN3
Hermansky-Pudlak syndrome type 8 ORPHA:231537	13/101	0.3648771937878493	0.9999961656375117	0	0	1.1489754180534948	1.1583906251784755	ZNF581;ZNF580;RHOG;COMMD5;FAM110A;LSM10;BLOC1S4;SERTAD1;PIGBOS1;BLOC1S3;MGAT1;GEMIN7;BORCS6
Late-onset junctional epidermolysis bullosa ORPHA:79406	13/101	0.3648771937878493	0.9999961656375117	0	0	1.1489754180534948	1.1583906251784755	FGFBP1;ARL14;TACSTD2;CALML3;CLDN4;GJB4;GJB3;GJB5;RNASE7;SFN;SPRR1A;SPRR1B;IVL
Mesoaxial synostotic syndactyly with phalangeal reduction ORPHA:157801	13/101	0.3648771937878493	0.9999961656375117	0	0	1.1489754180534948	1.1583906251784755	BHLHA9;KCNJ4;SPPL2C;OR14I1;HTR1A;SSTR4;MOS;TCEAL6;NEUROD6;NPBWR2;PABPC1L2B;RPRML;PFN3
Occipital encephalocele ORPHA:268823	13/101	0.3648771937878493	0.9999961656375117	0	0	1.1489754180534948	1.1583906251784755	MAGEL2;TMEM200A;TMEM200C;PABPC5;NAP1L3;PRSS35;TCEAL7;ARMCX1;ARMCX2;FIBIN;NDN;GAS1;CD248
Otodental syndrome ORPHA:2791	13/101	0.3648771937878493	0.9999961656375117	0	0	1.1489754180534948	1.1583906251784755	BHLHA9;ZCCHC12;CCDC177;OLIG3;SPPL2C;MRGPRG;SOX14;FZD10;SOX3;SOX1;ZNRF4;LRRC3B;NEUROG1
Partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome ORPHA:401959	13/101	0.3648771937878493	0.9999961656375117	0	0	1.1489754180534948	1.1583906251784755	TMEM184A;FGFBP1;ARL14;SOWAHB;TACSTD2;FUT3;FOXQ1;CLDN4;GJB4;PRR15L;GJB3;PRR15;SFN
RFVT3-related riboflavin transporter deficiency ORPHA:572550	13/101	0.3648771937878493	0.9999961656375117	0	0	1.1489754180534948	1.1583906251784755	TMEM184A;SOWAHB;FUT2;GRHL2;FUT3;RNF223;CLDN4;CLDN3;TMEM125;PRR15L;GJB3;PRR15;SFN
Tibial aplasia-ectrodactyly syndrome ORPHA:3329	13/101	0.3648771937878493	0.9999961656375117	0	0	1.1489754180534948	1.1583906251784755	BHLHA9;KCNJ4;SPPL2C;OR14I1;HTR1A;SSTR4;MOS;TCEAL6;NEUROD6;NPBWR2;PABPC1L2B;RPRML;PFN3
X-linked adrenal hypoplasia congenita ORPHA:95702	13/101	0.3648771937878493	0.9999961656375117	0	0	1.1489754180534948	1.1583906251784755	KCNF1;C8ORF48;TWIST1;FAM133A;VGF;TRNP1;PCDHB6;PCDHB5;TRAM1L1;SCG2;FJX1;CDK5R2;TCEAL9
X-linked congenital generalized hypertrichosis ORPHA:79495	13/101	0.3648771937878493	0.9999961656375117	0	0	1.1489754180534948	1.1583906251784755	CCDC177;MAGEL2;OLIG3;SOX11;SOX21;POU3F4;SOX2;CLDN6;SOX3;NHLH2;SOX1;FGFBP3;RPRM
X-linked intellectual disability with isolated growth hormone deficiency ORPHA:67045	13/101	0.3648771937878493	0.9999961656375117	0	0	1.1489754180534948	1.1583906251784755	CCDC177;MAGEL2;OLIG3;SOX11;SOX21;POU3F4;SOX2;CLDN6;SOX3;NHLH2;SOX1;FGFBP3;RPRM
Autosomal recessive infantile hypercalcemia ORPHA:300547	13/102	0.37863912067627675	0.9999961656375117	0	0	1.1360011498639493	1.1032521857597515	TMEM184A;FGFBP1;TACSTD2;CALML3;KLHDC7A;CLDN2;FOXQ1;CLDN4;GJB4;GJB3;GJB5;SFN;IVL
Bradyopsia ORPHA:75374	13/102	0.37863912067627675	0.9999961656375117	0	0	1.1360011498639493	1.1032521857597515	NANOS1;HIST1H2BN;ZSWIM1;FEM1A;KCNJ11;C12ORF60;MAFA;TEX19;KBTBD6;PDP2;RGS9BP;HIST3H2BB;HIST1H4C
Marie Unna hereditary hypotrichosis ORPHA:444	13/102	0.37863912067627675	0.9999961656375117	0	0	1.1360011498639493	1.1032521857597515	TMEM184A;ARL14;SOWAHB;FOXQ1;CLDN4;CLDN3;GJB1;PRR15L;GJB3;PRR15;SFN;SOWAHA;RNF186
Non-acquired panhypopituitarism ORPHA:90695	13/102	0.37863912067627675	0.9999961656375117	0	0	1.1360011498639493	1.1032521857597515	CCDC177;MAGEL2;OLIG3;SOX11;POU3F4;SOX2;MOS;SOX3;NHLH2;SOX1;PABPC1L2B;NEUROG1;RPRM
Cold-induced sweating syndrome ORPHA:157820	13/103	0.39245900575204806	0.9999961656375117	0	0	1.1233151987452825	1.050662756366888	FOXC2;FOXD1;FZD7;TPBG;DOLK;GPR3;VASN;DUSP14;ARL4D;UCN2;TRNP1;PHLDA1;FJX1
Generalized pseudohypoaldosteronism type 1 ORPHA:171876	12/100	0.47127588388485414	0.9999961656375117	0	0	1.06012506012506	0.7975443968401958	TMEM184A;CLDN4;CLDN3;TMEM125;SOWAHB;PRR15L;GJB3;CLDN8;TACSTD2;SFN;GRHL2;FUT3
Isolated Dandy-Walker malformation with hydrocephalus ORPHA:269212	12/100	0.47127588388485414	0.9999961656375117	0	0	1.06012506012506	0.7975443968401958	TCEAL7;SOX1;SLITRK1;TRIL;MAB21L1;PCDHB4;PCDHB3;LRRC3B;ASCL1;POU3F2;PCDHB10;POU3F3
Isolated Dandy-Walker malformation without hydrocephalus ORPHA:269215	12/100	0.47127588388485414	0.9999961656375117	0	0	1.06012506012506	0.7975443968401958	TCEAL7;SOX1;SLITRK1;TRIL;MAB21L1;PCDHB4;PCDHB3;LRRC3B;ASCL1;POU3F2;PCDHB10;POU3F3
Liddle syndrome ORPHA:526	12/100	0.47127588388485414	0.9999961656375117	0	0	1.06012506012506	0.7975443968401958	TMEM184A;CLDN4;CLDN3;TMEM125;SOWAHB;PRR15L;GJB3;CLDN8;TACSTD2;SFN;GRHL2;FUT3
Abruzzo-Erickson syndrome ORPHA:921	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	CLDN6;OR5H2;DCAF12L2;DCAF12L1;MAGEB3;NANOGP8;FAM46D;OR52A1;CABS1;VRTN;SUPT20HL2;OR5H6
Anophthalmia/microphthalmia-esophageal atresia syndrome ORPHA:77298	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	SOX2;SOX3;CCDC177;SOX1;FUT9;TMEM200C;FAM181B;SOX21;POU3F2;CCDC160;POU3F4;RPRM
Autosomal dominant Charcot-Marie-Tooth disease type 2 due to DGAT2 mutation ORPHA:487814	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	HCAR2;HCAR3;CEBPA;LINC00694;CXCR1;PTAFR;CXCR2;FPR1;OXER1;FFAR2;FPR2;ASPRV1
Autosomal dominant hypophosphatemic rickets ORPHA:89937	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	NEUROD1;KLLN;NEUROD2;MAS1;PCDHB1;KCNJ15;LCMT2;LPAR4;CHST5;PPIAL4G;GDPGP1;KCNJ2
Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency ORPHA:319581	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	HCAR2;CCR1;TLR1;HCAR3;PTAFR;C3AR1;RNASE6;FPR1;FPR2;CCR5;MPEG1;TLR2
Autosomal dominant optic atrophy and cataract ORPHA:67036	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	ZC3H10;EXOSC6;PGBD4;MOCS3;FKRP;FEM1A;CHST12;PCDHB1;BLOC1S3;TNFAIP8L1;ZNF843;TRIM56
Autosomal dominant popliteal pterygium syndrome ORPHA:1300	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	CLDN4;ARHGEF35;CLDN3;TMEM125;GJB4;SOWAHB;TMEM30B;PRR15L;GJB3;TACSTD2;GRHL2;FUT3
Autosomal recessive dopa-responsive dystonia ORPHA:101150	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	KCNF1;VGF;LRRC10B;FAM84A;SLITRK6;DIO3;ASCL1;CTXN1;FJX1;PCDHB10;CDK5R2;SLC18A3
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency ORPHA:319569	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	HCAR2;CCR1;TLR1;HCAR3;PTAFR;C3AR1;RNASE6;FPR1;FPR2;CCR5;MPEG1;TLR2
Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency ORPHA:420699	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	ARL11;LINC00694;CXCR1;PTAFR;CXCR2;FPR1;FFAR2;FPR2;TNFAIP8L2;RNASE2;C16ORF54;GAPT
Butyrylcholinesterase deficiency ORPHA:132	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	TMEM100;FLRT3;PABPC5;SLITRK3;PCDHB15;PCDHB5;TMEM74;PCDHB12;TRAM1L1;GPRASP2;PCDHB10;PCDHB7
CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome ORPHA:566067	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	ARL11;LINC00694;CXCR1;CXCR2;FPR1;RNASE3;FPR2;TNFAIP8L2;RNASE2;S1PR4;C16ORF54;GAPT
Char syndrome ORPHA:46627	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	NHLH2;CCDC177;SOX1;NEUROD4;TRIL;MAB21L1;SLITRK6;SOX11;LRRC4C;ASCL1;POU3F4;SLC18A3
Congenital bile acid synthesis defect type 4 ORPHA:79095	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	TMEM177;PLPP6;C1GALT1C1;ALDH1B1;TMEM99;PARS2;MAGEF1;CLDN12;TTC30A;ANG;THNSL1;SEPHS2
Congenital lactase deficiency ORPHA:53690	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	HIST1H2AM;HIST1H2BN;HIST1H2BO;HIST1H2AI;HIST1H3J;HIST1H2AH;HIST1H2BL;HIST1H2AJ;HIST1H2BF;HIST1H2AG;RAG2;HIST1H3B
Coralliform cataract ORPHA:98990	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	GPR27;C1QTNF4;SOX3;NHLH2;ZCCHC12;FOXB1;BEX1;TCEAL5;NAP1L3;RPRML;INSM1;RPRM
Corpus callosum agenesis-abnormal genitalia syndrome ORPHA:2508	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	SOX2;KCNF1;CHRM1;SOX1;KCNJ11;FUT9;LRRC10B;FOXG1;LRRC3B;ASCL1;POU3F2;CDK5R2
Duane retraction syndrome with congenital deafness ORPHA:529574	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	HCAR2;CCR1;THBD;CEBPA;MAFB;CEBPD;FPR1;FPR3;KCTD12;TLR5;MPEG1;TLR2
Enteric anendocrinosis ORPHA:83620	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	TIFAB;OLIG3;DCANP1;SOWAHD;SOX14;INSM1;RNF186;ASCL2;NEUROG1;ATOH1;CCDC182;NEUROG3
Familial Mediterranean fever ORPHA:342	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	ARL11;CXCR1;CXORF21;C5AR2;PTAFR;CXCR2;FPR1;FFAR2;FPR2;RNASE2;C16ORF54;GAPT
Hereditary hypercarotenemia and vitamin A deficiency ORPHA:199285	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	CLDN3;TMEM125;GJB1;SOWAHB;PRR15L;FLRT3;FAM84A;PRR15;KLHDC7A;SOWAHA;CLDN2;RNF186
Histidinemia ORPHA:2157	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	HCAR2;HCAR3;LINC00694;CXCR1;PTAFR;CXCR2;FPR1;FPR2;RNASE2;LTB4R;GAPT;TLR2
Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency ORPHA:401948	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	NPAP1;ZNF891;MAS1;CYSLTR1;PGBD4;PCDHB1;C5AR2;GPR82;OR7D2;PPIAL4G;GDPGP1;POU5F2
Idiopathic bronchiectasis ORPHA:60033	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	TMEM184A;CLDN4;CLDN3;TMEM125;SOWAHB;TMEM30B;PRR15L;CLDN8;TACSTD2;FUT2;GRHL2;FUT3
Infantile epileptic-dyskinetic encephalopathy ORPHA:364063	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	SOX2;KCNF1;CHRM1;SOX1;KCNJ11;FUT9;LRRC10B;FOXG1;LRRC3B;ASCL1;POU3F2;CDK5R2
Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency ORPHA:99898	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	HCAR2;CCR1;TLR1;HCAR3;PTAFR;C3AR1;RNASE6;FPR1;FPR2;CCR5;MPEG1;TLR2
Multicentric carpo-tarsal osteolysis with or without nephropathy ORPHA:2774	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	HCAR2;CCR1;THBD;CEBPA;MAFB;CEBPD;FPR1;FPR3;KCTD12;TLR5;MPEG1;TLR2
Myostatin-related muscle hypertrophy ORPHA:275534	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	TMEM100;TCEAL7;ISLR;SLN;MAB21L1;PABPC5;FIBIN;GAS1;PCDHB4;HSPB3;LRRC30;PCDHB7
NKX6-2-related autosomal recessive hypomyelinating leukodystrophy ORPHA:527497	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	NEUROD2;AMER3;TCEAL6;TCEAL5;SLITRK2;FUT9;SLITRK1;DIRAS2;GPR62;LRRC4C;TMEM229A;PIRT
Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome ORPHA:423454	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	TMEM184A;RNF223;CLDN4;CLDN3;TMEM125;SOWAHB;TMEM30B;PRR15L;STX19;TACSTD2;GRHL2;FUT3
Obesity due to melanocortin 4 receptor deficiency ORPHA:71529	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	MC4R;TCEAL7;NEUROD6;SLITRK1;LRRTM1;MAB21L1;CEND1;KCNA4;FBLL1;SCG2;CCDC184;CDK5R2
Partington syndrome ORPHA:94083	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	SOX2;KCNF1;CHRM1;SOX1;KCNJ11;FUT9;LRRC10B;FOXG1;LRRC3B;ASCL1;POU3F2;CDK5R2
Primary hypomagnesemia with secondary hypocalcemia ORPHA:30924	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	TAS2R40;CXCR1;C5AR2;P2RY14;PTAFR;CXCR2;FPR1;KCNJ15;FFAR2;TLR10;FPR2;CSNK1A1L
Sweet syndrome ORPHA:3243	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	ARL11;CXCR1;CXORF21;C5AR2;PTAFR;CXCR2;FPR1;FFAR2;FPR2;RNASE2;C16ORF54;GAPT
Syndromic microphthalmia type 5 ORPHA:178364	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	SOX2;CLDN6;SOX3;NHLH2;CCDC177;MAGEL2;OLIG3;LRRN1;NANOGP8;SOX21;VRTN;RPRM
TMEM199-CDG ORPHA:466703	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	BLOC1S4;DDX28;ZC3H10;MOCS3;PIGBOS1;TRAPPC2B;KTI12;TBCC;GEMIN7;ZNF830;RPP38;COMMD5
X-linked cleft palate and ankyloglossia ORPHA:324601	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	CLDN6;OR5H2;DCAF12L2;DCAF12L1;MAGEB3;NANOGP8;FAM46D;OR52A1;CABS1;VRTN;SUPT20HL2;OR5H6
X-linked lissencephaly with abnormal genitalia ORPHA:452	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	SOX2;KCNF1;CHRM1;SOX1;KCNJ11;FUT9;LRRC10B;FOXG1;LRRC3B;ASCL1;POU3F2;CDK5R2
X-linked spasticity-intellectual disability-epilepsy syndrome ORPHA:3175	12/101	0.4856217694484492	0.9999961656375117	0	0	1.0481540930979134	0.7571081256616612	SOX2;KCNF1;CHRM1;SOX1;KCNJ11;FUT9;LRRC10B;FOXG1;LRRC3B;ASCL1;POU3F2;CDK5R2
3-methylglutaconic aciduria type 3 ORPHA:67047	12/102	0.4998861171149413	0.9999961656375117	0	0	1.0364491475602586	0.7186478989515802	ZC3H10;EXOSC6;PGBD4;MOCS3;FKRP;FEM1A;CHST12;PCDHB1;BLOC1S3;TNFAIP8L1;ZNF843;TRIM56
Monosomy 5p ORPHA:281	12/102	0.4998861171149413	0.9999961656375117	0	0	1.0364491475602586	0.7186478989515802	TCEAL7;MAGEL2;TRIL;LRRTM1;TCEAL2;TMEM200C;PABPC5;FAM84A;PCDHB15;PCDHB4;LRRC4C;PCDHB10
NON RARE IN EUROPE: Asperger syndrome ORPHA:1162	12/102	0.4998861171149413	0.9999961656375117	0	0	1.0364491475602586	0.7186478989515802	CCDC177;MAGEL2;TCEAL5;SLITRK1;LRRTM1;TCEAL2;SLITRK3;NAP1L3;LRRN1;LRRC4C;LRRC3B;POU3F4
Neonatal severe primary hyperparathyroidism ORPHA:417	12/102	0.4998861171149413	0.9999961656375117	0	0	1.0364491475602586	0.7186478989515802	CLDN3;TMEM125;GJB1;SOWAHB;UCN3;TMEM30B;PRR15L;UBXN10;CLDN8;MFSD6L;GRHL2;FUT3
Duane retraction syndrome ORPHA:233	12/103	0.5140523237553363	0.9999961656375117	0	0	1.0250014535728822	0.6820669443078736	SOX3;TCEAL7;GJA1;MAGEL2;MAFB;TRIL;TMEM200C;PABPC5;PCDHB15;PCDHB5;PCDHB4;PCDHB3
Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome ORPHA:306661	12/103	0.5140523237553363	0.9999961656375117	0	0	1.0250014535728822	0.6820669443078736	CCR1;TMEM30B;MFSD6L;GPR160;PTAFR;RNASE6;KCNJ15;CCR5;TLR5;MPEG1;KCNJ2;TLR2
Localized junctional epidermolysis bullosa ORPHA:251393	11/100	0.5970948517081132	0.9999961656375117	0	0	0.960384468730966	0.4952503882866934	FOXQ1;CLDN4;FGFBP1;ARL14;GJB4;GJB3;GJB5;TACSTD2;SFN;GRHL2;SPRR1B
B-cell chronic lymphocytic leukemia ORPHA:67038	12/110	0.6092264529607301	0.9999961656375117	0	0	0.9514091350826045	0.47148529298502756	GPR174;ARL11;IGKC;CXORF21;GPR65;IGLC3;RHOH;TLR10;IGLC2;TNFAIP8L2;GPR18;C16ORF54
14q11.2 microduplication syndrome ORPHA:261229	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	SOX2;KCNJ4;ZCCHC12;SOX1;NEUROD6;SLITRK1;FOXG1;SLITRK3;SOX21;POU3F2;POU3F3
Adult Krabbe disease ORPHA:206448	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	MAP10;GPRIN3;ARMCX4;GPR34;LPAR6;GPR65;ZFP3;RNASE6;MPEG1;TSPYL5;TLR2
Alpha delta granule deficiency ORPHA:734	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	SPN;ARL11;GP9;LINC00694;CNR2;OR2W3;C5AR2;FFAR2;CCR4;C16ORF54;GAPT
Atypical dentin dysplasia due to SMOC2 deficiency ORPHA:314721	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	OR51E1;ISLR;TRIL;GJA4;APLNR;FAM84A;FIBIN;PCDHB4;CLEC14A;SOD3;ADRA2A
Autoimmune lymphoproliferative syndrome with recurrent viral infections ORPHA:275517	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	GPR174;TLR1;SAMD9;GPR65;RHOH;ANXA2R;TLR6;CCR4;S1PR4;GPR18;C16ORF54
Autosomal recessive spastic ataxia with leukoencephalopathy ORPHA:314603	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	ZBTB9;TMEM177;DDX28;ZBTB39;FEN1;PARS2;FIGNL1;MARS2;RRS1;KTI12;PIGW
Autosomal recessive spastic paraplegia type 75 ORPHA:459056	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	HEPN1;TCEAL6;CHRM1;TCEAL5;KCNJ10;NEUROD6;MAGEE2;HTR1A;PRR18;PABPC1L2B;PIRT
Ayme-Gripp syndrome ORPHA:1272	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	GPRIN3;BEX4;MAFB;GPR34;LPAR6;P2RY14;C3AR1;S1PR1;FPR3;CCR5;GIMAP7
Beckwith-Wiedemann syndrome due to CDKN1C mutation ORPHA:231120	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	C1QTNF4;CLDN5;MAGEL2;JUND;MAFB;CEBPD;NDN;GAS1;KCNA5;ZNF358;RHOB
Blau syndrome ORPHA:90340	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	CCR1;TLR1;HCAR3;CXORF21;PTAFR;RNASE6;FPR2;TNFAIP8L2;CCR5;MPEG1;TLR2
CLN13 disease ORPHA:352709	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	ISLR;TCEAL3;AMIGO1;TUSC1;FIBIN;LDOC1;CLEC14A;ZNF358;SOD3;FAM50B;TSPYL5
Combined immunodeficiency due to IL21R deficiency ORPHA:357329	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	GPR174;SPN;CNR2;CXORF21;GPR65;GPR183;RHOH;CCR4;S1PR4;GPR18;C16ORF54
Combined oxidative phosphorylation defect type 25 ORPHA:447954	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	ZBTB9;TMEM177;DDX28;ZBTB39;FEN1;PARS2;FIGNL1;MARS2;RRS1;KTI12;PIGW
Congenital hereditary facial paralysis-variable hearing loss syndrome ORPHA:306530	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	SOX2;CLDN6;SOX3;OLIG3;LRRC10B;MSGN1;SOX21;NEUROG1;VRTN;CCDC160;RPRM
Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome ORPHA:352333	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	SMIM10L2B;SMIM10L2A;TCEAL7;GJA1;MAGEE1;NAP1L3;NAP1L2;LDOC1;TRAM1L1;GPRASP2;CCDC184
FOXG1 syndrome ORPHA:561854	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	SOX2;KCNJ4;ZCCHC12;SOX1;NEUROD6;SLITRK1;FOXG1;SLITRK3;SOX21;POU3F2;POU3F3
FOXG1 syndrome due to 14q12 microdeletion ORPHA:261144	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	SOX2;KCNJ4;ZCCHC12;SOX1;NEUROD6;SLITRK1;FOXG1;SLITRK3;SOX21;POU3F2;POU3F3
Hyperinsulinism due to glucokinase deficiency ORPHA:79299	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	SMIM10L2B;SMIM10L2A;TCEAL7;MAGEL2;BEX1;TCEAL5;LRRTM1;TCEAL2;NAP1L3;FBLL1;CCDC184
Ichthyosis-hypotrichosis syndrome ORPHA:91132	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	CEBPA;CLDN4;CLDN3;TMEM125;TMEM30B;PRR15L;P2RY2;CLDN23;TACSTD2;ASCL2;GRHL2
Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome ORPHA:436144	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	C1QTNF4;CLDN5;MAGEL2;JUND;MAFB;CEBPD;NDN;GAS1;KCNA5;ZNF358;RHOB
Leri-Weill dyschondrosteosis  ORPHA:240	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	KLLN;ADAM29;MAS1;CYSLTR1;PGBD4;PCDHB1;LPAR4;OR7D2;PPIAL4G;GDPGP1;PRR23C
Langer mesomelic dysplasia ORPHA:2632	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	KLLN;ADAM29;MAS1;CYSLTR1;PGBD4;PCDHB1;LPAR4;OR7D2;PPIAL4G;GDPGP1;PRR23C
Late-infantile/juvenile Krabbe disease ORPHA:206443	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	MAP10;GPRIN3;ARMCX4;GPR34;LPAR6;GPR65;ZFP3;RNASE6;MPEG1;TSPYL5;TLR2
Lissencephaly type 1 due to doublecortin gene mutation ORPHA:2148	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	CCDC177;AMER3;SOX1;TCEAL5;FUT9;SLITRK1;LRRTM1;SOX11;LRRC3B;ASCL1;POU3F4
MGAT2-CDG ORPHA:79329	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	DDX28;C1GALT1C1;NXT1;SMIM15;CDCA4;HNRNPF;KTI12;DOLK;HPS6;MGAT2;ARF6
Menstrual cycle-dependent periodic fever ORPHA:498251	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	TCEAL6;TCEAL5;HTR1E;NEUROD6;SLITRK1;LRRTM1;KCNA1;TCEAL2;HTR1A;PABPC1L2B;LRRC3B
Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency ORPHA:314637	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	NPAP1;ZNF891;CYSLTR1;PGBD4;PCDHB1;C12ORF60;OR7D2;PPIAL4G;GDPGP1;TIGD1;POU5F2
Multifocal pattern dystrophy simulating fundus flavimaculatus ORPHA:99003	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	ARMCX4;TCEAL7;ISLR;PLN;FLRT2;B3GALT2;FIBIN;CLEC14A;CD248;GPRASP1;NKAPL
NLRC4-related familial cold autoinflammatory syndrome ORPHA:576349	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	CCR1;CXCR1;PTAFR;CXCR2;RNASE6;FPR1;FPR2;TNFAIP8L2;RNASE2;MPEG1;GAPT
NLRP12-associated hereditary periodic fever syndrome ORPHA:247868	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	ARL11;CNR2;CXCR1;C5AR2;CXCR2;FPR1;FFAR2;FPR2;RNASE2;C16ORF54;GAPT
Naxos disease ORPHA:34217	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	CLDN4;CLDN3;TMEM125;SOWAHB;GJB3;CDC42EP4;TACSTD2;SP6;PRR15;SFN;NRARP
PRUNE1-related neurological syndrome ORPHA:544469	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	LSM10;ZNF672;PIGC;OST4;HMGN4;NCBP2L;FASTKD5;TAF7;METTL18;THAP11;TMEM60
Periodic fever-infantile enterocolitis-autoinflammatory syndrome ORPHA:436166	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	CCR1;CXCR1;PTAFR;CXCR2;RNASE6;FPR1;FPR2;TNFAIP8L2;RNASE2;MPEG1;GAPT
REN-related autosomal dominant tubulointerstitial kidney disease ORPHA:217330	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	TMEM184A;CLDN4;CLDN3;TMEM125;SOWAHB;PRR15L;GJB3;DNAJB3;TACSTD2;SP6;GRHL2
Recurrent Neisseria infections due to factor D deficiency ORPHA:169467	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	HCAR2;CCR1;CEBPA;CEBPB;TIFAB;CEBPD;RNASE6;FPR1;FPR2;RNASE2;MPEG1
SHOX-related short stature ORPHA:314795	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	KLLN;ADAM29;MAS1;CYSLTR1;PGBD4;PCDHB1;LPAR4;OR7D2;PPIAL4G;GDPGP1;PRR23C
Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome ORPHA:397623	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	SOX3;FOXD3;RAB6C;FOXD1;FZD7;FZD9;TWIST1;FZD8;PCDHB3;ADRA2C;PCDHB8
Spinocerebellar ataxia type 34 ORPHA:1955	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	SMIM10L2B;SMIM10L2A;TCEAL7;GJA1;MAGEE1;NAP1L3;NAP1L2;LDOC1;TRAM1L1;GPRASP2;CCDC184
Sterile multifocal osteomyelitis with periostitis and pustulosis ORPHA:210115	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	HCAR2;CCR1;HCAR3;PTAFR;RNASE6;FPR1;FPR2;GPR84;CCR5;MPEG1;TLR2
Susceptibility to localized juvenile periodontitis ORPHA:447740	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	CCR1;CXCR1;PTAFR;CXCR2;FPR1;FFAR2;FPR2;RNASE2;MPEG1;GAPT;TLR2
Vibratory urticaria ORPHA:493342	11/101	0.6107193316091695	0.9999961656375117	0	0	0.9496596640712992	0.4682940694967486	SPN;ARL11;CXORF21;C5AR2;PTAFR;FPR1;FFAR2;FPR2;MPEG1;C16ORF54;GAPT
Intermittent hydrarthrosis ORPHA:329967	11/102	0.6241167449879328	0.9999961656375117	0	0	0.9391705694041524	0.4427417582009181	CCR1;HCAR3;CXCR1;C5AR2;PTAFR;CXCR2;FPR1;FFAR2;FPR2;RNASE2;TLR2
Megalencephalic leukoencephalopathy with subcortical cysts ORPHA:2478	11/102	0.6241167449879328	0.9999961656375117	0	0	0.9391705694041524	0.4427417582009181	P2RY12;NEUROD2;HEPN1;TCEAL6;KCNJ10;GPR12;SLITRK2;OR2L13;NEUROD6;OLIG1;OLIG2
Metaphyseal anadysplasia ORPHA:1040	11/102	0.6241167449879328	0.9999961656375117	0	0	0.9391705694041524	0.4427417582009181	HCAR2;CCR1;HCAR3;THBD;HSPA6;PTAFR;C3AR1;TACSTD2;FPR3;GPR84;TLR2
Partial hydatidiform mole ORPHA:254693	11/102	0.6241167449879328	0.9999961656375117	0	0	0.9391705694041524	0.4427417582009181	CLDN6;TRIM60;OLIG3;GJA10;MRGPRX1;NANOGP8;OR52A1;HDGFL1;PRR23B;VRTN;SUPT20HL2
Proximal symphalangism ORPHA:3250	11/102	0.6241167449879328	0.9999961656375117	0	0	0.9391705694041524	0.4427417582009181	FOXC2;FZD2;TMEM158;DSEL;NOG;CDC42EP3;AMIGO2;TWIST2;GPR1;CCIN;FOXL1
Erythrokeratodermia variabilis ORPHA:317	11/103	0.6372766129650285	0.9999961656375117	0	0	0.9289094985341176	0.4185215441423	FOXQ1;GJA1;FGFBP1;GJB4;GJB3;TPBG;GJB5;RNASE7;CALML3;SFN;SPRR1B
Haddad syndrome ORPHA:99803	11/103	0.6372766129650285	0.9999961656375117	0	0	0.9289094985341176	0.4185215441423	CCDC177;TCEAL5;HTR1E;LRRTM1;INSM2;INSM1;FBLL1;ASCL1;TMEM229A;CDK5R2;SLC18A3
Idiopathic juvenile osteoporosis ORPHA:85193	11/103	0.6372766129650285	0.9999961656375117	0	0	0.9289094985341176	0.4185215441423	FGFBP1;FOXC1;GJB3;TPBG;GJB5;SP6;IER5L;KCTD11;SFN;PHLDA2;TMEM121
Hypoplastic amelogenesis imperfecta ORPHA:100031	11/106	0.6752407813145529	0.9999961656375117	0	0	0.8994224211918072	0.35319053771574466	TMEM184A;GJB2;FGFBP1;ARL14;GJB4;SAMD9;GJB3;P2RY2;TACSTD2;GCNT3;SFN
Intermediate generalized junctional epidermolysis bullosa ORPHA:79402	10/100	0.7165341757220984	0.9999961656375117	0	0	0.8629466470876163	0.28764543175940793	FOXQ1;CLDN4;GJB2;FGFBP1;ARL14;GJB4;GJB3;GJB5;TACSTD2;SFN
3-methylglutaconic aciduria type 8 ORPHA:505208	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	LSM10;DDX28;SF3B5;RNF113A;POP7;NXT1;ZNF581;KTI12;RPP25L;COMMD5
ALys amyloidosis ORPHA:93561	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CCR1;PTAFR;RNASE6;FPR1;FPR2;RNASE2;CCR5;MPEG1;GAPT;TLR2
Acromesomelic dysplasia, Hunter-Thompson type ORPHA:968	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	FOXC2;C8ORF48;LRRN4CL;TWIST2;BDKRB1;GPR1;CCIN;DIRC1;FOXL1;VASN
Adult hypophosphatasia ORPHA:247676	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	GPR27;CXCR1;C10ORF105;CXCR2;FPR1;LRRC4;OXER1;LRRN1;FPR2;CSNK1A1L
Angel-shaped phalango-epiphyseal dysplasia ORPHA:63442	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	FOXC2;C8ORF48;LRRN4CL;TWIST2;BDKRB1;GPR1;CCIN;DIRC1;FOXL1;VASN
Apparent mineralocorticoid excess ORPHA:320	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	TMEM184A;CLDN4;CLDN3;TMEM125;SOWAHB;PRR15L;PRR15;NRARP;GRHL2;FUT3
Aquagenic palmoplantar keratoderma ORPHA:498359	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	TMEM125;GJB1;UCN3;PRR15L;STX19;FAM84A;FUT2;RNF186;GRHL2;FUT3
Autosomal dominant Charcot-Marie-Tooth disease type 2E ORPHA:99939	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	SMIM10L2A;ZCCHC12;CCDC177;SLITRK1;TMEM200C;SLITRK3;NAP1L3;NAP1L2;FBLL1;CCDC184
Autosomal dominant deafness-onychodystrophy syndrome ORPHA:79499	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CCR1;C3AR1;RNASE6;FPR1;OLIG1;FPR2;GPR84;TNFAIP8L2;RNASE2;TLR2
Autosomal dominant keratitis ORPHA:2334	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	ZCCHC12;CCDC177;SOX1;SLITRK1;FOXG1;SLITRK5;PNMA2;POU3F2;POU3F3;CDK5R2
Autosomal dominant omodysplasia ORPHA:93328	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	FZD2;FOXD1;MARVELD1;FZD7;H2AFX;IER5L;ZBTB12;SOX12;CHST14;FJX1
Autosomal recessive spastic paraplegia type 35 ORPHA:171629	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CLDN4;CLDN3;TMEM125;SOWAHB;PRR15L;GJB3;PRR15;SFN;SOWAHA;GRHL2
Beta-thalassemia intermedia ORPHA:231222	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CXCR1;IGKC;P2RY14;RNASE6;FPR1;FPR2;IGLC2;GIMAP7;MPEG1;GAPT
Beta-thalassemia major ORPHA:231214	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CXCR1;IGKC;P2RY14;RNASE6;FPR1;FPR2;IGLC2;GIMAP7;MPEG1;GAPT
Bleeding disorder due to P2Y12 defect ORPHA:36355	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	P2RY12;GP9;GPR34;P2RY14;C2ORF88;RNASE6;FPR1;GIMAP7;MPEG1;GAPT
CCDC115-CDG ORPHA:468684	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	LSM10;OST4;RNF113A;C6ORF226;B3GALT4;RHOG;TBCC;COX14;BORCS6;COMMD5
CINCA syndrome ORPHA:1451	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CCR1;CXORF21;GPR65;C3AR1;RNASE6;FPR1;FPR2;TNFAIP8L2;RNASE2;GAPT
Cataract-glaucoma syndrome ORPHA:162	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	KBTBD13;FOXC2;RGS9BP;KCNJ12;MYADML2;FZD9;HSPB3;MAFA;KLF14;LRRC30
Charcot-Marie-Tooth disease type 1F ORPHA:101085	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	SMIM10L2A;ZCCHC12;CCDC177;SLITRK1;TMEM200C;SLITRK3;NAP1L3;NAP1L2;FBLL1;CCDC184
Charcot-Marie-Tooth disease type 2B5 ORPHA:228374	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	SMIM10L2A;ZCCHC12;CCDC177;SLITRK1;TMEM200C;SLITRK3;NAP1L3;NAP1L2;FBLL1;CCDC184
Childhood encephalopathy due to thiamine pyrophosphokinase deficiency ORPHA:293955	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	SPN;TLR1;ARL11;CXORF21;GPR65;GPR183;TNFAIP8L2;GPR18;C16ORF54;GAPT
Childhood-onset hypophosphatasia ORPHA:247667	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	GPR27;CXCR1;C10ORF105;CXCR2;FPR1;LRRC4;OXER1;LRRN1;FPR2;CSNK1A1L
Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome ORPHA:435930	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	SOX3;MAGEL2;NEUROD4;SLN;TMEM215;MAB21L1;SOX11;INSM2;OR10R2;BHLHE23
Cone dystrophy with supernormal rod response ORPHA:209932	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	TAS2R50;ZNF594;CLDN20;TAS2R30;TAS2R31;RBM12B;TAS2R13;GPR75;TAS2R3;TAS2R19
Congenital hereditary endothelial dystrophy type I ORPHA:98975	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CLDN4;CLDN3;TMEM125;SOWAHB;PRR15L;GJB3;PRR15;SFN;GRHL2;FUT3
Dihydropteridine reductase deficiency ORPHA:226	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	ENHO;SMIM10L2B;HEPN1;TCEAL6;TCEAL5;RNF208;PRR18;GPR62;FAM43B;CDK5R2
Dominant beta-thalassemia ORPHA:231226	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CXCR1;IGKC;P2RY14;RNASE6;FPR1;FPR2;IGLC2;GIMAP7;MPEG1;GAPT
Early-onset calcifying leukoencephalopathy-skeletal dysplasia ORPHA:556985	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CCR1;TIFAB;GPR34;C3AR1;RNASE6;FPR1;FPR3;CCR5;MPEG1;TLR2
Early-onset myopathy-areflexia-respiratory distress-dysphagia syndrome ORPHA:439212	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	SOX2;TCEAL7;MAGEL2;TCEAL5;TRIL;TMEM200C;SLITRK3;PCDHB15;LRRC4C;LRRC3B
Familial cold urticaria ORPHA:47045	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CCR1;CXORF21;GPR65;C3AR1;RNASE6;FPR1;FPR2;TNFAIP8L2;RNASE2;GAPT
Familial mitral valve prolapse ORPHA:741	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	ARMCX4;TCEAL7;ARMCX1;MAGEL2;ARMCX2;PABPC5;NAP1L3;NDN;CD248;GPRASP1
Fatty acid hydroxylase-associated neurodegeneration ORPHA:329308	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CLDN4;CLDN3;TMEM125;SOWAHB;PRR15L;GJB3;PRR15;SFN;SOWAHA;GRHL2
Feingold syndrome type 1 ORPHA:391641	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	SOX2;CLDN6;SOX3;MAGEL2;TCEAL5;TRIL;LRRTM1;TMEM200C;SOX11;LRRN1
Foveal hypoplasia-presenile cataract syndrome ORPHA:2253	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	ZCCHC12;CCDC177;SOX1;SLITRK1;FOXG1;SLITRK5;PNMA2;POU3F2;POU3F3;CDK5R2
Fructose-1,6-bisphosphatase deficiency ORPHA:348	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CCR1;CEBPA;PTAFR;RNASE6;FPR3;CCR5;TLR5;ASCL2;MPEG1;TLR2
GM2 gangliosidosis, AB variant ORPHA:309246	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	HCAR2;CCR1;HCAR3;TIFAB;CLDN23;PTAFR;RNASE6;FPR3;MGAT1;GPR84
Ghosal hematodiaphyseal dysplasia ORPHA:1802	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CCR1;CXORF21;GPR65;C3AR1;RNASE6;FPR1;FPR2;TNFAIP8L2;MPEG1;GAPT
Hemoglobin C disease ORPHA:2132	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CXCR1;IGKC;P2RY14;RNASE6;FPR1;FPR2;IGLC2;GIMAP7;MPEG1;GAPT
Hemoglobin C-beta-thalassemia syndrome ORPHA:231242	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CXCR1;IGKC;P2RY14;RNASE6;FPR1;FPR2;IGLC2;GIMAP7;MPEG1;GAPT
Hemoglobin D disease ORPHA:90039	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CXCR1;IGKC;P2RY14;RNASE6;FPR1;FPR2;IGLC2;GIMAP7;MPEG1;GAPT
Hemoglobin E disease ORPHA:2133	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CXCR1;IGKC;P2RY14;RNASE6;FPR1;FPR2;IGLC2;GIMAP7;MPEG1;GAPT
Hemoglobin E-beta-thalassemia syndrome ORPHA:231249	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CXCR1;IGKC;P2RY14;RNASE6;FPR1;FPR2;IGLC2;GIMAP7;MPEG1;GAPT
Hereditary sensory and autonomic neuropathy type 8 ORPHA:478664	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	FOXD4;ATOH7;VGF;RGS9BP;GPRIN1;H2AFX;C19ORF73;SOX12;CTXN1;TEX19
Hyperammonemia due to N-acetylglutamate synthase deficiency ORPHA:927	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	ZNHIT2;FKBPL;PARS2;CLDN23;DOLK;HPS6;ANG;UFSP1;CCDC71;ADAT3
Infantile hypophosphatasia ORPHA:247651	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	GPR27;CXCR1;C10ORF105;CXCR2;FPR1;LRRC4;OXER1;LRRN1;FPR2;CSNK1A1L
Isolated optic nerve hypoplasia/aplasia ORPHA:137902	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	ZCCHC12;CCDC177;SOX1;SLITRK1;FOXG1;SLITRK5;PNMA2;POU3F2;POU3F3;CDK5R2
Isolated oxycephaly ORPHA:63440	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	TCEAL7;SOX1;SLITRK1;TRIL;MAB21L1;SLITRK3;LRRC3B;ASCL1;POU3F2;POU3F3
Kaposiform hemangioendothelioma ORPHA:2122	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	ISLR;TMEM125;TRIL;GJA4;APLNR;FAM84A;PCDHB4;CLEC14A;SOD3;ADRA2A
Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency ORPHA:319558	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	ADAM29;MAS1;CNR2;PCDHB1;CHRM5;C9ORF66;OTUD6A;OR7D2;CCR4;PPIAL4G
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency ORPHA:319552	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	SPN;CNR2;CXORF21;GPR65;RHOH;TNFAIP8L2;CCR4;S1PR4;GPR18;C16ORF54
Metaphyseal chondrodysplasia, Spahr type ORPHA:2501	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	SPRR3;CLDN4;FGFBP1;GJB4;ACTBL2;GJB3;TACSTD2;SLITRK6;SFN;SPRR1B
Morning glory disc anomaly ORPHA:35737	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	ZCCHC12;CCDC177;SOX1;SLITRK1;FOXG1;SLITRK5;PNMA2;POU3F2;POU3F3;CDK5R2
Muckle-Wells syndrome ORPHA:575	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CCR1;CXORF21;GPR65;C3AR1;RNASE6;FPR1;FPR2;TNFAIP8L2;RNASE2;GAPT
Multiple mitochondrial dysfunctions syndrome type 4 ORPHA:457406	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	BLOC1S4;IMP3;PIGBOS1;C14ORF119;COX14;GEMIN7;MRPL57;RPP38;RPP25L;TMEM60
Neonatal acute respiratory distress due to SP-B deficiency ORPHA:217563	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	ADAM29;CYSLTR1;CNR2;PCDHB1;C5AR2;C9ORF66;KCNJ15;OR7D2;PPIAL4G;GDPGP1
Non-epidermolytic palmoplantar keratoderma ORPHA:2337	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	SPRR3;TMEM125;GJB4;RASSF10;GJB3;LRRC10B;GJB5;TACSTD2;SPRR1B;FUT3
Obesity due to CEP19 deficiency ORPHA:397615	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	TIGD3;ZC3H10;FRAT1;LINC00694;CNR2;PIGBOS1;CXCR2;ANXA2R;FFAR2;EID2B
Oculocutaneous albinism type 3 ORPHA:79433	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	LCE1A;LCE2B;LCE2C;LCE2A;KCNS3;LCE6A;C1ORF68;PCDHB4;TRAM1L1;LCE2D
Odontohypophosphatasia ORPHA:247685	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	GPR27;CXCR1;C10ORF105;CXCR2;FPR1;LRRC4;OXER1;LRRN1;FPR2;CSNK1A1L
Pancreatic insufficiency-anemia-hyperostosis syndrome ORPHA:199337	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	OR51E1;CLDN5;ISLR;FOXS1;GJA5;GJA4;APLNR;CLEC14A;RNASE1;SOD3
Perinatal lethal hypophosphatasia ORPHA:247623	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	GPR27;CXCR1;C10ORF105;CXCR2;FPR1;LRRC4;OXER1;LRRN1;FPR2;CSNK1A1L
Prenatal benign hypophosphatasia ORPHA:247638	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	GPR27;CXCR1;C10ORF105;CXCR2;FPR1;LRRC4;OXER1;LRRN1;FPR2;CSNK1A1L
Prune belly syndrome ORPHA:2970	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	LINGO2;CHRM3;CHRM1;TCEAL5;FUT9;SLITRK1;LRRTM1;TCEAL2;TMEM200C;SLITRK3
SURF1-related Charcot-Marie-Tooth disease type 4 ORPHA:391351	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	LSM10;SF3B5;DPM3;C6ORF226;TMEM203;SCO2;COX14;RPP25L;TMEM187;COMMD5
Severe myopia-generalized joint laxity-short stature syndrome ORPHA:527450	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	FAM220A;PURB;ZBTB39;ZBTB6;EXOC8;ATXN1L;ZBTB33;ZBTB5;ADO;ZBED4
Sickle cell anemia ORPHA:232	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CXCR1;IGKC;P2RY14;RNASE6;FPR1;FPR2;IGLC2;GIMAP7;MPEG1;GAPT
Sickle cell-beta-thalassemia disease syndrome ORPHA:251359	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CXCR1;IGKC;P2RY14;RNASE6;FPR1;FPR2;IGLC2;GIMAP7;MPEG1;GAPT
Sickle cell-hemoglobin C disease syndrome ORPHA:251365	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CXCR1;IGKC;P2RY14;RNASE6;FPR1;FPR2;IGLC2;GIMAP7;MPEG1;GAPT
Sickle cell-hemoglobin D disease syndrome ORPHA:251370	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CXCR1;IGKC;P2RY14;RNASE6;FPR1;FPR2;IGLC2;GIMAP7;MPEG1;GAPT
Sickle cell-hemoglobin E disease syndrome ORPHA:251375	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CXCR1;IGKC;P2RY14;RNASE6;FPR1;FPR2;IGLC2;GIMAP7;MPEG1;GAPT
Snowflake vitreoretinal degeneration ORPHA:91496	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	TAS2R50;TAS2R30;TAS2R43;GPR22;TAS2R13;TAS2R46;GPR52;HIST1H1E;TIGD1;POU5F2
Spinocerebellar ataxia type 23 ORPHA:101108	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CCDC177;TCEAL6;TCEAL5;SLITRK1;LRRTM1;TCEAL2;HTR1A;PABPC1L2B;LRRC3B;POU3F4
Split hand-split foot-deafness syndrome ORPHA:71271	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	GJA1;FOXC1;FOXG1;FAM84A;TWIST1;GAS1;ADRA2C;TRAM1L1;SOX21;PCDHB10
Spondyloepimetaphyseal dysplasia, Missouri type ORPHA:93356	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	SPRR3;CLDN4;FGFBP1;GJB4;ACTBL2;GJB3;TACSTD2;SLITRK6;SFN;SPRR1B
Subcutaneous panniculitis-like T-cell lymphoma ORPHA:86884	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CCR1;CXORF21;GPR65;GPR183;C3AR1;RNASE6;TNFAIP8L2;CCR5;GIMAP7;MPEG1
Thrombomodulin-related bleeding disorder ORPHA:436169	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	HCAR2;THBD;CEBPB;MAFB;CEBPD;P2RY2;FPR1;G0S2;KCTD12;TLR2
Timothy syndrome ORPHA:65283	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	CHRM2;ARMCX4;TCEAL7;ISLR;FIBIN;NAP1L3;KCNA4;CD248;GPRASP1;CDR1
Tubulinopathy-associated dysgyria ORPHA:467166	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	ZCCHC12;TCEAL7;MAGEL2;PNMA2;FBLL1;CTXN1;SCG2;FJX1;CCDC184;PCDHB10
Tufted angioma ORPHA:1063	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	ISLR;TMEM125;TRIL;GJA4;APLNR;FAM84A;PCDHB4;CLEC14A;SOD3;ADRA2A
WHIM syndrome ORPHA:51636	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	GPR174;CXORF21;GPR65;GPR183;RNASE6;KCNA3;RHOH;TNFAIP8L2;GIMAP7;S1PR4
Xq21 microdeletion syndrome ORPHA:1435	10/101	0.7281621701024986	0.9999961656375117	0	0	0.8534153071598005	0.27073021328809294	SOX2;SOX3;CCDC177;SOX1;TCEAL5;FUT9;SLITRK1;LRRC3B;POU3F3;POU3F4
Adenosine monophosphate deaminase deficiency ORPHA:45	10/102	0.7394714448100219	0.9999961656375117	0	0	0.8440911702738939	0.2547632693038496	CCR1;TLR1;SAMD9L;IGKC;PTAFR;RNASE6;IGLC2;CCR5;MPEG1;LRRC30
Familial isolated hypoparathyroidism due to impaired PTH secretion ORPHA:189466	10/102	0.7394714448100219	0.9999961656375117	0	0	0.8440911702738939	0.2547632693038496	CNR2;C5AR2;CXCR2;FFAR2;TLR10;OR52K1;CCR4;PPIAL4G;GPR18;C16ORF54
Hemochromatosis type 2 ORPHA:79230	10/102	0.7394714448100219	0.9999961656375117	0	0	0.8440911702738939	0.2547632693038496	MAS1;CYSLTR1;PGBD4;PCDHB1;C5AR2;GPR82;OR7D2;CYP8B1;GDPGP1;CPN2
Isolated growth hormone deficiency type IB ORPHA:231671	10/102	0.7394714448100219	0.9999961656375117	0	0	0.8440911702738939	0.2547632693038496	MOS;SOX3;OR1S2;OR10H3;OR10H4;SOX14;NANOGP8;OR52A1;OR13A1;VRTN
Nasu-Hakola disease ORPHA:2770	10/102	0.7394714448100219	0.9999961656375117	0	0	0.8440911702738939	0.2547632693038496	CCR1;TIFAB;GPR34;PTAFR;C3AR1;RNASE6;FPR3;CCR5;MPEG1;TLR2
Palmoplantar keratoderma-hereditary motor and sensory neuropathy syndrome ORPHA:538574	10/102	0.7394714448100219	0.9999961656375117	0	0	0.8440911702738939	0.2547632693038496	HCAR3;FGFBP2;LINC00694;CXCR1;CXCR2;RNASE6;FPR2;TNFAIP8L2;S1PR4;ASPRV1
Spinocerebellar ataxia type 37 ORPHA:363710	10/102	0.7394714448100219	0.9999961656375117	0	0	0.8440911702738939	0.2547632693038496	TCEAL7;MAGEL2;TCEAL5;LRRTM1;TCEAL2;TMEM200C;SLITRK3;NAP1L3;LRRC3B;TMEM229A
Spondyloepimetaphyseal dysplasia with joint laxity ORPHA:93359	10/102	0.7394714448100219	0.9999961656375117	0	0	0.8440911702738939	0.2547632693038496	RBM15B;FZD7;TRNP1;FZD8;B3GALT6;ADO;GPRASP2;FJX1;CENPB;PHLDA3
X-linked hypohidrotic ectodermal dysplasia ORPHA:181	10/102	0.7394714448100219	0.9999961656375117	0	0	0.8440911702738939	0.2547632693038496	SMIM10L2B;C8ORF48;GJA1;PCDHB2;PABPC5;FZD8;PCDHB5;ADRA2C;GPRASP2;PHLDA3
Acquired schizencephaly ORPHA:485275	10/103	0.7504601255233826	0.9999961656375117	0	0	0.8349675524608025	0.23969309981540568	NEUROD1;KLLN;NEUROD2;SLITRK2;GPR85;SLITRK5;SOX11;LPAR4;LRRC4C;CHST5
Pediatric systemic lupus erythematosus ORPHA:93552	10/103	0.7504601255233826	0.9999961656375117	0	0	0.8349675524608025	0.23969309981540568	CCR1;TLR1;SOCS3;CEBPB;C3AR1;RHOG;MGAT1;GPR84;TICAM1;CCR5
Follicular lymphoma ORPHA:545	10/104	0.7611272090998724	0.9999961656375117	0	0	0.8260380541756491	0.2254710309245431	CCR1;TLR1;CXORF21;GPR65;GPR183;RNASE6;TNFAIP8L2;CCR5;GIMAP7;MPEG1
NON RARE IN EUROPE: Dementia with Lewy body ORPHA:1648	10/104	0.7611272090998724	0.9999961656375117	0	0	0.8260380541756491	0.2254710309245431	ENHO;SMIM10L2B;KCNF1;TCEAL6;TCEAL5;TCEAL2;FAM43B;FBLL1;TPBGL;PNMA6A
Diffuse cutaneous systemic sclerosis ORPHA:220393	10/105	0.7714725162064245	0.9999961656375117	0	0	0.8172965453280779	0.21205104720220402	CCR1;TLR1;IGKC;CXORF21;PTAFR;RNASE6;IGLC3;IGLC2;CCR5;MPEG1
Multiple endocrine neoplasia type 1 ORPHA:652	10/105	0.7714725162064245	0.9999961656375117	0	0	0.8172965453280779	0.21205104720220402	GJD3;IRF2BP1;KCTD11;HPS6;ZBTB22;ABHD16B;TICAM1;CENPB;ADAT3;TMEM187
Primary biliary cholangitis ORPHA:186	10/108	0.8005873445316579	0.9999961656375117	0	0	0.7921424076238425	0.1761801077308656	SPN;ARL11;CNR2;CXORF21;GPR65;PTAFR;RHOH;TLR10;S1PR4;C16ORF54
Omenn syndrome ORPHA:39041	10/109	0.8096585610514728	0.9999961656375117	0	0	0.7840964713211409	0.16555620661460407	GPR174;SPN;CXORF21;GPR65;RHOH;RAG2;S1PR4;GPR18;RAG1;C16ORF54
Delta-beta-thalassemia ORPHA:231237	9/100	0.8184263846480624	0.9999961656375117	0	0	0.7677355669429645	0.15383257709444162	GP9;LINC00694;CXCR1;OR2W3;CXCR2;FPR1;FPR2;RNASE2;GAPT
Hemoglobin M disease ORPHA:330041	9/100	0.8184263846480624	0.9999961656375117	0	0	0.7677355669429645	0.15383257709444162	GP9;CXCR1;IGKC;CXCR2;FPR1;FPR2;IGLC2;GIMAP7;MPEG1
Acro-renal-ocular syndrome ORPHA:959	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CLDN6;SOX3;PCDHB2;SKIDA1;ZFP42;SOX11;NANOGP8;VRTN;RPRM
Acute mast cell leukemia ORPHA:566393	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	BEX4;ARMCX4;TCEAL7;P2RY1;APLNR;LRRC4;NAP1L3;NDN;GPRASP1
Alpha-1-antitrypsin deficiency ORPHA:60	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	HCAR2;CCR1;HCAR3;PTAFR;RNASE6;FPR1;FPR2;MPEG1;TLR2
Anterior segment developmental anomaly ORPHA:88632	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	FOXE3;FOXD2;FZD2;FOXD1;H2AFX;SP6;SOX12;ADRA2C;CTXN1
Aplasia of lacrimal and salivary glands ORPHA:86815	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	TMEM100;TCEAL7;GJA1;ISLR;MAGEL2;TRIL;PABPC5;APLNR;FIBIN
Atypical chronic myeloid leukemia ORPHA:98824	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CXCR1;CXCR2;RNASE6;FPR1;FFAR2;FPR2;RNASE2;MPEG1;GAPT
Autosomal recessive cerebral atrophy ORPHA:363969	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	RNF223;CLDN4;GJB4;PRR15L;STX19;GCNT3;FUT2;GRHL2;FUT3
Autosomal recessive severe congenital neutropenia due to CSF3R deficiency ORPHA:420702	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CXCR1;CXCR2;RNASE6;FPR1;FFAR2;FPR2;RNASE2;MPEG1;GAPT
Autosomal recessive severe congenital neutropenia due to JAGN1 deficiency ORPHA:423384	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	COA4;DDX28;SF3B5;POP7;NXT1;IMP3;KTI12;GEMIN7;RPP25L
Autosomal recessive spastic paraplegia type 74 ORPHA:468661	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	ZNF891;EXOSC6;PGBD4;FEM1A;CHST12;PCDHB1;C12ORF60;OR7D2;GDPGP1
Biliary atresia with splenic malformation syndrome ORPHA:244283	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	MAGEL2;AMER3;TCEAL5;LRRTM1;TCEAL2;GPR148;KCNA5;INSM1;CDK5R2
Bleeding diathesis due to thromboxane synthesis deficiency ORPHA:220443	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	GP9;CNR2;CHST12;C5AR2;BLOC1S3;TRAPPC5;RHOG;ANXA2R;GP5
Blomstrand lethal chondrodysplasia ORPHA:50945	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	SMIM10L2B;TMEM100;TCEAL7;GJA1;ISLR;TRIL;APLNR;FIBIN;SOD3
Bullous diffuse cutaneous mastocytosis ORPHA:280785	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	BEX4;ARMCX4;TCEAL7;P2RY1;APLNR;LRRC4;NAP1L3;NDN;GPRASP1
Charcot-Marie-Tooth disease type 1C ORPHA:101083	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	HCAR2;CCR1;HCAR3;CXCR1;PTAFR;FPR1;RHOG;FPR2;TLR2
Charcot-Marie-Tooth disease type 1D ORPHA:101084	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CCR1;SOCS3;GPR65;GPR183;C3AR1;FPR3;GPR84;CCR5;JUNB
Charcot-Marie-Tooth disease type 2T ORPHA:495274	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CCDC71L;TAS2R40;CXCR1;PPP1R3B;CXCR2;FPR1;KCNJ15;CD248;CSNK1A1L
Charcot-Marie-Tooth disease type 4E ORPHA:99951	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CCR1;SOCS3;GPR65;GPR183;C3AR1;FPR3;GPR84;CCR5;JUNB
Chondrodysplasia-disorder of sex development syndrome ORPHA:1422	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	FZD1;ARL4D;C8ORF48;CCDC89;TTC30B;FLRT3;TPBG;TTC30A;TRIM32
Chronic enteropathy associated with SLCO2A1 gene ORPHA:468641	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	GJA1;ISLR;GJA5;GJA4;APLNR;FAM84A;CLEC14A;SOD3;C3ORF36
Chronic mast cell leukemia ORPHA:566396	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	BEX4;ARMCX4;TCEAL7;P2RY1;APLNR;LRRC4;NAP1L3;NDN;GPRASP1
Chronic neutrophilic leukemia ORPHA:86829	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CXCR1;CXCR2;RNASE6;FPR1;FFAR2;FPR2;RNASE2;MPEG1;GAPT
Combined immunodeficiency due to STK4 deficiency ORPHA:314689	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	GPR174;SPN;CNR2;CXORF21;GPR65;RHOH;CCR4;GPR18;C16ORF54
Congenital brain dysgenesis due to glutamine synthetase deficiency ORPHA:71278	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	BEX4;MAFB;UBXN10;RNASE6;LRRC4;FPR3;TLR5;RNASE1;TLR2
Congenital dyserythropoietic anemia type IV ORPHA:293825	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	GP9;FRAT1;FRAT2;LINC00694;CXCR1;OR2W3;CXCR2;RNASE3;RNASE2
Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization ORPHA:69063	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CCDC71L;TAS2R40;CXCR1;PPP1R3B;CXCR2;FPR1;KCNJ15;CD248;CSNK1A1L
Congenital primary aphakia ORPHA:83461	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	FOXE3;FOXD2;FZD2;FOXD1;H2AFX;SP6;SOX12;ADRA2C;CTXN1
Congenital tufting enteropathy ORPHA:92050	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CLDN4;CLDN3;TMEM125;SOWAHB;PRR15L;PRR15;SFN;GRHL2;FUT3
Congenitally uncorrected transposition of the great arteries with cardiac malformation ORPHA:216729	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	MAGEL2;AMER3;TCEAL5;LRRTM1;TCEAL2;GPR148;KCNA5;INSM1;CDK5R2
Congenitally uncorrected transposition of the great arteries with coarctation ORPHA:99042	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	MAGEL2;AMER3;TCEAL5;LRRTM1;TCEAL2;GPR148;KCNA5;INSM1;CDK5R2
Cranio-cervical dystonia with laryngeal and upper-limb involvement ORPHA:420485	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	TCEAL6;SLITRK1;KCNS2;KCNA1;KCNA4;PRR18;PCDHB4;LRRC4C;CDR1
Craniosynostosis-microretrognathia-severe intellectual disability syndrome ORPHA:565858	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	PURA;RAB6C;TCEAL6;CHRM1;TSPYL1;NEUROD6;KCNS2;SLITRK4;PABPC1L2B
Cutaneous mastocytoma ORPHA:79455	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	BEX4;ARMCX4;TCEAL7;P2RY1;APLNR;LRRC4;NAP1L3;NDN;GPRASP1
DK1-CDG ORPHA:91131	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	ZBTB9;TMEM177;POP7;FKBPL;PARS2;RNF26;DOLK;HPS6;UFSP1
DPM3-CDG ORPHA:263494	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	MRPL41;SF3B5;DPM3;ZNHIT2;POP7;C6ORF226;COX14;EMC6;RPP25L
Distal arthrogryposis type 5D ORPHA:329457	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	SOX3;ZCCHC12;CCDC177;MAGEL2;TMEM200C;DIO3;INSM1;FBLL1;RPRM
EEM syndrome ORPHA:1897	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CLDN4;FGFBP1;TMEM125;GJB4;GJB3;GJB5;TACSTD2;SFN;GRHL2
Eiken syndrome ORPHA:79106	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	SMIM10L2B;TMEM100;TCEAL7;GJA1;ISLR;TRIL;APLNR;FIBIN;SOD3
Episodic ataxia type 1 ORPHA:37612	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	TCEAL6;TCEAL5;NEUROD6;MAGEE2;SLITRK1;KCNA1;TCEAL2;KCNA4;LRRC4C
Familial cylindromatosis ORPHA:211	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	GPR174;TLR1;SAMD9L;GPR65;GPR183;GPR171;KCNA3;GIMAP7;GPR18
Familial expansile osteolysis ORPHA:85195	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CLDN4;GJB2;CLDN3;ARL14;PRR15L;GPR160;CLDN23;GCNT3;FUT3
Familial gestational hyperthyroidism ORPHA:99819	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	P2RY12;CYSLTR2;TAS2R30;TAS2R13;KCNA3;GPR52;OR13D1;GPR18;POU5F2
Familial hyperthyroidism due to mutations in TSH receptor ORPHA:424	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	P2RY12;CYSLTR2;TAS2R30;TAS2R13;KCNA3;GPR52;OR13D1;GPR18;POU5F2
Familial multiple trichoepithelioma ORPHA:867	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	GPR174;TLR1;SAMD9L;GPR65;GPR183;GPR171;KCNA3;GIMAP7;GPR18
Farber disease ORPHA:333	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CCR1;GPR34;PTAFR;RNASE6;FPR1;FPR3;TLR5;MPEG1;TLR2
Female restricted epilepsy with intellectual disability ORPHA:101039	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	TCEAL7;MAGEL2;TRIL;TMEM200C;PCDHB15;PCDHB4;PCDHB3;PCDHB10;CDR1
Foveal hypoplasia-optic nerve decussation defect-anterior segment dysgenesis syndrome ORPHA:397618	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	KCNJ4;CHRM1;LRRC10B;GPR148;PRR18;GPR62;FBLL1;SSTR4;CDK5R2
Genetic transient congenital hypothyroidism ORPHA:226316	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	SPRR3;CLDN4;GJB4;PRR15L;GCNT3;FUT2;SPRR2A;SPRR1B;FUT3
Graham Little-Piccardi-Lassueur syndrome ORPHA:505	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CCR1;TLR1;IGKC;CXORF21;GPR65;GPR183;RNASE6;CCR5;MPEG1
Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation ORPHA:178396	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	HCAR2;CCR1;HCAR3;PTAFR;RNASE6;FPR1;FPR2;MPEG1;TLR2
Hereditary continuous muscle fiber activity ORPHA:972	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	TCEAL6;TCEAL5;NEUROD6;MAGEE2;SLITRK1;KCNA1;TCEAL2;KCNA4;LRRC4C
Hereditary neutrophilia ORPHA:279943	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CXCR1;CXCR2;RNASE6;FPR1;FFAR2;FPR2;RNASE2;MPEG1;GAPT
Hypothyroidism due to TSH receptor mutations ORPHA:90673	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	P2RY12;CYSLTR2;TAS2R30;TAS2R13;KCNA3;GPR52;OR13D1;GPR18;POU5F2
Hypotrichosis with juvenile macular degeneration ORPHA:1573	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CLDN4;FGFBP1;TMEM125;GJB4;GJB3;GJB5;TACSTD2;SFN;GRHL2
IVIC syndrome ORPHA:2307	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CLDN6;SOX3;PCDHB2;SKIDA1;ZFP42;SOX11;NANOGP8;VRTN;RPRM
Immunodeficiency due to CD25 deficiency ORPHA:169100	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	GPR174;CXORF21;GPR65;GPR183;GPR171;RHOH;TNFAIP8L2;CCR5;CCR4
Infantile dystonia-parkinsonism ORPHA:238455	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CLDN6;SOX3;NEUROD4;OLIG3;NANOGP8;MAFA;ADRA2B;NEUROG1;RPRM
Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency ORPHA:352563	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	DDX28;RNF113A;TRMT10C;TAF9;FASTKD5;KTI12;GEMIN7;RPP25L;TMEM60
Intellectual disability-severe speech delay-mild dysmorphism syndrome ORPHA:391372	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CYSLTR1;GPR183;GPR171;GIMAP7;GPR82;CCR4;PPIAL4G;GDPGP1;GPR18
Isolated autosomal dominant hypomagnesemia, Glaudemans type ORPHA:199326	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	TCEAL6;TCEAL5;NEUROD6;MAGEE2;SLITRK1;KCNA1;TCEAL2;KCNA4;LRRC4C
Isolated bone marrow mastocytosis ORPHA:158778	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	BEX4;ARMCX4;TCEAL7;P2RY1;APLNR;LRRC4;NAP1L3;NDN;GPRASP1
Keppen-Lubinsky syndrome ORPHA:435628	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	NPAP1;ZNF891;MAS1;AMER3;OR11A1;SSTR2;PPIAL4G;TIGD1;POU5F2
Lethal congenital contracture syndrome type 2 ORPHA:137776	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	TMEM184A;CLDN4;CLDN3;TMEM125;GJB1;SOWAHB;PRR15L;GRHL2;FUT3
Low isolated anorectal malformation ORPHA:171215	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CLDN4;CLDN3;TMEM125;GJB1;SOWAHB;PRR15L;FAM84A;GRHL2;FUT3
Lysinuric protein intolerance ORPHA:470	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CCR1;TLR1;PTAFR;RNASE6;FPR1;FPR2;MPEG1;GAPT;TLR2
MME-related autosomal dominant Charcot Marie Tooth disease type 2 ORPHA:497757	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CCDC71L;TAS2R40;CXCR1;PPP1R3B;CXCR2;FPR1;KCNJ15;CD248;CSNK1A1L
MUC1-related autosomal dominant tubulointerstitial kidney disease ORPHA:88949	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CLDN4;CLDN3;TMEM125;PRR15L;GJB3;TACSTD2;PRR15;SFN;FUT3
Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency ORPHA:319563	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	LSM10;DPM3;SOCS1;C6ORF226;SERTAD1;SCO2;TREX1;RHOG;COMMD5
Metaphyseal chondrodysplasia, Jansen type ORPHA:33067	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	SMIM10L2B;TMEM100;TCEAL7;GJA1;ISLR;TRIL;APLNR;FIBIN;SOD3
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome ORPHA:457351	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	HIST1H2BN;TAS2R30;HIST1H4B;HIST2H2AB;TOR1AIP2;HIST1H1E;HIST1H3B;HIST1H4C;HIST2H2AC
Multiple mitochondrial dysfunctions syndrome type 3 ORPHA:363424	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	ZNF891;EXOSC6;PGBD4;FEM1A;CHST12;PCDHB1;C12ORF60;OR7D2;GDPGP1
NON RARE IN EUROPE: Berger disease ORPHA:34145	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CH25H;MAFB;GJA4;TMEM119;C2CD4B;FPR3;CLEC14A;CD248;RNASE1
Neuropathy with hearing impairment ORPHA:139512	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	FOXQ1;CLDN4;FGFBP1;GJB4;GJB3;GJB5;TACSTD2;SFN;SPRR1B
Nodular urticaria pigmentosa ORPHA:158772	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	BEX4;ARMCX4;TCEAL7;P2RY1;APLNR;LRRC4;NAP1L3;NDN;GPRASP1
Null syndrome ORPHA:280234	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	TCEAL7;TCEAL6;TCEAL5;KCNJ10;SLITRK1;TRIL;LRRTM1;TCEAL2;LRRC3B
Occult macular dystrophy ORPHA:247834	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	NPAP1;PGBD4;PCDHB1;CHRM5;C12ORF60;OR7D2;PPIAL4G;TIGD1;POU5F2
Oculoauricular syndrome, Schorderet type ORPHA:157962	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	ZCCHC12;CCDC177;RPRML;INSM2;INSM1;FBLL1;ADRA2C;POU3F2;RPRM
Okihiro syndrome due to 20q13 microdeletion ORPHA:261638	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CLDN6;SOX3;PCDHB2;SKIDA1;ZFP42;SOX11;NANOGP8;VRTN;RPRM
Okihiro syndrome due to a point mutation ORPHA:261647	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CLDN6;SOX3;PCDHB2;SKIDA1;ZFP42;SOX11;NANOGP8;VRTN;RPRM
Osteopetrosis-hypogammaglobulinemia syndrome ORPHA:178389	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CLDN4;GJB2;CLDN3;ARL14;PRR15L;GPR160;CLDN23;GCNT3;FUT3
Ovarian hyperstimulation syndrome ORPHA:64739	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	OR1S2;MAGEL2;FLRT2;HTR1E;LRRTM1;OR2M5;MAGEB3;USP17L2;USP17L11
PPARG-related familial partial lipodystrophy ORPHA:79083	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	FOXQ1;ITPRIPL2;HRH1;GJB2;ARL14;SOWAHC;CLDN23;HRCT1;PHLDA2
Pancytopenia due to IKZF1 mutations ORPHA:317473	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	GPR174;SPN;CXORF21;GPR65;GPR183;RNASE6;RHOH;TNFAIP8L2;C16ORF54
Pelizaeus-Merzbacher disease in female carriers ORPHA:280229	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	TCEAL7;TCEAL6;TCEAL5;KCNJ10;SLITRK1;TRIL;LRRTM1;TCEAL2;LRRC3B
Pelizaeus-Merzbacher disease, classic form ORPHA:280219	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	TCEAL7;TCEAL6;TCEAL5;KCNJ10;SLITRK1;TRIL;LRRTM1;TCEAL2;LRRC3B
Pelizaeus-Merzbacher disease, connatal form ORPHA:280210	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	TCEAL7;TCEAL6;TCEAL5;KCNJ10;SLITRK1;TRIL;LRRTM1;TCEAL2;LRRC3B
Pelizaeus-Merzbacher disease, transitional form ORPHA:280224	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	TCEAL7;TCEAL6;TCEAL5;KCNJ10;SLITRK1;TRIL;LRRTM1;TCEAL2;LRRC3B
Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome ORPHA:397744	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CLDN4;CLDN3;TMEM125;GJB1;SOWAHB;PRR15L;FAM84A;GRHL2;FUT3
Plaque-form urticaria pigmentosa ORPHA:158769	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	BEX4;ARMCX4;TCEAL7;P2RY1;APLNR;LRRC4;NAP1L3;NDN;GPRASP1
Primary failure of tooth eruption ORPHA:412206	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	SMIM10L2B;TMEM100;TCEAL7;GJA1;ISLR;TRIL;APLNR;FIBIN;SOD3
Pseudoxanthomatous diffuse cutaneous mastocytosis ORPHA:280794	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	BEX4;ARMCX4;TCEAL7;P2RY1;APLNR;LRRC4;NAP1L3;NDN;GPRASP1
RNF13-related severe early-onset epileptic encephalopathy ORPHA:544503	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CCR1;TLR1;GPR34;PTAFR;RNASE6;FPR1;FPR2;MPEG1;TLR2
Renin-angiotensin-aldosterone system-blocker-induced angioedema ORPHA:100057	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	IGKC;RNASE6;IGLC3;OXER1;CD248;IGLC2;CCR5;GIMAP7;MPEG1
Retinal macular dystrophy type 2 ORPHA:319640	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	SOX2;CLDN3;TMEM125;TMEM200C;FAM84A;KLHDC7A;LRRN1;CCDC160;FUT3
Right sided atrial isomerism ORPHA:97548	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	KCNJ4;KCNF1;VGF;FLRT1;FAM43B;FBLL1;POU3F2;CTXN1;CDK5R2
Schnyder corneal dystrophy ORPHA:98967	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	DDX28;NXT1;MARS2;NUP62;ZNF526;KTI12;GEMIN7;PIGW;RPP38
Smoldering systemic mastocytosis ORPHA:158775	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	BEX4;ARMCX4;TCEAL7;P2RY1;APLNR;LRRC4;NAP1L3;NDN;GPRASP1
Spastic paraplegia type 2 ORPHA:99015	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	TCEAL7;TCEAL6;TCEAL5;KCNJ10;SLITRK1;TRIL;LRRTM1;TCEAL2;LRRC3B
Spinal muscular atrophy-progressive myoclonic epilepsy syndrome ORPHA:2590	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CCR1;GPR34;PTAFR;RNASE6;FPR1;FPR3;TLR5;MPEG1;TLR2
Spinocerebellar ataxia type 41 ORPHA:458798	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	ZCCHC12;TCEAL7;TMEM200C;SLITRK3;RNF182;NAP1L3;PNMA2;SERTM1;POU3F2
Spinocerebellar ataxia type 43 ORPHA:497764	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	CCDC71L;TAS2R40;CXCR1;PPP1R3B;CXCR2;FPR1;KCNJ15;CD248;CSNK1A1L
Telangiectasia macularis eruptiva perstans ORPHA:90389	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	BEX4;ARMCX4;TCEAL7;P2RY1;APLNR;LRRC4;NAP1L3;NDN;GPRASP1
Testicular seminomatous germ cell tumor ORPHA:842	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	BEX4;ARMCX4;TCEAL7;P2RY1;APLNR;LRRC4;NAP1L3;NDN;GPRASP1
Tuberculosis ORPHA:3389	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	ARL11;C5AR2;PTAFR;CXCR2;FPR1;FFAR2;FPR2;MPEG1;GAPT
Typical urticaria pigmentosa ORPHA:158766	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	BEX4;ARMCX4;TCEAL7;P2RY1;APLNR;LRRC4;NAP1L3;NDN;GPRASP1
Xanthinuria type I ORPHA:93601	9/101	0.8272565669838801	0.9999961656375117	0	0	0.759347538912182	0.14400296637221996	TMEM184A;CLDN4;FGFBP1;ARL14;GJB4;SOWAHB;GJB3;SFN;FUT3
Acute basophilic leukemia ORPHA:86849	9/102	0.8357518887352333	0.9999961656375117	0	0	0.7511398985809861	0.13477214490292452	GPR174;SPN;ARL11;GP9;LINC00694;RHOH;RNASE3;C16ORF54;GAPT
Andersen-Tawil syndrome ORPHA:37553	9/102	0.8357518887352333	0.9999961656375117	0	0	0.7511398985809861	0.13477214490292452	CYSLTR1;GPR34;C5AR2;KCNJ15;GPR82;MPEG1;PPIAL4G;GDPGP1;KCNJ2
Bernard-Soulier syndrome ORPHA:274	9/102	0.8357518887352333	0.9999961656375117	0	0	0.7511398985809861	0.13477214490292452	GP9;LINC00694;CXCR1;OR2W3;CXCR2;FPR1;GPBAR1;GP1BA;GP5
Budd-Chiari syndrome ORPHA:131	9/102	0.8357518887352333	0.9999961656375117	0	0	0.7511398985809861	0.13477214490292452	TLR1;GPR65;GPR183;RNASE6;CCR5;GIMAP7;MPEG1;GAPT;TLR2
Bullous pemphigoid ORPHA:703	9/102	0.8357518887352333	0.9999961656375117	0	0	0.7511398985809861	0.13477214490292452	CCR1;IGKC;CXORF21;GPR65;GPR183;RNASE6;CCR5;GIMAP7;MPEG1
Congenital chronic diarrhea with protein-losing enteropathy ORPHA:329242	9/102	0.8357518887352333	0.9999961656375117	0	0	0.7511398985809861	0.13477214490292452	CLDN5;CEBPA;B3GNT8;IGKC;IGLC3;OXER1;IGLC2;RNASE1;MPEG1
Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome ORPHA:251380	9/102	0.8357518887352333	0.9999961656375117	0	0	0.7511398985809861	0.13477214490292452	GP9;LINC00694;CXCR1;OR2W3;CXCR2;FPR1;FPR2;RNASE2;GAPT
Hereditary pulmonary alveolar proteinosis ORPHA:264675	9/102	0.8357518887352333	0.9999961656375117	0	0	0.7511398985809861	0.13477214490292452	CCR1;CXORF21;PTAFR;RNASE6;FPR1;FPR2;TNFAIP8L2;MPEG1;GAPT
Horizontal gaze palsy with progressive scoliosis ORPHA:2744	9/102	0.8357518887352333	0.9999961656375117	0	0	0.7511398985809861	0.13477214490292452	GPR173;TCEAL7;MAGEL2;SOX1;SLITRK1;POU3F2;CCDC184;POU3F3;POU3F4
Jervell and Lange-Nielsen syndrome ORPHA:90647	9/102	0.8357518887352333	0.9999961656375117	0	0	0.7511398985809861	0.13477214490292452	PTAFR;CXCR2;RNASE6;FPR1;FPR2;MPEG1;C16ORF54;GAPT;TLR2
LIG4 syndrome ORPHA:99812	9/102	0.8357518887352333	0.9999961656375117	0	0	0.7511398985809861	0.13477214490292452	ABHD13;FAM200A;ZBTB6;TRMT10C;RMI1;JRKL;SOCS4;METTL18;MED7
Limbic encephalitis with LGI1 antibodies ORPHA:163908	9/102	0.8357518887352333	0.9999961656375117	0	0	0.7511398985809861	0.13477214490292452	CCR1;IGKC;CXORF21;GPR65;GPR183;RNASE6;CCR5;GIMAP7;MPEG1
Microvillus inclusion disease ORPHA:2290	9/102	0.8357518887352333	0.9999961656375117	0	0	0.7511398985809861	0.13477214490292452	CLDN4;CLDN3;TMEM125;SOWAHB;PRR15L;PRR15;SFN;GRHL2;FUT3
Parkinsonian-pyramidal syndrome ORPHA:171695	9/102	0.8357518887352333	0.9999961656375117	0	0	0.7511398985809861	0.13477214490292452	P2RY12;GP9;LINC00694;CXCR1;OR2W3;CXCR2;FPR1;FPR2;RNASE2
Pediatric multiple sclerosis ORPHA:477738	9/102	0.8357518887352333	0.9999961656375117	0	0	0.7511398985809861	0.13477214490292452	CCR1;IGKC;CXORF21;GPR65;GPR183;RNASE6;CCR5;GIMAP7;MPEG1
Spinocerebellar ataxia with axonal neuropathy type 2 ORPHA:64753	9/102	0.8357518887352333	0.9999961656375117	0	0	0.7511398985809861	0.13477214490292452	GPR174;CXORF21;GPR65;GPR183;TNFAIP8L2;MPEG1;GPR18;C16ORF54;GAPT
Activated PI3K-delta syndrome ORPHA:397596	9/103	0.8439181085613255	0.9999961656375117	0	0	0.7431068888951348	0.12610510295634184	GPR174;TLR1;CXORF21;GPR65;GPR183;MPEG1;GPR18;C16ORF54;GAPT
Antenatal Bartter syndrome ORPHA:93604	9/103	0.8439181085613255	0.9999961656375117	0	0	0.7431068888951348	0.12610510295634184	BEX4;GPR27;ARMCX4;MAGEH1;ARMCX2;C10ORF105;LRRC4;CTXN2;C21ORF62
Familial Chilblain lupus ORPHA:481662	9/103	0.8439181085613255	0.9999961656375117	0	0	0.7431068888951348	0.12610510295634184	TLR1;SAMD9L;SAMD9;TREX1;C3AR1;RHOG;TNFAIP8L2;CCR5;S1PR4
Isolated microphthalmia-anophthalmia-coloboma ORPHA:2542	9/103	0.8439181085613255	0.9999961656375117	0	0	0.7431068888951348	0.12610510295634184	SOX2;CLDN6;SOX3;NHLH2;CCDC177;MAGEL2;TMEM200C;SOX21;RPRM
Isolated scaphocephaly ORPHA:35093	9/103	0.8439181085613255	0.9999961656375117	0	0	0.7431068888951348	0.12610510295634184	FOXC1;FOXD1;MARVELD1;FZD7;TWIST2;TWIST1;FZD8;FJX1;VASN
Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) ORPHA:98829	9/104	0.8517614441367003	0.9999961656375117	0	0	0.7352429952026698	0.1179688463654658	SPN;CYSLTR2;IGKC;CXORF21;GPR183;P2RY14;RNASE6;MPEG1;GAPT
Giant cell arteritis ORPHA:397	9/104	0.8517614441367003	0.9999961656375117	0	0	0.7352429952026698	0.1179688463654658	CCR1;TLR1;SAMD9L;GPR65;GPR183;C3AR1;RNASE6;CCR5;MPEG1
46,XX testicular disorder of sex development ORPHA:393	9/105	0.8592885182775387	0.9999961656375117	0	0	0.7275429326287979	0.11033227603674266	SOX2;CLDN6;SOX3;MAGEL2;PCDHB2;FZD7;FAM43B;SRY;ADRA2C
Acute myeloid leukemia with t(8;21)(q22;q22) translocation ORPHA:102724	9/105	0.8592885182775387	0.9999961656375117	0	0	0.7275429326287979	0.11033227603674266	CEBPA;TIFAB;P2RY14;RNASE6;RNASE3;RNASE2;MPEG1;GAPT;TLR2
Autosomal recessive spondylocostal dysostosis ORPHA:2311	9/105	0.8592885182775387	0.9999961656375117	0	0	0.7275429326287979	0.11033227603674266	ATOH7;VGF;GPRIN1;H2AFX;FZD9;SOX12;FBLL1;CTXN1;CDK5R2
Stargardt disease ORPHA:827	9/105	0.8592885182775387	0.9999961656375117	0	0	0.7275429326287979	0.11033227603674266	TCEAL7;GJA1;FLRT3;TRIL;FAM84A;PCDHB15;PCDHB4;PCDHB3;RNF152
Benign adult familial myoclonic epilepsy ORPHA:86814	9/106	0.8665063081752911	0.9999961656375117	0	0	0.7200016342317068	0.10316607481054388	CCDC177;TCEAL5;FUT9;SLITRK1;LRRTM1;TCEAL2;LRRC4C;LRRC3B;ADRA2B
Limited cutaneous systemic sclerosis ORPHA:220402	9/106	0.8665063081752911	0.9999961656375117	0	0	0.7200016342317068	0.10316607481054388	CCR1;TLR1;IGKC;PTAFR;RNASE6;IGLC3;IGLC2;CCR5;MPEG1
MODY ORPHA:552	9/108	0.8800434245094763	0.9999961656375117	0	0	0.7053760858252272	0.09013579658030456	NEUROD1;GJB1;UCN3;KCNJ11;GPR119;GPR148;SOWAHA;INSM1;RNF186
Exfoliative ichthyosis ORPHA:289586	8/100	0.8957682662913418	0.9999961656375117	0	0	0.6746785058175138	0.07426424530999566	HCAR2;CCR1;TLR1;HCAR3;SAMD9L;SAMD9;PTAFR;TLR2
Hemoglobin Lepore-beta-thalassemia syndrome ORPHA:330032	8/100	0.8957682662913418	0.9999961656375117	0	0	0.6746785058175138	0.07426424530999566	GP9;LINC00694;CXCR1;CXCR2;FPR1;FPR2;RNASE2;GAPT
Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome ORPHA:46532	8/100	0.8957682662913418	0.9999961656375117	0	0	0.6746785058175138	0.07426424530999566	GP9;LINC00694;CXCR1;OR2W3;CXCR2;FPR1;FPR2;RNASE2
Lethal acantholytic erosive disorder ORPHA:158687	8/100	0.8957682662913418	0.9999961656375117	0	0	0.6746785058175138	0.07426424530999566	CLDN4;CLDN3;TMEM125;SOWAHB;GJB3;SP6;PRR15;SFN
Ocular albinism with congenital sensorineural deafness ORPHA:352740	8/100	0.8957682662913418	0.9999961656375117	0	0	0.6746785058175138	0.07426424530999566	LCE1A;LCE2B;ITPRIPL2;LCE2C;LCE2A;LCE6A;C1ORF68;LCE2D
Partial pancreatic agenesis ORPHA:2805	8/100	0.8957682662913418	0.9999961656375117	0	0	0.6746785058175138	0.07426424530999566	ATOH7;POM121L2;GPR119;GPR148;SOWAHA;INSM1;ATOH1;CDK5R2
Severe generalized junctional epidermolysis bullosa ORPHA:79404	8/100	0.8957682662913418	0.9999961656375117	0	0	0.6746785058175138	0.07426424530999566	CLDN4;GJB2;FGFBP1;ARL14;GJB4;GJB3;TACSTD2;SFN
17q23.1q23.2 microdeletion syndrome ORPHA:261279	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	HCAR1;ZNF70;PCDHB1;GDF5OS;FOXL2NB;PCDHB16;PCDHB13;OR11A1
ALG2-CDG ORPHA:79326	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	TMEM185B;C1GALT1C1;SMIM15;TRMT10C;UTP3;KTI12;DOLK;MGAT2
Acrocapitofemoral dysplasia ORPHA:63446	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	CLDN3;GJB1;ARL14;PRR15L;NAT2;CLDN2;RNF186;ATOH1
Acute megakaryoblastic leukemia in Down syndrome ORPHA:99887	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	GP9;LINC00694;CXCR1;OR2W3;CXCR2;RNASE3;RNASE2;GAPT
Acute myeloid leukemia with minimal differentiation ORPHA:98832	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	TIFAB;LINGO3;CXORF21;RNASE6;RNASE3;RNASE2;MPEG1;GAPT
Apert syndrome ORPHA:87	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	SOX2;TMEM125;SOWAHB;FLRT3;TRIL;FAM84A;SOX21;GRHL2
Autism spectrum disorder due to AUTS2 deficiency ORPHA:352490	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	ARMCX4;ARMCX2;TRIL;TMEM200C;NAP1L3;NAP1L2;LRRN1;GPRASP1
Autoimmune polyendocrinopathy type 1 ORPHA:3453	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	SPN;CNR2;C5AR2;FFAR2;TLR10;CCR4;PPIAL4G;C16ORF54
Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency ORPHA:319589	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	HCAR2;TLR1;HCAR3;PTAFR;FPR1;MGAT1;FPR2;TLR2
Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome ORPHA:440354	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	TCEAL7;GJA1;MAGEL2;PABPC5;FIBIN;PCDHB15;PCDHB5;PCDHB10
Autosomal dominant primary microcephaly ORPHA:2514	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	NEUROD1;NEUROD2;AMER3;TCEAL6;TCEAL5;SLITRK2;FUT9;LRRC4C
Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to WWOX deficiency ORPHA:284282	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	USP17L7;HIST1H1D;HIST1H1E;HIST1H4C;USP17L2;USP17L11;TIGD1;POU5F2
Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency ORPHA:363432	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	CCDC177;TCEAL5;SLITRK1;LRRTM1;TCEAL2;TMEM200C;SLITRK3;LRRC3B
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency ORPHA:319574	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	HCAR2;TLR1;HCAR3;PTAFR;FPR1;MGAT1;FPR2;TLR2
Autosomal recessive omodysplasia ORPHA:93329	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	GJA1;PCDHB2;PCDHB15;PCDHB5;PCDHB3;PCDHB12;TRAM1L1;PCDHB10
Autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity ORPHA:437552	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	CCR1;C3AR1;RNASE6;FPR1;FPR2;CCR5;GIMAP7;MPEG1
Autosomal spastic paraplegia type 30 ORPHA:101010	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	KCNJ4;ZCCHC12;CCDC177;TCEAL5;LRRTM1;TCEAL2;SLITRK3;FBLL1
Autosomal spastic paraplegia type 72 ORPHA:401849	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	ZCCHC12;TCEAL7;CEND1;FAM43B;PNMA2;FBLL1;POU3F2;CDK5R2
Bartsocas-Papas syndrome ORPHA:1234	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	FOXQ1;CLDN4;FGFBP1;CLDN3;SOWAHB;GJB3;PRR15;SFN
Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	TMEM184A;CLDN4;ARHGEF35;SOWAHB;TMEM30B;PRR15L;TACSTD2;GRHL2
Beta-thalassemia-X-linked thrombocytopenia syndrome ORPHA:231393	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	GP9;LINC00694;CXCR1;OR2W3;CXCR2;RNASE3;RNASE2;GAPT
Bilateral multicystic dysplastic kidney ORPHA:97364	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	CLDN3;GJB1;PRR15L;GCNT3;KLHDC7A;CLDN2;RNF186;SMIM6
Blue rubber bleb nevus ORPHA:1059	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	TCEAL7;GJA1;ISLR;GJA5;GJA4;APLNR;FIBIN;CLEC14A
C syndrome ORPHA:1308	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	GPR174;GPR65;GPR171;RHOH;GIMAP7;CCR4;S1PR4;C16ORF54
CHAND syndrome ORPHA:1401	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	FOXQ1;CLDN4;FGFBP1;CLDN3;SOWAHB;GJB3;PRR15;SFN
Cernunnos-XLF deficiency ORPHA:169079	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	DDX28;RNF113A;NXT1;ZNF581;FASTKD5;KTI12;RPP25L;METTL18
Charcot-Marie-Tooth disease type 4D ORPHA:99950	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	PRNP;THBD;HRH1;MAFB;CEBPD;RNASE4;JUNB;RHOB
Chronic beryllium disease ORPHA:133	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	IGKC;CXORF21;GPR65;GPR183;RNASE6;CCR5;GIMAP7;MPEG1
Classical-like Ehlers-Danlos syndrome type 2 ORPHA:536532	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	C11ORF96;ISLR;ARMCX2;PABPC5;FIBIN;NDN;CLEC14A;CD248
Combined immunodeficiency due to CD3gamma deficiency ORPHA:169082	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	GPR174;GPR65;GPR171;RHOH;GIMAP7;CCR4;GPR18;C16ORF54
Combined immunodeficiency due to DOCK8 deficiency ORPHA:217390	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	SPN;ARL11;CXORF21;GPR65;GPR183;RNASE6;TNFAIP8L2;C16ORF54
Combined immunodeficiency due to ITK deficiency ORPHA:538963	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	GPR174;GPR65;GPR171;RHOH;GIMAP7;CCR4;GPR18;C16ORF54
Complete androgen insensitivity syndrome ORPHA:99429	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	DSEL;PABPC5;PCDHB15;PCDHB5;PCDHB4;PCDHB3;PCDHB12;PCDHB7
Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency ORPHA:90793	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	CYSLTR1;C5AR2;C9ORF66;GPR82;OR7D2;PPIAL4G;GDPGP1;PRR23C
Congenital intrauterine infection-like syndrome ORPHA:1229	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	TMEM184A;CLDN4;CLDN3;TMEM125;SOWAHB;PRR15L;GRHL2;FUT3
Coxopodopatellar syndrome ORPHA:1509	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	HCAR1;ZNF70;PCDHB1;GDF5OS;FOXL2NB;PCDHB16;PCDHB13;OR11A1
Craniofacial-deafness-hand syndrome ORPHA:1529	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	SOX2;NHLH2;FOXD3;MAB21L1;GAS1;POU3F2;CCDC140;POU3F3
Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome ORPHA:1555	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	SOX2;TMEM125;SOWAHB;FLRT3;TRIL;FAM84A;SOX21;GRHL2
Cyclic neutropenia ORPHA:2686	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	GP9;LINC00694;CXORF21;CXCR2;RNASE3;FPR2;RNASE2;GAPT
Desminopathy ORPHA:98909	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	ISLR;PLN;APLNR;FIBIN;CLEC14A;CD248;HSPB3;SOD3
EAST syndrome ORPHA:199343	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	HEPN1;TCEAL6;TCEAL5;KCNJ10;NEUROD6;SLITRK3;LRRC3B;PIRT
EMILIN-1-related connective tissue disease ORPHA:485418	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	C11ORF96;ISLR;CDC42EP5;TMEM119;FIBIN;CD248;ZNF358;SOD3
Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation ORPHA:289266	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	TCEAL6;TCEAL5;SLITRK1;LRRTM1;KCNA1;TCEAL2;LRRC4C;LRRC3B
Ebstein malformation of the tricuspid valve ORPHA:1880	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	KBTBD13;PLN;SLN;MYADML2;XIRP1;KCNA5;HSPB3;LRRC30
FGFR2-related bent bone dysplasia ORPHA:313855	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	SOX2;TMEM125;SOWAHB;FLRT3;TRIL;FAM84A;SOX21;GRHL2
Familial clubfoot due to 17q23.1q23.2 microduplication ORPHA:238578	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	HCAR1;ZNF70;PCDHB1;GDF5OS;FOXL2NB;PCDHB16;PCDHB13;OR11A1
Familial hyperprolactinemia ORPHA:397685	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	CLDN4;CLDN3;SOWAHB;TMEM30B;PRR15L;NAT2;SPTSSB;GRHL2
Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis with severe ocular involvement ORPHA:2196	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	CLDN6;SOX3;ZFP42;DCAF12L1;KLHDC7A;NANOGP8;OR52A1;VRTN
Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement ORPHA:31043	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	FOXQ1;FGFBP1;GJB4;GJB3;GJB5;TACSTD2;CYP8B1;IVL
Familial scaphocephaly syndrome, McGillivray type ORPHA:168624	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	SOX2;TMEM125;SOWAHB;FLRT3;TRIL;FAM84A;SOX21;GRHL2
Fatal congenital hypertrophic cardiomyopathy due to glycogen storage disease ORPHA:439854	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	TLR1;THBD;C3AR1;FPR1;ADRB2;CCR5;GIMAP7;TLR2
Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome ORPHA:306542	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	GJC1;FOXD3;FOXD1;PABPC4L;TWIST1;TMEM74;TRAM1L1;TCEAL9
Hereditary central diabetes insipidus ORPHA:30925	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	C1QTNF4;MOS;GP9;JUND;LINGO3;RNASE3;RNASE2;S1PR4
High myopia-sensorineural deafness syndrome ORPHA:363396	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	CLDN4;TMEM125;SOWAHB;FLRT3;CLDN12;FAM84A;SLITRK6;GRHL2
Histiocytoid cardiomyopathy ORPHA:137675	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	SLC35A4;ZNF580;PCBP1;RNF208;C22ORF46;TOB2;BLCAP;ZBED3
Hyaline body myopathy ORPHA:53698	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	KBTBD13;PLN;SLN;MYADML2;XIRP1;KCNA5;HSPB3;LRRC30
Hydroxykynureninuria ORPHA:79155	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	NPAP1;MAS1;CYSLTR1;PCDHB1;C5AR2;PPIAL4G;GDPGP1;POU5F2
Hypodontia-dysplasia of nails syndrome ORPHA:2228	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	GJC1;FOXC2;FOXC1;FOXD1;TWIST1;ADRA2C;FJX1;TCEAL9
Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome ORPHA:69735	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	C11ORF96;CLDN5;FOXS1;GJA5;GJA4;APLNR;CLEC14A;ADRA2C
Intellectual disability-strabismus syndrome ORPHA:363528	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	ZNHIT2;ZNF837;CCDC85B;H2AFX;IRF2BP1;TSSK6;ABHD16B;ADAT3
Isolated neonatal sclerosing cholangitis ORPHA:480556	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	CLDN3;GJB1;SOWAHB;PRR15L;FLRT3;KLHDC7A;KAAG1;CLDN2
Jackson-Weiss syndrome ORPHA:1540	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	SOX2;TMEM125;SOWAHB;FLRT3;TRIL;FAM84A;SOX21;GRHL2
Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation ORPHA:254534	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	RTL1;GPR173;TCEAL7;MAGEL2;TCEAL5;LRRTM1;PABPC5;SOX11
Kagami-Ogata syndrome due to maternal 14q32.2 microdeletion ORPHA:254528	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	RTL1;GPR173;TCEAL7;MAGEL2;TCEAL5;LRRTM1;PABPC5;SOX11
Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14 ORPHA:96334	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	RTL1;GPR173;TCEAL7;MAGEL2;TCEAL5;LRRTM1;PABPC5;SOX11
Kennedy disease ORPHA:481	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	DSEL;PABPC5;PCDHB15;PCDHB5;PCDHB4;PCDHB3;PCDHB12;PCDHB7
Laing early-onset distal myopathy ORPHA:59135	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	KBTBD13;PLN;SLN;MYADML2;XIRP1;KCNA5;HSPB3;LRRC30
Landau-Kleffner syndrome ORPHA:98818	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	TCEAL6;TCEAL5;SLITRK1;LRRTM1;KCNA1;TCEAL2;LRRC4C;LRRC3B
Late-onset retinal degeneration ORPHA:67042	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	C11ORF96;TCEAL7;GJA1;ISLR;CDC42EP5;FIBIN;CLEC14A;SOD3
Lenz-Majewski hyperostotic dwarfism ORPHA:2658	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	DDX28;FEN1;NXT1;CDCA4;MARS2;RRS1;KTI12;PIGW
Limited systemic sclerosis ORPHA:220407	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	CCR1;IGKC;CXORF21;GPR183;RNASE6;CCR5;GIMAP7;MPEG1
Lymphedema-distichiasis syndrome ORPHA:33001	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	FOXC2;FOXC1;FOXD1;TWIST2;TWIST1;FZD8;HRCT1;FOXL1
MYH7-related late-onset scapuloperoneal muscular dystrophy ORPHA:437572	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	KBTBD13;PLN;SLN;MYADML2;XIRP1;KCNA5;HSPB3;LRRC30
Marshall syndrome ORPHA:560	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	TCEAL7;GJA1;MAGEL2;PABPC5;FIBIN;PCDHB15;PCDHB5;PCDHB10
Medullary sponge kidney ORPHA:1309	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	CLDN3;GJB1;PRR15L;GCNT3;KLHDC7A;CLDN2;RNF186;SMIM6
Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency ORPHA:319547	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	HCAR2;TLR1;HCAR3;PTAFR;FPR1;MGAT1;FPR2;TLR2
Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency ORPHA:319600	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	CCR1;CXORF21;GPR65;GPR183;RNASE6;TNFAIP8L2;CCR5;MPEG1
Monilethrix ORPHA:573	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	TMEM184A;CLDN4;FGFBP1;GJB3;GJB5;SP6;SFN;PHLDA2
Mucocutaneous venous malformations ORPHA:2451	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	TCEAL7;GJA1;ISLR;GJA5;GJA4;APLNR;FIBIN;CLEC14A
NON RARE IN EUROPE: Rheumatoid arthritis ORPHA:284130	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	CCR1;IGKC;CXORF21;GPR183;RNASE6;CCR5;GIMAP7;MPEG1
NON RARE IN EUROPE: Wolff-Parkinson-White syndrome ORPHA:907	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	TLR1;THBD;C3AR1;FPR1;ADRB2;CCR5;GIMAP7;TLR2
Neonatal alloimmune neutropenia ORPHA:464370	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	CXCR1;PTAFR;CXCR2;FPR1;FFAR2;FPR2;MPEG1;GAPT
Neurogenic scapuloperoneal syndrome, Kaeser type ORPHA:85146	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	ISLR;PLN;APLNR;FIBIN;CLEC14A;CD248;HSPB3;SOD3
Non-progressive cerebellar ataxia with intellectual disability ORPHA:314647	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	CCDC177;TCEAL6;TCEAL5;SLITRK1;TCEAL2;SLITRK3;LRRC4C;LRRC3B
Osteopetrosis with renal tubular acidosis ORPHA:2785	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	P2RY12;CEBPA;PTAFR;P2RY1;RNASE6;RNASE1;MPEG1;TLR2
PMP2-related Charcot-Marie-Tooth disease type 1 ORPHA:476394	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	HEPN1;TCEAL6;KCNJ10;SLITRK2;MAGEE2;FAM181B;LRRC3B;PIRT
Partial androgen insensitivity syndrome ORPHA:90797	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	DSEL;PABPC5;PCDHB15;PCDHB5;PCDHB4;PCDHB3;PCDHB12;PCDHB7
Pfeiffer syndrome type 2 ORPHA:93259	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	SOX2;TMEM125;SOWAHB;FLRT3;TRIL;FAM84A;SOX21;GRHL2
Pfeiffer syndrome type 3 ORPHA:93260	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	SOX2;TMEM125;SOWAHB;FLRT3;TRIL;FAM84A;SOX21;GRHL2
Pontocerebellar hypoplasia type 7 ORPHA:284339	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	DDX28;FEN1;RNF113A;NXT1;CDCA4;KTI12;GEMIN7;C19ORF48
Primary dystonia, DYT6 type ORPHA:98806	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	LIPT1;RNF113A;TRMT10C;TAF9;ZNF830;METTL18;MED7;TMEM60
Reducing body myopathy ORPHA:97239	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	TMEM100;TCEAL7;GJA1;ISLR;ARMCX2;FIBIN;NAP1L3;GAS1
Renal dysplasia, bilateral ORPHA:93173	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	CLDN3;GJB1;PRR15L;GCNT3;KLHDC7A;CLDN2;RNF186;SMIM6
Renal dysplasia, unilateral ORPHA:93172	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	CLDN3;GJB1;PRR15L;GCNT3;KLHDC7A;CLDN2;RNF186;SMIM6
Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome ORPHA:391307	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	HIST1H2AM;HIST1H2BN;HIST1H2BJ;HIST1H2AH;HIST1H2AD;HIST1H2AG;HIST1H4C;RPP38
Spinocerebellar ataxia type 14 ORPHA:98763	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	KCNJ4;KCNF1;ZCCHC12;CCDC177;SLITRK1;HTR1A;PABPC1L2B;CDK5R2
Spinocerebellar ataxia type 21 ORPHA:98773	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	SMIM10L2B;GJC2;CEND1;RNF208;SOX12;ZNF358;FBLL1;CTXN1
Spondyloepiphyseal dysplasia tarda ORPHA:93284	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	ZNF891;CYSLTR1;PGBD4;CNR2;PCDHB1;OR7D2;PPIAL4G;GDPGP1
Stickler syndrome type 2 ORPHA:90654	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	TCEAL7;GJA1;MAGEL2;PABPC5;FIBIN;PCDHB15;PCDHB5;PCDHB10
Sudden infant death-dysgenesis of the testes syndrome ORPHA:168593	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	SMIM10L2B;MOAP1;TSPYL1;KBTBD6;NAP1L2;ATXN7L3B;GPRASP2;TSPYL4
Syndromic congenital sodium diarrhea ORPHA:563708	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	CLDN4;CLDN3;TMEM125;SOWAHB;TMEM30B;PRR15L;TACSTD2;GRHL2
T-B+ severe combined immunodeficiency due to CD45 deficiency ORPHA:169157	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	GPR174;SPN;CXORF21;GPR65;GPR183;TNFAIP8L2;CCR5;C16ORF54
T-B+ severe combined immunodeficiency due to gamma chain deficiency ORPHA:276	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	GPR174;SPN;CXORF21;GPR65;RHOH;TNFAIP8L2;S1PR4;C16ORF54
TRIM32-related  limb-girdle muscular dystrophy R8 ORPHA:1878	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	TMEM177;ZBED8;KDM4D;PARS2;MAGEF1;DOLK;GPRASP2;TRIM32
Temple syndrome due to maternal uniparental disomy of chromosome 14 ORPHA:96184	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	RTL1;GPR173;TCEAL7;MAGEL2;TCEAL5;LRRTM1;PABPC5;SOX11
Temple syndrome due to paternal 14q32.2 hypomethylation ORPHA:254531	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	RTL1;GPR173;TCEAL7;MAGEL2;TCEAL5;LRRTM1;PABPC5;SOX11
Temple syndrome due to paternal 14q32.2 microdeletion ORPHA:254525	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	RTL1;GPR173;TCEAL7;MAGEL2;TCEAL5;LRRTM1;PABPC5;SOX11
Temple-Baraitser syndrome ORPHA:420561	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	SLITRK1;KCNS2;PCDHB12;PNMA2;SCG2;PCDHB10;CDK5R2;CDR1
Thrombocytopenia with congenital dyserythropoietic anemia ORPHA:67044	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	GP9;LINC00694;CXCR1;OR2W3;CXCR2;RNASE3;RNASE2;GAPT
Transient myeloproliferative syndrome ORPHA:420611	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	GP9;LINC00694;CXCR1;OR2W3;CXCR2;RNASE3;RNASE2;GAPT
Tumor necrosis factor receptor 1 associated periodic syndrome ORPHA:32960	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	TOR4A;THBD;CEBPB;CEBPD;TMEM127;MYADM;CDC42EP2;MGAT1
Unilateral multicystic dysplastic kidney ORPHA:97363	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	CLDN3;GJB1;PRR15L;GCNT3;KLHDC7A;CLDN2;RNF186;SMIM6
Vacuolar myopathy with sarcoplasmic reticulum protein aggregates ORPHA:88635	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	KBTBD13;SLN;MYADML2;XIRP1;KCNA5;HSPB3;LRRC3B;LRRC30
Waardenburg syndrome type 1 ORPHA:894	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	SOX2;NHLH2;FOXD3;MAB21L1;GAS1;POU3F2;CCDC140;POU3F3
Waardenburg syndrome type 3 ORPHA:896	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	SOX2;NHLH2;FOXD3;MAB21L1;GAS1;POU3F2;CCDC140;POU3F3
X-linked dyserythropoietic anemia with abnormal platelets and neutropenia ORPHA:363727	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	GP9;LINC00694;CXCR1;OR2W3;CXCR2;RNASE3;RNASE2;GAPT
X-linked erythropoietic protoporphyria ORPHA:443197	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	GP9;LINC00694;CXCR1;OR2W3;CXCR2;FPR1;FFAR2;FPR2
X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome ORPHA:500188	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	SMIM10L2B;TCEAL7;PCDHB15;PCDHB5;PCDHB12;TRAM1L1;GPRASP2;PCDHB10
X-linked myopathy with postural muscle atrophy ORPHA:178461	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	TMEM100;TCEAL7;GJA1;ISLR;ARMCX2;FIBIN;NAP1L3;GAS1
X-linked scapuloperoneal muscular dystrophy ORPHA:431272	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	TMEM100;TCEAL7;GJA1;ISLR;ARMCX2;FIBIN;NAP1L3;GAS1
X-linked sideroblastic anemia ORPHA:75563	8/101	0.9016617318016427	0.9999961656375117	0	0	0.6673860366500076	0.06908503248336714	GP9;LINC00694;CXCR1;OR2W3;CXCR2;FPR1;FFAR2;FPR2
Recurrent infections associated with rare immunoglobulin isotypes deficiency ORPHA:183675	7/91	0.906076049200244	0.9999961656375117	0	0	0.6465757442440241	0.06377308269548101	IGKC;IGLC7;IGLC3;RNASE6;IGLC2;GIMAP7;MPEG1
17q12 microdeletion syndrome ORPHA:261265	8/102	0.9072710661669319	0.9999961656375117	0	0	0.660248726400959	0.06425145337847606	CLDN3;ARL14;FZD5;SOWAHB;FLRT3;KLHDC7A;KAAG1;CLDN2
Central areolar choroidal dystrophy ORPHA:75377	8/102	0.9072710661669319	0.9999961656375117	0	0	0.660248726400959	0.06425145337847606	TCEAL7;MAGEL2;TCEAL5;TMEM215;TCEAL2;NDN;KCNA5;NKAPL
Continuous spikes and waves during sleep ORPHA:725	8/102	0.9072710661669319	0.9999961656375117	0	0	0.660248726400959	0.06425145337847606	AMER3;TCEAL6;TCEAL5;SLITRK2;FUT9;SLITRK1;KCNA1;DIRAS2
Desbuquois syndrome ORPHA:1425	8/102	0.9072710661669319	0.9999961656375117	0	0	0.660248726400959	0.06425145337847606	B3GNT8;TMEM127;ZNF319;HPS6;MGAT1;ZNF865;ZBTB22;CCDC71
Distal hereditary motor neuropathy type 7 ORPHA:139589	8/102	0.9072710661669319	0.9999961656375117	0	0	0.660248726400959	0.06425145337847606	SMIM10L2B;TCEAL7;MAGEL2;TCEAL5;LRRTM1;PCDHB15;GPRASP2;CCDC184
Encephalocraniocutaneous lipomatosis ORPHA:2396	8/102	0.9072710661669319	0.9999961656375117	0	0	0.660248726400959	0.06425145337847606	GJC1;TCEAL7;GJA1;MAGEL2;FZD7;NAP1L3;PNMA2;SOCS5
Hypocalcemic vitamin D-dependent rickets ORPHA:289157	8/102	0.9072710661669319	0.9999961656375117	0	0	0.660248726400959	0.06425145337847606	DDX28;CDCA4;FIGNL1;MARS2;KTI12;C1ORF74;PIGW;C19ORF48
Intravascular large B-cell lymphoma ORPHA:98839	8/102	0.9072710661669319	0.9999961656375117	0	0	0.660248726400959	0.06425145337847606	CCR1;TLR1;GPR65;P2RY14;CCR5;GIMAP7;MPEG1;TLR2
Isolated congenitally uncorrected transposition of the great arteries ORPHA:216718	8/102	0.9072710661669319	0.9999961656375117	0	0	0.660248726400959	0.06425145337847606	SOX3;NHLH2;CCDC177;MAGEL2;TCEAL5;LRRTM1;TCEAL2;INSM1
Isolated growth hormone deficiency type II ORPHA:231679	8/102	0.9072710661669319	0.9999961656375117	0	0	0.660248726400959	0.06425145337847606	GPR174;PTTG2;CXORF21;RHOH;TLR10;OR52N4;GPR18;GAPT
Isolated trigonocephaly ORPHA:3366	8/102	0.9072710661669319	0.9999961656375117	0	0	0.660248726400959	0.06425145337847606	TCEAL7;GJA1;MAGEL2;TRIL;PABPC5;PCDHB15;PCDHB5;PCDHB4
Junctional epidermolysis bullosa with pyloric atresia ORPHA:79403	8/102	0.9072710661669319	0.9999961656375117	0	0	0.660248726400959	0.06425145337847606	FOXQ1;CLDN4;FGFBP1;GJB4;GJB3;GJB5;TACSTD2;SFN
NON RARE IN EUROPE: Vitiligo ORPHA:3435	8/102	0.9072710661669319	0.9999961656375117	0	0	0.660248726400959	0.06425145337847606	BEX4;FOXD3;S1PR1;NAP1L3;ZCCHC18;POU3F1;CCDC184;CHST2
Pachydermoperiostosis ORPHA:2796	8/102	0.9072710661669319	0.9999961656375117	0	0	0.660248726400959	0.06425145337847606	CLDN3;TMEM125;SOWAHB;TMEM30B;PRR15L;GJA4;RNASE1;C3ORF36
Paroxysmal kinesigenic dyskinesia ORPHA:98809	8/102	0.9072710661669319	0.9999961656375117	0	0	0.660248726400959	0.06425145337847606	TCEAL6;TCEAL5;SLITRK1;LRRTM1;KCNA1;TCEAL2;PABPC1L2B;LRRC4C
Progressive familial intrahepatic cholestasis type 1 ORPHA:79306	8/102	0.9072710661669319	0.9999961656375117	0	0	0.660248726400959	0.06425145337847606	TMEM184A;CLDN4;CLDN3;TMEM125;SOWAHB;PRR15L;PRR15;GRHL2
Townes-Brocks syndrome ORPHA:857	8/102	0.9072710661669319	0.9999961656375117	0	0	0.660248726400959	0.06425145337847606	TCEAL7;GJA1;MAGEL2;ARMCX2;TMEM200C;PABPC5;NAP1L3;PRSS35
Midline interhemispheric variant of holoprosencephaly ORPHA:93926	9/113	0.909009923247045	0.9999961656375117	0	0	0.6712732445889645	0.06403897629658313	SOX2;CLDN6;SOX3;MAGEL2;PCDHB2;FZD7;PCDHB15;GAS1;RPRM
Septopreoptic holoprosencephaly ORPHA:280195	9/113	0.909009923247045	0.9999961656375117	0	0	0.6712732445889645	0.06403897629658313	SOX2;CLDN6;SOX3;MAGEL2;PCDHB2;FZD7;PCDHB15;GAS1;RPRM
Adult-onset myasthenia gravis ORPHA:391490	8/103	0.9126060380016429	0.9999961656375117	0	0	0.6532616753150482	0.05974142971147307	IGKC;GPR65;GPR183;GPR171;CCR5;GIMAP7;MPEG1;GPR18
Alveolar rhabdomyosarcoma ORPHA:99756	8/103	0.9126060380016429	0.9999961656375117	0	0	0.6532616753150482	0.05974142971147307	SOX2;NHLH2;TMEM200C;GAS1;POU3F1;SOX21;CCDC140;CCDC160
Chronic granulomatous disease ORPHA:379	8/103	0.9126060380016429	0.9999961656375117	0	0	0.6532616753150482	0.05974142971147307	CCR1;CXORF21;GPR65;PTAFR;RNASE6;TNFAIP8L2;MPEG1;GAPT
Female infertility due to zona pellucida defect ORPHA:404466	8/103	0.9126060380016429	0.9999961656375117	0	0	0.6532616753150482	0.05974142971147307	HCAR1;PGBD4;PCDHB1;MAGEA10;OR7D2;ACSF3;USP29;PPIAL4G
Hermansky-Pudlak syndrome without pulmonary fibrosis ORPHA:231512	8/103	0.9126060380016429	0.9999961656375117	0	0	0.6532616753150482	0.05974142971147307	C1GALT1C1;ZBTB6;HNRNPF;KTI12;B3GNT2;HPS6;MGAT2;CMTR2
Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome ORPHA:238569	8/103	0.9126060380016429	0.9999961656375117	0	0	0.6532616753150482	0.05974142971147307	CCR1;CXORF21;GPR65;GPR183;RNASE6;TNFAIP8L2;CCR5;MPEG1
NON RARE IN EUROPE: Tourette syndrome ORPHA:856	8/103	0.9126060380016429	0.9999961656375117	0	0	0.6532616753150482	0.05974142971147307	TCEAL5;LRRN3;OR2L13;HTR1F;MAGEE2;SLITRK1;LRRC3B;C21ORF62
Pendred syndrome ORPHA:705	8/103	0.9126060380016429	0.9999961656375117	0	0	0.6532616753150482	0.05974142971147307	TCEAL6;CHRM1;KCNJ10;SLITRK2;NEUROD6;DIRAS2;OMG;PRR18
Thyrotoxic periodic paralysis ORPHA:79102	8/103	0.9126060380016429	0.9999961656375117	0	0	0.6532616753150482	0.05974142971147307	CCDC177;SLN;KCNJ12;MYADML2;PYDC1;CTXN3;LRRC3B;LRRC30
WAGR syndrome ORPHA:893	8/103	0.9126060380016429	0.9999961656375117	0	0	0.6532616753150482	0.05974142971147307	ZBED8;RAB40A;RNF182;SLC35G2;PNMA2;POU3F2;SCG2;FJX1
Behcet disease ORPHA:117	9/114	0.9140321460508702	0.9999961656375117	0	0	0.6648424230986979	0.05976237786452702	CCR1;TLR1;SAMD9L;CXORF21;GPR65;GPR183;C3AR1;TNFAIP8L2;CCR5
Familial short QT syndrome ORPHA:51083	8/104	0.9176764068820493	0.9999961656375117	0	0	0.6464201877934272	0.055534248222722536	GPRIN3;GPR27;CLDN5;LRRC4;OLIG1;KCNA5;KCNJ2;KBTBD11
NON RARE IN EUROPE: Essential hypertension ORPHA:243761	8/104	0.9176764068820493	0.9999961656375117	0	0	0.6464201877934272	0.055534248222722536	TMEM100;TCEAL7;ISLR;TRIL;APLNR;FIBIN;CLEC14A;SOD3
NON RARE IN EUROPE: Hereditary essential tremor ORPHA:862	8/104	0.9176764068820493	0.9999961656375117	0	0	0.6464201877934272	0.055534248222722536	SOX2;SOX3;CCDC177;MAGEL2;TCEAL5;LRRTM1;TCEAL2;TMEM200C
Narcolepsy type 2 ORPHA:83465	8/104	0.9176764068820493	0.9999961656375117	0	0	0.6464201877934272	0.055534248222722536	CXORF21;GPR65;GPR183;RNASE6;TNFAIP8L2;CCR5;GIMAP7;MPEG1
Silver-Russell syndrome due to a point mutation ORPHA:397590	8/104	0.9176764068820493	0.9999961656375117	0	0	0.6464201877934272	0.055534248222722536	CLDN6;GJC1;TCEAL7;GJA1;MAGEL2;CCDC8;PABPC4L;TCEAL9
Cystic fibrosis ORPHA:586	8/105	0.9224918889253941	0.9999961656375117	0	0	0.6397197618701902	0.051610476497006404	FOXQ1;ARL14;GJB4;UCN3;GJB3;CDC42EP5;FAM84A;FUT3
Fetal akinesia deformation sequence ORPHA:994	8/105	0.9224918889253941	0.9999961656375117	0	0	0.6397197618701902	0.051610476497006404	KBTBD13;SLN;MYADML2;XIRP1;HSPB3;MAFA;LRRC30;SLC18A3
Granulomatosis with polyangiitis ORPHA:900	8/105	0.9224918889253941	0.9999961656375117	0	0	0.6397197618701902	0.051610476497006404	CXORF21;GPR65;GPR183;RNASE6;TNFAIP8L2;CCR5;S1PR4;C16ORF54
Myoclonus-dystonia syndrome ORPHA:36899	8/105	0.9224918889253941	0.9999961656375117	0	0	0.6397197618701902	0.051610476497006404	C8ORF48;GPRIN1;DOLK;TRAM1L1;CTXN1;FJX1;CCDC184;PCDHB10
Usher syndrome type 3 ORPHA:231183	8/105	0.9224918889253941	0.9999961656375117	0	0	0.6397197618701902	0.051610476497006404	NPAP1;ZNF891;PGBD4;PCDHB1;OR7D2;PPIAL4G;TIGD1;POU5F2
Bilateral striopallidodentate calcinosis ORPHA:1980	8/106	0.9270621265813666	0.9999961656375117	0	0	0.6331560793331417	0.04795188362957275	TCEAL7;GJA1;ISLR;TRIL;FIBIN;PCDHB15;PCDHB4;MYORG
NON RARE IN EUROPE: Multiple sclerosis ORPHA:802	8/106	0.9270621265813666	0.9999961656375117	0	0	0.6331560793331417	0.04795188362957275	CCR1;IGKC;PTAFR;RNASE6;CCR5;GIMAP7;S1PR4;MPEG1
Oligoarticular juvenile idiopathic arthritis ORPHA:85410	8/107	0.931396660679799	0.9999961656375117	0	0	0.6267249964433063	0.044541366624119096	GPR174;GPR65;GPR183;GPR171;RHOH;GIMAP7;S1PR4;C16ORF54
Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis ORPHA:85408	8/107	0.931396660679799	0.9999961656375117	0	0	0.6267249964433063	0.044541366624119096	GPR174;GPR65;GPR183;GPR171;RHOH;GIMAP7;S1PR4;C16ORF54
Kallmann syndrome ORPHA:478	9/120	0.9394580911638613	0.9999961656375117	0	0	0.6286907779642258	0.03926303966857595	SOX2;TCEAL7;GJA1;MAGEL2;FLRT3;TRIL;TMEM200C;PCDHB15;LRRC3B
X-linked non-syndromic intellectual disability ORPHA:777	10/132	0.9433212174048107	0.9999961656375117	0	0	0.6354445006138514	0.03707718313969334	ZCCHC12;USP27X;TCEAL5;SLITRK1;TCEAL2;SLITRK3;NAP1L3;AGTR2;GPRASP1;CDR1
Familial atrial fibrillation ORPHA:334	9/122	0.9463328714221817	0.9999961656375117	0	0	0.6174933657544336	0.034061489356658	KCNE2;PLN;GJA5;MUM1L1;XIRP1;KCNA4;KCNA5;HSPB3;KCNJ2
Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16 ORPHA:98791	7/100	0.9473653214253634	0.9999961656375117	0	0	0.5837058692741818	0.03156126417959401	GP9;LINC00694;CXCR1;CXCR2;FPR1;FPR2;MPEG1
Autosomal recessive distal renal tubular acidosis ORPHA:402041	7/100	0.9473653214253634	0.9999961656375117	0	0	0.5837058692741818	0.03156126417959401	CLDN4;CALML5;GJB3;CLDN8;TACSTD2;CALML3;SFN
Deafness-infertility syndrome ORPHA:94064	7/100	0.9473653214253634	0.9999961656375117	0	0	0.5837058692741818	0.03156126417959401	NPAP1;ZNF891;MAS1;PGBD4;PPIAL4G;TAS2R4;POU5F2
Hb Bart's hydrops fetalis ORPHA:163596	7/100	0.9473653214253634	0.9999961656375117	0	0	0.5837058692741818	0.03156126417959401	GP9;LINC00694;CXCR1;CXCR2;FPR1;FPR2;MPEG1
Hemoglobin H disease ORPHA:93616	7/100	0.9473653214253634	0.9999961656375117	0	0	0.5837058692741818	0.03156126417959401	GP9;LINC00694;CXCR1;CXCR2;FPR1;FPR2;MPEG1
Immunodeficiency due to a classical component pathway complement deficiency ORPHA:169147	7/100	0.9473653214253634	0.9999961656375117	0	0	0.5837058692741818	0.03156126417959401	ISLR;GPR34;GJA4;APLNR;FPR3;CLEC14A;RNASE1
Pitt-Hopkins-like syndrome ORPHA:221150	7/100	0.9473653214253634	0.9999961656375117	0	0	0.5837058692741818	0.03156126417959401	CCDC177;TCEAL5;FUT9;SLITRK1;LRRTM1;SLITRK3;LRRC3B
19p13.3 microduplication syndrome ORPHA:447980	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	FZD1;ISLR;CDC42EP4;IGIP;FIBIN;HRCT1;SOD3
22q11.2 duplication syndrome ORPHA:1727	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	FOXC1;GJD3;RGS9BP;FZD9;SP6;NRARP;CTXN1
2q24 microdeletion syndrome ORPHA:1617	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	NEUROD2;AMER3;TCEAL6;SLITRK2;FUT9;NEUROD6;SLITRK1
46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome ORPHA:168563	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	C11ORF96;CLDN5;FOXD3;FOXC2;FOXS1;CLEC14A;GPR4
AA amyloidosis ORPHA:85445	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	GJB2;FGFBP1;GJB4;GJB3;RNASE7;TACSTD2;ANG
ABri amyloidosis ORPHA:97345	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	CXCR1;LPAR6;RNASE6;FPR1;TLR5;GIMAP7;TLR2
ADan amyloidosis ORPHA:97346	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	CXCR1;LPAR6;RNASE6;FPR1;TLR5;GIMAP7;TLR2
Aarskog-Scott syndrome ORPHA:915	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	GPRIN1;FZD7;ZBTB12;SOX12;CTXN1;GPRASP2;FJX1
Ablepharon macrostomia syndrome ORPHA:920	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	FOXC2;GJA1;TPBG;TWIST2;TWIST1;GAS1;FOXL1
Alexander disease type I ORPHA:363717	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	HEPN1;TCEAL6;KCNJ10;NEUROD6;DIRAS2;LRRC3B;PIRT
Alexander disease type II ORPHA:363722	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	HEPN1;TCEAL6;KCNJ10;NEUROD6;DIRAS2;LRRC3B;PIRT
Alpha-sarcoglycan-related  limb-girdle muscular dystrophy R3 ORPHA:62	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	KBTBD13;ISLR;PLN;SLN;XIRP1;CD248;HSPB3
Anonychia congenita totalis ORPHA:94150	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	CLDN6;SMIM10L2B;SMIM10L2A;MAGEL2;DCAF12L2;TCEAL2;FBLL1
Anterior maxillary protrusion-strabismus-intellectual disability syndrome ORPHA:562559	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	TCEAL7;TMEM200C;PCDHB15;PCDHB4;PCDHB12;GPRASP2;PCDHB10
Argininemia ORPHA:90	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	LINC00694;CXCR1;CXCR2;FPR1;FPR2;MPEG1;GAPT
Atrial septal defect-atrioventricular conduction defects syndrome ORPHA:1479	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	GJC1;FOXD3;FOXC1;FOXD1;GJA3;PLAC1;TMEM74
Autosomal dominant spastic paraplegia type 3 ORPHA:100984	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	TCEAL7;TCEAL6;TCEAL5;MAGEE2;SLITRK1;TCEAL2;SCG2
Autosomal dominant thrombocytopenia with platelet secretion defect ORPHA:466806	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	GPR174;SPN;GP9;RHOH;GP5;S1PR4;C16ORF54
Autosomal recessive axonal Charcot-Marie-Tooth disease due to copper metabolism defect ORPHA:521411	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	LSM10;SF3B5;SCO2;RHOG;HPS6;RPP25L;COMMD5
Autosomal recessive cerebellar ataxia-psychomotor delay syndrome ORPHA:284271	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	AMER3;SLITRK1;B3GALT1;GPR85;SLITRK5;SOX11;PNMA2
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency ORPHA:477857	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	TMEM184A;LINGO4;TMEM30B;PRR15L;FAM46C;CXCR6;GIMAP7
Autosomal recessive spastic paraplegia type 5A ORPHA:100986	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	ISLR;PABPC5;APLNR;FIBIN;NDN;BHLHE22;CDR1
Autosomal recessive spastic paraplegia type 64 ORPHA:401810	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	CXORF21;GPR65;GPR183;RNASE6;TLR10;MPEG1;GAPT
Barber-Say syndrome ORPHA:1231	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	FOXC2;GJA1;TPBG;TWIST2;TWIST1;GAS1;FOXL1
Beta-mannosidosis ORPHA:118	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	TLR1;CXORF21;RNASE6;FPR2;RNASE2;GAPT;TLR2
Beta-ureidopropionase deficiency ORPHA:65287	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	CNR2;C5AR2;C9ORF66;FFAR2;CYP8B1;PPIAL4G;CPN2
Brachydactyly type B2 ORPHA:140908	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	PSMB11;CCDC85B;NOG;CDC42EP3;AMIGO2;S1PR5;THAP11
Burkitt lymphoma ORPHA:543	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	NXT1;CDCA4;HNRNPF;MARS2;RRS1;KTI12;C19ORF48
CLN2 disease ORPHA:228349	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	TMEM127;PCBP1;C3AR1;RNASE6;RHOG;MGAT1;TICAM1
Carnitine palmitoyl transferase 1A deficiency ORPHA:156	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	SAMD9;PRR15L;P2RY2;LENG9;ZBTB42;TICAM1;TRIM56
Carnitine-acylcarnitine translocase deficiency ORPHA:159	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	LSM10;OST4;RNF113A;RHOG;COX14;BORCS6;RPP25L
Cerebrotendinous xanthomatosis ORPHA:909	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	CCR1;MAFB;CEBPD;OXER1;FPR3;RNASE1;TLR2
Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia ORPHA:284324	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	TMEM127;PCBP1;C3AR1;RNASE6;RHOG;MGAT1;TICAM1
Chronic respiratory distress with surfactant metabolism deficiency ORPHA:217566	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	TCEAL6;CHRM1;SPPL2C;NEUROD6;MAGEE2;AGTR2;SSTR4
Classic Bartter syndrome ORPHA:93605	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	CLDN6;SMIM10L2B;TMEM246;KCNJ12;FZD7;CCDC8;PABPC4L
Classical-like Ehlers-Danlos syndrome type 1 ORPHA:230839	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	CLDN5;ISLR;GJA4;APLNR;CLEC14A;CD248;SOD3
Combined immunodeficiency due to Moesin deficiency ORPHA:504530	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	TLR1;SAMD9L;CDC42EP3;RHOG;S1PR1;TLR6;CHST2
Congenital bile acid synthesis defect type 3 ORPHA:79302	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	ISLR;PABPC5;APLNR;FIBIN;NDN;BHLHE22;CDR1
Congenital contractural arachnodactyly ORPHA:115	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	GJA1;FZD2;BASP1;MARVELD1;PABPC4L;TWIST2;PRSS35
Congenital cornea plana ORPHA:53691	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	TMEM100;OR51E1;ISLR;FIBIN;CD248;AGTR2;DIRC1
Congenital enteropathy due to enteropeptidase deficiency ORPHA:168601	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	FOXR2;MAGEA12;NAA11;MAGEA1;OR51B4;MAGEC2;MAGEA6
Congenital muscular dystrophy with intellectual disability and severe epilepsy ORPHA:329178	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	LSM10;DPM3;POP7;ZNF581;GEMIN7;RPP25L;COMMD5
DOORS syndrome ORPHA:79500	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	EXOSC6;KBTBD6;PDP2;ZNF70;FLRT1;SOX12;SPRN
Distal monosomy 1q ORPHA:36367	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	LRRC4;S1PR1;OLIG1;KCTD12;GPRASP1;KBTBD11;CDK5R1
Epidermolysis bullosa simplex due to exophilin 5 deficiency ORPHA:412189	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	TMEM184A;RNF223;CLDN4;STX19;TOR1AIP2;FUT2;GRHL2
Familial aortic dissection ORPHA:229	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	PLN;GPR34;IGKC;P2RY14;IGLC3;IGLC2;MPEG1
Familial atrial tachyarrhythmia-infra-Hisian cardiac conduction disease ORPHA:436242	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	PLN;MAGEE2;KCNA4;KCNA5;HSPB3;LRRC3B;RAB9B
Familial dyskinesia and facial myokymia ORPHA:324588	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	SMIM10L2B;TCEAL5;TRIL;LRRTM1;TCEAL2;PCDHB15;PCDHB4
Familial encephalopathy with neuroserpin inclusion bodies ORPHA:85110	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	TCEAL6;TCEAL5;OR2L13;NEUROD6;MAGEE2;TCEAL2;NAP1L3
Familial episodic pain syndrome with predominantly lower limb involvement ORPHA:391392	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	ZNF660;ZNF891;CYSLTR1;SSTR2;PRND;OR7D2;ZNF345
Familial renal glucosuria ORPHA:69076	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	BLOC1S4;DPM3;PTGDR2;TRAPPC5;TREX2;LENG9;MRPL57
Familial sick sinus syndrome ORPHA:166282	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	CLDN6;SMIM10L2B;KCNJ4;MAGEL2;TMEM200C;MYADML2;MUM1L1
Focal epilepsy-intellectual disability-cerebro-cerebellar malformation ORPHA:352587	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	EXOSC6;KBTBD6;PDP2;ZNF70;FLRT1;SOX12;SPRN
Focal facial dermal dysplasia type III ORPHA:1807	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	FOXC2;GJA1;TPBG;TWIST2;TWIST1;GAS1;FOXL1
Gamma-sarcoglycan-related  limb-girdle muscular dystrophy R5 ORPHA:353	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	TCEAL7;ARMCX1;SLN;PABPC5;PCDHB4;PCDHB3;HSPB3
Glucose-galactose malabsorption ORPHA:35710	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	TMEM125;PRR15L;STX19;FUT2;RNF186;GRHL2;FUT3
Hemochromatosis type 4 ORPHA:139491	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	GPR34;RNASE6;FPR3;TLR5;GIMAP7;RNASE1;MPEG1
Hemochromatosis type 5 ORPHA:447792	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	CLDN5;GP9;THBD;FOXC2;TMEM158;CDC42EP2;KCTD12
Hemoglobinopathy Toms River ORPHA:280615	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	SPN;GP9;LINC00694;CXCR1;OR2W3;CXCR2;FFAR2
Hereditary sensorimotor neuropathy with hyperelastic skin ORPHA:280598	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	ISLR;TWIST2;TMEM119;FIBIN;GAS1;CLEC14A;CD248
Hereditary sensory and autonomic neuropathy type 7 ORPHA:391397	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	ZNF660;ZNF891;CYSLTR1;SSTR2;PRND;OR7D2;ZNF345
Hydrocephalus with stenosis of the aqueduct of Sylvius ORPHA:2182	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	VGF;GPRIN1;ELFN2;CTXN1;SCG2;ZNF488;CDK5R2
Hyperbiliverdinemia ORPHA:276405	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	LSM10;SF3B5;RAB9A;COX14;EMC6;TMEM187;TMEM60
Hypocomplementemic urticarial vasculitis ORPHA:36412	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	IGKC;RNASE6;IGLC3;FPR3;TLR10;IGLC2;MPEG1
Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism ORPHA:100034	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	CLDN4;CALML5;TPBG;TACSTD2;SP6;SFN;IVL
Hypoplastic pancreas-intestinal atresia-hypoplastic gallbladder syndrome ORPHA:293864	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	UCN3;GPR119;GPR148;SOWAHA;INSM1;RNF186;ATOH1
Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency ORPHA:70592	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	TLR1;SAMD9L;SAMD9;CXORF21;GPR65;RHOH;C16ORF54
Interstitial lung disease due to SP-C deficiency ORPHA:440392	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	TCEAL6;CHRM1;SPPL2C;NEUROD6;MAGEE2;AGTR2;SSTR4
Keratolytic winter erythema ORPHA:50943	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	ITPRIPL2;THBD;CEBPD;TMEM127;FPR3;MGAT1;RNASE1
Leukocyte adhesion deficiency type I ORPHA:99842	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	CCR1;CXORF21;GPR65;RNASE6;TNFAIP8L2;CCR5;S1PR4
MASA syndrome ORPHA:2466	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	VGF;GPRIN1;ELFN2;CTXN1;SCG2;ZNF488;CDK5R2
Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome ORPHA:487796	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	PLEKHF2;ABHD13;HMGN4;TIFA;B3GNT2;ARF6;PNRC2
Malan overgrowth syndrome ORPHA:420179	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	FZD1;ISLR;CDC42EP4;IGIP;FIBIN;HRCT1;SOD3
Male infertility with teratozoospermia due to single gene mutation ORPHA:399808	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	NANOS1;GJC1;KBTBD6;RGS9BP;SKIDA1;MAFA;FJX1
Marshall-Smith syndrome ORPHA:561	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	FZD1;ISLR;CDC42EP4;IGIP;FIBIN;HRCT1;SOD3
NON RARE IN EUROPE: Patent arterial duct ORPHA:706	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	PLN;GPR34;IGKC;P2RY14;IGLC3;IGLC2;MPEG1
Native American myopathy ORPHA:168572	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	ARL11;CXORF21;OXER1;GPR84;TNFAIP8L2;RNASE2;GAPT
Neutral lipid storage disease with ichthyosis ORPHA:98907	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	HCAR2;PLEKHF2;HCAR3;CXCR1;FPR2;TMEM140;HIST1H2AC
Obesity due to congenital leptin deficiency ORPHA:66628	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	HCAR1;LRRN4CL;C5AR2;TMEM119;ACKR2;THRSP;PRR23C
Overhydrated hereditary stomatocytosis ORPHA:3203	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	GP9;LINC00694;DUSP21;OR2W3;OR2AT4;OR2T8;OR52A5
PRKAR1B-related neurodegenerative dementia with intermediate filaments ORPHA:412066	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	MRPL41;VGF;CCDC85B;GPRIN1;CEND1;RNF208;CTXN1
Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease ORPHA:163746	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	TCEAL6;CHRM1;TCEAL5;KCNJ10;SLITRK2;LRRTM1;GPR62
Pigmented paravenous retinochoroidal atrophy ORPHA:251295	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	NEUROD1;NEUROD2;AMER3;SLITRK2;SLITRK1;DIRAS2;SLITRK5
Polymicrogyria due to TUBB2B mutation ORPHA:300573	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	SOX2;ZCCHC12;TCEAL7;MAGEL2;TMEM200C;FAM43B;FBLL1
Primary dystonia, DYT2 type ORPHA:99657	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	KCNJ4;TCEAL6;TCEAL5;NEUROD6;SLITRK1;PABPC1L2B;CDK5R2
Primary immunodeficiency syndrome due to LAMTOR2 deficiency ORPHA:90023	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	LSM10;OST4;SF3B5;DPM3;COX14;EMC6;RPP25L
Progressive myoclonic epilepsy with dystonia ORPHA:352596	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	EXOSC6;KBTBD6;PDP2;ZNF70;FLRT1;SOX12;SPRN
Properdin deficiency ORPHA:2966	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	CXORF21;FPR1;FPR2;TNFAIP8L2;S1PR4;C16ORF54;GAPT
Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies ORPHA:397758	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	CXCR1;LPAR6;RNASE6;FPR1;TLR5;GIMAP7;TLR2
Ribose-5-P isomerase deficiency ORPHA:440706	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	LSM10;DDX28;RNF113A;NXT1;ZNF581;HNRNPF;KTI12
Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome ORPHA:163727	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	EXOSC6;KBTBD6;PDP2;ZNF70;FLRT1;SOX12;SPRN
SLC35A1-CDG ORPHA:238459	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	PLEKHF2;ABHD13;C1GALT1C1;PEX2;KRCC1;METTL18;MED7
Severe combined immunodeficiency due to adenosine deaminase deficiency ORPHA:277	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	LSM10;DDX28;RNF113A;NXT1;ZNF581;RHOG;KTI12
Stapes ankylosis with broad thumbs and toes ORPHA:140917	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	PSMB11;CCDC85B;NOG;CDC42EP3;AMIGO2;S1PR5;THAP11
T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency ORPHA:169154	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	SAMD9L;GPR65;GPR183;GPR171;CCR5;GIMAP7;CCR4
T-cell immunodeficiency with epidermodysplasia verruciformis ORPHA:324294	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	GPR174;SPN;CXORF21;GPR65;RHOH;S1PR4;C16ORF54
Tarsal-carpal coalition syndrome ORPHA:1412	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	PSMB11;CCDC85B;NOG;CDC42EP3;AMIGO2;S1PR5;THAP11
Telethonin-related  limb-girdle muscular dystrophy R7 ORPHA:34514	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	KBTBD13;UCN;PROB1;SLN;MYADML2;XIRP1;ZNF865
Toriello-Lacassie-Droste syndrome ORPHA:3339	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	ABHD13;ZNF770;ZBTB6;ZNF518A;ZBTB33;CGGBP1;SOCS4
Tricho-dento-osseous syndrome ORPHA:3352	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	CLDN4;CALML5;TPBG;TACSTD2;SP6;SFN;IVL
X-linked complicated corpus callosum dysgenesis ORPHA:1497	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	VGF;GPRIN1;ELFN2;CTXN1;SCG2;ZNF488;CDK5R2
X-linked complicated spastic paraplegia type 1 ORPHA:306617	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	VGF;GPRIN1;ELFN2;CTXN1;SCG2;ZNF488;CDK5R2
X-linked epilepsy-learning disabilities-behavior disorders syndrome ORPHA:85294	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	TCEAL6;TCEAL5;SLITRK1;LRRTM1;TCEAL2;FBLL1;CDK5R2
X-linked intellectual disability due to GRIA3 mutations ORPHA:364028	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	TCEAL7;TCEAL6;TCEAL5;TCEAL2;KCNA4;LRRC4C;CDR1
X-linked mendelian susceptibility to mycobacterial diseases due to CYBB deficiency ORPHA:319623	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	CCR1;CXORF21;PTAFR;RNASE6;CCR5;MPEG1;GAPT
X-linked recessive ocular albinism ORPHA:54	7/101	0.9507687656031651	0.9999961656375117	0	0	0.5774634703410059	0.029152893752545275	CLDN6;CLDN4;CLDN3;TMEM125;SOWAHB;KCNS3;GRHL2
Alobar holoprosencephaly ORPHA:93925	8/113	0.9529699052262022	0.9999961656375117	0	0	0.5907109322602281	0.028455700336212524	SOX2;CLDN6;SOX3;PCDHB2;SKIDA1;FZD7;GAS1;RPRM
Lobar holoprosencephaly ORPHA:93924	8/113	0.9529699052262022	0.9999961656375117	0	0	0.5907109322602281	0.028455700336212524	CLDN6;SOX3;GJA1;MAGEL2;PCDHB2;FZD7;PCDHB15;GAS1
Agnathia-holoprosencephaly-situs inversus syndrome ORPHA:990	7/102	0.9539738447192838	0.9999961656375117	0	0	0.571352490332739	0.026921571902420206	TCEAL7;GJA1;MAGEL2;TMEM200C;PABPC5;FIBIN;PCDHB15
Benign familial neonatal epilepsy ORPHA:1949	7/102	0.9539738447192838	0.9999961656375117	0	0	0.571352490332739	0.026921571902420206	CCDC177;TCEAL5;SLITRK1;LRRTM1;TCEAL2;LRRC3B;CDK5R2
Blepharo-cheilo-odontic syndrome ORPHA:1997	7/102	0.9539738447192838	0.9999961656375117	0	0	0.571352490332739	0.026921571902420206	CLDN4;CLDN3;TMEM125;SOWAHB;PRR15L;PRR15;GRHL2
Classic mycosis fungoides ORPHA:2584	7/102	0.9539738447192838	0.9999961656375117	0	0	0.571352490332739	0.026921571902420206	GPR174;GPR65;GPR183;GPR171;CCR5;GIMAP7;S1PR4
Diffuse panbronchiolitis ORPHA:171700	7/102	0.9539738447192838	0.9999961656375117	0	0	0.571352490332739	0.026921571902420206	TMEM184A;CLDN4;CLDN3;PRR15L;FUT2;GRHL2;FUT3
Fibrochondrogenesis ORPHA:2021	7/102	0.9539738447192838	0.9999961656375117	0	0	0.571352490332739	0.026921571902420206	GPR173;TCEAL7;MAGEL2;PABPC5;PCDHB15;PCDHB5;PCDHB10
Glanzmann thrombasthenia ORPHA:849	7/102	0.9539738447192838	0.9999961656375117	0	0	0.571352490332739	0.026921571902420206	GP9;LINC00694;OR2W3;FPR1;GP1BA;FPR2;GP5
Hypomyelination with atrophy of basal ganglia and cerebellum ORPHA:139441	7/102	0.9539738447192838	0.9999961656375117	0	0	0.571352490332739	0.026921571902420206	MOAP1;ZCCHC12;MRFAP1L1;NAP1L3;ATXN7L3B;CGGBP1;TSPYL4
Idiopathic ventricular fibrillation, non Brugada type ORPHA:228140	7/102	0.9539738447192838	0.9999961656375117	0	0	0.571352490332739	0.026921571902420206	GPR173;TCEAL7;TCEAL5;LRRTM1;TCEAL2;PNMA2;SERTM1
Infantile Krabbe disease ORPHA:206436	7/102	0.9539738447192838	0.9999961656375117	0	0	0.571352490332739	0.026921571902420206	CCR1;TMEM127;C3AR1;RNASE6;FPR3;MPEG1;TLR2
Infantile convulsions and choreoathetosis ORPHA:31709	7/102	0.9539738447192838	0.9999961656375117	0	0	0.571352490332739	0.026921571902420206	GPR173;TCEAL7;SLITRK1;CEND1;PNMA2;FBLL1;CDK5R2
Insulinoma ORPHA:97279	7/102	0.9539738447192838	0.9999961656375117	0	0	0.571352490332739	0.026921571902420206	H2AFX;IRF2BP1;H1FX;ZBTB12;ZNF865;SOX12;HNRNPA0
Microcephaly-polymicrogyria-corpus callosum agenesis syndrome ORPHA:171703	7/102	0.9539738447192838	0.9999961656375117	0	0	0.571352490332739	0.026921571902420206	GPR174;FGFBP2;GPR65;GPR171;KCNA3;GIMAP7;C16ORF54
Musculocontractural Ehlers-Danlos syndrome ORPHA:2953	7/102	0.9539738447192838	0.9999961656375117	0	0	0.571352490332739	0.026921571902420206	CCDC71L;ITPRIPL2;B3GNT9;FZD2;MARVELD1;TWIST2;CHST14
Oguchi disease ORPHA:75382	7/102	0.9539738447192838	0.9999961656375117	0	0	0.571352490332739	0.026921571902420206	ZNF891;PGBD4;PCDHB1;TAF1L;OR7D2;PPIAL4G;GDPGP1
Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection ORPHA:431166	7/102	0.9539738447192838	0.9999961656375117	0	0	0.571352490332739	0.026921571902420206	CCR1;TLR1;SAMD9L;CXORF21;GPR65;TNFAIP8L2;CCR5
Recurrent infection due to specific granule deficiency ORPHA:169142	7/102	0.9539738447192838	0.9999961656375117	0	0	0.571352490332739	0.026921571902420206	FRAT1;FRAT2;B3GNT8;SOWAHD;RHOG;TNFAIP8L2;S1PR4
Sezary syndrome ORPHA:3162	7/102	0.9539738447192838	0.9999961656375117	0	0	0.571352490332739	0.026921571902420206	GPR174;GPR65;GPR183;GPR171;CCR5;GIMAP7;S1PR4
Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia ORPHA:632	7/102	0.9539738447192838	0.9999961656375117	0	0	0.571352490332739	0.026921571902420206	ARL11;CXORF21;PTAFR;RNASE6;RHOG;TNFAIP8L2;GAPT
Vogt-Koyanagi-Harada disease ORPHA:3437	7/102	0.9539738447192838	0.9999961656375117	0	0	0.571352490332739	0.026921571902420206	GPR174;TLR1;SAMD9L;SAMD9;GPR65;GPR183;S1PR4
Semilobar holoprosencephaly ORPHA:220386	8/114	0.9559085906685318	0.9999961656375117	0	0	0.5851049694392771	0.026384130755864075	SOX2;CLDN6;GJC1;SOX3;PCDHB2;SKIDA1;FZD7;GAS1
Congenital vertebral-cardiac-renal anomalies syndrome ORPHA:521438	7/103	0.9569902327521811	0.9999961656375117	0	0	0.5653688224079777	0.024854797141144237	ARL11;C5AR2;PTAFR;OXER1;ACSF3;MPEG1;TLR2
Familial vesicoureteral reflux ORPHA:289365	7/103	0.9569902327521811	0.9999961656375117	0	0	0.5653688224079777	0.024854797141144237	GJA1;ISLR;TRIL;GJA4;APLNR;FIBIN;CLEC14A
Idiopathic central precocious puberty ORPHA:169615	7/103	0.9569902327521811	0.9999961656375117	0	0	0.5653688224079777	0.024854797141144237	CLDN6;SOX1;VGF;NHLH1;MKRN3;FGFBP3;POU3F2
Isolated Klippel-Feil syndrome ORPHA:2345	7/103	0.9569902327521811	0.9999961656375117	0	0	0.5653688224079777	0.024854797141144237	FOXC2;GJA1;MAGEL2;GJA5;TWIST2;GAS1;CD248
NON RARE IN EUROPE: Celiac disease ORPHA:555	7/103	0.9569902327521811	0.9999961656375117	0	0	0.5653688224079777	0.024854797141144237	IGKC;CXORF21;GPR65;GPR183;RNASE6;CCR5;MPEG1
NON RARE IN EUROPE: Diabetes mellitus type 1 ORPHA:243377	7/103	0.9569902327521811	0.9999961656375117	0	0	0.5653688224079777	0.024854797141144237	IGKC;CXORF21;GPR65;GPR183;RNASE6;CCR5;MPEG1
Autosomal dominant severe congenital neutropenia ORPHA:486	7/104	0.9598272986388099	0.9999961656375117	0	0	0.5595085290796032	0.022940917209329267	CXORF21;RHOG;ANXA2R;RNASE3;TNFAIP8L2;RNASE2;S1PR4
Cranioectodermal dysplasia ORPHA:1515	7/104	0.9598272986388099	0.9999961656375117	0	0	0.5595085290796032	0.022940917209329267	ZBED8;RAB40A;TTC30B;MORF4L2;TTC30A;TRAM1L1;GPRASP2
Early-onset anterior polar cataract ORPHA:98988	7/104	0.9598272986388099	0.9999961656375117	0	0	0.5595085290796032	0.022940917209329267	ATOH7;MOS;CLDN3;FZD5;GPR119;NAT2;SSTR5
MALT lymphoma ORPHA:52417	7/104	0.9598272986388099	0.9999961656375117	0	0	0.5595085290796032	0.022940917209329267	TLR1;SAMD9L;SAMD9;GPR65;GPR183;CCR4;GPR18
Septo-optic dysplasia spectrum ORPHA:3157	7/104	0.9598272986388099	0.9999961656375117	0	0	0.5595085290796032	0.022940917209329267	SOX2;SOX3;CCDC177;MAGEL2;TMEM200C;SOX21;RPRM
Autosomal recessive Stickler syndrome ORPHA:250984	7/105	0.9624940993662543	0.9999961656375117	0	0	0.5537678335742569	0.021169073119950997	TCEAL7;MAGEL2;TCEAL5;TRIL;LRRTM1;TCEAL2;TMEM200C
Autosomal systemic lupus erythematosus ORPHA:300345	7/105	0.9624940993662543	0.9999961656375117	0	0	0.5537678335742569	0.021169073119950997	IGKC;RNASE6;IGLC3;OXER1;FPR3;IGLC2;MPEG1
Dysequilibrium syndrome ORPHA:1766	7/105	0.9624940993662543	0.9999961656375117	0	0	0.5537678335742569	0.021169073119950997	SMIM10L2B;SMIM10L2A;MAGEL2;TCEAL5;TMEM200C;FBLL1;GPRASP2
Familial glucocorticoid deficiency ORPHA:361	7/105	0.9624940993662543	0.9999961656375117	0	0	0.5537678335742569	0.021169073119950997	MC2R;PGBD4;PCDHB1;FOXL2NB;OR7D2;GDPGP1;POU5F2
Familial multiple meningioma ORPHA:263662	7/105	0.9624940993662543	0.9999961656375117	0	0	0.5537678335742569	0.021169073119950997	FZD2;MARVELD1;RNF26;ZBTB12;SOX12;ZNF358;HNRNPA0
Herpes simplex virus encephalitis ORPHA:1930	7/105	0.9624940993662543	0.9999961656375117	0	0	0.5537678335742569	0.021169073119950997	TLR1;SAMD9L;SAMD9;TREX1;TLR6;TICAM1;JUNB
Hyperphosphatasia-intellectual disability syndrome ORPHA:247262	7/105	0.9624940993662543	0.9999961656375117	0	0	0.5537678335742569	0.021169073119950997	ZBTB9;DDX28;DOLK;PIGW;PIGY;C19ORF48;TMEM187
NON RARE IN EUROPE: Ulcerative colitis ORPHA:771	7/105	0.9624940993662543	0.9999961656375117	0	0	0.5537678335742569	0.021169073119950997	CXORF21;GPR65;GPR183;TNFAIP8L2;CCR5;S1PR4;C16ORF54
Peters anomaly ORPHA:708	7/105	0.9624940993662543	0.9999961656375117	0	0	0.5537678335742569	0.021169073119950997	FOXC2;FOXE3;FOXC1;FOXD1;FZD7;TPBG;FJX1
Posterior polymorphous corneal dystrophy ORPHA:98973	7/105	0.9624940993662543	0.9999961656375117	0	0	0.5537678335742569	0.021169073119950997	ISLR;CLDN4;TMEM125;TMEM30B;TACSTD2;FAM84A;GRHL2
Transient neonatal diabetes mellitus ORPHA:99886	7/105	0.9624940993662543	0.9999961656375117	0	0	0.5537678335742569	0.021169073119950997	SMIM10L2A;TCEAL6;TCEAL5;KCNJ11;LRRTM1;KCNA5;PABPC1L2B
Combined pituitary hormone deficiencies, genetic forms ORPHA:95494	7/107	0.9673515523911616	0.9999961656375117	0	0	0.5426308842938847	0.0180117097704065	SOX2;CLDN6;SOX3;FOXD3;RAB40A;FZD5;FZD7
Early-onset posterior polar cataract ORPHA:98993	7/108	0.9695587318119498	0.9999961656375117	0	0	0.5372278098905359	0.016607982276571183	FOXC1;FOXD1;GJA3;FZD7;TRNP1;FZD8;FJX1
Isolated ATP synthase deficiency ORPHA:254913	7/108	0.9695587318119498	0.9999961656375117	0	0	0.5372278098905359	0.016607982276571183	ZNF580;DNAJC30;PCBP1;RNF208;C22ORF46;SEPHS2;ZBED3
NON RARE IN EUROPE: Crohn disease ORPHA:206	7/108	0.9695587318119498	0.9999961656375117	0	0	0.5372278098905359	0.016607982276571183	CXORF21;GPR65;GPR183;RHOH;TNFAIP8L2;S1PR4;C16ORF54
Situs ambiguus ORPHA:157769	7/109	0.9716287005449816	0.9999961656375117	0	0	0.5319306781225469	0.015309785592097495	SOX2;MAGEL2;TCEAL5;TMEM200C;LRRN1;LRRC3B;CCDC160
Presynaptic congenital myasthenic syndromes ORPHA:98914	7/110	0.9735689288823556	0.9999961656375117	0	0	0.5267364032820916	0.01410950444377263	TCEAL7;MAGEL2;LRRTM1;FBLL1;SCG2;CDK5R2;SLC18A3
Arthrogryposis-renal dysfunction-cholestasis syndrome ORPHA:2697	6/100	0.9771492724254096	0.9999961656375117	0	0	0.4947510245326447	0.011436591506829866	ZBTB9;DDX28;RNF113A;FKBPL;HPS6;HNRNPA1L2
Autosomal dominant primary hypomagnesemia with hypocalciuria ORPHA:34528	6/100	0.9771492724254096	0.9999961656375117	0	0	0.4947510245326447	0.011436591506829866	GJB1;NAT8;GCNT3;CLDN2;RNF186;SMIM6
Malignant hyperthermia of anesthesia ORPHA:423	6/100	0.9771492724254096	0.9999961656375117	0	0	0.4947510245326447	0.011436591506829866	KBTBD13;SLN;MYADML2;CTXN3;LRRC3B;LRRC30
Rh deficiency syndrome ORPHA:71275	6/100	0.9771492724254096	0.9999961656375117	0	0	0.4947510245326447	0.011436591506829866	SPN;GP9;LINC00694;DUSP21;OR2W3;OR52A5
Severe congenital nemaline myopathy ORPHA:171430	6/100	0.9771492724254096	0.9999961656375117	0	0	0.4947510245326447	0.011436591506829866	KBTBD13;PLN;SLN;XIRP1;HSPB3;LRRC30
1p21.3 microdeletion syndrome ORPHA:293948	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TLR1;SAMD9L;SAMD9;GPR65;C3AR1;TLR2
2q37 microdeletion syndrome ORPHA:1001	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TAS2R40;CYSLTR2;LINGO3;C10ORF105;P2RY14;GPRASP1
3-hydroxy-3-methylglutaryl-CoA synthase deficiency ORPHA:35701	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	CLDN3;GJB1;SOWAHB;PRR15L;NAT2;RNF186
5q14.3 microdeletion syndrome ORPHA:228384	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	P2RY12;CXORF21;C2ORF88;RNASE6;MPEG1;GAPT
ACys amyloidosis ORPHA:100008	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	THBD;MAFB;CEBPD;CDC42EP4;RNASE1;RHOB
AGel amyloidosis ORPHA:85448	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ITPRIPL2;THBD;CEBPD;CDC42EP5;RNASE1;SOD3
AXIN2-related attenuated familial adenomatous polyposis ORPHA:401911	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	SMIM10L2A;MAGEE1;AMIGO1;NAP1L3;LRRN1;GPRASP1
Acrofacial dysostosis, Rodriguez type ORPHA:1788	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	SLC35A4;ZNF581;PCBP1;RNF26;NUP62;EMC6
Acromesomelic dysplasia, Maroteaux type ORPHA:40	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TCEAL7;GJA1;ISLR;ARMCX2;PCDHB15;CD248
Alacrimia-choreoathetosis-liver dysfunction syndrome ORPHA:404454	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	GPR174;SPN;LIPT1;CNR2;RHOH;GPR18
Alpha-B crystallin-related late-onset myopathy ORPHA:399058	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TCEAL7;GJA1;ISLR;FIBIN;PCDHB4;SOD3
Amish lethal microcephaly ORPHA:99742	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	DDX28;NXT1;NUP62;KTI12;GEMIN7;RPP38
Amish nemaline myopathy ORPHA:98902	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	FOXD3;FZD2;RGS9BP;PLAC1;MAFA;TEX19
Aromatic L-amino acid decarboxylase deficiency ORPHA:35708	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	CLDN3;GJB1;PRR15L;NAT2;CLDN2;RNF186
Aspartylglucosaminuria ORPHA:93	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	C1GALT1C1;RNF113A;RPL36AL;RAB9A;MGAT2;METTL18
Ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome ORPHA:370022	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	GJC1;GJA1;MAGEL2;RAB40A;CCDC8;TMEM200C
Attenuated Chediak-Higashi syndrome ORPHA:352723	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TLR1;SAMD9L;CYSLTR2;GPR65;GPR183;GPR18
Autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation ORPHA:324611	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ZCCHC12;TCEAL5;SLITRK1;TCEAL2;CEND1;CDK5R2
Autosomal dominant Charcot-Marie-Tooth disease type 2B ORPHA:99936	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	LSM10;RRAGA;SLC35A4;PCBP1;TICAM1;SEPHS2
Autosomal dominant spastic paraplegia type 10 ORPHA:100991	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ZCCHC12;TCEAL5;SLITRK1;TCEAL2;CEND1;CDK5R2
Autosomal dominant spastic paraplegia type 6 ORPHA:100988	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	VGF;PNMA1;GPRIN1;ZNF664;CDK5R2;C5ORF30
Autosomal dominant spastic paraplegia type 73 ORPHA:444099	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	GPR173;TCEAL7;MAGEL2;CEND1;SOX11;PNMA2
Autosomal recessive ataxia, Beauce type ORPHA:88644	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	GPRIN3;LRRN3;B3GALT2;OMG;S1PR1;GPRASP1
Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency ORPHA:404493	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	PLEKHF2;ABHD13;RAB9A;SEPHS2;PNRC2;TMEM60
Autosomal recessive congenital cerebellar ataxia due to MGLUR1 deficiency ORPHA:324262	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TCEAL6;TCEAL5;NEUROD6;SLITRK1;KCNA4;LRRC3B
Autosomal recessive extra-oral halitosis ORPHA:562538	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	CLDN3;TMEM125;CDC42EP4;SOD3;ADRA2A;RHOB
Autosomal recessive myogenic arthrogryposis multiplex congenita ORPHA:319332	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	GPRIN3;LRRN3;B3GALT2;OMG;S1PR1;GPRASP1
Autosomal recessive spastic paraplegia type 44 ORPHA:320401	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	GJC2;IRF2BP1;ZNF865;ZNF358;CTXN1;CENPB
BNAR syndrome ORPHA:217266	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TCEAL7;TRIL;PABPC5;APLNR;PCDHB15;PCDHB4
Bainbridge-Ropers syndrome ORPHA:352577	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TCEAL7;MAGEL2;LRRTM1;TMEM200C;LRRC4C;SERTM1
Beta-sarcoglycan-related  limb-girdle muscular dystrophy R4 ORPHA:119	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TCEAL7;GJA1;TRAM1L1;GPRASP2;PCDHB10;PCDHB7
Bile acid CoA ligase deficiency and defective amidation ORPHA:276066	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	PGBD4;PCDHB1;C12ORF60;GDPGP1;CPN2;POU5F2
Biotinidase deficiency ORPHA:79241	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	C1GALT1C1;RRAGA;RNASE4;DOLK;ANG;TMEM187
Bowen-Conradi syndrome ORPHA:1270	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	COA4;DDX28;NXT1;TRMT10C;IMP3;GEMIN7
Brachydactyly type B1 ORPHA:572385	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	FZD7;TPBG;CCDC8;PABPC4L;GAS1;ADRA2C
Brachydactyly-syndactyly, Zhao type ORPHA:93409	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	FOXD3;FOXD1;TWIST1;PLAC1;POU3F2;CCDC140
Brain-lung-thyroid syndrome ORPHA:209905	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	FOXD3;FOXC1;FOXE1;ELFN2;CTXN1;RPRM
C1 inhibitor deficiency ORPHA:459353	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ISLR;MAFB;GJA4;APLNR;CD248;RNASE1
CIDEC-related familial partial lipodystrophy ORPHA:435651	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	RNASE4;HRCT1;ANG;THRSP;CLDN2;RNF186
CLN4B disease ORPHA:228343	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	IRF2BP1;ZNF865;ZBTB22;ABHD16B;CENPB;SPRN
Cerebrocostomandibular syndrome ORPHA:1393	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	POP7;NXT1;ZNF581;CDCA4;HNRNPF;C19ORF48
Chediak-Higashi syndrome ORPHA:167	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TLR1;SAMD9L;CYSLTR2;GPR65;GPR183;GPR18
Cholangiocarcinoma ORPHA:70567	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TMEM184A;CLDN4;SOWAHB;GJB3;CLDN12;GRHL2
Chondromyxoid fibroma ORPHA:404507	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TCEAL6;TCEAL5;NEUROD6;SLITRK1;KCNA4;LRRC3B
Chronic infantile diarrhea due to guanylate cyclase 2C overactivity ORPHA:314373	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	IGKC;MFSD6L;OXER1;FPR3;RNF186;MPEG1
Classic glucose transporter type 1 deficiency syndrome ORPHA:71277	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	CDCA4;GJB3;H2AFX;SP6;SFN;CTXN1
Coats disease ORPHA:190	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	GPR173;TCEAL7;TCEAL6;KCNA4;LRRC4C;LRRC3B
Combined immunodeficiency due to CD70 deficiency ORPHA:538958	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	FEN1;NXT1;CDCA4;NUP62;TIFA;KTI12
Combined immunodeficiency due to ORAI1 deficiency ORPHA:317428	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	FAM110A;LSM10;BLOC1S4;RHOG;S1PR4;BORCS6
Combined malonic and methylmalonic acidemia ORPHA:289504	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	SPN;CNR2;CHST12;C5AR2;ACSF3;C16ORF54
Complete cryptophthalmia ORPHA:98949	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	SOX2;SOX3;FLRT3;MUM1L1;CCDC160;RPRM
Congenital alveolar capillary dysplasia ORPHA:210122	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	C11ORF96;FOXC2;TWIST2;FIBIN;FOXL1;SSTR1
Congenital factor V deficiency ORPHA:326	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	RNASE6;FPR1;FPR2;CCR5;GIMAP7;MPEG1
Congenital limbs-face contractures-hypotonia-developmental delay syndrome ORPHA:562528	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TCEAL6;FLRT2;DSEL;PNMA2;SCG2;CDR1
Congenital muscular dystrophy with integrin alpha-7 deficiency ORPHA:34520	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	SMIM10L2B;TCEAL7;ISLR;FZD7;FIBIN;PCDHB15
Congenital myopathy with excess of thin filaments ORPHA:98904	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	KBTBD13;SLN;MYADML2;XIRP1;HSPB3;LRRC30
Congenital myopathy with reduced type 2 muscle fibers ORPHA:544602	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	KBTBD13;SLN;MYADML2;XIRP1;HSPB3;LRRC30
Congenital myopathy, Paradas type ORPHA:199329	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	THBD;CXCR1;C3AR1;FPR1;FPR2;TLR2
Congenital stromal corneal dystrophy ORPHA:101068	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ISLR;TMEM119;FIBIN;CLEC14A;CD248;SOD3
Congenital vertical talus, bilateral ORPHA:295203	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	FOXC1;FOXD1;PABPC4L;TWIST2;TWIST1;GAS1
Congenital vertical talus, unilateral ORPHA:295201	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	FOXC1;FOXD1;PABPC4L;TWIST2;TWIST1;GAS1
Craniofacial dysplasia-osteopenia syndrome ORPHA:314555	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	FOXC1;FOXD1;FZD7;TPBG;CTXN1;FJX1
Craniosynostosis, Boston type ORPHA:1541	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	FOXC1;FOXD1;FZD7;TPBG;SP6;ADRA2C
Cryptogenic multifocal ulcerous stenosing enteritis ORPHA:468635	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ITPRIPL2;TLR1;THBD;SAMD9;KCTD12;TLR6
Cystinuria type A ORPHA:93612	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	GCNT3;RNF186;GPR82;CHST5;GDPGP1;POU5F2
Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder ORPHA:477787	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ITPRIPL2;TLR1;THBD;SAMD9;KCTD12;TLR6
Diaphragmatic hernia-short bowel-asplenia syndrome ORPHA:527468	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	CCR1;TIFAB;C3AR1;FPR1;FPR2;RNASE2
Diencephalic-mesencephalic junction dysplasia ORPHA:319192	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	CLDN5;GPR34;GJA4;CLEC14A;GIMAP7;MPEG1
Dihydropyrimidine dehydrogenase deficiency ORPHA:1675	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TLR1;SAMD9L;SAMD9;GPR65;C3AR1;TLR2
Distal monosomy 15q ORPHA:1596	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	GPR174;TLR1;S1PR4;GPR18;C16ORF54;GAPT
Distal myopathy with anterior tibial onset ORPHA:178400	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	THBD;CXCR1;C3AR1;FPR1;FPR2;TLR2
Distal myopathy, Tateyama type ORPHA:488650	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	KBTBD13;SLN;MYADML2;XIRP1;HSPB3;LRRC30
Donnai-Barrow syndrome ORPHA:2143	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	SOX2;CCDC177;FUT9;TMEM200C;SLITRK3;LRRC4C
Dysferlin-related  limb-girdle muscular dystrophy R2 ORPHA:268	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	THBD;CXCR1;C3AR1;FPR1;FPR2;TLR2
Early-onset Lafora body disease ORPHA:324290	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	SAMD9L;GPR68;CDC42EP3;KCNA3;S1PR1;CHST2
East Texas bleeding disorder ORPHA:391320	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	RNASE6;FPR1;FPR2;CCR5;GIMAP7;MPEG1
FKRP-related  limb-girdle muscular dystrophy R9 ORPHA:34515	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TIGD5;FKRP;ZNF580;B3GALT6;SPRN;ZNF497
Fabry disease ORPHA:324	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	RNF113A;NXT1;C14ORF119;TAF9;KTI12;TMEM60
Familial atypical multiple mole melanoma syndrome ORPHA:404560	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ZNHIT2;FOXD1;FOXE1;CDCA4;PHLDA2;UFSP1
Familial benign flecked retina ORPHA:363989	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	OR51E1;HEPN1;GJA4;APLNR;FIBIN;CLEC14A
Familial hyperaldosteronism type III ORPHA:251274	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	NPAP1;MAS1;CYSLTR1;SSTR2;GPR82;POU5F2
Familial osteochondritis dissecans ORPHA:251262	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ISLR;FLRT2;PABPC5;TMEM119;FIBIN;CDR1
Familial steroid-resistant nephrotic syndrome with adrenal insufficiency ORPHA:506334	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	CLDN4;GJB2;SOWAHB;SOWAHC;CLDN23;GRHL2
Fatal infantile hypertonic myofibrillar myopathy ORPHA:280553	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TCEAL7;GJA1;ISLR;FIBIN;PCDHB4;SOD3
Ferro-cerebro-cutaneous syndrome ORPHA:397922	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	PLEKHF2;EXOC8;MIS12;EBLN2;ZBTB33;PNRC2
Frontonasal dysplasia-alopecia-genital anomalies syndrome ORPHA:228390	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	FOXD3;FOXC1;FOXD1;FZD9;TWIST1;ADRA2C
Frontorhiny ORPHA:391474	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	IRF2BP1;C15ORF62;TSSK6;ZBTB12;ZNF865;CCDC71
Generalized epilepsy-paroxysmal dyskinesia syndrome ORPHA:79137	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TCEAL7;ISLR;FIBIN;PCDHB4;CDR1;PCDHB7
Glutamate-cysteine ligase deficiency ORPHA:33574	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	GJB2;FZD5;SOWAHB;CLDN23;DNAJB3;KLHDC7A
Glycogen storage disease due to phosphoglycerate mutase deficiency ORPHA:97234	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	KBTBD13;SLN;MYADML2;KCNA5;HSPB3;LRRC30
Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency ORPHA:263297	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	LSM10;OST4;C14ORF119;COX14;RPP25L;TMEM60
Goldberg-Shprintzen megacolon syndrome ORPHA:66629	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ZBED8;MORF4L2;CLDN12;TRAM1L1;GPRASP2;FJX1
Hemolytic anemia due to diphosphoglycerate mutase deficiency ORPHA:714	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	PIGC;OST4;HMGN4;RNF113A;RAB9A;TMEM60
Hemolytic uremic syndrome with DGKE deficiency ORPHA:357008	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ZNF891;CYSLTR1;PGBD4;AKAP5;TIGD1;POU5F2
Hereditary angioedema type 1 ORPHA:100050	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ISLR;MAFB;GJA4;APLNR;CD248;RNASE1
Hereditary angioedema type 2 ORPHA:100051	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ISLR;MAFB;GJA4;APLNR;CD248;RNASE1
Hereditary arterial and articular multiple calcification syndrome ORPHA:289601	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ITPRIPL2;HRH1;IFNE;HRCT1;FOXL1;PHLDA1
Hereditary cryohydrocytosis with reduced stomatin ORPHA:168577	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	CDCA4;GJB3;H2AFX;SP6;SFN;CTXN1
Hereditary myopathy with lactic acidosis due to ISCU deficiency ORPHA:43115	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	DUSP22;OST4;RPL36AL;COX14;GIMAP7;SRSF8
Holt-Oram syndrome ORPHA:392	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	CHRM2;ISLR;FIBIN;CD248;HSPB3;SOD3
Hyperphenylalaninemia due to DNAJC12 deficiency ORPHA:508523	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	SLC10A5;ZBED8;MORF4L2;CLDN12;SOWAHA;CDK5R2
Hyperprolinemia type 1 ORPHA:419	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	SOX2;SMIM10L2A;CHST6;TMEM125;FUT9;SOX21
Intellectual disability, Birk-Barel type ORPHA:166108	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ZCCHC12;CCDC177;TCEAL6;NEUROD6;SLITRK1;CDK5R2
Intellectual disability-expressive aphasia-facial dysmorphism syndrome ORPHA:436151	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ARMCX4;ACKR3;LRRN1;PCDHB4;GPRASP1;CDR1
Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency ORPHA:314376	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	IGKC;MFSD6L;OXER1;FPR3;RNF186;MPEG1
Isolated asymptomatic elevation of creatine phosphokinase ORPHA:206599	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	KBTBD13;SLN;MYADML2;XIRP1;HSPB3;LRRC30
Isolated congenital megalocornea ORPHA:91489	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TCEAL7;GJA1;ISLR;TRIL;PABPC5;CDR1
Isolated delta-storage pool disease ORPHA:248340	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	SAMD9L;CXORF21;GPR65;GPR183;TNFAIP8L2;GIMAP7
Jacobsen syndrome ORPHA:2308	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	SAMD9L;CXORF21;GPR65;GPR183;TNFAIP8L2;GIMAP7
Kindler epidermolysis bullosa ORPHA:2908	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	CLDN4;FGFBP1;GJB3;TPBG;CLDN12;SFN
Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome ORPHA:447974	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	KBTBD13;PLN;SLN;XIRP1;HSPB3;LRRC30
LIMS2-related limb-girdle muscular dystrophy ORPHA:466801	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	CLDN5;ISLR;S1PR1;CLEC14A;CD248;SOD3
Laron syndrome with immunodeficiency ORPHA:220465	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	GPR174;LINGO3;TNFAIP8L2;GIMAP7;S1PR4;C16ORF54
Late-onset distal myopathy, Markesbery-Griggs type ORPHA:98912	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	KBTBD13;PLN;SLN;MYADML2;XIRP1;HSPB3
Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome ORPHA:2570	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	DDX28;RNF113A;POP7;FKBPL;SDHAF1;RPP25L
Lipoyl transferase 1 deficiency ORPHA:401862	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	LIPT1;PIGBOS1;ZNF830;RPP38;METTL18;MED7
MYBPC1-related autosomal recessive non-lethal arthrogryposis multiplex congenita syndrome ORPHA:498693	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	CHRM1;SLN;MYADML2;CTXN3;LRRC3B;LRRC30
MYO5B-related progressive familial intrahepatic cholestasis ORPHA:480491	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	CLDN4;CLDN3;TMEM125;SOWAHB;PRR15L;GRHL2
Macrocephaly-developmental delay syndrome ORPHA:397612	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ZNHIT2;POP7;ZNF581;FKBPL;RNF26;GEMIN7
Male infertility due to large-headed multiflagellar polyploid spermatozoa ORPHA:137893	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	FKBPL;KDM4D;MAGEB17;KCNE5;RNF26;GPR3
Malignant epithelial tumor of salivary glands ORPHA:276145	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	GJA1;PABPC5;PCDHB15;PCDHB5;TRAM1L1;PCDHB7
Martinique crinkled retinal pigment epitheliopathy ORPHA:466718	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	FAM110A;LSM10;DDX28;SCO2;RHOG;RPP25L
Maternal riboflavin deficiency ORPHA:411712	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	RNF222;HCAR1;PCDHB1;FUT2;OR7D2;GDPGP1
Mazabraud syndrome ORPHA:57782	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	PNMA1;RNF208;ZBTB12;SOX12;ZNF358;CTXN1
McCune-Albright syndrome ORPHA:562	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	PNMA1;RNF208;ZBTB12;SOX12;ZNF358;CTXN1
Melanoma and neural system tumor syndrome ORPHA:252206	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ZNHIT2;FOXD1;FOXE1;CDCA4;PHLDA2;UFSP1
Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria ORPHA:99646	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	FZD5;ALDH1B1;CLDN23;CLDN12;ANG;SOCS6
Methylmalonic acidemia with homocystinuria type cblF ORPHA:79284	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TLR1;ABHD13;GPR34;RNASE6;GIMAP7;KRCC1
Methylmalonic acidemia with homocystinuria, type cblC ORPHA:79282	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	KLLN;ZSWIM1;PGBD4;PDP2;TOR1AIP2;GDPGP1
Miyoshi myopathy ORPHA:45448	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	THBD;CXCR1;C3AR1;FPR1;FPR2;TLR2
Monostotic fibrous dysplasia ORPHA:93277	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	PNMA1;RNF208;ZBTB12;SOX12;ZNF358;CTXN1
Mucopolysaccharidosis-like syndrome with congenital heart defects and hematopoietic disorders ORPHA:505248	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	DDX28;MOCS3;PIGBOS1;MIS12;GEMIN7;RPP38
Multiple congenital anomalies-hypotonia-seizures syndrome type 2 ORPHA:300496	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	PLEKHF2;EXOC8;MIS12;EBLN2;ZBTB33;PNRC2
Multiple endocrine neoplasia type 4 ORPHA:276152	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	GPR174;MOAP1;FRAT1;LINGO3;SSTR3;OTUD1
Multiple epiphyseal dysplasia type 1 ORPHA:93308	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ISLR;LRRN4CL;TMEM119;FIBIN;CD248;DIRC1
NON RARE IN EUROPE: Brachydactyly type D ORPHA:93385	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	FOXD3;FOXD1;TWIST1;PLAC1;POU3F2;CCDC140
NON RARE IN EUROPE: Psoriatic arthritis ORPHA:40050	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	CXORF21;GPR65;GPR183;TNFAIP8L2;CCR5;S1PR4
Nager syndrome ORPHA:245	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	SLC35A4;ZNF581;PCBP1;RNF26;NUP62;EMC6
Nail-patella syndrome ORPHA:2614	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	NANOS1;RNF223;FOXD3;RAB6C;C6ORF141;ADRA2C
Nail-patella-like renal disease ORPHA:2613	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	NANOS1;RNF223;FOXD3;RAB6C;C6ORF141;ADRA2C
Neonatal ichthyosis-sclerosing cholangitis syndrome ORPHA:59303	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	FOXQ1;GJB2;SOWAHB;GJB3;SOWAHC;TPBG
Norrie disease ORPHA:649	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	GPR173;TCEAL7;TCEAL6;KCNA4;LRRC4C;LRRC3B
Oculotrichoanal syndrome ORPHA:2717	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TCEAL7;TRIL;PABPC5;APLNR;PCDHB15;PCDHB4
Oligodontia-cancer predisposition syndrome ORPHA:300576	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	SMIM10L2A;MAGEE1;AMIGO1;NAP1L3;LRRN1;GPRASP1
Orofaciodigital syndrome type 5 ORPHA:2919	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	PLEKHF2;LIPT1;TIFA;RHOH;ANXA2R;GPR18
Osteogenesis imperfecta type 5 ORPHA:216828	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	GPR174;GPR152;LINGO3;RXFP4;S1PR4;TRAJ1
Osteosclerotic metaphyseal dysplasia ORPHA:500548	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	NPAP1;CHST6;ZFP42;FOXL2NB;NANOGP8;VRTN
Parietal foramina with clavicular hypoplasia ORPHA:251290	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	FOXC1;FOXD1;FZD7;TPBG;SP6;ADRA2C
Paris-Trousseau thrombocytopenia ORPHA:851	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	SAMD9L;CXORF21;GPR65;GPR183;TNFAIP8L2;GIMAP7
Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity ORPHA:53583	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	CDCA4;GJB3;H2AFX;SP6;SFN;CTXN1
Paroxysmal nocturnal hemoglobinuria ORPHA:447	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	PLEKHF2;EXOC8;MIS12;EBLN2;ZBTB33;PNRC2
Pelizaeus-Merzbacher-like disease due to GJC2 mutation ORPHA:280282	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	GJC2;IRF2BP1;ZNF865;ZNF358;CTXN1;CENPB
Periodic paralysis with transient compartment-like syndrome ORPHA:397755	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	KBTBD13;SLN;MYADML2;XIRP1;HSPB3;LRRC30
Peripheral primitive neuroectodermal tumor ORPHA:370348	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	SAMD9L;CXORF21;GPR65;GPR183;TNFAIP8L2;GIMAP7
Pityriasis rubra pilaris ORPHA:2897	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TMEM184A;RNF223;RNF222;HCAR1;C5AR2;LTB4R
Poikiloderma with neutropenia ORPHA:221046	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	LSM10;SLC35A4;ZNF319;PCBP1;RNF26;RHOG
Polycythemia vera ORPHA:729	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TLR1;GP9;CYSLTR2;MPEG1;GPR18;GAPT
Polyglucosan body myopathy type 2 ORPHA:456369	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	LSM10;OST4;C14ORF119;COX14;RPP25L;TMEM60
Polymicrogyria with optic nerve hypoplasia ORPHA:250972	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	P2RY12;CLDN5;GP9;C2ORF88;GP1BA;OLIG1
Polyostotic fibrous dysplasia ORPHA:93276	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	PNMA1;RNF208;ZBTB12;SOX12;ZNF358;CTXN1
Porencephaly-microcephaly-bilateral congenital cataract syndrome ORPHA:306547	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TMEM100;TCEAL7;GJA1;MAGEL2;PABPC5;NAP1L3
Primary familial polycythemia ORPHA:90042	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	FAM110A;LSM10;ZNF581;RHOG;BORCS6;THAP11
Progressive osseous heteroplasia ORPHA:2762	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	PNMA1;RNF208;ZBTB12;SOX12;ZNF358;CTXN1
Progressive polyneuropathy with bilateral striatal necrosis ORPHA:217396	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	DDX28;NXT1;NUP62;KTI12;GEMIN7;RPP38
Progressive scapulohumeroperoneal distal myopathy ORPHA:447977	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	KBTBD13;SLN;MYADML2;XIRP1;HSPB3;LRRC30
Proximal myotonic myopathy ORPHA:606	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	HMGN4;TRMT10C;RPL36AL;HNRNPF;TAF7;PNRC2
Pseudoachondroplasia ORPHA:750	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ISLR;LRRN4CL;TMEM119;FIBIN;CD248;DIRC1
Pseudohypoparathyroidism type 1A ORPHA:79443	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	PNMA1;RNF208;ZBTB12;SOX12;ZNF358;CTXN1
Pseudohypoparathyroidism type 1C ORPHA:79444	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	PNMA1;RNF208;ZBTB12;SOX12;ZNF358;CTXN1
Pseudopseudohypoparathyroidism ORPHA:79445	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	PNMA1;RNF208;ZBTB12;SOX12;ZNF358;CTXN1
Quebec platelet disorder ORPHA:220436	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	HRH1;TPBG;FOXL1;PHLDA2;A4GALT;PHLDA1
Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome ORPHA:480864	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	C5AR2;FPR1;RHOG;FFAR2;TNFAIP8L2;TMEM140
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations ORPHA:247691	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	SCO2;TREX1;B3GALT4;RHOG;TICAM1;S1PR4
Ring dermoid of cornea ORPHA:91481	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	FOXC1;FOXD1;FZD7;TPBG;PABPC4L;TWIST1
Rippling muscle disease ORPHA:97238	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	KBTBD13;SLN;MYADML2;XIRP1;HSPB3;LRRC30
SLC39A8-CDG ORPHA:468699	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	PLEKHF2;HNRNPF;TIFA;B3GNT2;MGAT2;PNRC2
Schinzel-Giedion syndrome ORPHA:798	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ARMCX4;ACKR3;LRRN1;PCDHB4;GPRASP1;CDR1
Severe combined immunodeficiency due to LAT deficiency ORPHA:504523	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	SPN;GPR65;RHOH;CCR4;S1PR4;C16ORF54
Severe combined immunodeficiency due to LCK deficiency ORPHA:280142	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	GPR174;GPR171;RHOH;GIMAP7;S1PR4;C16ORF54
Severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome ORPHA:466688	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ARMCX4;TCEAL7;GJA1;ARMCX1;FLRT2;CDR1
Short stature due to growth hormone qualitative anomaly ORPHA:629	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	IGLC7;RHOH;TLR10;OR13A1;OR52N4;S1PR4
Short stature-advanced bone age-early-onset osteoarthritis syndrome ORPHA:435804	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ISLR;FLRT2;PABPC5;TMEM119;FIBIN;CDR1
Short stature-pituitary and cerebellar defects-small sella turcica syndrome ORPHA:85442	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	AMER1;ZBTB39;CLDN20;RBM12B;GPR75;CHML
Spondyloenchondrodysplasia ORPHA:1855	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	CCR1;C3AR1;RNASE6;FPR3;CCR5;MPEG1
Spondyloepimetaphyseal dysplasia, aggrecan type ORPHA:171866	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ISLR;FLRT2;PABPC5;TMEM119;FIBIN;CDR1
Spondyloepiphyseal dysplasia, Kimberley type ORPHA:93283	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ISLR;FLRT2;PABPC5;TMEM119;FIBIN;CDR1
Supravalvular aortic stenosis ORPHA:3193	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	ISLR;TMEM119;FIBIN;CLEC14A;CD248;SOD3
Syndactyly type 5 ORPHA:93406	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	FOXD3;FOXD1;TWIST1;PLAC1;POU3F2;CCDC140
Synpolydactyly type 1 ORPHA:295195	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	FOXD3;FOXD1;TWIST1;PLAC1;POU3F2;CCDC140
T-B+ severe combined immunodeficiency due to JAK3 deficiency ORPHA:35078	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	GPR174;GPR65;RHOH;TNFAIP8L2;S1PR4;C16ORF54
Tall stature-scoliosis-macrodactyly of the great toes syndrome ORPHA:329191	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TCEAL7;GJA1;ISLR;ARMCX2;PCDHB15;CD248
VACTERL/VATER association ORPHA:887	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	FOXD3;FOXD1;TWIST1;PLAC1;POU3F2;CCDC140
Ventriculomegaly-cystic kidney disease ORPHA:443988	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	CCDC177;SOX1;TCEAL5;LRRTM1;LRRC3B;POU3F4
X-linked Charcot-Marie-Tooth disease type 1 ORPHA:101075	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	GJB1;NAT8;SOWAHB;SOWAHA;CLDN2;RNF186
X-linked Charcot-Marie-Tooth disease type 6 ORPHA:352675	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	GPR174;GPR171;KCNA3;RHOH;GPR18;C16ORF54
X-linked intellectual disability, Stocco Dos Santos type ORPHA:85288	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	FLRT2;GJA5;GJA4;APLNR;CLEC14A;RNASE1
X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome ORPHA:324410	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	CYSLTR2;GPR183;C3AR1;RNASE6;FPR3;MPEG1
X-linked non progressive cerebellar ataxia ORPHA:314978	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TCEAL6;TCEAL5;NEUROD6;SLITRK1;LRRTM1;CDK5R2
X-linked progressive cerebellar ataxia ORPHA:1175	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	GJB1;NAT8;SOWAHB;SOWAHA;CLDN2;RNF186
X-linked retinoschisis ORPHA:792	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	AMER3;TCEAL6;NEUROD4;TCEAL5;SLITRK2;MAGEE2
Xanthinuria type II ORPHA:93602	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	TMEM184A;CLDN4;SOWAHC;CLDN12;SFN;PHLDA2
Zebra body myopathy ORPHA:97240	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	KBTBD13;SLN;MYADML2;XIRP1;HSPB3;LRRC30
Zygodactyly type 3 ORPHA:295191	6/101	0.9788153951624743	0.9999961656375117	0	0	0.48951534509095956	0.010481609737864129	FOXD3;FOXD1;TWIST1;PLAC1;POU3F2;CCDC140
Microform holoprosencephaly ORPHA:280200	7/114	0.9801709923688775	0.9999961656375117	0	0	0.5069301964138135	0.01015291990502488	CLDN6;SOX3;MAGEL2;PCDHB2;FZD7;PCDHB15;GAS1
Acromegaly ORPHA:963	6/102	0.9803679776763929	0.9999961656375117	0	0	0.48438874230430956	0.009604116245815572	LSM10;SF3B5;DPM3;RNF113A;ZNF581;GPR101
Autosomal dominant hypocalcemia ORPHA:428	6/102	0.9803679776763929	0.9999961656375117	0	0	0.48438874230430956	0.009604116245815572	SOWAHB;UCN3;CDC42EP5;CDC42EP4;SSTR1;SOWAHA
Brachydactyly type E ORPHA:93387	6/102	0.9803679776763929	0.9999961656375117	0	0	0.48438874230430956	0.009604116245815572	FOXC1;FOXD1;TPBG;TWIST1;PLAC1;FJX1
Congenital short bowel syndrome ORPHA:2301	6/102	0.9803679776763929	0.9999961656375117	0	0	0.48438874230430956	0.009604116245815572	FOXC2;FZD2;MARVELD1;TWIST2;FOXL1;VASN
Crisponi syndrome ORPHA:1545	6/102	0.9803679776763929	0.9999961656375117	0	0	0.48438874230430956	0.009604116245815572	B3GNT9;CDC42EP2;IER5L;KCTD11;PHLDA2;VASN
Cystic leukoencephalopathy without megalencephaly ORPHA:85136	6/102	0.9803679776763929	0.9999961656375117	0	0	0.48438874230430956	0.009604116245815572	LSM10;RNASE6;RHOG;COX14;TNFAIP8L2;S1PR4
Enlarged parietal foramina ORPHA:60015	6/102	0.9803679776763929	0.9999961656375117	0	0	0.48438874230430956	0.009604116245815572	FOXC1;FOXD1;FZD7;TPBG;TWIST1;ADRA2C
Hypohidrotic ectodermal dysplasia with immunodeficiency ORPHA:98813	6/102	0.9803679776763929	0.9999961656375117	0	0	0.48438874230430956	0.009604116245815572	SCO2;TREX1;RHOG;TICAM1;JUNB;S1PR4
Macrocephaly-intellectual disability-autism syndrome ORPHA:210548	6/102	0.9803679776763929	0.9999961656375117	0	0	0.48438874230430956	0.009604116245815572	KLLN;NEUROD2;GPR22;PPIAL4G;GDPGP1;POU5F2
Maffucci syndrome ORPHA:163634	6/102	0.9803679776763929	0.9999961656375117	0	0	0.48438874230430956	0.009604116245815572	CLDN3;FZD5;PRR15L;NAT2;CLDN23;ANG
Maligant granulosa cell tumor of the ovary ORPHA:99915	6/102	0.9803679776763929	0.9999961656375117	0	0	0.48438874230430956	0.009604116245815572	FOXL2NB;RBM12B;FOXL2;CHML;ZBED6;SOCS4
Multiple epiphyseal dysplasia due to collagen 9 anomaly ORPHA:166002	6/102	0.9803679776763929	0.9999961656375117	0	0	0.48438874230430956	0.009604116245815572	ENHO;C1QTNF4;TCEAL5;KCNJ10;LRRTM1;TCEAL2
Postaxial polydactyly type B ORPHA:93335	6/102	0.9803679776763929	0.9999961656375117	0	0	0.48438874230430956	0.009604116245815572	GJA1;FZD2;FZD7;PABPC4L;TWIST2;GAS1
Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome ORPHA:391408	6/102	0.9803679776763929	0.9999961656375117	0	0	0.48438874230430956	0.009604116245815572	ZBTB6;TRMT10C;FIGNL1;MIS12;ZBTB33;CMTR2
Rigid spine syndrome ORPHA:97244	6/102	0.9803679776763929	0.9999961656375117	0	0	0.48438874230430956	0.009604116245815572	KBTBD13;SLN;MYADML2;XIRP1;HSPB3;LRRC30
Sarcoidosis ORPHA:797	6/102	0.9803679776763929	0.9999961656375117	0	0	0.48438874230430956	0.009604116245815572	IGKC;RNASE6;IGLC3;IGLC2;CCR5;MPEG1
Solitary fibrous tumor/hemangiopericytoma ORPHA:2126	6/102	0.9803679776763929	0.9999961656375117	0	0	0.48438874230430956	0.009604116245815572	TOR4A;KCTD11;HPS6;MGAT1;TICAM1;JUNB
Spastic paraplegia-optic atrophy-neuropathy syndrome ORPHA:320406	6/102	0.9803679776763929	0.9999961656375117	0	0	0.48438874230430956	0.009604116245815572	GPRIN1;FLRT1;ZBTB12;SOX12;CTXN1;SPRN
Stevens-Johnson syndrome ORPHA:36426	6/102	0.9803679776763929	0.9999961656375117	0	0	0.48438874230430956	0.009604116245815572	CXORF21;GPR65;RNASE6;TNFAIP8L2;CCR5;S1PR4
Thyroid ectopia ORPHA:95712	6/102	0.9803679776763929	0.9999961656375117	0	0	0.48438874230430956	0.009604116245815572	FOXC1;FOXD1;GJA3;UCN2;KAAG1;PHLDA2
Autosomal dominant cutis laxa ORPHA:90348	6/103	0.9818140093973347	0.9999961656375117	0	0	0.4793678426678998	0.008798024186236762	GJA1;ISLR;FIBIN;GAS1;CD248;SOD3
Childhood-onset nemaline myopathy ORPHA:171439	6/103	0.9818140093973347	0.9999961656375117	0	0	0.4793678426678998	0.008798024186236762	KBTBD13;SLN;MYADML2;XIRP1;HSPB3;LRRC30
Congenital fibrosis of extraocular muscles ORPHA:45358	6/103	0.9818140093973347	0.9999961656375117	0	0	0.4793678426678998	0.008798024186236762	VGF;FBLL1;CTXN1;SCG2;FJX1;CDK5R2
Dehydrated hereditary stomatocytosis ORPHA:3202	6/103	0.9818140093973347	0.9999961656375117	0	0	0.4793678426678998	0.008798024186236762	TOR4A;RHOG;TLR6;JUNB;S1PR4;LTB4R
Distal hereditary motor neuropathy type 5 ORPHA:139536	6/103	0.9818140093973347	0.9999961656375117	0	0	0.4793678426678998	0.008798024186236762	SMIM10L2B;ZBED8;MORF4L2;FBLL1;CTXN1;SCG2
Familial medullary thyroid carcinoma ORPHA:99361	6/103	0.9818140093973347	0.9999961656375117	0	0	0.4793678426678998	0.008798024186236762	SPN;LINGO3;LRRN2;KCNA3;DNAJB8;CCR4
Familial thrombocytosis ORPHA:71493	6/103	0.9818140093973347	0.9999961656375117	0	0	0.4793678426678998	0.008798024186236762	P2RY12;GP9;C2ORF88;GP1BA;MPEG1;GAPT
Genetic recurrent myoglobinuria ORPHA:99845	6/103	0.9818140093973347	0.9999961656375117	0	0	0.4793678426678998	0.008798024186236762	SMIM10L1;TIAF1;C22ORF46;TOB2;BLCAP;ZBED3
High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement ORPHA:480541	6/103	0.9818140093973347	0.9999961656375117	0	0	0.4793678426678998	0.008798024186236762	GPR174;TLR1;CXORF21;GPR65;TNFAIP8L2;S1PR4
Isolated succinate-CoQ reductase deficiency ORPHA:3208	6/103	0.9818140093973347	0.9999961656375117	0	0	0.4793678426678998	0.008798024186236762	POP7;IMP3;SDHAF1;COX14;EMC6;RPP25L
Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome ORPHA:83473	6/103	0.9818140093973347	0.9999961656375117	0	0	0.4793678426678998	0.008798024186236762	TCEAL7;MAGEL2;ARMCX2;TCEAL2;TMEM200C;NAP1L3
Milroy disease ORPHA:79452	6/103	0.9818140093973347	0.9999961656375117	0	0	0.4793678426678998	0.008798024186236762	FOXC2;GJA1;GJC2;TWIST2;FZD8;ZNF358
NON RARE IN EUROPE: Ventricular septal defect ORPHA:1480	6/103	0.9818140093973347	0.9999961656375117	0	0	0.4793678426678998	0.008798024186236762	CLDN6;FZD2;FZD7;PABPC4L;FZD8;ADRA2C
Rolandic epilepsy ORPHA:1945	6/103	0.9818140093973347	0.9999961656375117	0	0	0.4793678426678998	0.008798024186236762	TCEAL7;TCEAL6;SLITRK1;LRRC4C;SCG2;CDR1
Squamous cell carcinoma of salivary glands ORPHA:500481	6/103	0.9818140093973347	0.9999961656375117	0	0	0.4793678426678998	0.008798024186236762	ABHD13;FRAT1;FRAT2;FFAR2;TLR6;C16ORF54
Squamous cell carcinoma of the hypopharynx ORPHA:494547	6/103	0.9818140093973347	0.9999961656375117	0	0	0.4793678426678998	0.008798024186236762	ABHD13;FRAT1;FRAT2;FFAR2;TLR6;C16ORF54
Squamous cell carcinoma of the larynx ORPHA:494550	6/103	0.9818140093973347	0.9999961656375117	0	0	0.4793678426678998	0.008798024186236762	ABHD13;FRAT1;FRAT2;FFAR2;TLR6;C16ORF54
Squamous cell carcinoma of the lip ORPHA:502366	6/103	0.9818140093973347	0.9999961656375117	0	0	0.4793678426678998	0.008798024186236762	ABHD13;FRAT1;FRAT2;FFAR2;TLR6;C16ORF54
Squamous cell carcinoma of the nasal cavity and paranasal sinuses ORPHA:500464	6/103	0.9818140093973347	0.9999961656375117	0	0	0.4793678426678998	0.008798024186236762	ABHD13;FRAT1;FRAT2;FFAR2;TLR6;C16ORF54
Squamous cell carcinoma of the oral cavity ORPHA:502363	6/103	0.9818140093973347	0.9999961656375117	0	0	0.4793678426678998	0.008798024186236762	ABHD13;FRAT1;FRAT2;FFAR2;TLR6;C16ORF54
Squamous cell carcinoma of the oropharynx ORPHA:500478	6/103	0.9818140093973347	0.9999961656375117	0	0	0.4793678426678998	0.008798024186236762	ABHD13;FRAT1;FRAT2;FFAR2;TLR6;C16ORF54
Thyroid hypoplasia ORPHA:95720	6/103	0.9818140093973347	0.9999961656375117	0	0	0.4793678426678998	0.008798024186236762	MAS1;SAMD9L;KCNJ15;GPR82;PPIAL4G;POU5F2
Early infantile epileptic encephalopathy ORPHA:1934	7/116	0.9828652964686744	0.9999961656375117	0	0	0.49757221793935186	0.008599640813280206	NEUROD2;TCEAL6;NEUROD6;SLITRK1;KCNA1;DIRAS2;CDK5R2
Alternating hemiplegia of childhood ORPHA:2131	6/104	0.9831601204422229	0.9999961656375117	0	0	0.4744494103710086	0.00805770838499476	TCEAL6;TCEAL5;SLITRK1;KCNA1;TCEAL2;LRRC3B
Familial congenital mirror movements ORPHA:238722	6/104	0.9831601204422229	0.9999961656375117	0	0	0.4744494103710086	0.00805770838499476	FAM187A;KDM4D;GPRIN1;ZBTB12;CTXN1;FJX1
Familial or sporadic hemiplegic migraine ORPHA:569	6/104	0.9831601204422229	0.9999961656375117	0	0	0.4744494103710086	0.00805770838499476	AMER3;TCEAL6;TCEAL5;FUT9;SLITRK1;LRRC3B
Hereditary hemorrhagic telangiectasia ORPHA:774	6/104	0.9831601204422229	0.9999961656375117	0	0	0.4744494103710086	0.00805770838499476	GJA4;APLNR;FPR3;CLEC14A;CD248;RNASE1
Idiopathic achalasia ORPHA:930	6/104	0.9831601204422229	0.9999961656375117	0	0	0.4744494103710086	0.00805770838499476	SPN;CYSLTR1;CNR2;C5AR2;TLR10;MPEG1
Leigh syndrome with cardiomyopathy ORPHA:70474	6/104	0.9831601204422229	0.9999961656375117	0	0	0.4744494103710086	0.00805770838499476	LSM10;SF3B5;DPM3;SCO2;COX14;RPP25L
NON RARE IN EUROPE: Alzheimer disease ORPHA:238616	6/104	0.9831601204422229	0.9999961656375117	0	0	0.4744494103710086	0.00805770838499476	PTAFR;RNASE6;OXER1;FPR3;MPEG1;TLR2
Permanent neonatal diabetes mellitus ORPHA:99885	6/104	0.9831601204422229	0.9999961656375117	0	0	0.4744494103710086	0.00805770838499476	KCNJ11;GPR119;GPR148;SOWAHA;INSM1;CDK5R2
Primary myelofibrosis ORPHA:824	6/104	0.9831601204422229	0.9999961656375117	0	0	0.4744494103710086	0.00805770838499476	TLR1;SAMD9;GP1BA;MPEG1;GAPT;TMPPE
Squamous cell carcinoma of the esophagus ORPHA:99977	6/104	0.9831601204422229	0.9999961656375117	0	0	0.4744494103710086	0.00805770838499476	TLR1;SAMD9;LPAR6;GPR65;GPR183;GPR18
Typical nemaline myopathy ORPHA:171436	6/104	0.9831601204422229	0.9999961656375117	0	0	0.4744494103710086	0.00805770838499476	KBTBD13;PLN;SLN;XIRP1;HSPB3;LRRC30
Athyreosis ORPHA:95713	6/105	0.984412592578034	0.9999961656375117	0	0	0.4696303403427414	0.007377971738032913	FOXQ1;HRH1;FGFBP1;FOXC1;FOXE1;ACTBL2
Autoimmune lymphoproliferative syndrome ORPHA:3261	6/105	0.984412592578034	0.9999961656375117	0	0	0.4696303403427414	0.007377971738032913	GPR174;GPR65;GPR171;CCR5;GIMAP7;S1PR4
Benign familial infantile epilepsy ORPHA:306	6/105	0.984412592578034	0.9999961656375117	0	0	0.4696303403427414	0.007377971738032913	TCEAL5;SLITRK1;LRRTM1;TCEAL2;PNMA2;CDK5R2
Chronic mucocutaneous candidiasis ORPHA:1334	6/105	0.984412592578034	0.9999961656375117	0	0	0.4696303403427414	0.007377971738032913	HCAR2;CCR1;HCAR3;PTAFR;CCR5;TLR2
Congenital fiber-type disproportion myopathy ORPHA:2020	6/105	0.984412592578034	0.9999961656375117	0	0	0.4696303403427414	0.007377971738032913	KBTBD13;SLN;MYADML2;XIRP1;HSPB3;LRRC30
Romano-Ward syndrome ORPHA:101016	7/118	0.9852157189252366	0.9999961656375117	0	0	0.48855146391442034	0.007276806874115204	SMIM10L2B;TCEAL7;KCNE2;TRIL;LRRTM1;KCNA4;LRRC3B
Congenital generalized lipodystrophy ORPHA:528	6/106	0.9855773717719549	0.9999961656375117	0	0	0.46490765171503956	0.0067540134621683345	CEBPD;CLDN23;RNASE4;HRCT1;ANG;PHLDA2
Essential thrombocythemia ORPHA:3318	6/106	0.9855773717719549	0.9999961656375117	0	0	0.46490765171503956	0.0067540134621683345	TLR1;SAMD9;GP1BA;TLR6;GAPT;TMPPE
Aicardi-Goutieres syndrome ORPHA:51	6/107	0.9866600800534335	0.9999961656375117	0	0	0.4602784816740249	0.0061814000731507225	CXORF21;TREX1;RHOG;ANXA2R;TNFAIP8L2;S1PR4
Narcolepsy type 1 ORPHA:2073	6/108	0.9876660281613847	0.9999961656375117	0	0	0.45574007967303015	0.00565603816475681	CXORF21;GPR65;GPR183;RNASE6;TNFAIP8L2;S1PR4
Cleft lip/palate ORPHA:199306	6/109	0.9886002279316998	0.9999961656375117	0	0	0.45128980198273433	0.005174149296170512	CLDN4;SOWAHB;GJB3;SP6;SFN;GRHL2
Malignant migrating focal seizures of infancy ORPHA:293181	6/109	0.9886002279316998	0.9999961656375117	0	0	0.45128980198273433	0.005174149296170512	AMER3;TCEAL6;FUT9;NEUROD6;SLITRK1;CDK5R2
Osteogenesis imperfecta type 4 ORPHA:216820	6/109	0.9886002279316998	0.9999961656375117	0	0	0.45128980198273433	0.005174149296170512	GJA1;ISLR;TWIST2;FIBIN;GAS1;SOD3
MERRF ORPHA:551	6/110	0.9894674050787439	0.9999961656375117	0	0	0.44692510655571344	0.004732246505047218	ZNF580;PCBP1;RNF208;C22ORF46;AHDC1;ZBED3
Dyskeratosis congenita ORPHA:1775	6/111	0.990272010838262	0.9999961656375117	0	0	0.4426435481844453	0.004327112984621835	DDX28;FEN1;NXT1;CDCA4;NUP62;C19ORF48
Postsynaptic congenital myasthenic syndromes ORPHA:98913	6/111	0.990272010838262	0.9999961656375117	0	0	0.4426435481844453	0.004327112984621835	KBTBD13;SLN;MYADML2;XIRP1;HSPB3;LRRC30
Oligodontia ORPHA:99798	6/112	0.9910182351883192	0.9999961656375117	0	0	0.43844277393338976	0.0039557815421246085	CLDN4;TPBG;KCNS3;SP6;SFN;ADRA2C
Arthrochalasia Ehlers-Danlos syndrome ORPHA:1899	5/100	0.9917233532156788	0.9999961656375117	0	0	0.40775014459224984	0.003388847495875599	GJA1;ISLR;FIBIN;CD248;SOD3
Bifunctional enzyme deficiency ORPHA:300	5/100	0.9917233532156788	0.9999961656375117	0	0	0.40775014459224984	0.003388847495875599	FZD5;SOWAHB;NAT2;CLDN12;SOCS6
Ehlers-Danlos/osteogenesis imperfecta syndrome ORPHA:230857	5/100	0.9917233532156788	0.9999961656375117	0	0	0.40775014459224984	0.003388847495875599	GJA1;ISLR;FIBIN;CD248;SOD3
HNF1B-related autosomal dominant tubulointerstitial kidney disease ORPHA:93111	5/100	0.9917233532156788	0.9999961656375117	0	0	0.40775014459224984	0.003388847495875599	GJB1;GCNT3;CLDN2;RNF186;SMIM6
Hereditary spherocytosis ORPHA:822	5/100	0.9917233532156788	0.9999961656375117	0	0	0.40775014459224984	0.003388847495875599	GP9;LINC00694;OR2W3;C2ORF88;CXCR2
Osteogenesis imperfecta type 1 ORPHA:216796	5/100	0.9917233532156788	0.9999961656375117	0	0	0.40775014459224984	0.003388847495875599	GJA1;ISLR;FIBIN;CD248;SOD3
Simpson-Golabi-Behmel syndrome ORPHA:373	5/100	0.9917233532156788	0.9999961656375117	0	0	0.40775014459224984	0.003388847495875599	SMIM10L2B;TRIL;FZD7;TMEM200C;ADRA2C
15q13.3 microdeletion syndrome ORPHA:199318	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ZNF891;ZNF70;SLITRK5;SSTR2;TIGD1
20p12.3 microdeletion syndrome ORPHA:261295	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	GJA1;FLRT3;TPBG;FZD8;SPRY2
AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome ORPHA:412069	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	RNF208;ZNF865;SOX12;ZNF358;AHDC1
Achondrogenesis type 2 ORPHA:93296	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN6;SOX3;MAGEL2;PCDHB2;TMEM200C
Acroosteolysis-keloid-like lesions-premature aging syndrome ORPHA:363665	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ISLR;FIBIN;CLEC14A;CD248;SOD3
Acute intermittent porphyria ORPHA:79276	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	FEN1;POP7;FKBPL;RNF26;C19ORF48
Adrenocortical carcinoma ORPHA:1501	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ZNF581;CDCA4;NUP62;CHST14;C19ORF48
Adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency ORPHA:329314	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	LSM10;OST4;SF3B5;NXT1;TMEM60
Amyloidosis cutis dyschromia ORPHA:319635	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CH25H;ISLR;HRH1;FPR3;SOD3
Arnold-Chiari malformation type I ORPHA:268882	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	FOXC1;TPBG;TRNP1;PHLDA2;FJX1
Athabaskan brainstem dysgenesis syndrome ORPHA:69739	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	FOXD2;NXT1;FOXD1;CDCA4;KTI12
Auditory neuropathy-optic atrophy syndrome ORPHA:542585	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ZNHIT2;POP7;FKBPL;H2AFX;C19ORF48
Autosomal dominant Charcot-Marie-Tooth disease type 2C ORPHA:99937	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CDC42EP5;CLDN23;TACSTD2;ANG;A4GALT
Autosomal dominant Charcot-Marie-Tooth disease type 2F ORPHA:99940	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	MRPL41;ZNF358;PHLDA2;A4GALT;PHLDA3
Autosomal dominant Charcot-Marie-Tooth disease type 2K ORPHA:99944	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ZCCHC12;CCDC177;VGF;SLITRK1;CDK5R2
Autosomal dominant brachyolmia ORPHA:93304	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CDC42EP5;CLDN23;TACSTD2;ANG;A4GALT
Autosomal dominant congenital benign spinal muscular atrophy ORPHA:1216	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CDC42EP5;CLDN23;TACSTD2;ANG;A4GALT
Autosomal dominant dopa-responsive dystonia ORPHA:98808	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	PLEKHF2;TIFA;B3GNT2;KIAA0040;ARF6
Autosomal dominant focal dystonia, DYT25 type ORPHA:329466	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	SOX2;SMIM10L2A;CHST6;LRRC3B;SOX21
Autosomal dominant limb-girdle muscular dystrophy type 1A ORPHA:266	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	KBTBD13;PLN;SLN;HSPB3;LRRC30
Autosomal dominant rhegmatogenous retinal detachment ORPHA:209867	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN6;SOX3;MAGEL2;PCDHB2;TMEM200C
Autosomal dominant spastic paraplegia type 12 ORPHA:100993	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	TMEM158;INAFM1;RNF208;ZNF865;ZNF358
Autosomal dominant spastic paraplegia type 17 ORPHA:100998	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	TCEAL6;TCEAL5;LRRC10B;TCEAL2;CCDC184
Autosomal recessive Charcot-Marie-Tooth disease with hoarseness ORPHA:101097	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ZCCHC12;CCDC177;VGF;SLITRK1;CDK5R2
Autosomal recessive intermediate Charcot-Marie-Tooth disease type A ORPHA:217055	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ZCCHC12;CCDC177;VGF;SLITRK1;CDK5R2
Autosomal recessive spastic paraplegia type 21 ORPHA:101001	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	LSM10;SERTAD3;C14ORF119;RHOG;TMEM60
Autosomal recessive spastic paraplegia type 26 ORPHA:101006	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	VGF;GPRIN1;CTXN1;FJX1;CDK5R2
Autosomal recessive spondylometaphyseal dysplasia, Megarbane type ORPHA:401979	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	DPM3;POP7;GEMIN7;EMC6;RPP25L
Bilateral frontoparietal polymicrogyria ORPHA:101070	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN4;TMEM125;C2CD4D;GJB3;TACSTD2
Bilateral generalized polymicrogyria ORPHA:208447	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	TCEAL6;CHRM1;PABPC1L2B;SOWAHA;CDK5R2
Bilateral microtia-deafness-cleft palate syndrome ORPHA:140963	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	FOXC2;FOXC1;FOXD1;TWIST2;FOXL1
Bleeding disorder due to CalDAG-GEFI deficiency ORPHA:420566	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	LINGO3;KCNA3;TNFAIP8L2;S1PR4;C16ORF54
Bosley-Salih-Alorainy syndrome ORPHA:69737	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	FOXD2;NXT1;FOXD1;CDCA4;KTI12
Brain dopamine-serotonin vesicular transport disease ORPHA:352649	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	GP9;GPBAR1;GP1BA;GP5;GAPT
Branchio-oculo-facial syndrome ORPHA:1297	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	FOXC1;FOXD1;TPBG;SP6;FJX1
Branchioskeletogenital syndrome ORPHA:1299	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	TCEAL7;GJA1;ISLR;PABPC5;FIBIN
CHIME syndrome ORPHA:3474	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ZNF891;CYSLTR1;PGBD4;PCDHB1;OR7D2
COG8-CDG ORPHA:95428	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	EXOSC6;PDP2;FEM1A;ZNF526;PIGM
Cardiac-valvular Ehlers-Danlos syndrome ORPHA:230851	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	GJA1;ISLR;FIBIN;CD248;SOD3
Carney complex-trismus-pseudocamptodactyly syndrome ORPHA:319340	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	KBTBD13;SLN;XIRP1;HSPB3;LRRC30
Charcot-Marie-Tooth disease type 2H ORPHA:101102	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ZCCHC12;CCDC177;VGF;SLITRK1;CDK5R2
Charcot-Marie-Tooth disease type 4A ORPHA:99948	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ZCCHC12;CCDC177;VGF;SLITRK1;CDK5R2
Childhood-onset autosomal recessive myopathy with external ophthalmoplegia ORPHA:363677	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	KBTBD13;SLN;XIRP1;HSPB3;LRRC30
Cholesteryl ester storage disease ORPHA:75234	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CCR1;TLR1;TIFAB;FPR3;CCR5
Choroid plexus carcinoma ORPHA:251899	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ZNF581;CDCA4;NUP62;CHST14;C19ORF48
Chronic myeloproliferative disease, unclassifiable ORPHA:86830	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ISLR;FIBIN;CLEC14A;CD248;SOD3
Classic multiminicore myopathy ORPHA:324604	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	KBTBD13;PLN;SLN;XIRP1;HSPB3
Clear cell renal carcinoma ORPHA:319276	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CEBPB;CEBPD;TMEM127;PTAFR;MGAT1
Cleidocranial dysplasia ORPHA:1452	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	TLR1;SAMD9L;SAMD9;C3AR1;TLR6
Combined immunodeficiency due to MALT1 deficiency ORPHA:397964	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	GPR174;GPR15;GPR183;CCR4;GPR18
Combined immunodeficiency due to partial RAG1 deficiency ORPHA:231154	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	KDM4D;TTC30A;OR10R2;RAG2;RAG1
Congenital atransferrinemia ORPHA:1195	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	HEPN1;GJB1;KCNJ10;PRR18;CPN2
Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome ORPHA:330054	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ZNHIT2;POP7;H2AFX;SDHAF1;IRF2BP1
Congenital sialidosis type 2 ORPHA:93400	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	SERTAD3;SERTAD1;DOLK;MGAT1;COMMD5
Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation ORPHA:300570	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	VGF;GPRIN1;TRNP1;CTXN1;FJX1
Cortical dysplasia-focal epilepsy syndrome ORPHA:163681	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	SOX2;CCDC177;FUT9;LRRTM1;SLITRK3
DOCK2 deficiency ORPHA:447737	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	SPN;CXORF21;GPR65;GPR183;TNFAIP8L2
Delta-sarcoglycan-related  limb-girdle muscular dystrophy R6 ORPHA:219	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	TCEAL7;ISLR;PABPC5;FIBIN;CD248
Dent disease type 1 ORPHA:93622	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	AMER1;ZBTB39;FZD5;CLDN12;SOCS6
Distal myotilinopathy ORPHA:98911	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	KBTBD13;PLN;SLN;HSPB3;LRRC30
Distal nebulin myopathy ORPHA:399103	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	NPAP1;TAS2R30;TSPYL6;TIGD1;POU5F2
Dysbetalipoproteinemia ORPHA:412	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	C11ORF96;TRIL;APLNR;RNASE1;SOD3
Dysspondyloenchondromatosis ORPHA:85198	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN6;SOX3;MAGEL2;PCDHB2;TMEM200C
Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome ORPHA:352654	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	TCEAL7;GJA1;TMEM200C;TRAM1L1;GPRASP2
Ethylmalonic encephalopathy ORPHA:51188	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	SF3B5;DPM3;SCO2;RHOG;RPP25L
FTH1-related iron overload ORPHA:247790	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CEBPB;CEBPD;PCBP1;RHOG;TICAM1
Familial GPIHBP1 deficiency ORPHA:535458	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN5;GJA4;APLNR;CLEC14A;RNASE1
Familial cavitary optic disc anomaly ORPHA:464760	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CH25H;THBD;HRH1;TMEM119;FPR3
Familial clubfoot due to 5q31 microdeletion ORPHA:293144	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	TMEM184A;CLDN4;SP6;SFN;PHLDA2
Familial clubfoot due to PITX1 point mutation ORPHA:293150	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	TMEM184A;CLDN4;SP6;SFN;PHLDA2
Familial digital arthropathy-brachydactyly ORPHA:85169	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CDC42EP5;CLDN23;TACSTD2;ANG;A4GALT
Familial hypocalciuric hypercalcemia type 1 ORPHA:93372	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	UCN3;GPR119;MFSD6L;GPR148;RNF186
Familial isolated trichomegaly ORPHA:411788	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	GJC1;FLRT2;DSEL;GPR1;BLID
Familial lipoprotein lipase deficiency ORPHA:309015	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	GJA4;APLNR;FPR3;KCNA5;RNASE1
Fucosidosis ORPHA:349	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	C1GALT1C1;CLDN23;FPR3;ANG;SEPHS2
Fuhrmann syndrome ORPHA:2854	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	GJB6;ZBED2;GCNT4;S1PR5;SSTR3
GTP cyclohydrolase I deficiency ORPHA:2102	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	PLEKHF2;TIFA;B3GNT2;KIAA0040;ARF6
Generalized glucocorticoid resistance syndrome ORPHA:786	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	TLR1;SAMD9L;SAMD9;GPR183;TLR6
Growth delay due to insulin-like growth factor type 1 deficiency ORPHA:73272	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	PLN;GPR34;APLNR;CLEC14A;RNASE1
H syndrome ORPHA:168569	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	SCO2;RNF26;RHOG;DOLK;TMEM187
Haim-Munk syndrome ORPHA:2342	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	SPN;TLR1;SAMD9L;PTAFR;TLR6
Heart defect-tongue hamartoma-polysyndactyly syndrome ORPHA:1338	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	NPAP1;ZNF891;CYSLTR1;TIGD1;POU5F2
Heme oxygenase-1 deficiency ORPHA:562509	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CEBPB;CEBPD;TMEM127;ANG;MGAT1
Hemolytic anemia due to adenylate kinase deficiency ORPHA:86817	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	MRPL41;HRCT1;HSPB3;ZNF358;POMGNT2
Hereditary fructose intolerance ORPHA:469	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	GJB1;NAT8;NAT2;CLDN2;RNF186
Hereditary inclusion body myopathy-joint contractures-ophthalmoplegia syndrome ORPHA:79091	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	KBTBD13;SLN;XIRP1;HSPB3;LRRC30
Hereditary neuroendocrine tumor of small intestine ORPHA:456333	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	PLEKHF2;ABHD13;ZBTB6;EXOC8;ZBTB33
Hereditary pediatric Behcet-like disease ORPHA:476102	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	TLR1;SAMD9L;SAMD9;GPR183;JUNB
Hereditary thrombocytopenia with early-onset myelofibrosis ORPHA:480851	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	PPP1R26;H1F0;CDC42EP4;CLDN23;ZNF358
Hermansky-Pudlak syndrome type 7 ORPHA:231531	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	LSM10;RNF113A;PCBP1;RHOG;TBCC
Huntington disease-like 2 ORPHA:98934	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	KCNJ4;ZCCHC12;CCDC177;PABPC1L2B;CDK5R2
Hydranencephaly ORPHA:2177	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ZNF526;RHOG;ANXA2R;TLR6;LTB4R
Hyper-IgM syndrome type 3 ORPHA:101090	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	TLR1;IGKC;PTAFR;RNASE6;MPEG1
Hyperzincemia and hypercalprotectinemia ORPHA:251523	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CXORF21;GPR65;TNFAIP8L2;S1PR4;C16ORF54
Hypochondrogenesis ORPHA:93297	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN6;SOX3;MAGEL2;PCDHB2;TMEM200C
Immune thrombocytopenia ORPHA:3002	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CCR1;RNASE6;FPR1;MPEG1;GAPT
Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome ORPHA:522077	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	KCNF1;SLITRK1;PNMA2;SCG2;CDK5R2
Infantile systemic hyalinosis ORPHA:2176	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	SMIM3;SAMD9L;CDC42EP3;C3AR1;G0S2
Infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia ORPHA:572428	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CCR1;TLR1;SAMD9L;SAMD9;PTAFR
Juvenile hyaline fibromatosis ORPHA:2028	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	SMIM3;SAMD9L;CDC42EP3;C3AR1;G0S2
Juvenile sialidosis type 2 ORPHA:93399	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	SERTAD3;SERTAD1;DOLK;MGAT1;COMMD5
Keutel syndrome ORPHA:85202	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ISLR;GJA5;FIBIN;CLEC14A;SOD3
Kniest dysplasia ORPHA:485	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN6;SOX3;MAGEL2;PCDHB2;TMEM200C
L-Arginine:glycine amidinotransferase deficiency ORPHA:35704	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	GJB1;KCNJ10;APLNR;PRR18;RNASE1
Legg-Calve-Perthes disease ORPHA:2380	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN6;SOX3;MAGEL2;PCDHB2;TMEM200C
Lethal arteriopathy syndrome due to fibulin-4 deficiency ORPHA:314718	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ISLR;FIBIN;CD248;SOD3;VASN
Lethal brain and heart developmental defects ORPHA:580933	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ZNHIT2;ZNF581;ZNF865;ABHD16B;ADAT3
Lethal multiple pterygium syndrome ORPHA:33108	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	KBTBD13;MRLN;SLN;XIRP1;LRRC30
Leukocyte adhesion deficiency type II ORPHA:99843	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ZNHIT2;RNF26;ZBTB42;DOLK;HPS6
Leukocyte adhesion deficiency type III ORPHA:99844	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	SPN;CXORF21;GPR65;TNFAIP8L2;S1PR4
Lipoprotein glomerulopathy ORPHA:329481	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	C11ORF96;TRIL;APLNR;RNASE1;SOD3
MT-ATP6-related mitochondrial spastic paraplegia ORPHA:320360	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ZNF580;PCBP1;RNF208;C22ORF46;ZBED3
Machado-Joseph disease type 1 ORPHA:276238	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	NPAP1;ZNF891;OR11A1;TIGD1;POU5F2
Machado-Joseph disease type 2 ORPHA:276241	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	NPAP1;ZNF891;OR11A1;TIGD1;POU5F2
Machado-Joseph disease type 3 ORPHA:276244	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	NPAP1;ZNF891;OR11A1;TIGD1;POU5F2
Macular corneal dystrophy ORPHA:98969	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	SOX2;CHST6;APOBEC4;FUT2;CCDC160
Majeed syndrome ORPHA:77297	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	GPR174;GPR65;GPR171;KCNA3;GIMAP7
Megacystis-microcolon-intestinal hypoperistalsis syndrome ORPHA:2241	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ISLR;PLN;FIBIN;CLEC14A;SOD3
Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome ORPHA:2504	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	TLR1;SAMD9L;SAMD9;C3AR1;TLR6
Metatropic dysplasia ORPHA:2635	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CDC42EP5;CLDN23;TACSTD2;ANG;A4GALT
Microcornea-myopic chorioretinal atrophy-telecanthus syndrome ORPHA:369970	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	TCEAL7;GJA1;MAGEL2;FLRT2;CDR1
Microtia ORPHA:83463	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	FOXC2;FOXC1;FOXD1;TWIST2;FOXL1
Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis ORPHA:93279	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN6;SOX3;MAGEL2;PCDHB2;TMEM200C
Mirror-image polydactyly ORPHA:498494	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	TMEM184A;CLDN4;SP6;SFN;PHLDA2
Mitochondrial DNA depletion syndrome, encephalomyopathic form with renal tubulopathy ORPHA:255235	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	C1GALT1C1;ZBTB6;CMTR2;ZNF322;SOCS4
Mitochondrial DNA depletion syndrome, hepatocerebral form due to DGUOK deficiency ORPHA:279934	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	LSM10;OST4;SF3B5;NXT1;TMEM60
Multiple endocrine neoplasia type 2A ORPHA:247698	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	GPR27;SOX3;KCNF1;PABPC1L2B;ADRA2C
Multiple endocrine neoplasia type 2B ORPHA:247709	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	GPR27;SOX3;KCNF1;PABPC1L2B;ADRA2C
Multiple epiphyseal dysplasia, Beighton type ORPHA:166011	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN6;SOX3;MAGEL2;PCDHB2;TMEM200C
Multisystemic smooth muscle dysfunction syndrome ORPHA:404463	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ISLR;FIBIN;CLEC14A;CD248;SOD3
Myeloid/lymphoid neoplasm associated with PDGFRB rearrangement ORPHA:168950	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ISLR;FIBIN;CLEC14A;CD248;SOD3
Myeloperoxidase deficiency ORPHA:2587	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CXORF21;RNASE3;FPR2;RNASE2;GAPT
NARP syndrome ORPHA:644	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ZNF580;PCBP1;RNF208;C22ORF46;ZBED3
NDE1-related microhydranencephaly ORPHA:443162	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ZNF526;RHOG;ANXA2R;TLR6;LTB4R
NON RARE IN EUROPE: Immunoglobulin A deficiency ORPHA:69127	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	IGKC;IGLC3;RHOH;TLR10;IGLC2
Neurodegenerative syndrome due to cerebral folate transport deficiency ORPHA:217382	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN4;CLDN3;TMEM125;GJB3;SFN
OBSOLETE: Alpha-1-antichymotrypsin deficiency ORPHA:93594	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	GJB1;SOWAHB;FLRT3;PCDHB4;SOD3
Odonto-onycho-dermal dysplasia ORPHA:2721	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	GPR15;LPAR5;ZBED2;KLHDC7B;S1PR4
Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome ORPHA:543470	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ZNHIT2;POP7;FKBPL;H2AFX;C19ORF48
Orofaciodigital syndrome type 14 ORPHA:434179	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ZNF891;CYSLTR1;ZNF70;TIGD1;POU5F2
Orofaciodigital syndrome type 4 ORPHA:2753	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ZBTB9;TMEM177;C1GALT1C1;TMEM99;DOLK
Osteopathia striata-cranial sclerosis syndrome ORPHA:2780	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	AMER1;ZBTB39;RBM12B;ZBTB12;ZBTB5
PDE4D haploinsufficiency syndrome ORPHA:439822	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	GPRIN3;CYSLTR2;LRRN3;B3GALT2;GPR22
Papilloma of choroid plexus ORPHA:2807	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ZNF581;CDCA4;NUP62;CHST14;C19ORF48
Papillon-Lefevre ORPHA:678	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	SPN;TLR1;SAMD9L;PTAFR;TLR6
Parastremmatic dwarfism ORPHA:2646	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CDC42EP5;CLDN23;TACSTD2;ANG;A4GALT
Phocomelia, Schinzel type ORPHA:2879	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	GJB6;ZBED2;GCNT4;S1PR5;SSTR3
Pitt-Hopkins syndrome ORPHA:2896	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ARMCX4;ZNF660;TCEAL7;FLRT2;CDR1
Platyspondylic dysplasia, Torrance type ORPHA:85166	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN6;SOX3;MAGEL2;PCDHB2;TMEM200C
Predisposition to invasive fungal disease due to CARD9 deficiency ORPHA:457088	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	LINGO3;SOWAHD;RHOG;GPBAR1;ABHD16B
Predisposition to severe viral infection due to IRF7 deficiency ORPHA:574918	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	TREX1;B3GALT4;RHOG;JUNB;S1PR4
Primary dystonia, DYT27 type ORPHA:464440	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ISLR;TMEM119;FIBIN;CD248;SOD3
Progressive myoclonic epilepsy type 3 ORPHA:263516	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	MLLT11;C3ORF18;LRRN3;ZCCHC18;GPRASP1
Progressive myoclonic epilepsy type 8 ORPHA:424027	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	VGF;FZD9;FBLL1;POU3F2;CTXN1
Pseudohypoaldosteronism type 2D ORPHA:300525	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	GPRIN3;ARMCX4;LRRN3;S1PR1;GPRASP1
Purine nucleoside phosphorylase deficiency ORPHA:760	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	NXT1;CDCA4;HNRNPF;KTI12;MGAT2
Pycnodysostosis ORPHA:763	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ISLR;TMEM119;ACKR4;CD248;SOD3
Pyogenic arthritis-pyoderma gangrenosum-acne syndrome ORPHA:69126	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CXORF21;GPR65;TNFAIP8L2;S1PR4;C16ORF54
Renal coloboma syndrome ORPHA:1475	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ZCCHC12;ADRA2C;POU3F3;CDK5R2;NEUROG2
Revesz syndrome ORPHA:3088	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	TREX1;B3GALT4;RHOG;TNFAIP8L2;S1PR4
Richieri Costa-Pereira syndrome ORPHA:3102	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	FEN1;NXT1;CDCA4;HNRNPF;C19ORF48
SIX2-related frontonasal dysplasia ORPHA:488437	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	FOXC1;TPBG;PABPC4L;FZD8;A4GALT
Scapuloperoneal spinal muscular atrophy ORPHA:431255	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CDC42EP5;CLDN23;TACSTD2;ANG;A4GALT
Schopf-Schulz-Passarge syndrome ORPHA:50944	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	GPR15;LPAR5;ZBED2;KLHDC7B;S1PR4
Sea-blue histiocytosis ORPHA:158029	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	C11ORF96;TRIL;APLNR;RNASE1;SOD3
Severe combined immunodeficiency due to CARMIL2 deficiency ORPHA:542301	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	GPR174;LINGO3;KCNA3;SSTR3;S1PR4
Severe congenital hypochromic anemia with ringed sideroblasts ORPHA:300298	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	PPP1R26;MARVELD1;CDC42EP4;PHLDA2;A4GALT
Severe hypotonia-psychomotor developmental delay-strabismus-cardiac septal defect syndrome ORPHA:467176	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	LIPT1;RNF113A;RHOH;ZNF830;C16ORF54
Severe neurodegenerative syndrome with lipodystrophy ORPHA:363400	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	TCEAL6;TCEAL5;LRRC10B;TCEAL2;CCDC184
Sialidosis type 1 ORPHA:812	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	SERTAD3;SERTAD1;DOLK;MGAT1;COMMD5
Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome ORPHA:477831	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	ISLR;FIBIN;CLEC14A;CD248;SOD3
Spheroid body myopathy ORPHA:268129	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	KBTBD13;PLN;SLN;HSPB3;LRRC30
Spinocerebellar ataxia type 17 ORPHA:98759	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	RNF113A;NXT1;KTI12;ZNF830;RPP38
Spinocerebellar ataxia type 27 ORPHA:98764	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	TCEAL7;FIBIN;PCDHB4;SCG2;CDR1
Spondyloepimetaphyseal dysplasia congenita, Strudwick type ORPHA:93346	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN6;SOX3;MAGEL2;PCDHB2;TMEM200C
Spondyloepiphyseal dysplasia congenita ORPHA:94068	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN6;SOX3;MAGEL2;PCDHB2;TMEM200C
Spondyloepiphyseal dysplasia with metatarsal shortening ORPHA:137678	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN6;SOX3;MAGEL2;PCDHB2;TMEM200C
Spondyloepiphyseal dysplasia, Maroteaux type ORPHA:263482	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CDC42EP5;CLDN23;TACSTD2;ANG;A4GALT
Spondyloepiphyseal dysplasia, Stanescu type ORPHA:459051	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN6;SOX3;MAGEL2;PCDHB2;TMEM200C
Spondylometaphyseal dysplasia, Kozlowski type ORPHA:93314	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CDC42EP5;CLDN23;TACSTD2;ANG;A4GALT
Spondylometaphyseal dysplasia, Schmidt type ORPHA:93316	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN6;SOX3;MAGEL2;PCDHB2;TMEM200C
Spondyloperipheral dysplasia-short ulna syndrome ORPHA:1856	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN6;SOX3;MAGEL2;PCDHB2;TMEM200C
Stickler syndrome type 1 ORPHA:90653	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN6;SOX3;MAGEL2;PCDHB2;TMEM200C
TCR-alpha-beta-positive T-cell deficiency ORPHA:397959	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	GPR174;GPR65;GPR171;GIMAP7;S1PR4
Thiamine-responsive megaloblastic anemia syndrome ORPHA:49827	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	TIGD2;MORF4L2;FZD7;CLDN12;SOCS6
Transaldolase deficiency ORPHA:101028	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	FAM110A;LSM10;SCO2;RHOG;COMMD5
Trismus-pseudocamptodactyly syndrome ORPHA:3377	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	KBTBD13;SLN;XIRP1;HSPB3;LRRC30
Von Willebrand disease type 1 ORPHA:166078	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN5;GJA4;APLNR;CLEC14A;RNASE1
Von Willebrand disease type 2A ORPHA:166084	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN5;GJA4;APLNR;CLEC14A;RNASE1
Von Willebrand disease type 2B ORPHA:166087	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN5;GJA4;APLNR;CLEC14A;RNASE1
Von Willebrand disease type 2M ORPHA:166090	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN5;GJA4;APLNR;CLEC14A;RNASE1
Von Willebrand disease type 2N ORPHA:166093	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN5;GJA4;APLNR;CLEC14A;RNASE1
Von Willebrand disease type 3 ORPHA:166096	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN5;GJA4;APLNR;CLEC14A;RNASE1
Wolman disease ORPHA:75233	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CCR1;TLR1;TIFAB;FPR3;CCR5
X-linked agammaglobulinemia ORPHA:47	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CXORF21;RNASE6;TNFAIP8L2;MPEG1;GAPT
X-linked central congenital hypothyroidism with late-onset testicular enlargement ORPHA:329235	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	CLDN6;SOX3;PCDHB2;FUT9;SKIDA1
X-linked intellectual disability, Nascimento type ORPHA:163956	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	C1GALT1C1;C14ORF119;TAF9;RAB9A;TMEM60
X-linked severe congenital neutropenia ORPHA:86788	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	SPN;CXORF21;GPR65;TNFAIP8L2;S1PR4
X-linked spondyloepimetaphyseal dysplasia ORPHA:93349	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	GJA1;ISLR;FIBIN;CLEC14A;SOD3
X-linked thrombocytopenia with normal platelets ORPHA:852	5/101	0.9923956286813549	0.9999961656375117	0	0	0.4034798534798535	0.003079936012513534	SPN;CXORF21;GPR65;TNFAIP8L2;S1PR4
NON RARE IN EUROPE: Autism ORPHA:106	6/115	0.9929448443489908	0.9999961656375117	0	0	0.4263029217399724	0.0030182932959042243	CCDC177;TCEAL5;FUT9;SLITRK1;TCEAL2;SLITRK3
Antley-Bixler syndrome ORPHA:83	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	CLDN3;TMEM125;SOWAHB;CDC42EP4;KLHDC7A
Atrial standstill ORPHA:1344	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	KCNJ4;MYADML2;XIRP1;HSPB3;LRRC10
Autosomal dominant otospondylomegaepiphyseal dysplasia ORPHA:166100	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	CLDN6;SOX3;MAGEL2;ZBTB12;SOX12
Axenfeld anomaly ORPHA:98978	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	FOXC1;FOXD1;FZD7;TPBG;FJX1
Axenfeld-Rieger syndrome ORPHA:782	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	FOXC1;FOXD1;FZD7;TPBG;FJX1
Benign familial neonatal-infantile seizures ORPHA:140927	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	CCDC177;TCEAL5;SLITRK1;SLITRK3;CDK5R2
Brachydactyly-elbow wrist dysplasia syndrome ORPHA:1275	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	TMEM184A;CLDN4;SP6;SFN;PHLDA2
Congenital communicating hydrocephalus ORPHA:269505	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	CLDN6;GJA1;PCDHB2;TMEM200C;PCDHB15
Congenital sodium diarrhea ORPHA:103908	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	PRR15L;MFSD6L;CLDN23;RNF186;FUT3
Dubowitz syndrome ORPHA:235	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	ZBTB6;FIGNL1;PIGW;SOCS4;ZNF146
Gitelman syndrome ORPHA:358	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	CLDN6;KCNJ12;KLHDC7A;RNF183;RPRM
Hereditary mixed polyposis syndrome ORPHA:157794	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	GJC1;GJA1;FLRT2;DSEL;FIBIN
Hereditary renal hypouricemia ORPHA:94088	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	TLR1;NAT8;RNASE6;MPEG1;TLR2
Hypertrichotic osteochondrodysplasia, Cantu type ORPHA:1517	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	ISLR;PLN;APLNR;FIBIN;CDR1
Infantile myofibromatosis ORPHA:2591	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	GJA1;ISLR;FIBIN;CD248;SOD3
Isolated anencephaly ORPHA:563609	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	BEX4;SMIM10L2A;NDN;LRRN1;AHDC1
Isolated exencephaly ORPHA:563612	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	BEX4;SMIM10L2A;NDN;LRRN1;AHDC1
Large congenital melanocytic nevus ORPHA:626	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	ZBTB9;FEN1;MC1R;CDCA4;C19ORF48
Loeys-Dietz syndrome ORPHA:60030	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	TLR1;SOCS3;SAMD9L;SAMD9;TLR6
Mitochondrial myopathy and sideroblastic anemia ORPHA:2598	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	FEN1;CDCA4;RRS1;PIGW;C19ORF48
NON RARE IN EUROPE: Idiopathic infantile nystagmus ORPHA:651	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	SOX3;PCDHB5;PCDHB3;GRHL2;CCDC160
Otofaciocervical syndrome ORPHA:2792	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	SLITRK2;GPR85;FAM181B;SOX11;CCDC160
Paternal uniparental disomy of chromosome 6 ORPHA:96191	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	THBD;MYADM;TMEM119;CD248;KCTD12
Periodic paralysis with later-onset distal motor neuropathy ORPHA:397750	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	ZNF580;PCBP1;RNF208;C22ORF46;ZBED3
Persistent Mullerian duct syndrome ORPHA:2856	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	H2AFX;ZBTB12;SOX12;CTXN1;TEX19
Piebaldism ORPHA:2884	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	GJA1;ISLR;TMEM246;FIBIN;GAS1
Posterior hypospadias ORPHA:95706	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	DSEL;PCDHB5;PCDHB4;PCDHB10;PCDHB7
Rieger anomaly ORPHA:91483	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	FOXC1;FOXD1;FZD7;TPBG;FJX1
X-linked Emery-Dreifuss muscular dystrophy ORPHA:98863	5/102	0.9930155968370475	0.9999961656375117	0	0	0.399297609606888	0.0027986403204710484	INAFM1;LDOC1;ZNF358;POMGNT2;DEXI
Systemic lupus erythematosus ORPHA:536	7/128	0.9930772840016902	0.9999961656375117	0	0	0.4479207949591504	0.003111611323926208	TLR1;GPR65;TREX1;RNASE6;TNFAIP8L2;CCR5;S1PR4
46,XX ovotesticular disorder of sex development ORPHA:2138	5/103	0.9935870925858634	0.9999961656375117	0	0	0.3952007176496972	0.0025425469129168954	CLDN6;FLRT3;FAM43B;SRY;ADRA2C
Autosomal recessive centronuclear myopathy ORPHA:169186	5/103	0.9935870925858634	0.9999961656375117	0	0	0.3952007176496972	0.0025425469129168954	SLN;KLHL34;KCNA5;GPRASP1;LRRC3B
Hereditary elliptocytosis ORPHA:288	5/103	0.9935870925858634	0.9999961656375117	0	0	0.3952007176496972	0.0025425469129168954	SPN;GP9;LINC00694;OR2W3;GAPT
Immunodeficiency by defective expression of MHC class II ORPHA:572	5/103	0.9935870925858634	0.9999961656375117	0	0	0.3952007176496972	0.0025425469129168954	DDX28;RNF113A;NUP62;ANXA2R;S1PR4
Intermediate nemaline myopathy ORPHA:171433	5/103	0.9935870925858634	0.9999961656375117	0	0	0.3952007176496972	0.0025425469129168954	KBTBD13;SLN;XIRP1;HSPB3;LRRC30
Leber plus disease ORPHA:99718	5/103	0.9935870925858634	0.9999961656375117	0	0	0.3952007176496972	0.0025425469129168954	ZNF580;PCBP1;RNF208;C22ORF46;ZBED3
Takayasu arteritis ORPHA:3287	5/103	0.9935870925858634	0.9999961656375117	0	0	0.3952007176496972	0.0025425469129168954	CXORF21;GPR65;RHOG;TNFAIP8L2;S1PR4
UV-sensitive syndrome ORPHA:178338	5/103	0.9935870925858634	0.9999961656375117	0	0	0.3952007176496972	0.0025425469129168954	TAS2R30;RBM12B;EBLN2;ZBED6;TMPPE
Waardenburg-Shah syndrome ORPHA:897	5/103	0.9935870925858634	0.9999961656375117	0	0	0.3952007176496972	0.0025425469129168954	ISLR;TRIL;APLNR;RNASE1;SOD3
Weill-Marchesani syndrome ORPHA:3449	5/103	0.9935870925858634	0.9999961656375117	0	0	0.3952007176496972	0.0025425469129168954	GJA1;ISLR;TWIST2;FIBIN;CD248
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy ORPHA:155	6/117	0.9940034634771893	0.9999961656375117	0	0	0.4185742470702893	0.0025175516218321017	KBTBD13;PLN;SLN;MYADML2;XIRP1;HSPB3
Normosmic congenital hypogonadotropic hypogonadism ORPHA:432	6/117	0.9940034634771893	0.9999961656375117	0	0	0.4185742470702893	0.0025175516218321017	CLDN6;SOX3;ZCCHC12;MAGEL2;TCEAL5;FBLL1
Autosomal dominant Robinow syndrome ORPHA:3107	5/104	0.9941136937866755	0.9999961656375117	0	0	0.39118659118659116	0.0023094478087242556	FZD2;MARVELD1;FZD7;ZNF358;FJX1
Autosomal recessive hypohidrotic ectodermal dysplasia ORPHA:248	5/104	0.9941136937866755	0.9999961656375117	0	0	0.39118659118659116	0.0023094478087242556	FAM110A;HCAR2;HCAR3;ZBED2;KLHDC7B
Familial thyroid dyshormonogenesis ORPHA:95716	5/104	0.9941136937866755	0.9999961656375117	0	0	0.39118659118659116	0.0023094478087242556	B3GNT6;GCNT3;ACKR2;FUT2;FUT3
Iminoglycinuria ORPHA:42062	5/104	0.9941136937866755	0.9999961656375117	0	0	0.39118659118659116	0.0023094478087242556	PCDHB1;GCNT3;RNF186;CHST5;GDPGP1
Isolated brachycephaly ORPHA:35099	5/104	0.9941136937866755	0.9999961656375117	0	0	0.39118659118659116	0.0023094478087242556	GJA1;FZD7;PCDHB15;TWIST1;PCDHB10
Isolated plagiocephaly ORPHA:35098	5/104	0.9941136937866755	0.9999961656375117	0	0	0.39118659118659116	0.0023094478087242556	GJA1;FZD7;PCDHB15;TWIST1;PCDHB10
Sheldon-Hall syndrome ORPHA:1147	5/104	0.9941136937866755	0.9999961656375117	0	0	0.39118659118659116	0.0023094478087242556	SLN;XIRP1;CD248;HSPB3;LRRC30
Systemic-onset juvenile idiopathic arthritis ORPHA:85414	5/104	0.9941136937866755	0.9999961656375117	0	0	0.39118659118659116	0.0023094478087242556	SCO2;RHOG;MGAT1;TICAM1;JUNB
Atypical Rett syndrome ORPHA:3095	5/105	0.9945987354112276	0.9999961656375117	0	0	0.3872527472527473	0.0020973237636305	TCEAL6;SLITRK1;PNMA2;LRRC4C;CDR1
Autosomal agammaglobulinemia ORPHA:33110	5/105	0.9945987354112276	0.9999961656375117	0	0	0.3872527472527473	0.0020973237636305	GPR174;IGKC;IGLC3;IGLC2;S1PR4
Autosomal dominant macrothrombocytopenia ORPHA:140957	5/105	0.9945987354112276	0.9999961656375117	0	0	0.3872527472527473	0.0020973237636305	GP9;LINC00694;OR2W3;GP1BA;GP5
Coloboma of choroid and retina ORPHA:98942	5/105	0.9945987354112276	0.9999961656375117	0	0	0.3872527472527473	0.0020973237636305	FZD5;GPRIN1;CTXN1;ZNF664;FJX1
Coloboma of iris ORPHA:98944	5/105	0.9945987354112276	0.9999961656375117	0	0	0.3872527472527473	0.0020973237636305	FZD5;GPRIN1;CTXN1;ZNF664;FJX1
Distal arthrogryposis type 1 ORPHA:1146	5/105	0.9945987354112276	0.9999961656375117	0	0	0.3872527472527473	0.0020973237636305	KBTBD13;SLN;XIRP1;HSPB3;LRRC30
Fatal infantile cytochrome C oxidase deficiency ORPHA:1561	5/105	0.9945987354112276	0.9999961656375117	0	0	0.3872527472527473	0.0020973237636305	COA4;TRMT10C;IMP3;SCO2;RPP25L
Fetal and neonatal alloimmune thrombocytopenia ORPHA:853	5/105	0.9945987354112276	0.9999961656375117	0	0	0.3872527472527473	0.0020973237636305	GP9;TMEM158;OR2W3;GP1BA;GP5
Fuchs endothelial corneal dystrophy ORPHA:98974	5/105	0.9945987354112276	0.9999961656375117	0	0	0.3872527472527473	0.0020973237636305	ARMCX4;ISLR;FLRT2;TMEM119;FIBIN
Isolated split hand-split foot malformation ORPHA:2440	5/105	0.9945987354112276	0.9999961656375117	0	0	0.3872527472527473	0.0020973237636305	FOXG1;POU3F1;SOX21;POU3F2;CDK5R1
Uveal melanoma ORPHA:39044	5/105	0.9945987354112276	0.9999961656375117	0	0	0.3872527472527473	0.0020973237636305	CYSLTR2;LRRC4;KCTD12;GPRASP1;KBTBD11
Childhood absence epilepsy ORPHA:64280	5/106	0.9950453243438289	0.9999961656375117	0	0	0.3833968012185834	0.0019043283677854337	CCDC177;FUT9;SLITRK1;LRRTM1;CDK5R2
Catecholaminergic polymorphic ventricular tachycardia ORPHA:3286	5/107	0.9954563526261557	0.9999961656375117	0	0	0.37961646196940313	0.0017287737906912127	PLN;TRIL;KCNA4;LRRC3B;RAB9B
Hereditary clear cell renal cell carcinoma ORPHA:422526	5/107	0.9954563526261557	0.9999961656375117	0	0	0.37961646196940313	0.0017287737906912127	CXORF21;GPR65;C5AR2;TNFAIP8L2;C16ORF54
Neuroblastoma ORPHA:635	5/107	0.9954563526261557	0.9999961656375117	0	0	0.37961646196940313	0.0017287737906912127	CCDC177;SKIDA1;SOX11;POU3F2;SLC18A3
Renal agenesis, unilateral ORPHA:93100	5/107	0.9954563526261557	0.9999961656375117	0	0	0.37961646196940313	0.0017287737906912127	FLRT3;TRIL;MUM1L1;PCDHB15;PCDHB3
Precursor B-cell acute lymphoblastic leukemia ORPHA:99860	6/121	0.9956839979706263	0.9999961656375117	0	0	0.4039233681312378	0.0017471070533024646	GPR174;IGKC;IGLC3;KCNA3;IGLC2;MPEG1
Coffin-Siris syndrome ORPHA:1465	5/108	0.9958345107190372	0.9999961656375117	0	0	0.37590952736583805	0.0015691174514067764	ZBTB39;SOX11;SOX12;SOX4;ZBED4
Colobomatous microphthalmia ORPHA:98938	5/108	0.9958345107190372	0.9999961656375117	0	0	0.37590952736583805	0.0015691174514067764	GJA1;MAGEL2;PCDHB2;FLRT3;PCDHB15
Generalized epilepsy with febrile seizures-plus ORPHA:36387	5/108	0.9958345107190372	0.9999961656375117	0	0	0.37590952736583805	0.0015691174514067764	TCEAL6;TCEAL5;NEUROD6;SLITRK1;SLITRK3
Mitochondrial non-syndromic sensorineural deafness ORPHA:90641	5/108	0.9958345107190372	0.9999961656375117	0	0	0.37590952736583805	0.0015691174514067764	TMEM177;RNF26;SOX12;POU3F4;HNRNPA0
Familial melanoma ORPHA:618	5/111	0.9967959009702395	0.9999961656375117	0	0	0.36520837652913124	0.0011720424792992423	ZNHIT2;POP7;MC1R;H2AFX;C19ORF48
Leber hereditary optic neuropathy ORPHA:104	5/111	0.9967959009702395	0.9999961656375117	0	0	0.36520837652913124	0.0011720424792992423	ZNF580;PCBP1;RNF208;C22ORF46;ZBED3
Mitochondrial DNA-associated Leigh syndrome ORPHA:255210	5/111	0.9967959009702395	0.9999961656375117	0	0	0.36520837652913124	0.0011720424792992423	ZNF580;PCBP1;RNF208;C22ORF46;ZBED3
MELAS ORPHA:550	5/114	0.9975414538835616	0.9999961656375117	0	0	0.35509627986692205	8.740955227324968E-4	ZNF580;PCBP1;RNF208;C22ORF46;ZBED3
Autosomal recessive multiple pterygium syndrome ORPHA:2990	4/100	0.9976014272387079	0.9999961656375117	0	0	0.3226420620972466	7.748100528503263E-4	CLDN20;TAS2R30;MRLN;TAS2R43
Combined immunodeficiency with granulomatosis ORPHA:157949	4/100	0.9976014272387079	0.9999961656375117	0	0	0.3226420620972466	7.748100528503263E-4	OR10R2;RAG2;BHLHE23;RAG1
Immunodeficiency by defective expression of MHC class I ORPHA:34592	4/100	0.9976014272387079	0.9999961656375117	0	0	0.3226420620972466	7.748100528503263E-4	TLR1;SAMD9L;SAMD9;S1PR4
Periodontal Ehlers-Danlos syndrome ORPHA:75392	4/100	0.9976014272387079	0.9999961656375117	0	0	0.3226420620972466	7.748100528503263E-4	ISLR;FIBIN;CLEC14A;SOD3
Severe combined immunodeficiency due to complete RAG1/2 deficiency ORPHA:331206	4/100	0.9976014272387079	0.9999961656375117	0	0	0.3226420620972466	7.748100528503263E-4	OR10R2;RAG2;BHLHE23;RAG1
Infantile spasms syndrome ORPHA:3451	5/115	0.9977503785970292	0.9999961656375117	0	0	0.3518481518481518	7.92416786439521E-4	TCEAL6;TCEAL5;NEUROD6;SLITRK1;DIRAS2
12p12.1 microdeletion syndrome ORPHA:313884	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	SLITRK2;TMEM200C;LRRC4C;CDR1
2q23.1 microdeletion syndrome ORPHA:228402	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	NPAP1;ZNF891;TIGD1;POU5F2
46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency ORPHA:168558	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	CLDN6;ISLR;GJA5;SOD3
8p11.2 deletion syndrome ORPHA:251066	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GP9;OR2W3;C2ORF88;KLHL34
AICA-ribosiduria ORPHA:250977	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TMEM177;FEN1;RNF26;RRS1
ALG1-CDG ORPHA:79327	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TMEM177;DDX28;DOLK;C19ORF48
ALG11-CDG ORPHA:280071	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	NPAP1;ZNF891;TIGD1;POU5F2
ALG3-CDG ORPHA:79321	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	COA4;POP7;RNF26;C19ORF48
Acatalasemia ORPHA:926	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TLR1;SAMD9L;SAMD9;RNASE6
Achondrogenesis type 1B ORPHA:93298	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	JRKL;SOCS6;SLC5A3;SOCS4
Acrogeria ORPHA:2500	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GJA1;ISLR;FIBIN;SOD3
Acute encephalopathy with biphasic seizures and late reduced diffusion ORPHA:363549	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	RHOG;RHOH;TNFAIP8L2;S1PR4
Adenine phosphoribosyltransferase deficiency ORPHA:976	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	SF3B5;DPM3;ZNF581;RPP25L
Alopecia universalis ORPHA:701	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GJB3;CDC42EP4;SFN;PHLDA3
Alpha-N-acetylgalactosaminidase deficiency type 1 ORPHA:79279	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TIFAB;SCO2;RHOG;MGAT1
Alpha-N-acetylgalactosaminidase deficiency type 2 ORPHA:79280	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TIFAB;SCO2;RHOG;MGAT1
Alpha-N-acetylgalactosaminidase deficiency type 3 ORPHA:79281	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TIFAB;SCO2;RHOG;MGAT1
Anoctamin-5-related  limb-girdle muscular dystrophy R12 ORPHA:206549	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	LRRTM1;P2RY1;LRRC3B;SERTM1
Aromatase deficiency ORPHA:91	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	OR2F1;MRGPRX1;KCNA10;DIRC1
Aromatase excess syndrome ORPHA:178345	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	OR2F1;MRGPRX1;KCNA10;DIRC1
Atelosteogenesis type II ORPHA:56304	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	JRKL;SOCS6;SLC5A3;SOCS4
Atrichia with papular lesions ORPHA:86819	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GJB3;CDC42EP4;SFN;PHLDA3
Atypical Gaucher disease due to saposin C deficiency ORPHA:309252	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	MAFB;TMEM127;UBC;MGAT1
Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency ORPHA:436159	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GPR174;GPR171;CCR5;GIMAP7
Autosomal dominant Charcot-Marie-Tooth disease type 2I ORPHA:99942	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	LINC00694;C10ORF105;OXER1;TNFAIP8L2
Autosomal dominant Charcot-Marie-Tooth disease type 2J ORPHA:99943	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	LINC00694;C10ORF105;OXER1;TNFAIP8L2
Autosomal dominant hyper-IgE syndrome ORPHA:2314	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TLR1;SOCS3;SAMD9L;GIMAP7
Autosomal dominant intermediate Charcot-Marie-Tooth disease type D ORPHA:100046	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	LINC00694;C10ORF105;OXER1;TNFAIP8L2
Autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic pain ORPHA:324585	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	LINC00694;C10ORF105;OXER1;TNFAIP8L2
Autosomal dominant neovascular inflammatory vitreoretinopathy ORPHA:329211	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	OMP;CDC42EP5;CDC42EP4;TRNP1
Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome ORPHA:476119	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	CLDN3;GJB1;SOWAHB;CLDN2
Autosomal dominant spondylocostal dysostosis ORPHA:1797	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	RNASE10;TSSK6;FBXO46;LTB4R
Autosomal dominant vitreoretinochoroidopathy ORPHA:3086	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	C5AR2;FPR1;FFAR2;FPR2
Autosomal recessive bestrophinopathy ORPHA:139455	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	C5AR2;FPR1;FFAR2;FPR2
Autosomal recessive cerebellar ataxia due to STUB1 deficiency ORPHA:412057	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	MRPL41;ZNHIT2;CCDC85B;DEXI
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial JAK1 deficiency ORPHA:574957	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TLR1;SAMD9L;SAMD9;GIMAP7
Autosomal recessive proximal renal tubular acidosis ORPHA:93607	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TMEM246;FIBIN;SSTR1;CDR1
Autosomal recessive spastic paraplegia type 18 ORPHA:209951	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	CLDN12;TTC30A;SOCS6;ZNF664
Autosomal recessive spastic paraplegia type 28 ORPHA:101008	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	NPAP1;ZNF891;TIGD1;POU5F2
B4GALT1-CDG ORPHA:79332	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TOR4A;SERTAD3;TICAM1;ARF6
BENTA disease ORPHA:464336	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GPR174;PCED1B;RHOH;S1PR4
BICD2-related autosomal dominant childhood-onset proximal spinal muscular atrophy ORPHA:363454	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	LTB4R2;CAPNS2;ATXN1L;ZBED4
BRESEK syndrome ORPHA:85284	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	ZBED8;YY2;MORF4L2;CLDN12
Becker nevus syndrome ORPHA:64755	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	FAM110A;PCBP1;NUP62;RHOG
Benign familial mesial temporal lobe epilepsy ORPHA:163717	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GJB2;ARL14;SLITRK6;FUT3
Benign paroxysmal torticollis of infancy ORPHA:71518	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	ZNF891;MAS1;AMER3;SSTR2
Best vitelliform macular dystrophy ORPHA:1243	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	C5AR2;FPR1;FFAR2;FPR2
Bietti crystalline dystrophy ORPHA:41751	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	SAMD9L;GPR34;LPAR6;MPEG1
Birdshot chorioretinopathy ORPHA:179	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TLR1;SAMD9L;CCR5;S1PR4
Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency ORPHA:91135	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	SOWAHC;TOR1AIP2;CYP8B1;VASN
Bothnia retinal dystrophy ORPHA:85128	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	HEPN1;TCEAL6;KCNJ10;SLITRK2
CEDNIK syndrome ORPHA:66631	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	OST4;BLOC1S3;RHOG;TMEM140
CHILD syndrome ORPHA:139	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	POP7;FKBPL;TMEM99;DOLK
CK syndrome ORPHA:251383	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	POP7;FKBPL;TMEM99;DOLK
CLN11 disease ORPHA:314629	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TOR4A;SCO2;MGAT1;TICAM1
CLN8 disease ORPHA:228354	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	C5AR2;ZFP42;ZBTB43;VRTN
Caffey disease ORPHA:1310	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GJA1;ISLR;FIBIN;VASN
Camurati-Engelmann disease ORPHA:1328	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TOR4A;RHOG;TICAM1;JUNB
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome ORPHA:1171	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	KCNJ4;ZCCHC12;CDK5R2;CDK5R1
Charcot-Marie-Tooth disease type 1B ORPHA:101082	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	LINC00694;C10ORF105;OXER1;TNFAIP8L2
Charcot-Marie-Tooth disease type 4F ORPHA:99952	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	IRF2BP1;ZBTB12;ZNF865;CENPB
Cherubism ORPHA:184	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	PTAFR;FPR1;FPR2;MPEG1
Chromophobe renal cell carcinoma ORPHA:319303	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GJB1;GCNT3;CLDN2;RNF186
Chronic lymphoproliferative disorder of natural killer cells ORPHA:512017	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TLR1;SOCS3;SAMD9L;GIMAP7
Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome ORPHA:309854	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	PAQR9;GJB1;NAT2;SOWAHA
Classic Hodgkin lymphoma, nodular sclerosis type ORPHA:98843	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	CDC42EP4;NDN;ZNF358;POMGNT2
Classic congenital lipoid adrenal hyperplasia due to STAR deficency ORPHA:325524	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	SPN;ZNF660;ZNF280B;FOXL2NB
Classic homocystinuria ORPHA:394	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	FZD9;SOX12;CTXN1;PNMA6A
Classic progressive supranuclear palsy syndrome ORPHA:240071	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TCEAL6;FUT9;DIRAS2;CDK5R2
Combined immunodeficiency due to OX40 deficiency ORPHA:431149	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TNFAIP8L2;CCR5;GIMAP7;S1PR4
Combined immunodeficiency due to ZAP70 deficiency ORPHA:911	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GPR174;GPR171;GIMAP7;S1PR4
Combined oxidative phosphorylation defect type 15 ORPHA:319524	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	LIPT1;MOCS3;PIGBOS1;RPP38
Combined oxidative phosphorylation defect type 29 ORPHA:478029	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	LSM10;SF3B5;DPM3;RPP25L
Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome ORPHA:566175	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TLR1;SAMD9;TLR6;KIAA0040
Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency ORPHA:90791	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GJB1;NAT2;SSTR1;RNF186
Congenital alpha2-antiplasmin deficiency ORPHA:79	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	CEBPA;GJB1;NAT8;ANG
Congenital dyserythropoietic anemia type II ORPHA:98873	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	C1GALT1C1;SMIM15;HNRNPF;MGAT2
Congenital generalized hypercontractile muscle stiffness syndrome ORPHA:476406	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	RPL36AL;HNRNPF;RHOG;ARF6
Congenital isolated ACTH deficiency ORPHA:199296	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	RHOG;ANXA2R;S1PR4;LTB4R
Congenital myopathy with internal nuclei and atypical cores ORPHA:319160	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	MC1R;TSSK6;ZBTB12;ABHD16B
Congenital nephrotic syndrome, Finnish type ORPHA:839	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	NEUROD1;AMER3;PRLHR;SSTR2
Congenital non-communicating hydrocephalus ORPHA:269510	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GPR174;RHOH;S1PR4;C16ORF54
Congenital plasminogen activator inhibitor type 1 deficiency ORPHA:465	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	FOXC2;HRH1;FOXL1;PHLDA1
Congenital sucrase-isomaltase deficiency ORPHA:35122	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	PRR15L;NAT2;RNF186;ATOH1
Corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome ORPHA:52055	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	OST4;RNF113A;RPL36AL;COX14
Corpus callosum agenesis-neuronopathy syndrome ORPHA:1496	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TLR1;GPR65;C16ORF54;GAPT
Costello syndrome ORPHA:3071	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	MRPL41;ZNHIT2;POP7;CENPB
Craniofrontonasal dysplasia ORPHA:1520	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	CDC42EP5;MARVELD1;FZD8;ZNF358
Cutis marmorata telangiectatica congenita ORPHA:1556	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	NXT1;CDCA4;RMI1;TMEM60
DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome ORPHA:494444	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	LTB4R2;PCBP1;NUP62;GP1BA
Deficiency in anterior pituitary function-variable immunodeficiency syndrome ORPHA:293978	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	SOCS1;RHOG;TICAM1;JUNB
Dent disease type 2 ORPHA:93623	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	PPP1R26;CLDN12;SOCS6;GPRASP2
Dentatorubral pallidoluysian atrophy ORPHA:101	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	RNF208;ZNF865;ZNF358;AHDC1
Dermatosparaxis Ehlers-Danlos syndrome ORPHA:1901	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	ISLR;TMEM119;FIBIN;CD248
Developmental and speech delay due to SOX5 deficiency ORPHA:313892	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	SLITRK2;TMEM200C;LRRC4C;CDR1
Developmental malformations-deafness-dystonia syndrome ORPHA:79107	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	FAM110A;PCBP1;NUP62;RHOG
Diastrophic dwarfism ORPHA:628	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	JRKL;SOCS6;SLC5A3;SOCS4
Distal 17p13.3 microdeletion syndrome ORPHA:261257	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	MORF4L2;CTXN1;ZNF664;FJX1
Distal anoctaminopathy ORPHA:399096	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	LRRTM1;P2RY1;LRRC3B;SERTM1
Distal hereditary motor neuropathy, Jerash type ORPHA:139552	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TMEM177;POP7;RNF26;C19ORF48
Dystonia-parkinsonism-hypermanganesemia syndrome ORPHA:521406	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	ALDH1B1;MORF4L2;FZD7;CLDN12
Enamel-renal syndrome ORPHA:1031	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GPR34;LPAR6;FPR3;MPEG1
Encephalopathy due to prosaposin deficiency ORPHA:139406	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	MAFB;TMEM127;UBC;MGAT1
Estrogen resistance syndrome ORPHA:785	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TMEM30B;ZFP3;FPR3;TSPYL5
Familial Alzheimer-like prion disease ORPHA:280397	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	PRNP;RRAGA;HRH1;PHLDA1
Familial abdominal aortic aneurysm ORPHA:86	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GJA1;ISLR;FIBIN;SOD3
Familial episodic pain syndrome with predominantly upper body involvement ORPHA:391389	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	ISLR;TMEM200A;TWIST2;TMEM119
Familial hypocalciuric hypercalcemia type 3 ORPHA:101050	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	SF3B5;DPM3;POP7;EMC6
Familial lambdoid synostosis ORPHA:3267	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	IRF2BP1;ZNF865;CCDC71;CENPB
Familial mesial temporal lobe epilepsy with febrile seizures ORPHA:165805	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GJB2;ARL14;SLITRK6;FUT3
Familial multiple nevi flammei ORPHA:624	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	NRIP1;LRRC4;KCTD12;KBTBD11
Familial normophosphatemic tumoral calcinosis ORPHA:306658	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TLR1;SAMD9L;SAMD9;TLR6
Familial paroxysmal ataxia ORPHA:97	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	ZNF891;MAS1;AMER3;SSTR2
Familial visceral myopathy ORPHA:2604	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	ISLR;FIBIN;CD248;SOD3
Fatal familial insomnia ORPHA:466	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	PRNP;RRAGA;HRH1;PHLDA1
Fatal post-viral neurodegenerative disorder ORPHA:391343	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GPR174;GPR171;GIMAP7;S1PR4
GM1 gangliosidosis type 1 ORPHA:79255	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	C1GALT1C1;C14ORF119;DOLK;MGAT2
GM1 gangliosidosis type 2 ORPHA:79256	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	C1GALT1C1;C14ORF119;DOLK;MGAT2
GM1 gangliosidosis type 3 ORPHA:79257	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	C1GALT1C1;C14ORF119;DOLK;MGAT2
GM3 synthase deficiency ORPHA:370933	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GPRIN3;GPR65;KCNA3;GIMAP7
Galactokinase deficiency ORPHA:79237	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	DPM3;ZNHIT2;ZNF581;SCO2
Gerstmann-Straussler-Scheinker syndrome ORPHA:356	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	PRNP;RRAGA;HRH1;PHLDA1
Glycogen storage disease due to lactate dehydrogenase H-subunit deficiency ORPHA:284435	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TCEAL8;EID1;ZNF280B;GSPT2
Glycogen storage disease due to liver glycogen phosphorylase deficiency ORPHA:369	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	THBD;CEBPB;CEBPD;P2RY2
Glycogen storage disease due to muscle beta-enolase deficiency ORPHA:99849	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	KBTBD13;XIRP1;RPP25L;LRRC30
Glycogen storage disease due to muscle glycogen phosphorylase deficiency ORPHA:368	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	KBTBD13;P2RY14;KLHL34;KCNA5
Gnathodiaphyseal dysplasia ORPHA:53697	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	LRRTM1;P2RY1;LRRC3B;SERTM1
Growth retardation-mild developmental delay-chronic hepatitis syndrome ORPHA:391366	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	SAMD9L;C3AR1;RHOG;TLR6
Hamel cerebro-palato-cardiac syndrome ORPHA:93946	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	LSM10;SF3B5;RNF113A;POP7
Hepatic veno-occlusive disease-immunodeficiency syndrome ORPHA:79124	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TLR1;SAMD9L;SAMD9;GPR65
Hereditary coproporphyria ORPHA:79273	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	FEN1;FIGNL1;MARS2;RRS1
Hereditary folate malabsorption ORPHA:90045	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	PPP1R26;SOWAHB;CLDN12;SOWAHA
Hereditary sensory and autonomic neuropathy due to TECPR2 mutation ORPHA:320385	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TAS2R40;CXCR1;C10ORF105;LRRC4
Hermansky-Pudlak syndrome type 9 ORPHA:280663	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	ZNF891;CYSLTR1;TIGD1;POU5F2
Huntington disease-like 1 ORPHA:157941	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	PRNP;RRAGA;HRH1;PHLDA1
Hyperinsulinism due to HNF1A deficiency ORPHA:324575	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GJB1;GCNT3;CLDN2;RNF186
Hyperinsulinism due to HNF4A deficiency ORPHA:263455	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GJB1;GCNT3;CLDN2;RNF186
Hyperinsulinism due to UCP2 deficiency ORPHA:276556	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	RHOG;RHOH;TNFAIP8L2;S1PR4
Hypoparathyroidism-sensorineural deafness-renal disease syndrome ORPHA:2237	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	FAM110A;FGFBP2;PCED1B;KLHDC7B
Ichthyosis follicularis-alopecia-photophobia syndrome ORPHA:2273	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	ZBED8;YY2;MORF4L2;CLDN12
Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome ORPHA:529977	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TLR1;SAMD9L;SAMD9;CCR5
Immunodeficiency due to ficolin3 deficiency ORPHA:331190	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GJA5;GJA4;APLNR;CLEC14A
Infantile Bartter syndrome with sensorineural deafness ORPHA:89938	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	CLDN6;CCDC8;KLHDC7A;CCDC160
Infantile inflammatory bowel disease with neurological involvement ORPHA:565788	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TOR4A;RHOG;TICAM1;JUNB
Infantile multisystem neurologic-endocrine-pancreatic disease ORPHA:456312	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	COA4;TRMT10C;TAF9;PIGW
Inherited Creutzfeldt-Jakob disease ORPHA:282166	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	PRNP;RRAGA;HRH1;PHLDA1
Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency ORPHA:289548	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	CLDN6;ISLR;GJA5;SOD3
Interstitial lung disease due to ABCA3 deficiency ORPHA:440402	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	SMIM10L2A;RNF208;ZNF358;CTXN1
Isolated biliary atresia ORPHA:30391	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TPBG;TRNP1;FJX1;PHLDA3
Isolated cloverleaf skull syndrome ORPHA:2343	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	IRF2BP1;ZNF865;CCDC71;CENPB
Isolated sedoheptulokinase deficiency ORPHA:440713	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TMEM177;ALDH1B1;PARS2;C19ORF48
Kuru ORPHA:454745	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	PRNP;RRAGA;HRH1;PHLDA1
Laron syndrome ORPHA:633	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	PLN;THRSP;RNF152;CYP8B1
Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome ORPHA:478049	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TMEM177;TMEM99;PARS2;DOLK
Lissencephaly syndrome, Norman-Roberts type ORPHA:89844	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TCEAL7;LRRTM1;LRRC4C;CDR1
MIRAGE syndrome ORPHA:494433	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TLR1;SAMD9L;SAMD9;TLR6
MRCS syndrome ORPHA:263347	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	C5AR2;FPR1;FFAR2;FPR2
Mandibular hypoplasia-deafness-progeroid features-lipodystrophy syndrome ORPHA:363649	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	CDCA4;NUP62;H2AFX;C19ORF48
Marfan syndrome type 2 ORPHA:284973	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TLR1;THBD;SAMD9L;SAMD9
McLeod neuroacanthocytosis syndrome ORPHA:59306	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GP9;OR2W3;C2ORF88;P2RY1
Microcephaly-congenital cataract-psoriasiform dermatitis syndrome ORPHA:488168	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	SMIM15;MORF4L2;CLDN12;DUSP14
Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom ORPHA:500159	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TMEM158;TRNP1;PHLDA2;CTXN1
Microcystic stromal tumor ORPHA:569248	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	MORF4L2;FZD7;CLDN12;SOCS6
Microphthalmia with limb anomalies ORPHA:1106	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TMEM246;FLRT3;FIBIN;FAM43B
Microphthalmia-retinitis pigmentosa-foveoschisis-optic disc drusen syndrome ORPHA:251279	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	FOXC2;FLRT2;MAB21L1;CLEC14A
Mohr-Tranebjaerg syndrome ORPHA:52368	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	COA4;FEN1;TRMT10C;PIGW
Monoamine oxidase A deficiency ORPHA:3057	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	SOWAHB;CDC42EP4;CLDN12;FAM84A
Mucolipidosis type IV ORPHA:578	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	SCO2;RHOG;MGAT1;TICAM1
Mucopolysaccharidosis type 4B ORPHA:309310	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	C1GALT1C1;C14ORF119;DOLK;MGAT2
Multiple epiphyseal dysplasia type 4 ORPHA:93307	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	JRKL;SOCS6;SLC5A3;SOCS4
Multiple epiphyseal dysplasia type 5 ORPHA:93311	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TPBG;TRNP1;TRAM1L1;FJX1
Multiple self-healing squamous epithelioma ORPHA:65748	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	ZBTB6;ZBTB33;SLC5A3;SOCS4
Multiple system atrophy, cerebellar type ORPHA:227510	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	CDCA4;MGAT2;PIGW;TMEM60
Multiple system atrophy, parkinsonian type ORPHA:98933	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	CDCA4;MGAT2;PIGW;TMEM60
Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement ORPHA:168947	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TMEM100;GJA1;ISLR;FIBIN
Myopathic intestinal pseudoobstruction ORPHA:104077	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	ISLR;FIBIN;CD248;SOD3
Myosclerosis ORPHA:289380	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	ISLR;FIBIN;CD248;SOD3
NON RARE IN EUROPE: Ankylosing spondylitis ORPHA:825	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TLR1;SAMD9L;CCR5;S1PR4
NON RARE IN EUROPE: Hemochromatosis type 1 ORPHA:139498	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	ITPRIPL2;SAMD9L;SAMD9;RNASE4
NTHL1-related attenuated familial adenomatous polyposis ORPHA:454840	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TMEM177;ZNHIT2;POP7;C19ORF48
Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome ORPHA:457185	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	MRPL41;DNAJC30;HDHD3;MRPL57
Nijmegen breakage syndrome ORPHA:647	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	PLEKHF2;ZBTB6;CMTR2;SOCS4
Non-classic congenital lipoid adrenal hyperplasia due to STAR deficency ORPHA:325529	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	SPN;ZNF660;ZNF280B;FOXL2NB
Obesity due to pro-opiomelanocortin deficiency ORPHA:71526	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	KCNA3;TNFAIP8L2;GIMAP7;S1PR4
Obesity due to prohormone convertase I deficiency ORPHA:71528	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TCEAL7;TMEM246;SSTR1;SCG2
Oculocerebrorenal syndrome of Lowe ORPHA:534	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	PPP1R26;CLDN12;SOCS6;GPRASP2
Oculocutaneous albinism type 4 ORPHA:79435	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GJB1;PABPC5;PCDHB15;PCDHB5
Orofaciodigital syndrome type 3 ORPHA:2752	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	CHST6;LRRC10B;CLDN12;CTXN1
Oxoglutaric aciduria ORPHA:31	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	IRF2BP1;ZNF865;CCDC71;CENPB
PGM1-CDG ORPHA:319646	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	RRAGA;H1F0;HRCT1;ANG
POGLUT1-related  limb-girdle muscular dystrophy R21 ORPHA:480682	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	ABHD13;WDR5B;PIGM;CMTR2
Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome ORPHA:85112	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GJA1;ISLR;FIBIN;GAS1
Pentosuria ORPHA:2843	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	MRPL41;DPM3;POP7;RPP25L
Persistent polyclonal B-cell lymphocytosis ORPHA:300324	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GPR174;PCED1B;RHOH;S1PR4
Peutz-Jeghers syndrome ORPHA:2869	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	IRF2BP1;H1FX;ZNF865;ABHD16B
Phakomatosis pigmentokeratotica ORPHA:2874	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	MRPL41;ZNHIT2;POP7;CENPB
Pilomatrixoma ORPHA:91414	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	MORF4L2;FZD7;CLDN12;SOCS6
Polyglucosan body myopathy type 1 ORPHA:397937	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	SCO2;RHOG;MGAT1;TICAM1
Posterior urethral valve ORPHA:93110	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GJA1;DSEL;TWIST2;GAS1
PrP systemic amyloidosis ORPHA:397606	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	PRNP;RRAGA;HRH1;PHLDA1
Primary dystonia, DYT4 type ORPHA:98805	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	ENHO;KCNJ4;ZCCHC12;CDK5R2
Primary hyperoxaluria type 3 ORPHA:93600	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	C10ORF62;C12ORF60;CYP8B1;CPN2
Progressive epilepsy-intellectual disability syndrome, Finnish type ORPHA:1947	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	C5AR2;ZFP42;ZBTB43;VRTN
Progressive familial intrahepatic cholestasis type 5 ORPHA:480476	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GJB1;NAT8;NAT2;CLDN2
Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome ORPHA:477814	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	LTB4R2;PCBP1;NUP62;GP1BA
Progressive myoclonic epilepsy type 7 ORPHA:435438	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	ZCCHC12;CCDC177;SLITRK1;CDK5R2
Progressive supranuclear palsy-corticobasal syndrome ORPHA:240103	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TCEAL6;FUT9;DIRAS2;CDK5R2
Progressive supranuclear palsy-parkinsonism syndrome ORPHA:240085	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TCEAL6;FUT9;DIRAS2;CDK5R2
Progressive supranuclear palsy-progressive non-fluent aphasia syndrome ORPHA:240112	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TCEAL6;FUT9;DIRAS2;CDK5R2
Progressive supranuclear palsy-pure akinesia with gait freezing syndrome ORPHA:240094	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TCEAL6;FUT9;DIRAS2;CDK5R2
Proteasome-associated autoinflammatory syndrome ORPHA:324977	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TLR1;SAMD9L;SAMD9;TREX1
Pseudo-von Willebrand disease ORPHA:52530	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GP9;GPBAR1;GP1BA;GP5
Pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa ORPHA:436274	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	SOWAHC;TOR1AIP2;CYP8B1;VASN
Pulmonary alveolar microlithiasis ORPHA:60025	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	APOBEC4;FUT2;GRHL2;FUT3
Pulmonary arterial hypertension associated with connective tissue disease ORPHA:275798	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TLR1;SAMD9L;CCR5;S1PR4
Pyruvate dehydrogenase phosphatase deficiency ORPHA:79246	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	PRNP;ENC1;CDC42EP3;SOCS5
RIDDLE syndrome ORPHA:420741	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	HIST1H2BN;ZNF891;HIST1H4C;GDPGP1
Rapid-onset dystonia-parkinsonism ORPHA:71517	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	KCNJ4;ZCCHC12;CDK5R2;CDK5R1
Recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome ORPHA:280384	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	CLDN12;TTC30A;SOCS6;ZNF664
Renal pseudohypoaldosteronism type 1 ORPHA:171871	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GPRIN3;AMIGO1;IGIP;GPRASP1
STAT3-related early-onset multisystem autoimmune disease ORPHA:438159	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TLR1;SOCS3;SAMD9L;GIMAP7
Sanfilippo syndrome type C ORPHA:79271	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	THBD;MAFB;TMEM127;MGAT1
Serrated polyposis syndrome ORPHA:157798	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	LPAR5;PRR15L;GPR160;ASCL2
Severe combined immunodeficiency due to CARD11 deficiency ORPHA:357237	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GPR174;PCED1B;RHOH;S1PR4
Severe combined immunodeficiency due to CORO1A deficiency ORPHA:228003	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	CXORF21;GPR65;TNFAIP8L2;S1PR4
Severe intellectual disability-progressive spastic diplegia syndrome ORPHA:404473	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	MORF4L2;FZD7;CLDN12;SOCS6
Severe neurodevelopmental disorder with feeding difficulties-stereotypic hand movement-bilateral cataract ORPHA:500545	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	IRF2BP1;ZBTB12;ZNF865;CENPB
Short rib-polydactyly syndrome type 5 ORPHA:498497	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	RAB40A;SPIN3;TTC30A;ZNF146
Short stature due to partial GHR deficiency ORPHA:314802	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	PLN;THRSP;RNF152;CYP8B1
Spinocerebellar ataxia type 12 ORPHA:98762	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	AMER3;SLITRK2;TCEAL2;FAM181B
Spinocerebellar ataxia type 26 ORPHA:101112	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	RBM15B;IRF2BP1;ZBTB12;CENPB
Spinocerebellar ataxia type 31 ORPHA:217012	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	NPAP1;CHRM5;PPIAL4G;POU5F2
Spinocerebellar ataxia type 38 ORPHA:423296	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	HMGN4;MIS12;MGAT2;CGGBP1
Spinocerebellar ataxia type 40 ORPHA:423275	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GPR174;RHOH;S1PR4;C16ORF54
Spinocerebellar ataxia type 6 ORPHA:98758	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	ZNF891;MAS1;AMER3;SSTR2
Spondylo-megaepiphyseal-metaphyseal dysplasia ORPHA:228387	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	FOXD3;FOXD1;PLAC1;TEX19
Spondyloepimetaphyseal dysplasia, matrilin-3 type ORPHA:156728	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TPBG;TRNP1;TRAM1L1;FJX1
Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome ORPHA:85167	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	ITPRIPL2;TMEM127;PPP1R3D;MGAT1
Sporadic fatal insomnia ORPHA:586130	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	PRNP;RRAGA;HRH1;PHLDA1
Sporadic porphyria cutanea tarda ORPHA:443057	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	ITPRIPL2;SAMD9L;SAMD9;RNASE4
Sturge-Weber syndrome ORPHA:3205	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	NRIP1;LRRC4;KCTD12;KBTBD11
Susceptibility to respiratory infections associated with CD8alpha chain mutation ORPHA:169085	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	FGFBP2;GPR171;CCR5;GIMAP7
Symptomatic form of hemochromatosis type 1 ORPHA:465508	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	ITPRIPL2;SAMD9L;SAMD9;RNASE4
T-cell large granular lymphocyte leukemia ORPHA:86872	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TLR1;SOCS3;SAMD9L;GIMAP7
THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome ORPHA:363444	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	DDX28;NXT1;ZNF581;C19ORF48
TMEM70-related mitochondrial encephalo-cardio-myopathy ORPHA:1194	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TRMT10C;TAF9;COX14;TMEM60
TSH-secreting pituitary adenoma ORPHA:91347	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	C10ORF105;RNASE6;FPR1;MPEG1
Tangier disease ORPHA:31150	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	THBD;MAFB;FPR3;TLR2
Tatton-Brown-Rahman syndrome ORPHA:404443	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	ZNF660;ZNF891;SOX11;LRRN1
Thomsen and Becker disease ORPHA:614	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	KBTBD13;SLN;P2RY2;LRRC30
Transcobalamin deficiency ORPHA:859	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	ARMCX1;NDN;ANG;RNASE1
USP18 deficiency ORPHA:481665	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	C1GALT1C1;SCO2;MGAT2;TMEM187
Van den Ende-Gupta syndrome ORPHA:2460	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	IRF2BP1;CHST14;ZNF358;VASN
Variant ABeta2M amyloidosis ORPHA:314652	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	TLR1;SAMD9L;SAMD9;GPR65
Vascular Ehlers-Danlos syndrome ORPHA:286	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GJA1;ISLR;FIBIN;SOD3
Wagner disease ORPHA:898	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	LRRC4;CD248;KCTD12;CREB5
Woolly hair nevus ORPHA:79414	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	MRPL41;ZNHIT2;POP7;CENPB
X-linked hyper-IgM syndrome ORPHA:101088	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GPR174;GPR171;GIMAP7;CCR4
X-linked hypophosphatemia ORPHA:89936	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	SAMD9;IFNE;AMIGO2;ZNF860
X-linked intellectual disability, Golabi-Ito-Hall type ORPHA:93947	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	LSM10;SF3B5;RNF113A;POP7
X-linked intellectual disability, Porteous type ORPHA:93945	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	LSM10;SF3B5;RNF113A;POP7
X-linked intellectual disability, Sutherland-Haan type ORPHA:93950	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	LSM10;SF3B5;RNF113A;POP7
X-linked lymphoproliferative disease due to SH2D1A deficiency ORPHA:538931	4/101	0.9978160859408678	0.9999961656375117	0	0	0.31929773703187	6.980813695722343E-4	GPR174;GPR171;RHOH;GIMAP7
Acromesomelic dysplasia, Grebe type ORPHA:2098	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	C8ORF48;DSEL;FIBIN;TRAM1L1
Acromicric dysplasia ORPHA:969	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	ISLR;FIBIN;SOD3;VASN
Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form ORPHA:79408	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	UCN2;CDC42EP5;TPBG;FOXL1
Benign hereditary chorea ORPHA:1429	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	SMIM10L2B;KCNJ4;SMIM10L2A;TMEM200C
Brachydactyly type C ORPHA:93384	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	C8ORF48;DSEL;FIBIN;TRAM1L1
Cerebrofacioarticular syndrome ORPHA:314679	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	TCEAL7;GJA1;PABPC5;PCDHB15
Combined immunodeficiency with faciooculoskeletal anomalies ORPHA:221139	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	DDX28;CDCA4;NUP62;KTI12
Congenital erythropoietic porphyria ORPHA:79277	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	GP9;LINC00694;OR2W3;RNASE3
Craniometaphyseal dysplasia ORPHA:1522	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	GJA1;ISLR;FLRT2;FIBIN
Deletion 5q35 ORPHA:1627	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	GJC1;FOXD3;PABPC4L;CHML
Distal myopathy, Welander type ORPHA:603	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	UBC;TAF7;CMTR2;CGGBP1
Dominant hypophosphatemia with nephrolithiasis or osteoporosis ORPHA:244305	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	FAM110A;CLDN9;TMEM238;HDHD3
Duchenne muscular dystrophy ORPHA:98896	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	ISLR;APLNR;FIBIN;SOD3
Ependymoma ORPHA:251636	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	RHOG;ZNF865;TICAM1;JUNB
Familial calcium pyrophosphate deposition ORPHA:1416	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	ISLR;FIBIN;SSTR1;SOD3
Familial isolated pituitary adenoma ORPHA:314777	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	LINGO3;RHOG;TNFAIP8L2;S1PR4
Familial multinodular goiter ORPHA:276399	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	AMER1;ZBTB33;SOCS4;ZNF146
Familial patent arterial duct ORPHA:466729	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	FLRT3;TRIL;PCDHB3;TRAM1L1
Fibrolamellar hepatocellular carcinoma ORPHA:401920	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	INAFM1;PCBP1;IRF2BP1;ZNF865
Fibular aplasia-complex brachydactyly syndrome ORPHA:2639	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	C8ORF48;DSEL;FIBIN;TRAM1L1
Hereditary chronic pancreatitis ORPHA:676	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	UCN3;GPR119;GCNT3;RNF186
Hereditary sensory and autonomic neuropathy type 5 ORPHA:64752	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	FOXC2;TWIST2;TWIST1;CD248
Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency ORPHA:83639	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	TRMT10C;FIGNL1;PIGM;PIGW
IMAGe syndrome ORPHA:85173	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	H1FX;ZBTB12;SOX12;HNRNPA0
Juvenile Paget disease ORPHA:2801	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	HRH1;SOWAHC;REP15;A4GALT
Juvenile primary lateral sclerosis ORPHA:247604	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	CLDN12;SOCS6;ZNF664;GPRASP2
Lacrimoauriculodentodigital syndrome ORPHA:2363	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	GJA1;FLRT3;TRIL;FAM84A
Nephrogenic diabetes insipidus ORPHA:223	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	NHLRC4;MFSD6L;RXFP4;S1PR4
Occipital pachygyria and polymicrogyria ORPHA:280640	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	NEUROD6;LRRTM1;SLITRK3;HTR1A
Pfeiffer syndrome type 1 ORPHA:93258	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	GJA1;TRIL;TMEM200C;PCDHB15
Pseudohypoparathyroidism type 1B ORPHA:94089	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	ZNF580;PCBP1;RNF208;ZNF865
RELA fusion-positive ependymoma ORPHA:530792	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	RHOG;ZNF865;TICAM1;JUNB
Stormorken-Sjaastad-Langslet syndrome ORPHA:3204	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	TREX1;RHOG;S1PR4;BORCS6
Tetraamelia-multiple malformations syndrome ORPHA:3301	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	SMIM10L2B;TCEAL7;TMEM200C;SCG2
Tropical pancreatitis ORPHA:103918	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	GCNT3;GPR82;GDPGP1;PRR23C
Truncus arteriosus ORPHA:3384	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	FZD2;MARVELD1;CD248;VASN
Wiskott-Aldrich syndrome ORPHA:906	4/102	0.9980120110168162	0.9999961656375117	0	0	0.3160216634984398	6.288728889900546E-4	CXORF21;GPR65;TNFAIP8L2;S1PR4
Autosomal dominant secondary polycythemia ORPHA:247511	4/103	0.9981907823727549	0.9999961656375117	0	0	0.3128117732687153	5.66457150992667E-4	CDC42EP4;RNASE4;ANG;RHOB
BOR syndrome ORPHA:107	4/103	0.9981907823727549	0.9999961656375117	0	0	0.3128117732687153	5.66457150992667E-4	FOXC1;FZD7;TPBG;FJX1
Butterfly-shaped pigment dystrophy ORPHA:99001	4/103	0.9981907823727549	0.9999961656375117	0	0	0.3128117732687153	5.66457150992667E-4	TCEAL7;GJA1;MAGEL2;PCDHB15
Dysosteosclerosis ORPHA:1782	4/103	0.9981907823727549	0.9999961656375117	0	0	0.3128117732687153	5.66457150992667E-4	TOR4A;RHOG;MGAT1;TICAM1
Ellis Van Creveld syndrome ORPHA:289	4/103	0.9981907823727549	0.9999961656375117	0	0	0.3128117732687153	5.66457150992667E-4	GJA1;ISLR;CCDC8;FIBIN
Familial hypercholanemia ORPHA:238475	4/103	0.9981907823727549	0.9999961656375117	0	0	0.3128117732687153	5.66457150992667E-4	GJB1;SOWAHB;CDC42EP4;CLDN12
Female infertility due to oocyte meiotic arrest ORPHA:488191	4/103	0.9981907823727549	0.9999961656375117	0	0	0.3128117732687153	5.66457150992667E-4	GPR174;RHOH;OR52N4;C16ORF54
Geleophysic dysplasia ORPHA:2623	4/103	0.9981907823727549	0.9999961656375117	0	0	0.3128117732687153	5.66457150992667E-4	ISLR;FIBIN;CLEC14A;SOD3
Generalized juvenile polyposis/juvenile polyposis coli ORPHA:329971	4/103	0.9981907823727549	0.9999961656375117	0	0	0.3128117732687153	5.66457150992667E-4	GJA1;ISLR;FIBIN;GAS1
Hereditary diffuse gastric cancer ORPHA:26106	4/103	0.9981907823727549	0.9999961656375117	0	0	0.3128117732687153	5.66457150992667E-4	CLDN4;TMEM125;GJB3;TACSTD2
Hypokalemic periodic paralysis ORPHA:681	4/103	0.9981907823727549	0.9999961656375117	0	0	0.3128117732687153	5.66457150992667E-4	KBTBD13;SLN;MPEG1;LRRC30
Linear nevus sebaceus syndrome ORPHA:2612	4/103	0.9981907823727549	0.9999961656375117	0	0	0.3128117732687153	5.66457150992667E-4	FEN1;SMIM15;TRMT10C;CDCA4
Mitochondrial neurogastrointestinal encephalomyopathy ORPHA:298	4/103	0.9981907823727549	0.9999961656375117	0	0	0.3128117732687153	5.66457150992667E-4	SCO2;HPS6;MGAT1;JUNB
NON RARE IN EUROPE: Infantile capillary hemangioma ORPHA:464293	4/103	0.9981907823727549	0.9999961656375117	0	0	0.3128117732687153	5.66457150992667E-4	GJA1;GJA5;APLNR;CLEC14A
NON RARE IN EUROPE: Recurrent acute pancreatitis ORPHA:64740	4/103	0.9981907823727549	0.9999961656375117	0	0	0.3128117732687153	5.66457150992667E-4	GPR119;GCNT3;FUT2;RNF186
Progressive cone dystrophy ORPHA:1871	4/103	0.9981907823727549	0.9999961656375117	0	0	0.3128117732687153	5.66457150992667E-4	NEUROD4;TMEM215;GJA10;TIGD1
Tubular aggregate myopathy ORPHA:2593	4/103	0.9981907823727549	0.9999961656375117	0	0	0.3128117732687153	5.66457150992667E-4	ZNF672;RHOG;S1PR4;BORCS6
Zimmermann-Laband syndrome ORPHA:3473	4/103	0.9981907823727549	0.9999961656375117	0	0	0.3128117732687153	5.66457150992667E-4	TCEAL6;TCEAL5;SLITRK1;KCNA1
Congenital glaucoma ORPHA:98976	4/104	0.9983538529345245	0.9999961656375117	0	0	0.3096660808435852	5.101759378706266E-4	ISLR;FIBIN;CLEC14A;SOD3
Congenital muscular dystrophy without intellectual disability ORPHA:370980	4/104	0.9983538529345245	0.9999961656375117	0	0	0.3096660808435852	5.101759378706266E-4	FKRP;ZFP41;ZBTB12;SPRN
Dowling-Degos disease ORPHA:79145	4/104	0.9983538529345245	0.9999961656375117	0	0	0.3096660808435852	5.101759378706266E-4	C1GALT1C1;TMEM99;DOLK;MGAT2
Male infertility due to globozoospermia ORPHA:171709	4/104	0.9983538529345245	0.9999961656375117	0	0	0.3096660808435852	5.101759378706266E-4	ZBED8;RAB40A;ZNF664;GPRASP2
Renal agenesis, bilateral ORPHA:1848	4/104	0.9983538529345245	0.9999961656375117	0	0	0.3096660808435852	5.101759378706266E-4	TCEAL7;GJA1;TRIL;CDR1
Renal tubular dysgenesis of genetic origin ORPHA:97369	4/104	0.9983538529345245	0.9999961656375117	0	0	0.3096660808435852	5.101759378706266E-4	ISLR;FIBIN;CLEC14A;SOD3
Aggressive systemic mastocytosis ORPHA:98850	4/105	0.9985025575815394	0.9999961656375117	0	0	0.30658267935756667	4.5943398271713264E-4	LTB4R2;SERTAD2;EBLN2;TLR6
Autosomal dominant progressive external ophthalmoplegia ORPHA:254892	4/105	0.9985025575815394	0.9999961656375117	0	0	0.30658267935756667	4.5943398271713264E-4	FIGNL1;MARS2;RRS1;ZNF146
Dravet syndrome ORPHA:33069	4/105	0.9985025575815394	0.9999961656375117	0	0	0.30658267935756667	4.5943398271713264E-4	TCEAL6;TCEAL5;NEUROD6;SLITRK1
Familial cerebral saccular aneurysm ORPHA:231160	4/105	0.9985025575815394	0.9999961656375117	0	0	0.30658267935756667	4.5943398271713264E-4	ISLR;FIBIN;CLEC14A;CD248
Hypothyroidism due to deficient transcription factors involved in pituitary development or function ORPHA:226307	4/105	0.9985025575815394	0.9999961656375117	0	0	0.30658267935756667	4.5943398271713264E-4	FOXD4;FOXD4L5;FOXD4L1;TEX19
Primary hypereosinophilic syndrome ORPHA:314950	4/105	0.9985025575815394	0.9999961656375117	0	0	0.30658267935756667	4.5943398271713264E-4	ISLR;TMEM119;FIBIN;CD248
Skeletal Ewing sarcoma ORPHA:319	4/105	0.9985025575815394	0.9999961656375117	0	0	0.30658267935756667	4.5943398271713264E-4	GJA1;GJA5;SPRY2;CLEC14A
Hoyeraal-Hreidarsson syndrome ORPHA:3322	4/106	0.998638122668992	0.9999961656375117	0	0	0.30355973672421516	4.1369288751782335E-4	FEN1;CDCA4;NUP62;C19ORF48
NON RARE IN EUROPE: Primary adult open-angle glaucoma ORPHA:353225	4/106	0.998638122668992	0.9999961656375117	0	0	0.30355973672421516	4.1369288751782335E-4	KBTBD13;SLN;A4GALT;LRRC30
Autosomal dominant nocturnal frontal lobe epilepsy ORPHA:98784	4/107	0.9987616739753236	0.9999961656375117	0	0	0.3005954920060744	3.72465885377143E-4	AMER3;CRH;FNDC9;SSTR2
Hypomaturation amelogenesis imperfecta ORPHA:100033	4/107	0.9987616739753236	0.9999961656375117	0	0	0.3005954920060744	3.72465885377143E-4	GPR68;PTAFR;TLR5;MPEG1
Myoclonic-astatic epilepsy ORPHA:1942	4/107	0.9987616739753236	0.9999961656375117	0	0	0.3005954920060744	3.72465885377143E-4	TCEAL5;SLITRK1;TCEAL2;TSPYL4
Galloway-Mowat syndrome ORPHA:2065	4/108	0.9988742446902509	0.9999961656375117	0	0	0.29768825199405163	3.353129059068474E-4	FEN1;CDCA4;PIGW;C19ORF48
Cowden syndrome ORPHA:201	4/109	0.9989767825280474	0.9999961656375117	0	0	0.2948363879822579	3.0183619193148946E-4	KLLN;PLEKHF2;ABHD13;PEX2
Meningioma ORPHA:2495	4/110	0.9990701567251624	0.9999961656375117	0	0	0.2920383327254037	2.7167620741026344E-4	H2AFX;IRF2BP1;ZBTB12;SOX12
NON RARE IN EUROPE: Hypodontia ORPHA:2227	4/110	0.9990701567251624	0.9999961656375117	0	0	0.2920383327254037	2.7167620741026344E-4	CLDN4;TMEM125;SOWAHB;TMEM30B
46,XY partial gonadal dysgenesis ORPHA:251510	4/111	0.9991551634734018	0.9999961656375117	0	0	0.2892925775668085	2.445082356957262E-4	ZNF280A;PLAC1;SRY;ADRA2C
Young-onset Parkinson disease ORPHA:2828	4/111	0.9991551634734018	0.9999961656375117	0	0	0.2892925775668085	2.445082356957262E-4	TCEAL7;TCEAL6;TCEAL5;NAP1L3
Infantile Refsum disease ORPHA:772	4/112	0.9992325326267419	0.9999961656375117	0	0	0.28659766972596495	2.2003880787391122E-4	TMEM177;PARS2;DOLK;PEX2
Neonatal adrenoleukodystrophy ORPHA:44	4/112	0.9992325326267419	0.9999961656375117	0	0	0.28659766972596495	2.2003880787391122E-4	TMEM177;PARS2;DOLK;PEX2
Walker-Warburg syndrome ORPHA:899	4/112	0.9992325326267419	0.9999961656375117	0	0	0.28659766972596495	2.2003880787391122E-4	FKRP;POMGNT2;GPRASP2;FJX1
Zellweger syndrome ORPHA:912	4/112	0.9992325326267419	0.9999961656375117	0	0	0.28659766972596495	2.2003880787391122E-4	TMEM177;PARS2;DOLK;PEX2
Bardet-Biedl syndrome ORPHA:110	4/114	0.9993669742569944	0.9999961656375117	0	0	0.2813548490174149	1.781612586303459E-4	ZBED8;BBS12;TTC30A;TRIM32
Autosomal recessive non-syndromic sensorineural deafness type DFNB ORPHA:90636	8/172	0.9994209067194086	0.9999961656375117	0	0	0.37693232566128476	2.183422033830525E-4	GJA1;GJB2;GJB3;CLDN14;GJB6;FAM84A;SLITRK6;S1PR2
Familial thoracic aortic aneurysm and aortic dissection ORPHA:91387	4/115	0.9994252182714525	0.9999961656375117	0	0	0.27880428759163384	1.602976828524479E-4	GJA1;ISLR;FOXE3;FIBIN
Autosomal recessive cutis laxa type 1 ORPHA:90349	3/100	0.9994775534967382	0.9999961656375117	0	0	0.23936813224128328	1.250897228719453E-4	ISLR;FIBIN;CD248
Baraitser-Winter cerebrofrontofacial syndrome ORPHA:2995	3/100	0.9994775534967382	0.9999961656375117	0	0	0.23936813224128328	1.250897228719453E-4	RNF26;NUP62;H2AFX
Bethlem myopathy ORPHA:610	3/100	0.9994775534967382	0.9999961656375117	0	0	0.23936813224128328	1.250897228719453E-4	ISLR;FIBIN;SOD3
Classical Ehlers-Danlos syndrome ORPHA:287	3/100	0.9994775534967382	0.9999961656375117	0	0	0.23936813224128328	1.250897228719453E-4	GJA1;ISLR;FIBIN
Congenital muscular dystrophy, Ullrich type ORPHA:75840	3/100	0.9994775534967382	0.9999961656375117	0	0	0.23936813224128328	1.250897228719453E-4	ISLR;FIBIN;SOD3
De novo thrombotic microangiopathy after kidney transplantation ORPHA:244275	3/100	0.9994775534967382	0.9999961656375117	0	0	0.23936813224128328	1.250897228719453E-4	ISLR;RNASE4;CLEC14A
Familial rhabdoid tumor ORPHA:231108	3/100	0.9994775534967382	0.9999961656375117	0	0	0.23936813224128328	1.250897228719453E-4	H2AFX;ZBTB12;SOX12
Hyperandrogenism due to cortisone reductase deficiency ORPHA:168588	3/100	0.9994775534967382	0.9999961656375117	0	0	0.23936813224128328	1.250897228719453E-4	G0S2;RNASE4;FPR3
Multicentric osteolysis-nodulosis-arthropathy spectrum ORPHA:371428	3/100	0.9994775534967382	0.9999961656375117	0	0	0.23936813224128328	1.250897228719453E-4	GJA1;ISLR;CDC42EP5
Neu-Laxova syndrome ORPHA:2671	3/100	0.9994775534967382	0.9999961656375117	0	0	0.23936813224128328	1.250897228719453E-4	KDM4D;CTXN1;FJX1
Pleomorphic salivary gland adenoma ORPHA:454821	3/100	0.9994775534967382	0.9999961656375117	0	0	0.23936813224128328	1.250897228719453E-4	CLDN6;GJC1;CCDC8
Singleton-Merten dysplasia ORPHA:85191	3/100	0.9994775534967382	0.9999961656375117	0	0	0.23936813224128328	1.250897228719453E-4	TLR1;SAMD9L;SAMD9
T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta ORPHA:169160	3/100	0.9994775534967382	0.9999961656375117	0	0	0.23936813224128328	1.250897228719453E-4	GPR174;GPR171;GIMAP7
X-linked Alport syndrome-diffuse leiomyomatosis ORPHA:1018	3/100	0.9994775534967382	0.9999961656375117	0	0	0.23936813224128328	1.250897228719453E-4	GJA1;FLRT3;TPBG
3-hydroxy-3-methylglutaric aciduria ORPHA:20	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	RNASE4;COX14;ANG
46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency ORPHA:752	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	P2RY12;GJB1;NAT8
ALG13-CDG ORPHA:324422	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZNF891;ZNF345;TIGD1
ALG6-CDG ORPHA:79320	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TRMT10C;FIGNL1;METTL18
ALG9-CDG ORPHA:79328	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZNF891;TOR1AIP2;TIGD1
ANE syndrome ORPHA:157954	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZNF891;DCAF16;ZNF70
ANGPT1-related hereditary angioedema with normal C1Inh ORPHA:537891	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	DSEL;FIBIN;SMIM10
Abetalipoproteinemia ORPHA:14	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJB1;NAT8;NAT2
Absence of fingerprints-congenital milia syndrome ORPHA:1658	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZNF770;RBM12B;ZNF146
Acetazolamide-responsive myotonia ORPHA:99736	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	KBTBD13;SLN;LRRC30
Acrodermatitis enteropathica ORPHA:37	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	DPM3;FOXD2;TMEM238
Acromelic frontonasal dysplasia ORPHA:1827	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	BASP1;LRRC4;KCTD12
Action myoclonus-renal failure syndrome ORPHA:163696	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	CDC42EP4;CLDN12;SOCS6
Adenylosuccinate synthetase-like 1-related distal myopathy ORPHA:482601	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	KBTBD13;SLN;LRRC30
Adrenomyeloneuropathy ORPHA:139399	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	HPS6;ZNF865;ABHD16B
Adult-onset autosomal recessive cerebellar ataxia ORPHA:284289	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	MARVELD1;TPBG;TCEAL9
Alkaptonuria ORPHA:56	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJB1;NAT8;SMIM6
Allan-Herndon-Dudley syndrome ORPHA:59	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJA1;PCDHB15;PCDHB10
Aneurysm-osteoarthritis syndrome ORPHA:284984	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	IRS1;IFNE;FOXL1
Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome ORPHA:69088	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	SCO2;RHOG;BORCS6
Arthrogryposis-anterior horn cell disease syndrome ORPHA:53696	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	DDX28;FKBPL;HNRNPF
Ataxia-hypogonadism-choroidal dystrophy syndrome ORPHA:1180	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	IRF2BP1;ZNF865;ABHD16B
Ataxia-pancytopenia syndrome ORPHA:2585	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TLR1;SAMD9L;SAMD9
Atypical Werner syndrome ORPHA:79474	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PHLDA2;A4GALT;PHLDA3
Atypical teratoid rhabdoid tumor ORPHA:99966	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	RNF26;H2AFX;ZBTB12
Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome ORPHA:391487	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TLR1;SAMD9L;SAMD9
Autosomal dominant Kenny-Caffey syndrome ORPHA:93325	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	SAMD9L;SAMD9;TRIM56
Autosomal dominant generalized dystrophic epidermolysis bullosa ORPHA:231568	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	UCN2;TPBG;VASN
Autosomal dominant hyperinsulinism due to Kir6.2 deficiency ORPHA:276580	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	KCNJ4;KCNJ11;MYADML2
Autosomal dominant hyperinsulinism due to SUR1 deficiency ORPHA:276575	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TCEAL6;TCEAL5;CDK5R2
Autosomal dominant intermediate Charcot-Marie-Tooth disease type F ORPHA:352670	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	BASP1;S1PR3;KCTD12
Autosomal dominant mitochondrial myopathy with exercise intolerance ORPHA:457050	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	MRPL41;DPM3;DEXI
Autosomal dominant palmoplantar keratoderma and congenital alopecia ORPHA:1010	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TCEAL7;GJA1;FIBIN
Autosomal dominant spastic ataxia type 1 ORPHA:251282	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GPR174;LINGO3;SSTR3
Autosomal recessive Emery-Dreifuss muscular dystrophy ORPHA:98855	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PHLDA2;A4GALT;PHLDA3
Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to RUBCN deficiency ORPHA:404499	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	CNR2;KCNA3;TLR10
Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form ORPHA:89842	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	UCN2;TPBG;VASN
Autosomal recessive hyperinsulinism due to Kir6.2 deficiency ORPHA:79644	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	KCNJ4;KCNJ11;MYADML2
Autosomal recessive hyperinsulinism due to SUR1 deficiency ORPHA:79643	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TCEAL6;TCEAL5;CDK5R2
Autosomal recessive nail dysplasia ORPHA:280654	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	FOXC1;TPBG;CLDN12
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency ORPHA:331176	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	RNF26;CHST14;CTXN1
Autosomal recessive spastic ataxia of Charlevoix-Saguenay ORPHA:98	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	RBM12B;CHML;SOCS4
Autosomal recessive spastic paraplegia type 39 ORPHA:139480	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	IRF2BP1;ZNF865;ABHD16B
Autosomal recessive spastic paraplegia type 59 ORPHA:401795	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZNF891;GDPGP1;POU5F2
Autosomal recessive spastic paraplegia type 66 ORPHA:401815	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJA1;TWIST2;VASN
Autosomal semi-dominant severe lipodystrophic laminopathy ORPHA:280365	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PHLDA2;A4GALT;PHLDA3
BAP1-related tumor predisposition syndrome ORPHA:289539	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	IRF2BP1;H1FX;ZNF865
BVES-related limb-girdle muscular dystrophy ORPHA:476084	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJC1;FLRT2;TWIST1
Bacterial susceptibility due to TLR signaling pathway deficiency ORPHA:183713	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PCED1B;RHOG;S1PR4
Baller-Gerold syndrome ORPHA:1225	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	FEN1;H2AFX;C19ORF48
Becker muscular dystrophy ORPHA:98895	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PLN;FLRT2;CDR1
Beta-propeller protein-associated neurodegeneration ORPHA:329284	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	RHOG;MGAT1;TMEM140
Biotin-thiamine-responsive basal ganglia disease ORPHA:65284	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ACKR2;CYP8B1;CPN2
Bjornstad syndrome ORPHA:123	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TMEM177;POP7;C19ORF48
Bleeding diathesis due to glycoprotein VI deficiency ORPHA:98885	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	SPN;GP9;GPR18
Borjeson-Forssman-Lehmann syndrome ORPHA:127	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	FIGNL1;CHML;SOCS4
Brachyolmia-amelogenesis imperfecta syndrome ORPHA:2899	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZNF358;VASN;AHDC1
Brachytelephalangic chondrodysplasia punctata ORPHA:79345	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJB1;NAT2;CLDN2
Brody myopathy ORPHA:53347	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PROB1;MYADML2;LRRC30
Buschke-Ollendorff syndrome ORPHA:1306	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	EXOC8;RBM12B;ZBTB33
CLCN4-related X-linked intellectual disability syndrome ORPHA:485350	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TCEAL7;LRRC3B;GPRASP2
CLN10 disease ORPHA:228337	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	CEBPB;TMEM127;MGAT1
CLN5 disease ORPHA:228360	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	OR11A1;TIGD1;POU5F2
Calpain-3-related  limb-girdle muscular dystrophy R1 ORPHA:267	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TLR1;RNASE6;MPEG1
Cardiospondylocarpofacial syndrome ORPHA:3238	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZNF770;RBM12B;ZNF146
Catel-Manzke syndrome ORPHA:1388	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TRMT10C;MIS12;METTL18
Cathepsin A-related arteriopathy-strokes-leukoencephalopathy ORPHA:575553	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TMEM127;RHOG;TICAM1
Cerebellar ataxia, Cayman type ORPHA:94122	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	AMER3;FUT9;SLITRK1
Cerebrofaciothoracic dysplasia ORPHA:1394	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	C1GALT1C1;SMIM15;TRMT10C
Charcot-Marie-Tooth disease type 2B1 ORPHA:98856	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PHLDA2;A4GALT;PHLDA3
Charcot-Marie-Tooth disease type 2R ORPHA:397968	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	FLRT3;FAM84A;PCDHB15
Charcot-Marie-Tooth disease type 4G ORPHA:99953	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PNMA1;FNDC10;CHST2
Charcot-Marie-Tooth disease type 4H ORPHA:99954	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	MAFB;LRRC4;KCNJ2
Childhood-onset basal ganglia degeneration syndrome ORPHA:497906	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZNF865;ABHD16B;ADAT3
Childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome ORPHA:466921	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TAS2R30;PLN;TIGD1
Chondrodysplasia with joint dislocations, gPAPP type ORPHA:280586	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	MORF4L2;CLDN12;ZNF664
Coffin-Lowry syndrome ORPHA:192	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ABHD13;EXOC8;SAMD9
Combined immunodeficiency-enteropathy spectrum ORPHA:436252	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	RHOG;MGAT1;S1PR4
Combined oxidative phosphorylation defect type 30 ORPHA:478042	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TRMT10C;TAF9;METTL18
Congenital bile acid synthesis defect type 1 ORPHA:79301	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	CLDN23;RNASE4;ANG
Congenital chloride diarrhea ORPHA:53689	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	NAT2;RNF186;ATOH1
Congenital factor X deficiency ORPHA:328	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ISLR;SSTR1;SOD3
Congenital factor XII deficiency ORPHA:330	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZNHIT2;POP7;TMEM238
Congenital hereditary endothelial dystrophy type II ORPHA:293603	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TPBG;PHLDA2;CTXN1
Congenital lethal myopathy, Compton-North type ORPHA:210163	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TMEM246;TCEAL5;CDR1
Congenital muscular dystrophy due to LMNA mutation ORPHA:157973	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PHLDA2;A4GALT;PHLDA3
Connective tissue disorder due to lysyl hydroxylase-3 deficiency ORPHA:300284	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	MARVELD1;CHST14;PHLDA2
Corneal dystrophy-perceptive deafness syndrome ORPHA:1490	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TPBG;PHLDA2;CTXN1
Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome ORPHA:352662	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	KCNA3;S1PR1;GIMAP7
Crigler-Najjar syndrome type 1 ORPHA:79234	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ACKR2;CYP8B1;CPN2
Crigler-Najjar syndrome type 2 ORPHA:79235	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ACKR2;CYP8B1;CPN2
Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies ORPHA:221145	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	H1FX;ZNF865;ZNF358
DPAGT1-CDG ORPHA:86309	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZBTB9;RNF26;DOLK
Deafness-lymphedema-leukemia syndrome ORPHA:3226	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	MARVELD1;CDC42EP2;OR2B6
Desmoplastic/nodular medulloblastoma ORPHA:251863	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZNF319;ZNF865;CHST14
Diaphyseal medullary stenosis-bone malignancy syndrome ORPHA:85182	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJC1;KLHL9;TOR1AIP2
Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency ORPHA:276603	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	KCNJ4;KCNJ11;MYADML2
Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency ORPHA:276598	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TCEAL6;TCEAL5;CDK5R2
Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome ORPHA:2229	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PHLDA2;A4GALT;PHLDA3
Dimethylglycine dehydrogenase deficiency ORPHA:243343	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	NAT8;THRSP;CYP8B1
Distal 22q11.2 microdeletion syndrome ORPHA:261330	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ATXN1L;ATXN7L3B;ZBED4
Dystrophic epidermolysis bullosa pruriginosa ORPHA:89843	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	UCN2;TPBG;VASN
Early-onset myopathy with fatal cardiomyopathy ORPHA:289377	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TAS2R30;PLN;TIGD1
Early-onset seizures-distal limb anomalies-facial dysmorphism-global developmental delay syndrome ORPHA:505237	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	FIGNL1;SOCS4;ZNF146
Embryonal rhabdomyosarcoma ORPHA:99757	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	SCO2;MGAT1;TICAM1
Episodic ataxia type 5 ORPHA:211067	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	SSTR2;TIGD1;POU5F2
Epithelial basement membrane dystrophy ORPHA:98956	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ITPRIPL2;THBD;CEBPD
Essential fructosuria ORPHA:2056	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TMEM177;C19ORF73;SEPHS2
External auditory canal aplasia/hypoplasia ORPHA:141074	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PURA;IGIP;GPRASP1
F12-related hereditary angioedema with normal C1Inh ORPHA:100054	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZNHIT2;POP7;TMEM238
FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome ORPHA:404451	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJA1;ISLR;FIBIN
Familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome ORPHA:313846	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TAS2R30;ZBED6;SOCS4
Familial dilated cardiomyopathy with conduction defect due to LMNA mutation ORPHA:300751	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PHLDA2;A4GALT;PHLDA3
Familial drusen ORPHA:75376	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ISLR;FIBIN;CLEC14A
Familial partial lipodystrophy, Dunnigan type ORPHA:2348	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PHLDA2;A4GALT;PHLDA3
Familial partial lipodystrophy, Kobberling type ORPHA:79084	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PHLDA2;A4GALT;PHLDA3
Familial retinal arterial macroaneurysm ORPHA:284247	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ISLR;FIBIN;CLEC14A
Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 ORPHA:168566	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	COA4;POP7;TRMT10C
Fatty acyl-CoA reductase 1 deficiency ORPHA:438178	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZBTB6;ZBED5;SOCS4
Fetal encasement syndrome ORPHA:465824	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZBTB6;EXOC8;SOCS4
Focal dermal hypoplasia ORPHA:2092	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZBTB9;RNF26;DOLK
Fraser syndrome ORPHA:2052	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	SOX2;FLRT3;MUM1L1
Free sialic acid storage disease, infantile form ORPHA:309324	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	C1GALT1C1;C14ORF119;RNASE4
Friedreich ataxia ORPHA:95	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GEMIN7;PIGW;RPP38
GNB5-related intellectual disability-cardiac arrhythmia syndrome ORPHA:542306	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	NEUROD2;OR2L13;CHST12
GRACILE syndrome ORPHA:53693	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TMEM177;POP7;C19ORF48
Gabriele-de Vries syndrome ORPHA:506358	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZCCHC3;ZBED4;HNRNPA0
Galactosialidosis ORPHA:351	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TMEM127;RHOG;TICAM1
Gamma-aminobutyric acid transaminase deficiency ORPHA:2066	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	KCNJ10;DIRAS2;ASCL1
Genetic hyperferritinemia without iron overload ORPHA:254704	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	OST4;RHOG;MGAT1
Giant axonal neuropathy ORPHA:643	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZNF891;TOR1AIP2;TIGD1
Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome ORPHA:2084	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJA1;ISLR;FIBIN
Global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndrome ORPHA:488613	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PNMA1;GPRIN1;HNRNPA0
Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia ORPHA:79258	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	NAT8;CYP8B1;CPN2
Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib ORPHA:79259	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TMEM177;PARS2;RNF26
Glycogen storage disease due to muscle phosphofructokinase deficiency ORPHA:371	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	MYADML2;PCDHB15;GPRASP2
Gorlin-Chaudhry-Moss syndrome ORPHA:2095	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	C1GALT1C1;SMIM15;MGAT2
Granular corneal dystrophy type I ORPHA:98962	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ITPRIPL2;THBD;CEBPD
Granular corneal dystrophy type II ORPHA:98963	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ITPRIPL2;THBD;CEBPD
Greig cephalopolysyndactyly syndrome ORPHA:380	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJA1;GAS1;PCDHB10
Griscelli syndrome type 2 ORPHA:79477	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GPR65;S1PR4;C16ORF54
Guanidinoacetate methyltransferase deficiency ORPHA:382	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	MRPL41;UCN;RNF208
Hartsfield syndrome ORPHA:2117	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TCEAL7;GJA1;FZD7
Heart-hand syndrome, Slovenian type ORPHA:168796	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PHLDA2;A4GALT;PHLDA3
Hereditary hyperferritinemia-cataract syndrome ORPHA:163	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	OST4;RHOG;MGAT1
Hereditary myopathy with early respiratory failure ORPHA:178464	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TAS2R30;PLN;TIGD1
High bone mass osteogenesis imperfecta ORPHA:314029	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJA1;ISLR;FIBIN
Huriez syndrome ORPHA:384	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZNF770;RBM12B;ZNF146
Hyperekplexia-epilepsy syndrome ORPHA:163985	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	FUT9;TCEAL2;LRRC4C
Hyperkalemic periodic paralysis ORPHA:682	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	KBTBD13;SLN;LRRC30
Hyperlipidemia due to hepatic triacylglycerol lipase deficiency ORPHA:140905	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	NAT8;CYP8B1;CPN2
Hyperlysinemia ORPHA:2203	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJA1;PCDHB15;PCDHB5
Hypermethioninemia due to glycine N-methyltransferase deficiency ORPHA:289891	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TIGD3;UCN;FRAT1
Hypocalcemic vitamin D-resistant rickets ORPHA:93160	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TOR4A;SAMD9;TICAM1
Hypoplasminogenemia ORPHA:722	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	NAT8;CYP8B1;CPN2
ITPA-related lethal infantile neurological disorder with cataract and cardiac involvement ORPHA:457375	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	SF3B5;POP7;NXT1
Ichthyosis-prematurity syndrome ORPHA:88621	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GPRIN1;IRF2BP1;CENPB
Idiopathic CD4 lymphocytopenia ORPHA:228000	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TIGD3;ZNF581;SOWAHD
Incontinentia pigmenti ORPHA:464	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	SCO2;RHOG;BORCS6
Infant acute respiratory distress syndrome ORPHA:70587	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TCEAL6;CHRM1;PNMA2
Infantile spasms-psychomotor retardation-progressive brain atrophy-basal ganglia disease syndrome ORPHA:263410	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ACKR2;CYP8B1;CPN2
Intellectual disability-epilepsy-extrapyramidal syndrome ORPHA:468620	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	IRF2BP1;H1FX;SOX12
Intellectual disability-seizures-abnormal gait-facial dysmorphism syndrome ORPHA:513456	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PURB;EXOC8;ATXN1L
Intermediate DEND syndrome ORPHA:99989	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	KCNJ4;KCNJ11;MYADML2
Intermediate severe Salla disease ORPHA:309331	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	C1GALT1C1;C14ORF119;RNASE4
Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	HRH1;GJB3;TPBG
Isolated congenital adermatoglyphia ORPHA:289465	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZNF770;RBM12B;ZNF146
Isolated focal cortical dysplasia type Ia ORPHA:268973	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	FKBPL;DOLK;PHLDA2
Isolated osteopoikilosis ORPHA:166119	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	EXOC8;RBM12B;ZBTB33
Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome ORPHA:445062	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PLEKHF2;ABHD13;SAMD9
KCNQ2-related epileptic encephalopathy ORPHA:439218	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZCCHC12;CCDC177;CDK5R2
L-ferritin deficiency ORPHA:440731	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	OST4;RHOG;MGAT1
LMNA-related cardiocutaneous progeria syndrome ORPHA:363618	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PHLDA2;A4GALT;PHLDA3
Laminin subunit alpha 2-related congenital muscular dystrophy ORPHA:258	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJA1;ISLR;FIBIN
Lattice corneal dystrophy type I ORPHA:98964	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ITPRIPL2;THBD;CEBPD
Laurence-Moon syndrome ORPHA:2377	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	IRF2BP1;ZNF865;ABHD16B
Lethal congenital contracture syndrome type 1 ORPHA:1486	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	DDX28;FKBPL;HNRNPF
Lethal neonatal spasticity-epileptic encephalopathy syndrome ORPHA:435845	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZNHIT2;ABHD16B;ADAT3
Lethal osteosclerotic bone dysplasia ORPHA:1832	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	FZD1;CDC42EP4;ZNF358
Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome ORPHA:314051	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TMEM177;ALDH1B1;PARS2
Leydig cell hypoplasia due to LHB deficiency ORPHA:325448	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	FOXD4;H2AFX;ADAT3
Localized dystrophic epidermolysis bullosa, acral form ORPHA:158673	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	UCN2;TPBG;VASN
Localized dystrophic epidermolysis bullosa, nails only ORPHA:158676	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	UCN2;TPBG;VASN
Localized dystrophic epidermolysis bullosa, pretibial form ORPHA:79410	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	UCN2;TPBG;VASN
Lower motor neuron syndrome with late-adult onset ORPHA:276435	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	MRPL41;DPM3;DEXI
MEND syndrome ORPHA:401973	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	COA4;POP7;C19ORF48
MOGS-CDG ORPHA:79330	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	IRF2BP1;HPS6;CCDC71
Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome ORPHA:457485	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	AMER1;ZBTB39;GPR75
Mandibuloacral dysplasia with type A lipodystrophy ORPHA:90153	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PHLDA2;A4GALT;PHLDA3
Mandibuloacral dysplasia with type B lipodystrophy ORPHA:90154	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	C1GALT1C1;SMIM15;TRMT10C
Mandibulofacial dysostosis with alopecia ORPHA:443995	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJA1;ISLR;FIBIN
Marfan syndrome type 1 ORPHA:284963	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJA1;ISLR;FIBIN
Medulloblastoma with extensive nodularity ORPHA:251858	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZNF319;ZNF865;CHST14
Melorheostosis with osteopoikilosis ORPHA:1879	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	EXOC8;RBM12B;ZBTB33
Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency ORPHA:319595	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TLR1;SAMD9L;SAMD9
Methylcobalamin deficiency type cblDv1 ORPHA:308380	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	C1GALT1C1;TRMT10C;TAF9
Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency ORPHA:308425	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	C1GALT1C1;TRMT10C;METTL18
Methylmalonic acidemia with homocystinuria, type cblD ORPHA:79283	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	C1GALT1C1;TRMT10C;TAF9
Metopic ridging-ptosis-facial dysmorphism syndrome ORPHA:502430	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PCDHB15;PCDHB12;PCDHB10
Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome ORPHA:521445	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJA1;ISLR;FIBIN
Microcytic anemia with liver iron overload ORPHA:83642	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	CLDN12;SOCS6;GRHL2
Microduplication Xp11.22p11.23 syndrome ORPHA:217377	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PPP1R26;CDC42EP4;ZNF358
Mild Canavan disease ORPHA:314918	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	NPAP1;TIGD1;POU5F2
Mild hemophilia A ORPHA:169808	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	CLEC14A;THRSP;NKAPL
Moderately severe hemophilia A ORPHA:169805	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	CLEC14A;THRSP;NKAPL
Monocytopenia with susceptibility to infections ORPHA:228423	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	MARVELD1;CDC42EP2;OR2B6
Mowat-Wilson syndrome due to a ZEB2 point mutation ORPHA:261552	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	CYSLTR2;C3AR1;MPEG1
Mowat-Wilson syndrome due to monosomy 2q22 ORPHA:261537	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	CYSLTR2;C3AR1;MPEG1
Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome ORPHA:280679	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TRMT10C;RMI1;FIGNL1
Mucopolysaccharidosis type 2, attenuated form ORPHA:217093	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TCEAL6;GPRASP1;UBQLN2
Mucopolysaccharidosis type 2, severe form ORPHA:217085	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TCEAL6;GPRASP1;UBQLN2
Multiple intestinal atresia ORPHA:2300	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	RHOG;MGAT1;S1PR4
Multiple mitochondrial dysfunctions syndrome type 5 ORPHA:569274	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	FAM200B;SMIM10L1;CGGBP1
Muscular dystrophy, Selcen type ORPHA:199340	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PHLDA2;A4GALT;PHLDA3
Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement ORPHA:168953	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TCEAL7;GJA1;FZD7
Myotonia fluctuans ORPHA:99734	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	KBTBD13;SLN;LRRC30
Myotonia permanens ORPHA:99735	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	KBTBD13;SLN;LRRC30
NIK deficiency ORPHA:447731	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TICAM1;JUNB;S1PR4
NON RARE IN EUROPE: Exfoliation syndrome ORPHA:529819	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TPBG;TWIST2;VASN
NON RARE IN EUROPE: Gilbert syndrome ORPHA:357	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ACKR2;CYP8B1;CPN2
NON RARE IN EUROPE: Isolated keratoconus ORPHA:2335	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	AMER3;CHRM5;TIGD1
NON RARE IN EUROPE: Non rare obesity ORPHA:521399	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	AMER3;TCEAL6;FUT9
Neonatal Marfan syndrome ORPHA:284979	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJA1;ISLR;FIBIN
Neonatal severe cardiopulmonary failure due to mitochondrial methylation defect ORPHA:466784	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	LIPT1;COX14;MRPL57
Nephrogenic syndrome of inappropriate antidiuresis ORPHA:93606	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	SPN;LINGO3;S1PR4
Nestor-Guillermo progeria syndrome ORPHA:280576	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	POP7;RNF26;EMC6
Neuralgic amyotrophy ORPHA:2901	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZNF865;ABHD16B;CENPB
Neuroferritinopathy ORPHA:157846	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	OST4;RHOG;MGAT1
Neurogenic arthrogryposis multiplex congenita ORPHA:1143	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZBTB42;CHST14;CENPB
Neurological conditions associated with aminoacylase 1 deficiency ORPHA:137754	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	COA4;TMEM177;ALDH1B1
Neutral lipid storage myopathy ORPHA:98908	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	INAFM1;ZNF865;TICAM1
Neutrophil immunodeficiency syndrome ORPHA:183707	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	RHOG;TNFAIP8L2;S1PR4
Niemann-Pick disease type A ORPHA:77292	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TMEM127;INAFM1;MGAT1
Niemann-Pick disease type B ORPHA:77293	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TMEM127;INAFM1;MGAT1
Non-immune hydrops fetalis ORPHA:363999	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	FOXC2;GJA1;FOXL1
Non-spherocytic hemolytic anemia due to hexokinase deficiency ORPHA:90031	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PNMA1;FNDC10;CHST2
Oculodentodigital dysplasia ORPHA:2710	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TCEAL7;GJA1;FIBIN
Oculofaciocardiodental syndrome ORPHA:2712	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	AMER1;ZBTB39;ZBED4
Osteocraniostenosis ORPHA:2763	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	SAMD9L;SAMD9;TRIM56
Osteoglosphonic dysplasia ORPHA:2645	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TCEAL7;GJA1;FZD7
Overgrowth-macrocephaly-facial dysmorphism syndrome ORPHA:137634	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PTAFR;RHOG;TLR6
PLG-related hereditary angioedema with normal C1Inh ORPHA:537072	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	NAT8;CYP8B1;CPN2
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation ORPHA:438216	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PURA;IGIP;ZHX1
Pallister-Hall syndrome ORPHA:672	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJA1;GAS1;PCDHB10
Palmoplantar keratoderma-esophageal carcinoma syndrome ORPHA:2198	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PTAFR;RHOG;TICAM1
Paramyotonia congenita of Von Eulenburg ORPHA:684	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	KBTBD13;SLN;LRRC30
Pelviscapular dysplasia ORPHA:93333	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TMEM100;ISLR;FIBIN
Peters plus syndrome ORPHA:709	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	BBS12;FIGNL1;SOCS5
Polysyndactyly ORPHA:93338	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJA1;GAS1;PCDHB10
Posterior column ataxia-retinitis pigmentosa syndrome ORPHA:88628	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZNF891;DCAF16;CHML
Primary CD59 deficiency ORPHA:169464	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	HRH1;HRCT1;A4GALT
Primary hyperaldosteronism-seizures-neurological abnormalities syndrome ORPHA:369929	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	SSTR2;GDPGP1;PBOV1
Primary microcephaly-epilepsy-permanent neonatal diabetes syndrome ORPHA:306558	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	SMIM15;TRMT10C;TAF9
Progeroid and marfanoid aspect-lipodystrophy syndrome ORPHA:300382	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJA1;ISLR;FIBIN
Progeroid features-hepatocellular carcinoma predisposition syndrome ORPHA:435953	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TRMT10C;FIGNL1;PIGW
Progeroid syndrome, Petty type ORPHA:2963	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	C1GALT1C1;SMIM15;MGAT2
Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome ORPHA:457212	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TCEAL6;KCNA1;CDK5R2
Progressive familial intrahepatic cholestasis type 4 ORPHA:480483	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TMEM125;SOWAHB;CDC42EP4
Pyle disease ORPHA:3005	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ISLR;FOXS1;FIBIN
RAPADILINO syndrome ORPHA:3021	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	FEN1;H2AFX;C19ORF48
RFVT2-related riboflavin transporter deficiency ORPHA:572543	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZNHIT2;POP7;ADAT3
RIN2 syndrome ORPHA:217335	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ITPRIPL2;THBD;HRH1
Recessive dystrophic epidermolysis bullosa inversa ORPHA:79409	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	UCN2;TPBG;VASN
Reis-Bucklers corneal dystrophy ORPHA:98961	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ITPRIPL2;THBD;CEBPD
Renal tubulopathy-encephalopathy-liver failure syndrome ORPHA:254902	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TMEM177;POP7;C19ORF48
Resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha ORPHA:566231	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	AMIGO1;ZNF358;AHDC1
Rothmund-Thomson syndrome type 2 ORPHA:221016	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	FEN1;H2AFX;C19ORF48
SLC35A2-CDG ORPHA:356961	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	FKBPL;DOLK;PHLDA2
SMARCA4-deficient sarcoma of thorax ORPHA:466962	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZBTB12;SOX12;CTXN1
SSR4-CDG ORPHA:370927	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	OST4;SF3B5;DPM3
STING-associated vasculopathy with onset in infancy ORPHA:425120	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	SAMD9L;SAMD9;RHOG
Saccharopinuria ORPHA:3124	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJA1;PCDHB15;PCDHB5
Salla disease ORPHA:309334	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	C1GALT1C1;C14ORF119;RNASE4
Sandhoff disease, adult form ORPHA:309169	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	C1GALT1C1;CLDN23;MGAT2
Sandhoff disease, infantile form ORPHA:309155	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	C1GALT1C1;CLDN23;MGAT2
Sandhoff disease, juvenile form ORPHA:309162	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	C1GALT1C1;CLDN23;MGAT2
Sanfilippo syndrome type D ORPHA:79272	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ITPRIPL2;FZD1;TMEM127
Seizures-scoliosis-macrocephaly syndrome ORPHA:466926	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	MORF4L2;TPBG;DOLK
Self-improving dystrophic epidermolysis bullosa ORPHA:79411	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	UCN2;TPBG;VASN
Severe Canavan disease ORPHA:314911	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	NPAP1;TIGD1;POU5F2
Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome ORPHA:488627	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TRMT10C;RPP38;METTL18
Severe hemophilia A ORPHA:169802	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	CLEC14A;THRSP;NKAPL
Severe intellectual disability-progressive postnatal microcephaly-midline stereotypic hand movements syndrome ORPHA:397933	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PPP1R26;CDC42EP4;ZNF358
Severe neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion ORPHA:314655	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PURA;IGIP;ZHX1
Short stature-optic atrophy-Pelger-Huet anomaly syndrome ORPHA:391677	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TAS2R30;TAS2R31;ZBED6
Sinoatrial node dysfunction and deafness ORPHA:324321	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	SSTR2;GDPGP1;PBOV1
Small cell carcinoma of the ovary ORPHA:370396	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZBTB12;SOX12;CTXN1
Spinocerebellar ataxia type 15/16 ORPHA:98769	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	SPN;CYSLTR2;GPR183
Spinocerebellar ataxia type 29 ORPHA:208513	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	SPN;CYSLTR2;GPR183
Spinocerebellar ataxia type 42 ORPHA:458803	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	CCDC177;FAM43B;PNMA2
Spondyloepimetaphyseal dysplasia with multiple dislocations ORPHA:93360	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	FEN1;CDCA4;C19ORF48
Spondyloepimetaphyseal dysplasia, Genevieve type ORPHA:168454	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	COA4;C14ORF119;PHLDA2
Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome ORPHA:93358	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TMEM100;ISLR;FIBIN
Stiff skin syndrome ORPHA:2833	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJA1;ISLR;FIBIN
Succinic semialdehyde dehydrogenase deficiency ORPHA:22	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	KCNJ11;AMIGO1;SOWAHA
Susceptibility to viral and mycobacterial infections due to STAT1 deficiency ORPHA:391311	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TLR1;SAMD9L;SAMD9
Symptomatic form of Coffin-Lowry syndrome in female carriers ORPHA:276630	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ABHD13;EXOC8;SAMD9
Symptomatic form of hemophilia A in female carriers ORPHA:177926	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	CLEC14A;THRSP;NKAPL
Symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers ORPHA:206546	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PLN;FLRT2;CDR1
Syndactyly type 3 ORPHA:93404	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TCEAL7;GJA1;FIBIN
Synpolydactyly type 2 ORPHA:295197	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJA1;ISLR;FIBIN
Systemic primary carnitine deficiency ORPHA:158	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TMEM184A;PRR15L;TOB1
TELO2-related intellectual disability-neurodevelopmental disorder ORPHA:488642	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	IRF2BP1;ABHD16B;ADAT3
TOR1AIP1-related limb-girdle muscular dystrophy ORPHA:424261	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	SAMD9L;EXOC8;SAMD9
Thiamine-responsive encephalopathy ORPHA:199348	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ACKR2;CYP8B1;CPN2
Thiel-Behnke corneal dystrophy ORPHA:98960	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ITPRIPL2;THBD;CEBPD
Tibial hemimelia ORPHA:93322	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJA1;GAS1;PCDHB10
Tibial muscular dystrophy ORPHA:609	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TAS2R30;PLN;TIGD1
Titin-related  limb-girdle muscular dystrophy R10 ORPHA:140922	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	TAS2R30;PLN;TIGD1
Transient familial neonatal hyperbilirubinemia ORPHA:2312	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ACKR2;CYP8B1;CPN2
Transient infantile hypertriglyceridemia and hepatosteatosis ORPHA:300293	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	GJB1;APLNR;THRSP
Trichomegaly-retina pigmentary degeneration-dwarfism syndrome ORPHA:3363	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	IRF2BP1;ZNF865;ABHD16B
Triglyceride deposit cardiomyovasculopathy ORPHA:565612	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	INAFM1;ZNF865;TICAM1
Tritanopia ORPHA:88629	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	KDM4D;SLC35G2;GPR3
Vitamin B12-responsive methylmalonic acidemia, type cblDv2 ORPHA:308442	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	C1GALT1C1;TRMT10C;TAF9
Vocal cord and pharyngeal distal myopathy ORPHA:600	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZNF770;CHML;ZNF146
Waldenstrom macroglobulinemia ORPHA:33226	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PCED1B;RHOG;S1PR4
X-linked centronuclear myopathy ORPHA:596	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PLEKHF2;TLR1;ABHD13
X-linked cerebral adrenoleukodystrophy ORPHA:139396	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	HPS6;ZNF865;ABHD16B
X-linked creatine transporter deficiency ORPHA:52503	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	PPP1R26;CDC42EP4;TRNP1
X-linked dominant chondrodysplasia punctata ORPHA:35173	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	COA4;POP7;C19ORF48
X-linked intellectual disability-cerebellar hypoplasia syndrome ORPHA:137831	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZNF891;OR11A1;TIGD1
X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency ORPHA:319612	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	SCO2;RHOG;BORCS6
Xq25 microduplication syndrome ORPHA:521258	3/101	0.9995284018252129	0.9999961656375117	0	0	0.23691215616681455	1.1175369392389938E-4	ZNF518A;ZBTB33;SOCS4
Autosomal dominant non-syndromic intellectual disability ORPHA:178469	5/133	0.9995618276899151	0.9999961656375117	0	0	0.30206043956043954	1.323835261037333E-4	FUT9;SLITRK1;CHAMP1;CDK5R2;CDR1
17p13.3 microduplication syndrome ORPHA:217385	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	MORF4L2;ZNF664;GPRASP2
3C syndrome ORPHA:7	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	ZNF581;SCO2;HPS6
46,XY disorder of sex development due to isolated 17,20-lyase deficiency ORPHA:90796	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	NAT8;ACKR2;CYP8B1
Acute megakaryoblastic leukemia without Down syndrome ORPHA:329469	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	RNF208;ZNF865;AHDC1
Alveolar soft tissue sarcoma ORPHA:163699	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	IRF2BP1;ZNF865;ABHD16B
Atypical hemolytic uremic syndrome with complement gene abnormality ORPHA:544472	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	THBD;RNASE4;RNASE1
Autosomal recessive Robinow syndrome ORPHA:1507	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	FZD7;TPBG;FJX1
Autosomal recessive progressive external ophthalmoplegia ORPHA:254886	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	ZNF319;HPS6;MGAT1
Brittle cornea syndrome ORPHA:90354	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	ARMCX4;FLRT2;CDR1
Cap myopathy ORPHA:171881	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	FOXC2;TWIST2;FOXL1
Carpenter syndrome ORPHA:65759	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	FZD7;GPRASP2;FJX1
Caudal regression sequence ORPHA:3027	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	FKBPL;MARVELD1;CHST14
Coats plus syndrome ORPHA:313838	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	GPR174;S1PR4;C16ORF54
Cockayne syndrome type 3 ORPHA:90324	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	TAS2R31;ZBED6;SOCS4
Congenital bilateral absence of vas deferens ORPHA:48	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	GCNT3;FUT2;GRHL2
Congenital cataract microcornea with corneal opacity ORPHA:289499	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	ATOH7;TRAM1L1;FJX1
Congenital factor XIII deficiency ORPHA:331	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	RNASE6;OXER1;MPEG1
Congenital neutropenia-myelofibrosis-nephromegaly syndrome ORPHA:369852	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	ZNF623;GPRASP2;TSPYL4
Congenital ptosis ORPHA:91411	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	TCEAL7;GJA1;CDR1
Cushing syndrome due to macronodular adrenal hyperplasia ORPHA:189427	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	IRF2BP1;H1FX;ZNF865
FRAXE intellectual disability ORPHA:100973	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	ZNF660;LRRC4;NAP1L3
Familial avascular necrosis of femoral head ORPHA:86820	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	CLDN6;TPBG;FZD8
Familial infantile myoclonic epilepsy ORPHA:352582	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	FLRT1;CTXN1;CDK5R2
Familial primary hypomagnesemia with normocalciuria and normocalcemia ORPHA:34527	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	SLITRK5;SOX11;LPAR4
Familial primary localized cutaneous amyloidosis ORPHA:353220	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	ITPRIPL2;HRH1;UCN2
Freeman-Sheldon syndrome ORPHA:2053	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	FLRT2;PNMA2;FAM106A
Glycogen storage disease due to muscle phosphorylase kinase deficiency ORPHA:715	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	SLN;RGS9BP;MYADML2
Hereditary methemoglobinemia ORPHA:621	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	RNASE4;ANG;SOD3
Hermansky-Pudlak syndrome with pulmonary fibrosis ORPHA:231500	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	SPN;ACSF3;S1PR4
Hutchinson-Gilford progeria syndrome ORPHA:740	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	SMIM15;PHLDA2;DUSP14
Hyperostosis corticalis generalisata ORPHA:3416	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	FZD7;TPBG;FZD8
Hypoplastic left heart syndrome ORPHA:2248	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	GJA1;PABPC4L;FZD8
Hypoplastic tibiae-postaxial polydactyly syndrome ORPHA:3332	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	SOWAHB;CLDN12;ZNF664
Imerslund-Grasbeck syndrome ORPHA:35858	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	IGKC;IGLC3;IGLC2
Isolated ectopia lentis ORPHA:1885	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	ISLR;TWIST2;CD248
Isolated growth hormone deficiency type IA ORPHA:231662	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	CNR2;TLR10;GPR18
Leigh syndrome with nephrotic syndrome ORPHA:255249	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	C1GALT1C1;TRMT10C;PIGW
Lethal congenital contracture syndrome type 3 ORPHA:137783	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	RNF208;ZNF358;AHDC1
Lymphomatoid papulosis ORPHA:98842	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	CDCA4;NUP62;C19ORF48
Malignant peripheral nerve sheath tumor ORPHA:3148	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	GJA1;ISLR;FIBIN
Marinesco-Sjogren syndrome ORPHA:559	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	SCO2;TREX1;MGAT1
Microcephalic primordial dwarfism-insulin resistance syndrome ORPHA:436182	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	TRMT10C;TAF9;METTL18
NON RARE IN EUROPE: Melanoma ORPHA:411533	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	ZBTB33;CHML;SOCS4
Neurofibromatosis-Noonan syndrome ORPHA:638	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	IRF2BP1;ZBTB12;ZNF865
Nodular fasciitis ORPHA:477742	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	LTB4R2;ATXN1L;TRIM56
Oculocutaneous albinism type 2 ORPHA:79432	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	MC1R;GPRIN1;CTXN1
PEHO syndrome ORPHA:2836	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	CCDC177;FUT9;B3GALT1
Paroxysmal non-kinesigenic dyskinesia ORPHA:98810	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	MRPL41;RNF208;ZNF358
Phosphoenolpyruvate carboxykinase deficiency ORPHA:2880	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	NAT2;ANG;RNF186
Polydactyly of a triphalangeal thumb ORPHA:93336	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	SOWAHB;CLDN12;ZNF664
Prenatal-onset spinal muscular atrophy with congenital bone fractures ORPHA:486811	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	LIPT1;RPP38;MED7
Primary cutaneous anaplastic large cell lymphoma ORPHA:300865	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	CDCA4;NUP62;C19ORF48
Proteus syndrome ORPHA:744	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	FRAT1;ZBTB22;CENPB
Proximal spinal muscular atrophy type 4 ORPHA:83420	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	TRMT10C;TAF9;PIGW
RAS-associated autoimmune leukoproliferative disease ORPHA:268114	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	ZBTB6;ZBTB33;SOCS4
Radial hemimelia ORPHA:93321	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	SOWAHB;CLDN12;ZNF664
Renal-hepatic-pancreatic dysplasia ORPHA:294415	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	CNR2;ZNF345;TRIM56
Restrictive dermopathy ORPHA:1662	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	SMIM15;PHLDA2;DUSP14
Roussy-Levy syndrome ORPHA:3115	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	C11ORF96;SPRY2;SMIM10
Shprintzen-Goldberg syndrome ORPHA:2462	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	GJA1;ISLR;VASN
Syndactyly type 4 ORPHA:93405	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	SOWAHB;CLDN12;ZNF664
Triphalangeal thumb-polysyndactyly syndrome ORPHA:2950	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	SOWAHB;CLDN12;ZNF664
X-linked myotubular myopathy-abnormal genitalia syndrome ORPHA:456328	3/102	0.9995743402674804	0.9999961656375117	0	0	0.2345057957706179	9.984092494052908E-5	PRNP;RRAGA;UBQLN2
Acrocallosal syndrome ORPHA:36	3/103	0.9996158342197714	0.9999961656375117	0	0	0.2321475625823452	8.920028445330072E-5	FZD7;FZD8;FJX1
Atypical juvenile parkinsonism ORPHA:391411	3/103	0.9996158342197714	0.9999961656375117	0	0	0.2321475625823452	8.920028445330072E-5	RNF182;PNMA2;CDK5R2
Brachydactyly type A2 ORPHA:93396	3/103	0.9996158342197714	0.9999961656375117	0	0	0.2321475625823452	8.920028445330072E-5	GJA1;DSEL;FIBIN
Channelopathy-associated congenital insensitivity to pain ORPHA:88642	3/103	0.9996158342197714	0.9999961656375117	0	0	0.2321475625823452	8.920028445330072E-5	CHRM2;ZNF660;FLRT2
Clear cell papillary renal cell carcinoma ORPHA:404511	3/103	0.9996158342197714	0.9999961656375117	0	0	0.2321475625823452	8.920028445330072E-5	TAS2R30;TOR1AIP2;ZBED6
Cockayne syndrome type 2 ORPHA:90322	3/103	0.9996158342197714	0.9999961656375117	0	0	0.2321475625823452	8.920028445330072E-5	HIST1H2AH;SLC25A51;ZBED6
Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome ORPHA:1369	3/103	0.9996158342197714	0.9999961656375117	0	0	0.2321475625823452	8.920028445330072E-5	COA4;TMEM177;MAGEF1
Familial infantile bilateral striatal necrosis ORPHA:225154	3/103	0.9996158342197714	0.9999961656375117	0	0	0.2321475625823452	8.920028445330072E-5	PCBP1;NUP62;ZNF865
Familial papillary or follicular thyroid carcinoma ORPHA:319487	3/103	0.9996158342197714	0.9999961656375117	0	0	0.2321475625823452	8.920028445330072E-5	FOXE1;FLRT3;CLDN12
Isolated aniridia ORPHA:250923	3/103	0.9996158342197714	0.9999961656375117	0	0	0.2321475625823452	8.920028445330072E-5	FOXC1;ZNF664;FJX1
Microphthalmia with linear skin defects syndrome ORPHA:2556	3/103	0.9996158342197714	0.9999961656375117	0	0	0.2321475625823452	8.920028445330072E-5	SF3B5;POP7;COX14
Miller-Dieker syndrome ORPHA:531	3/103	0.9996158342197714	0.9999961656375117	0	0	0.2321475625823452	8.920028445330072E-5	TCEAL7;ZNF664;FJX1
Mutilating palmoplantar keratoderma with periorificial keratotic plaques ORPHA:659	3/103	0.9996158342197714	0.9999961656375117	0	0	0.2321475625823452	8.920028445330072E-5	SOWAHC;TPBG;CLDN12
NON RARE IN EUROPE: Hidradenitis suppurativa ORPHA:387	3/103	0.9996158342197714	0.9999961656375117	0	0	0.2321475625823452	8.920028445330072E-5	C1GALT1C1;SERTAD3;MGAT1
NON RARE IN EUROPE: Metabolic syndrome ORPHA:411969	3/103	0.9996158342197714	0.9999961656375117	0	0	0.2321475625823452	8.920028445330072E-5	ZNF358;ZNF664;GPRASP2
Paroxysmal extreme pain disorder ORPHA:46348	3/103	0.9996158342197714	0.9999961656375117	0	0	0.2321475625823452	8.920028445330072E-5	CHRM2;ZNF660;FLRT2
Primary erythromelalgia ORPHA:90026	3/103	0.9996158342197714	0.9999961656375117	0	0	0.2321475625823452	8.920028445330072E-5	CHRM2;ZNF660;FLRT2
Primary sclerosing cholangitis ORPHA:171	3/103	0.9996158342197714	0.9999961656375117	0	0	0.2321475625823452	8.920028445330072E-5	RNASE6;OXER1;MPEG1
Rare isolated myopia ORPHA:98619	3/103	0.9996158342197714	0.9999961656375117	0	0	0.2321475625823452	8.920028445330072E-5	SCO2;MGAT1;COMMD5
Saethre-Chotzen syndrome ORPHA:794	3/103	0.9996158342197714	0.9999961656375117	0	0	0.2321475625823452	8.920028445330072E-5	GJA1;FLRT3;TWIST1
Sodium channelopathy-related small fiber neuropathy ORPHA:306577	3/103	0.9996158342197714	0.9999961656375117	0	0	0.2321475625823452	8.920028445330072E-5	CHRM2;ZNF660;FLRT2
Subcortical band heterotopia ORPHA:99796	3/103	0.9996158342197714	0.9999961656375117	0	0	0.2321475625823452	8.920028445330072E-5	GPR173;TCEAL7;PNMA2
X-linked non-syndromic sensorineural deafness type DFN ORPHA:90625	3/103	0.9996158342197714	0.9999961656375117	0	0	0.2321475625823452	8.920028445330072E-5	ALDH1B1;MORF4L2;FZD7
Familial isolated dilated cardiomyopathy ORPHA:154	5/135	0.9996358942948873	0.9999961656375117	0	0	0.2973795435333897	1.0829730541434985E-4	PLN;SLN;XIRP1;DOLK;HSPB3
Autosomal recessive isolated optic atrophy ORPHA:98676	3/104	0.9996533062538492	0.9999961656375117	0	0	0.22983602708096898	7.969652917165768E-5	TMEM177;POP7;PARS2
Cardiofaciocutaneous syndrome ORPHA:1340	3/104	0.9996533062538492	0.9999961656375117	0	0	0.22983602708096898	7.969652917165768E-5	ZNF770;EXOC8;CDK5R1
Coloboma of eye lens ORPHA:98943	3/104	0.9996533062538492	0.9999961656375117	0	0	0.22983602708096898	7.969652917165768E-5	SMIM10L2B;FZD5;GPRASP2
Coloboma of eyelid ORPHA:98946	3/104	0.9996533062538492	0.9999961656375117	0	0	0.22983602708096898	7.969652917165768E-5	SMIM10L2B;FZD5;GPRASP2
Coloboma of macula ORPHA:98945	3/104	0.9996533062538492	0.9999961656375117	0	0	0.22983602708096898	7.969652917165768E-5	SMIM10L2B;FZD5;GPRASP2
Coloboma of optic disc ORPHA:98947	3/104	0.9996533062538492	0.9999961656375117	0	0	0.22983602708096898	7.969652917165768E-5	SMIM10L2B;FZD5;GPRASP2
Complete hydatidiform mole ORPHA:254688	3/104	0.9996533062538492	0.9999961656375117	0	0	0.22983602708096898	7.969652917165768E-5	RHOH;S1PR4;C16ORF54
Dejerine-Sottas syndrome ORPHA:64748	3/104	0.9996533062538492	0.9999961656375117	0	0	0.22983602708096898	7.969652917165768E-5	C11ORF96;SOCS3;ZNF865
Distal hereditary motor neuropathy type 2 ORPHA:139525	3/104	0.9996533062538492	0.9999961656375117	0	0	0.22983602708096898	7.969652917165768E-5	FIBIN;HSPB3;SOD3
Familial bicuspid aortic valve ORPHA:402075	3/104	0.9996533062538492	0.9999961656375117	0	0	0.22983602708096898	7.969652917165768E-5	FZD2;FZD7;FZD8
Short rib-polydactyly syndrome, Verma-Naumoff type ORPHA:93271	3/104	0.9996533062538492	0.9999961656375117	0	0	0.22983602708096898	7.969652917165768E-5	RAB40A;TTC30A;ZNF664
Smith-Magenis syndrome ORPHA:819	3/104	0.9996533062538492	0.9999961656375117	0	0	0.22983602708096898	7.969652917165768E-5	IRF2BP1;ZNF865;ZNF358
1p36 deletion syndrome ORPHA:1606	3/105	0.9996871393299602	0.9999961656375117	0	0	0.22756981580510993	7.120878484861225E-5	C1QTNF4;ZNF865;AHDC1
Congenital muscular dystrophy with intellectual disability ORPHA:370968	3/105	0.9996871393299602	0.9999961656375117	0	0	0.22756981580510993	7.120878484861225E-5	FKRP;KLHL25;SPRN
Congenital myasthenic syndromes with glycosylation defect ORPHA:353327	3/105	0.9996871393299602	0.9999961656375117	0	0	0.22756981580510993	7.120878484861225E-5	COA4;SMIM15;DOLK
Early-onset posterior subcapsular cataract ORPHA:441447	3/105	0.9996871393299602	0.9999961656375117	0	0	0.22756981580510993	7.120878484861225E-5	ZNF865;ZNF358;CENPB
Endometrial stromal sarcoma ORPHA:213711	3/105	0.9996871393299602	0.9999961656375117	0	0	0.22756981580510993	7.120878484861225E-5	CHAMP1;GPR75;ZBTB12
Familial isolated restrictive cardiomyopathy ORPHA:75249	3/105	0.9996871393299602	0.9999961656375117	0	0	0.22756981580510993	7.120878484861225E-5	GJC1;FZD7;HSPB3
Idiopathic aplastic anemia ORPHA:88	3/105	0.9996871393299602	0.9999961656375117	0	0	0.22756981580510993	7.120878484861225E-5	GPR174;GPR171;RHOH
NON RARE IN EUROPE: Aldosterone-producing adenoma ORPHA:85142	3/105	0.9996871393299602	0.9999961656375117	0	0	0.22756981580510993	7.120878484861225E-5	LRRTM1;DIRAS2;SOWAHA
Ondine syndrome ORPHA:661	3/105	0.9996871393299602	0.9999961656375117	0	0	0.22756981580510993	7.120878484861225E-5	TCEAL7;MAB21L1;SCG2
Osteogenesis imperfecta type 2 ORPHA:216804	3/105	0.9996871393299602	0.9999961656375117	0	0	0.22756981580510993	7.120878484861225E-5	MARVELD1;TWIST2;VASN
Pontocerebellar hypoplasia type 2 ORPHA:2524	3/105	0.9996871393299602	0.9999961656375117	0	0	0.22756981580510993	7.120878484861225E-5	HNRNPF;RPP38;METTL18
Familial exudative vitreoretinopathy ORPHA:891	3/106	0.9997176809142563	0.9999961656375117	0	0	0.22534760863169476	6.362891309440297E-5	FZD7;CLDN12;FJX1
Juvenile myelomonocytic leukemia ORPHA:86834	3/106	0.9997176809142563	0.9999961656375117	0	0	0.22534760863169476	6.362891309440297E-5	CHML;ZBED6;SOCS4
Perrault syndrome ORPHA:2855	3/106	0.9997176809142563	0.9999961656375117	0	0	0.22534760863169476	6.362891309440297E-5	TMEM177;PARS2;DOLK
Non-specific early-onset epileptic encephalopathy ORPHA:442835	5/138	0.9997244001987411	0.9999961656375117	0	0	0.29062215979509215	8.010644864873751E-5	TCEAL6;TCEAL5;SLITRK1;PARS2;CDK5R2
Frontotemporal dementia with motor neuron disease ORPHA:275872	3/107	0.9997452458299005	0.9999961656375117	0	0	0.22316813621161447	5.686025633449668E-5	RNF26;RRS1;SEPHS2
Hypotrichosis simplex ORPHA:55654	3/107	0.9997452458299005	0.9999961656375117	0	0	0.22316813621161447	5.686025633449668E-5	CLDN4;RPL36AL;LPAR6
Osteogenesis imperfecta type 3 ORPHA:216812	3/107	0.9997452458299005	0.9999961656375117	0	0	0.22316813621161447	5.686025633449668E-5	ISLR;TWIST2;VASN
Periventricular nodular heterotopia ORPHA:98892	3/107	0.9997452458299005	0.9999961656375117	0	0	0.22316813621161447	5.686025633449668E-5	MORF4L2;CLDN12;ZNF664
Trichothiodystrophy ORPHA:33364	3/107	0.9997452458299005	0.9999961656375117	0	0	0.22316813621161447	5.686025633449668E-5	RNF113A;NXT1;GEMIN7
Common variable immunodeficiency ORPHA:1572	3/110	0.9998128027446539	0.9999961656375117	0	0	0.2168741457648406	4.0602045257004716E-5	GPR174;IGKC;S1PR4
Left ventricular noncompaction ORPHA:54260	3/110	0.9998128027446539	0.9999961656375117	0	0	0.2168741457648406	4.0602045257004716E-5	MYADML2;XIRP1;HSPB3
Usher syndrome type 1 ORPHA:231169	3/110	0.9998128027446539	0.9999961656375117	0	0	0.2168741457648406	4.0602045257004716E-5	ENHO;SMIM10L2A;SOWAHA
Lynch syndrome ORPHA:144	3/111	0.9998310586543288	0.9999961656375117	0	0	0.21485385253501196	3.6300765406341174E-5	ZNF770;RBM12B;SOCS4
Differentiated thyroid carcinoma ORPHA:146	4/129	0.9998525247943353	0.9999961656375117	0	0	0.24738137082601055	3.648530894553667E-5	FOXE1;LPAR4;CHML;ZNF146
Autosomal dominant non-syndromic sensorineural deafness type DFNA ORPHA:90635	5/145	0.9998562941565097	0.9999961656375117	0	0	0.2759811616954474	3.966295559639204E-5	GJB2;GJB3;GJB6;CLDN12;GRHL2
Male infertility with azoospermia or oligozoospermia due to single gene mutation ORPHA:399805	3/115	0.999887794299243	0.9999961656375117	0	0	0.20713344626388105	2.324285750319203E-5	NANOS1;GPR63;CHML
Acrofacial dysostosis, Weyers type ORPHA:952	2/100	0.9999218564366181	0.9999961656375117	0	0	0.1578721040655068	1.233717081179525E-5	GJA1;ARMCX2
Charcot-Marie-Tooth disease type 2B2 ORPHA:101101	2/100	0.9999218564366181	0.9999961656375117	0	0	0.1578721040655068	1.233717081179525E-5	ZNF865;ABHD16B
Combined deficiency of factor V and factor VIII ORPHA:35909	2/100	0.9999218564366181	0.9999961656375117	0	0	0.1578721040655068	1.233717081179525E-5	MORF4L2;CLDN12
DEND syndrome ORPHA:79134	2/100	0.9999218564366181	0.9999961656375117	0	0	0.1578721040655068	1.233717081179525E-5	KCNJ11;CDK5R2
Metachromatic leukodystrophy, adult form ORPHA:309271	2/100	0.9999218564366181	0.9999961656375117	0	0	0.1578721040655068	1.233717081179525E-5	TMEM127;MGAT1
Metachromatic leukodystrophy, juvenile form ORPHA:309263	2/100	0.9999218564366181	0.9999961656375117	0	0	0.1578721040655068	1.233717081179525E-5	TMEM127;MGAT1
Metachromatic leukodystrophy, late infantile form ORPHA:309256	2/100	0.9999218564366181	0.9999961656375117	0	0	0.1578721040655068	1.233717081179525E-5	TMEM127;MGAT1
Rotor syndrome ORPHA:3111	2/100	0.9999218564366181	0.9999961656375117	0	0	0.1578721040655068	1.233717081179525E-5	CLDN2;CYP8B1
17p11.2 microduplication syndrome ORPHA:1713	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	IRF2BP1;ZNF865
1q44 microdeletion syndrome ORPHA:238769	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	RBM12B;CHML
3-methylglutaconic aciduria type 7 ORPHA:445038	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FEN1;MARS2
3MC syndrome ORPHA:293843	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CHRM2;CPN2
5-oxoprolinase deficiency ORPHA:33572	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CITED4;CLDN23
5q35 microduplication syndrome ORPHA:228415	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	RBM12B;ZBED6
6q16 microdeletion syndrome ORPHA:171829	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CCDC8;MAB21L1
7q31 microdeletion syndrome ORPHA:251061	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	SLITRK5;RNF152
8q24.3 microdeletion syndrome ORPHA:508488	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNHIT2;POP7
Aland Islands eye disease ORPHA:178333	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	SPN;C16ORF54
AKT2-related familial partial lipodystrophy ORPHA:79085	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF865;CENPB
ANK3-related intellectual disability-sleep disturbance syndrome ORPHA:356996	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FUT9;FAM84A
APC-related attenuated familial adenomatous polyposis ORPHA:247806	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GPR22;CDR1
Acheiropodia ORPHA:931	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	RBM12B;CHML
Acrokeratosis verruciformis of Hopf ORPHA:79151	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CLDN12;ZNF664
Acute myeloid leukaemia with myelodysplasia-related features ORPHA:86845	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CYSLTR1;POU5F2
Adenocarcinoma of ovary ORPHA:213504	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	HRH1;PHLDA1
Adult polyglucosan body disease ORPHA:206583	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	C1GALT1C1;MGAT2
Alazami syndrome ORPHA:319671	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TRMT10C;PNRC2
Alpha-mannosidosis, adult form ORPHA:309288	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	RHOG;MGAT1
Alpha-mannosidosis, infantile form ORPHA:309282	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	RHOG;MGAT1
Alstrom syndrome ORPHA:64	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	RBM12B;ZBED6
Arnold-Chiari malformation type II ORPHA:1136	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	NHLRC4;INAFM1
Arterial tortuosity syndrome ORPHA:3342	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CDC42EP5;SOD3
Arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome ORPHA:1154	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJA1;FLRT2
Ataxia with vitamin E deficiency ORPHA:96	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CYP8B1;CPN2
Ataxia-oculomotor apraxia type 1 ORPHA:1168	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TRMT10C;TAF9
Atrophoderma vermiculata ORPHA:79100	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ISLR;FIBIN
Autism spectrum disorder-epilepsy-arthrogryposis syndrome ORPHA:370943	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TOR1AIP2;GCNT3
Autosomal dominant Charcot-Marie-Tooth disease type 2V ORPHA:447964	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	DOLK;HPS6
Autosomal dominant intermediate Charcot-Marie-Tooth disease type C ORPHA:100045	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FEN1;C19ORF48
Autosomal dominant intermediate Charcot-Marie-Tooth disease type E ORPHA:93114	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF358;CENPB
Autosomal dominant optic atrophy plus syndrome ORPHA:1215	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF770;CHML
Autosomal dominant spastic paraplegia type 4 ORPHA:100985	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF518A;ZBTB33
Autosomal recessive anterior segment dysgenesis ORPHA:519388	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF83;C5AR2
Autosomal recessive ataxia due to PEX10 deficiency ORPHA:247815	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNHIT2;IRF2BP1
Autosomal recessive cerebellar ataxia due to CWF19L1 deficiency ORPHA:453521	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	DDX28;LIPT1
Autosomal recessive cerebelloparenchymal disorder type 3 ORPHA:1170	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	POP7;C19ORF48
Autosomal recessive intermediate Charcot-Marie-Tooth disease type D ORPHA:435998	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	SF3B5;POP7
Autosomal recessive optic atrophy, OPA7 type ORPHA:227976	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TRMT10C;TAF9
Autosomal recessive spastic ataxia-optic atrophy-dysarthria syndrome ORPHA:254343	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF891;TOR1AIP2
Autosomal recessive spastic paraplegia type 48 ORPHA:306511	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	MGAT1;ABHD16B
Autosomal recessive spastic paraplegia type 60 ORPHA:401800	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZBTB33;PNRC2
Autosomal recessive spastic paraplegia type 61 ORPHA:401780	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	SMIM15;MORF4L2
Autosomal recessive spastic paraplegia type 69 ORPHA:401830	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CHML;ZBED6
Autosomal recessive spastic paraplegia type 71 ORPHA:401840	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CHML;ZNF146
Autosomal recessive spastic paraplegia type 77 ORPHA:466722	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	DDX28;FASTKD5
Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome ORPHA:95433	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	IRF2BP1;ZBTB22
B-cell immunodeficiency-limb anomaly-urogenital malformation syndrome ORPHA:567502	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	RBM12B;ZNF146
Beckwith-Wiedemann syndrome due to NSD1 mutation ORPHA:238613	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	RBM12B;ZBED6
Benign Samaritan congenital myopathy ORPHA:324581	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	KCNA5;LRRC3B
Brachydactyly-arterial hypertension syndrome ORPHA:1276	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJA1;PABPC5
Brain demyelination due to methionine adenosyltransferase deficiency ORPHA:168598	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJB1;KLHDC7A
C11ORF73-related autosomal recessive hypomyelinating leukodystrophy ORPHA:495844	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TAF9;TMEM60
CDKL5-related epileptic encephalopathy ORPHA:505652	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF891;SSTR2
CLN1 disease ORPHA:228329	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	LSM10;DDX28
CLN3 disease ORPHA:228346	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	C5AR2;ACSF3
CLN4A disease ORPHA:228340	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	NUP62;C19ORF48
CLN6 disease ORPHA:228363	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	NUP62;C19ORF48
CLN7 disease ORPHA:228366	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ABHD13;CMTR2
CTCF-related neurodevelopmental disorder ORPHA:363611	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	HNRNPF;ZBED4
Campomelic dysplasia ORPHA:140	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FLRT3;CLDN12
Carbamoyl-phosphate synthetase 1 deficiency ORPHA:147	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ALDH1B1;CLDN12
Carcinoid syndrome ORPHA:100093	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	C1GALT1C1;COX14
Carnitine palmitoyl transferase II deficiency, myopathic form ORPHA:228302	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FZD5;NAT2
Carnitine palmitoyl transferase II deficiency, neonatal form ORPHA:228308	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FZD5;NAT2
Carnitine palmitoyl transferase II deficiency, severe infantile form ORPHA:228305	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FZD5;NAT2
Caroli disease ORPHA:53035	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	NAT8;CPN2
Carvajal syndrome ORPHA:65282	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CLDN4;SOWAHB
Central core disease ORPHA:597	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	KCNA5;LRRC3B
Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy ORPHA:136	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJA1;FZD7
Cerebral autosomal recessive arteriopathy-subcortical infarcts-leukoencephalopathy ORPHA:199354	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJA1;FIBIN
Charcot-Marie-Tooth disease type 2P ORPHA:300319	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	IRF2BP1;ZNF865
Charcot-Marie-Tooth disease type 4B1 ORPHA:99955	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	RAB40A;TCEAL9
Charcot-Marie-Tooth disease type 4B3 ORPHA:363981	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	IRF2BP1;ZNF865
Childhood apraxia of speech ORPHA:209908	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	SLITRK5;RNF152
Chondrosarcoma ORPHA:55880	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	SOWAHC;TPBG
Choreoacanthocytosis ORPHA:2388	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TAS2R30;ZBED6
Chuvash erythrocytosis ORPHA:238557	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	DCAF16;LTB4R2
Chylomicron retention disease ORPHA:71	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	PURA;TOR1AIP2
Class I glucose-6-phosphate dehydrogenase deficiency ORPHA:466026	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF865;ABHD16B
Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form ORPHA:315306	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	NAT8;CYP8B1
Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form ORPHA:315311	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	NAT8;CYP8B1
Classic phenylketonuria ORPHA:79254	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJB1;NAT8
Cleft lip and palate-craniofacial dysmorphism-congenital heart defect-hearing loss syndrome ORPHA:508476	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	MARVELD1;DOLK
Combined immunodeficiency due to CD27 deficiency ORPHA:238505	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GPR174;S1PR4
Combined oxidative phosphorylation defect type 14 ORPHA:319519	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	DDX28;FASTKD5
Combined oxidative phosphorylation defect type 21 ORPHA:420733	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TMEM177;C19ORF48
Combined oxidative phosphorylation defect type 26 ORPHA:477684	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZBED8;ZNF146
Congenital bile acid synthesis defect type 2 ORPHA:79303	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CYP8B1;CPN2
Congenital cataract-severe neonatal hepatopathy-global developmental delay syndrome ORPHA:521432	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	MORF4L2;CLDN12
Congenital cataracts-facial dysmorphism-neuropathy syndrome ORPHA:48431	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF319;HPS6
Congenital deficiency in alpha-fetoprotein ORPHA:168612	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CLDN6;PAQR9
Congenital high-molecular-weight kininogen deficiency ORPHA:483	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	NAT8;CYP8B1
Congenital insensitivity to pain with severe intellectual disability ORPHA:453510	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FZD2;MARVELD1
Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome ORPHA:391376	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FEN1;GPRIN1
Congenital multicore myopathy with external ophthalmoplegia ORPHA:98905	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	KCNA5;LRRC3B
Congenital muscular dystrophy, Fukuyama type ORPHA:272	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZBED8;FIGNL1
Congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome ORPHA:486815	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	RNF113A;RHOG
Congenital myopathy with myasthenic-like onset ORPHA:424107	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	KCNA5;LRRC3B
Corticosteroid-binding globulin deficiency ORPHA:199247	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJB1;NAT8
Cranio-osteoarthropathy ORPHA:1525	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TMEM30B;GIMAP7
Craniosynostosis-dental anomalies ORPHA:284149	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	S1PR1;CD248
Curry-Jones syndrome ORPHA:1553	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJA1;FZD7
Cystinuria type B ORPHA:93613	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	NAT8;CYP8B1
DNAJB2-related Charcot-Marie-Tooth disease type 2 ORPHA:443950	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF865;ZNF358
DNAJB6-related  limb-girdle muscular dystrophy D1 ORPHA:34516	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FASTKD5;TRAPPC2B
DPM1-CDG ORPHA:79322	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TRMT10C;TAF9
Darier disease ORPHA:218	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CLDN12;ZNF664
Deafness-encephaloneuropathy-obesity-valvulopathy syndrome ORPHA:254898	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TRMT10C;PIGW
Diaphanospondylodysostosis ORPHA:66637	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJA1;FIBIN
Dicarboxylic aminoaciduria ORPHA:2195	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FLRT3;CLDN12
Distal 16p11.2 microdeletion syndrome ORPHA:261222	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	IRF2BP1;ZNF865
Distal myopathy with posterior leg and anterior hand involvement ORPHA:63273	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJA1;FZD7
Dopa-responsive dystonia due to sepiapterin reductase deficiency ORPHA:70594	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ALDH1B1;PHLDA2
Dopamine beta-hydroxylase deficiency ORPHA:230	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CD248;SSTR3
Dystonia 16 ORPHA:210571	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TRMT10C;TAF9
Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome ORPHA:500144	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CHST12;ACSF3
Endocrine-cerebro-osteodysplasia syndrome ORPHA:199332	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF664;UTP14C
Epidermolysis bullosa simplex with muscular dystrophy ORPHA:257	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF865;CENPB
Epileptic encephalopathy with global cerebral demyelination ORPHA:353217	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TRIM32;RAB9B
Episodic ataxia type 6 ORPHA:209967	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FIBIN;LRRC3B
Erythrokeratodermia-cardiomyopathy syndrome ORPHA:476096	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CLDN4;SOWAHB
Exercise-induced malignant hyperthermia ORPHA:466650	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	KCNA5;LRRC3B
FASTKD2-related infantile mitochondrial encephalomyopathy ORPHA:166105	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	SMIM15;TRMT10C
FLNA-related X-linked myxomatous valvular dysplasia ORPHA:555877	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FZD2;ABHD16B
FRAXF syndrome ORPHA:100974	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	PNMA1;BORCS6
Familial adenomatous polyposis due to 5q22.2 microdeletion ORPHA:261584	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GPR22;CDR1
Familial benign chronic pemphigus ORPHA:2841	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CLDN12;ZNF664
Familial congenital nasolacrimal duct obstruction ORPHA:451612	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CLDN12;FJX1
Familial cortical myoclonus ORPHA:319189	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CDC42EP4;PHLDA3
Familial hypocalciuric hypercalcemia type 2 ORPHA:101049	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CDC42EP4;TRNP1
Familial male-limited precocious puberty ORPHA:3000	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	PABPC5;CDR1
Familial steroid-resistant nephrotic syndrome with sensorineural deafness ORPHA:280406	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	COX14;MRPL57
Fanconi-Bickel syndrome ORPHA:2088	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJB1;NAT8
Fetal Gaucher disease ORPHA:85212	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	DOLK;TICAM1
Fibrodysplasia ossificans progressiva ORPHA:337	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	PRNP;AMIGO2
Fukutin-related  limb-girdle muscular dystrophy R13 ORPHA:206554	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZBED8;FIGNL1
GNE myopathy ORPHA:602	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ITPRIPL2;SOCS6
Galactose mutarotase deficiency ORPHA:570422	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TMEM140;CCR5
Gardner syndrome ORPHA:79665	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GPR22;CDR1
Gastric adenocarcinoma and proximal polyposis of the stomach ORPHA:314022	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GPR22;CDR1
Gaucher disease type 2 ORPHA:77260	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	DOLK;TICAM1
Gaucher disease type 3 ORPHA:77261	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	DOLK;TICAM1
Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome ORPHA:2072	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	DOLK;TICAM1
Glaucoma secondary to spherophakia/ectopia lentis and megalocornea ORPHA:238763	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ISLR;TWIST2
Glomuvenous malformation ORPHA:83454	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TRMT10C;FIGNL1
Glutaric acidemia type 3 ORPHA:35706	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ALDH1B1;TCEAL9
Glutaryl-CoA dehydrogenase deficiency ORPHA:25	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	DDX28;RPP25L
Glycogen storage disease due to glycogen branching enzyme deficiency, adult neuromuscular form ORPHA:308712	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	C1GALT1C1;MGAT2
Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form ORPHA:308684	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	C1GALT1C1;MGAT2
Glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form ORPHA:308698	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	C1GALT1C1;MGAT2
Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form ORPHA:308670	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	C1GALT1C1;MGAT2
Glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form ORPHA:308655	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	C1GALT1C1;MGAT2
Glycogen storage disease due to glycogen branching enzyme deficiency, non progressive hepatic form ORPHA:308638	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	C1GALT1C1;MGAT2
Glycogen storage disease due to glycogen branching enzyme deficiency, progressive hepatic form ORPHA:308621	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	C1GALT1C1;MGAT2
Glycogen storage disease due to muscle and heart glycogen synthase deficiency ORPHA:137625	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	PROB1;ZNF865
Gordon syndrome ORPHA:376	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJA1;FLRT2
Greenberg dysplasia ORPHA:1426	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	HNRNPF;PNRC2
Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome ORPHA:391348	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	COA4;TMEM177
Guttmacher syndrome ORPHA:2957	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FOXC1;FOXD1
Gyrate atrophy of choroid and retina ORPHA:414	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	PRNP;MORF4L2
HSD10 disease, atypical type ORPHA:85295	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	SF3B5;POP7
HSD10 disease, infantile type ORPHA:391428	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	SF3B5;POP7
HSD10 disease, neonatal type ORPHA:391457	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	SF3B5;POP7
HTRA1-related autosomal dominant cerebral small vessel disease ORPHA:482077	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJA1;FIBIN
Hand-foot-genital syndrome ORPHA:2438	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FOXC1;FOXD1
Hemolytic anemia due to glutathione reductase deficiency ORPHA:90030	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FZD5;TEX19
Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency ORPHA:35120	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	PLEKHF2;ABHD13
Hereditary North American Indian childhood cirrhosis ORPHA:168583	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FEN1;PIGW
Hereditary hypophosphatemic rickets with hypercalciuria ORPHA:157215	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJD3;ZBTB12
Hereditary persistence of alpha-fetoprotein ORPHA:168615	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CLDN6;PAQR9
Hereditary sensory and autonomic neuropathy type 4 ORPHA:642	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GPR174;SPN
Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency ORPHA:217467	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CYP8B1;CPN2
Homocystinuria due to methylene tetrahydrofolate reductase deficiency ORPHA:395	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	SPN;MPEG1
Hot water reflex epilepsy ORPHA:166412	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FLRT3;CLDN12
Hurler syndrome ORPHA:93473	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF865;ABHD16B
Hurler-Scheie syndrome ORPHA:93476	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF865;ABHD16B
Hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome ORPHA:528091	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TMEM177;MARS2
Hyper-IgM syndrome type 5 ORPHA:101092	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TMEM177;FEN1
Hyperimmunoglobulinemia D with periodic fever ORPHA:343	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TMEM177;DOLK
Hyperinsulinism due to INSR deficiency ORPHA:263458	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	APLNR;RNF152
Hypermethioninemia encephalopathy due to adenosine kinase deficiency ORPHA:289290	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TRMT10C;TAF9
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome ORPHA:415	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TMEM177;FEN1
Hyperprolinemia type 2 ORPHA:79101	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CDC42EP4;ZNF358
Hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome ORPHA:363694	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	RNF26;C19ORF48
Hypoinsulinemic hypoglycemia and body hemihypertrophy ORPHA:293964	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF865;CENPB
Hypotonia with lactic acidemia and hyperammonemia ORPHA:137908	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TRMT10C;TAF9
Hypoxanthine guanine phosphoribosyltransferase partial deficiency ORPHA:79233	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TRMT10C;TAF9
Idiopathic hypercalciuria ORPHA:2197	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	PAQR9;CPN2
Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome ORPHA:37042	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GPR25;KLHDC7B
Immunodeficiency due to MASP-2 deficiency ORPHA:331187	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GPR75;CPN2
Immunodeficiency with factor H anomaly ORPHA:200421	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ISLR;CLEC14A
Immunodeficiency with factor I anomaly ORPHA:200418	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	RNASE4;CLEC14A
Infantile nephropathic cystinosis ORPHA:411629	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF672;MGAT1
Infantile-onset periodic fever-panniculitis-dermatosis syndrome ORPHA:500062	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	EXOC8;TMPPE
Insulin-resistance syndrome type A ORPHA:2297	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	APLNR;RNF152
Intellectual disability-cardiac anomalies-short stature-joint laxity syndrome ORPHA:508498	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNHIT2;POP7
Intellectual disability-cataracts-calcified pinnae-myopathy syndrome ORPHA:3042	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	B3GALT2;POU5F2
Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome ORPHA:457279	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	RNF26;IRF2BP1
Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome ORPHA:369837	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	RNF26;DOLK
Ischiovertebral syndrome ORPHA:85200	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJA1;FIBIN
Isolated Dandy-Walker malformation ORPHA:217	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJA1;TWIST2
Isolated Pierre Robin syndrome ORPHA:718	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FLRT3;CLDN12
Isolated congenital digital clubbing ORPHA:217059	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TMEM30B;GIMAP7
Isolated megalencephaly ORPHA:268920	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	KLLN;C12ORF60
Isovaleric acidemia ORPHA:33	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	DNAJC30;ZBED3
Juvenile cataract-microcornea-renal glucosuria syndrome ORPHA:247794	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJA1;CCDC8
Juvenile nephropathic cystinosis ORPHA:411634	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF672;MGAT1
KLHL9-related early-onset distal myopathy ORPHA:399081	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	KLHL9;B3GALT2
Karyomegalic interstitial nephritis ORPHA:401996	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF770;RBM12B
Keipert syndrome ORPHA:2662	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FZD7;KCNS3
Keratosis linearis-ichthyosis congenita-sclerosing keratoderma syndrome ORPHA:281201	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TRMT10C;RPL36AL
King-Denborough syndrome ORPHA:99741	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	KCNA5;LRRC3B
Klippel-Trenaunay syndrome ORPHA:90308	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZBTB6;SOCS4
Knobloch syndrome ORPHA:1571	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF358;VASN
Kostmann syndrome ORPHA:99749	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	POP7;RPP25L
Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency ORPHA:300179	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJC1;CLDN12
L-2-hydroxyglutaric aciduria ORPHA:79314	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF891;PDP2
LIPE-related familial partial lipodystrophy ORPHA:435660	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	C1QTNF4;ZNF865
Laryngo-onycho-cutaneous syndrome ORPHA:2407	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FGFBP1;GJB3
Lateral meningocele syndrome ORPHA:2789	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJA1;FZD7
Lathosterolosis ORPHA:46059	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	MORF4L2;CLDN12
Laurin-Sandrow syndrome ORPHA:2378	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	RBM12B;CHML
Legius syndrome ORPHA:137605	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	SPRY2;SOCS6
Leprechaunism ORPHA:508	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	APLNR;RNF152
Lesch-Nyhan syndrome ORPHA:510	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TRMT10C;TAF9
Leukoencephalopathy with mild cerebellar ataxia and white matter edema ORPHA:363540	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	VGF;FLRT1
Leukoencephalopathy-dystonia-motor neuropathy syndrome ORPHA:163684	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	RNASE4;KRCC1
Leukoencephalopathy-spondyloepimetaphyseal dysplasia syndrome ORPHA:83629	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TMEM177;FEN1
Leukonychia totalis ORPHA:2387	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CD248;ZBTB22
Leydig cell hypoplasia due to complete LH resistance ORPHA:96265	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	PABPC5;CDR1
Leydig cell hypoplasia due to partial LH resistance ORPHA:96266	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	PABPC5;CDR1
Lipoid proteinosis ORPHA:530	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	HRH1;UCN2
Low phospholipid-associated cholelithiasis ORPHA:69663	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	OXER1;MPEG1
MORM syndrome ORPHA:75858	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	IRF2BP1;ZNF865
MPDU1-CDG ORPHA:79323	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FKBPL;DOLK
MSH3-related attenuated familial adenomatous polyposis ORPHA:480536	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TAS2R30;ZBED6
Mandibulofacial dysostosis-microcephaly syndrome ORPHA:79113	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FEN1;NUP62
Marden-Walker syndrome ORPHA:2461	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJA1;FLRT2
Maternal phenylketonuria ORPHA:2209	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJB1;NAT8
Melnick-Needles syndrome ORPHA:2484	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FZD2;ABHD16B
Menkes disease ORPHA:565	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	EXOC8;ZBED6
Methylcobalamin deficiency type cblE ORPHA:2169	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	MARS2;PIGW
Methylcobalamin deficiency type cblG ORPHA:2170	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	DCAF16;ZBED6
Methylmalonic aciduria due to transcobalamin receptor defect ORPHA:280183	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	POP7;C19ORF48
Mevalonic aciduria ORPHA:29	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TMEM177;DOLK
Mild hyperphenylalaninemia ORPHA:79651	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJB1;NAT8
Mild phenylketonuria ORPHA:79253	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJB1;NAT8
Mitochondrial DNA depletion syndrome, myopathic form ORPHA:254875	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CEBPD;RNASE4
Moderate multiminicore disease with hand involvement ORPHA:178145	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	KCNA5;LRRC3B
Monosomy 13q14 ORPHA:1587	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZBTB33;SOCS4
Mucopolysaccharidosis type 4A ORPHA:309297	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TMEM127;MGAT1
Multiple epiphyseal dysplasia, Al-Gazali type ORPHA:166024	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FZD7;FJX1
Multiple mitochondrial dysfunctions syndrome type 6 ORPHA:569290	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TRMT10C;TAF9
Multiple myeloma ORPHA:29073	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TPBG;FJX1
Multiple sulfatase deficiency ORPHA:585	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ITPRIPL2;RNASE4
Muscle filaminopathy ORPHA:171445	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJA1;FZD7
NAD(P)HX epimerase deficiency ORPHA:555407	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	COA4;POP7
NON RARE IN EUROPE: Glucose-6-phosphate-dehydrogenase deficiency ORPHA:362	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF865;ABHD16B
NON RARE IN EUROPE: Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency ORPHA:95698	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	NAT8;CYP8B1
NON RARE IN EUROPE: Parkinson disease ORPHA:319705	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	DOLK;TICAM1
NON RARE IN EUROPE: Primary bile acid malabsorption ORPHA:449262	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	RNF186;CHST5
NON RARE IN EUROPE: Trimethylaminuria ORPHA:35056	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	THRSP;CYP8B1
Nasopharyngeal carcinoma ORPHA:150	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GPR183;JUNB
Navajo neurohepatopathy ORPHA:255229	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	LSM10;OST4
Nephrotic syndrome-epidermolysis bullosa-sensorineural deafness syndrome ORPHA:300333	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	MARVELD1;PHLDA2
Neurodevelopmental delay-seizures-ophthalmic anomalies-osteopenia-cerebellar atrophy syndrome ORPHA:529665	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	MRPL41;ZNHIT2
Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to 9q21.3 microdeletion ORPHA:352665	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	HNRNPF;ZNF146
Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to a point mutation ORPHA:453504	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	HNRNPF;ZNF146
Neuronal intestinal pseudoobstruction ORPHA:99811	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FZD2;ABHD16B
Obesity due to SIM1 deficiency ORPHA:369873	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CCDC8;MAB21L1
Occipital horn syndrome ORPHA:198	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	EXOC8;ZBED6
Ocular cystinosis ORPHA:411641	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF672;MGAT1
Oculocerebrodental syndrome ORPHA:557003	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZBED6;SOCS4
Oculopharyngeal muscular dystrophy ORPHA:270	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	SOX12;HNRNPA0
Opsismodysplasia ORPHA:2746	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF865;CENPB
Ornithine transcarbamylase deficiency ORPHA:664	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJB1;NAT2
Otopalatodigital syndrome type 1 ORPHA:90650	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FZD2;ABHD16B
Otopalatodigital syndrome type 2 ORPHA:90652	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FZD2;ABHD16B
PGM3-CDG ORPHA:443811	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	MORF4L2;CLDN12
PLEC-related intermediate epidermolysis bullosa simplex without extracutaneous involvement ORPHA:79401	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF865;CENPB
PMM2-CDG ORPHA:79318	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF526;PIGW
PMP22-RAI1 contiguous gene duplication syndrome ORPHA:477817	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	IRF2BP1;ZNF865
POMT2-related  limb-girdle muscular dystrophy R14 ORPHA:206559	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CTXN1;FJX1
Pancytopenia-developmental delay syndrome ORPHA:401764	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TAS2R30;ZBED6
Peeling skin-leukonychia-acral punctate keratoses-cheilitis-knuckle pads syndrome ORPHA:444138	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ITPRIPL2;SAMD9
Pelizaeus-Merzbacher-like disease due to AIMP1 mutation ORPHA:280293	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TRMT10C;TAF9
Peroxisomal acyl-CoA oxidase deficiency ORPHA:2971	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TOR1AIP2;HIST1H2AC
Phakomatosis cesiomarmorata ORPHA:79484	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CDC42EP4;TRNP1
Phosphoserine aminotransferase deficiency, infantile/juvenile form ORPHA:284417	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TMEM177;KDM4D
Pierpont syndrome ORPHA:487825	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TAS2R30;ZNF518A
Plectin-related  limb-girdle muscular dystrophy R17 ORPHA:254361	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF865;CENPB
Polydactyly of a biphalangeal thumb ORPHA:93339	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	C10ORF105;SOWAHD
Pontocerebellar hypoplasia type 4 ORPHA:166063	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TMEM238;C19ORF48
Pontocerebellar hypoplasia type 8 ORPHA:324569	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNHIT2;COMMD5
Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome ORPHA:420584	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJA1;FZD7
Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome ORPHA:477673	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CLDN12;CTXN1
Primary hyperoxaluria type 1 ORPHA:93598	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CYP8B1;CPN2
Primary intraosseous venous malformation ORPHA:140436	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	UBC;UBQLN2
Progressive autosomal recessive ataxia-deafness syndrome ORPHA:448251	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF865;TICAM1
Progressive encephalopathy with leukodystrophy due to DECR deficiency ORPHA:431361	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	SLC10A5;ZHX1
Progressive external ophthalmoplegia-myopathy-emaciation syndrome ORPHA:352447	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CDCA4;HNRNPF
Progressive familial intrahepatic cholestasis type 3 ORPHA:79305	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	OXER1;MPEG1
Progressive myoclonic epilepsy type 6 ORPHA:280620	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TAF9;MGAT2
Proximal 16p11.2 microdeletion syndrome ORPHA:261197	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	IRF2BP1;ZNF865
Pseudohypoaldosteronism type 2B ORPHA:88939	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FOXD1;FOXL1
Pseudohypoaldosteronism type 2E ORPHA:300530	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF770;SOCS4
Pterin-4 alpha-carbinolamine dehydratase deficiency ORPHA:1578	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	COA4;ALDH1B1
QRICH1-related intellectual disability-chondrodysplasia syndrome ORPHA:580940	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZBTB39;RBM15B
RFT1-CDG ORPHA:244310	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CDCA4;PIGW
Rabson-Mendenhall syndrome ORPHA:769	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	APLNR;RNF152
Ramon syndrome ORPHA:3019	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	UBC;UBQLN2
Recessive X-linked ichthyosis ORPHA:461	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	IGIP;RNASE4
Refractory anemia ORPHA:98826	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CYSLTR1;POU5F2
Refractory anemia with excess blasts ORPHA:86839	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CYSLTR1;POU5F2
Regressive spondylometaphyseal dysplasia ORPHA:448267	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	HNRNPF;PNRC2
Reticular dystrophy of the retinal pigment epithelium ORPHA:99002	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF770;ZBTB33
Retinitis punctata albescens ORPHA:52427	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	HEPN1;NKAPL
Reynolds syndrome ORPHA:779	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	HNRNPF;PNRC2
Rhizomelic chondrodysplasia punctata type 1 ORPHA:309789	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TRMT10C;TMEM99
Rhizomelic chondrodysplasia punctata type 3 ORPHA:309803	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TCEAL8;TCEAL9
Rhizomelic chondrodysplasia punctata type 5 ORPHA:468717	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	IRF2BP1;ZBTB12
SHORT syndrome ORPHA:3163	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	LPAR6;GPRASP1
SIM1-related Prader-Willi-like syndrome ORPHA:398079	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CCDC8;MAB21L1
SRD5A3-CDG ORPHA:324737	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	COA4;HILPDA
SYNGAP1-related developmental and epileptic encephalopathy ORPHA:544254	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF865;AHDC1
Sanfilippo syndrome type B ORPHA:79270	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	DOLK;HPS6
Scalp-ear-nipple syndrome ORPHA:2036	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FLRT3;CTXN1
Scheie syndrome ORPHA:93474	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF865;ABHD16B
Schimke immuno-osseous dysplasia ORPHA:1830	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	RNF26;NUP62
Severe X-linked mitochondrial encephalomyopathy ORPHA:238329	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TMEM177;FEN1
Severe combined immunodeficiency due to DCLRE1C deficiency ORPHA:275	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CNR2;GPR18
Severe combined immunodeficiency due to IKK2 deficiency ORPHA:397787	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	SPN;TNFAIP8L2
Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency ORPHA:329249	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	IRF2BP1;ZNF865
Severe primary trimethylaminuria ORPHA:468726	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	THRSP;CYP8B1
Short chain acyl-CoA dehydrogenase deficiency ORPHA:26792	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	MRPL41;HDHD3
Sialuria ORPHA:3166	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ITPRIPL2;SOCS6
Sjogren-Larsson syndrome ORPHA:816	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	SOWAHC;CLDN12
Skin fragility-woolly hair-palmoplantar keratoderma syndrome ORPHA:293165	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CLDN4;SOWAHB
Sorsby pseudoinflammatory fundus dystrophy ORPHA:59181	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ISLR;FIBIN
Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome ORPHA:447997	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	C1ORF216;ZHX1
Spinocerebellar ataxia type 18 ORPHA:98771	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	OR2B2;HIST1H1T
Spinocerebellar ataxia type 19/22 ORPHA:98772	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	LRRC4C;RNF152
Spinocerebellar ataxia type 36 ORPHA:276198	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FEN1;C19ORF48
Spinocerebellar ataxia with axonal neuropathy type 1 ORPHA:94124	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CDCA4;TRIM59
Spondylometaphyseal dysplasia, Sedaghatian type ORPHA:93317	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	MRPL41;DPM3
Steinert myotonic dystrophy ORPHA:273	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF358;AHDC1
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B ORPHA:308393	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	MORF4L2;TCEAL1
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C ORPHA:308400	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	CLDN12;GPRASP2
Syndromic recessive X-linked ichthyosis ORPHA:281090	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	IGIP;RNASE4
Syndromic sensorineural deafness due to combined oxidative phosphorylation defect ORPHA:457223	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	COA4;POP7
TARP syndrome ORPHA:2886	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	H2AFX;IRF2BP1
Terminal osseous dysplasia-pigmentary defects syndrome ORPHA:88630	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FZD2;ABHD16B
Testicular regression syndrome ORPHA:983	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	NUP62;RRS1
Tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria ORPHA:293284	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJB1;NAT8
Toriello-Carey syndrome ORPHA:3338	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	EXOC8;ZBTB33
Trichorhinophalangeal syndrome type 1 and 3 ORPHA:77258	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	HIST1H1E;TIGD1
Triose phosphate-isomerase deficiency ORPHA:868	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FEN1;POP7
Turcot syndrome with polyposis ORPHA:99818	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GPR22;CDR1
Vein of Galen aneurysmal malformation ORPHA:1053	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TPBG;SP6
Vitamin B12-responsive methylmalonic acidemia type cblA ORPHA:79310	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	LPAR6;PEX2
Von Hippel-Lindau disease ORPHA:892	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	DCAF16;LTB4R2
Wolcott-Rallison syndrome ORPHA:1667	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZXDB;ZBTB5
Woodhouse-Sakati syndrome ORPHA:3464	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF770;RBM12B
X-linked Alport syndrome ORPHA:88917	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	GJA1;FLRT3
X-linked Charcot-Marie-Tooth disease type 4 ORPHA:101078	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TMEM177;FEN1
X-linked Ehlers-Danlos syndrome ORPHA:75497	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FZD2;ABHD16B
X-linked distal spinal muscular atrophy type 3 ORPHA:139557	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	EXOC8;ZBED6
X-linked hereditary sensory and autonomic neuropathy with deafness ORPHA:139583	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	TMEM177;FEN1
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia ORPHA:317476	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	C1GALT1C1;MGAT2
X-linked intellectual disability, Cabezas type ORPHA:85293	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZBTB33;ZNF146
X-linked intellectual disability, Siderius type ORPHA:85287	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZBTB39;ZBTB5
X-linked intellectual disability-hypotonia-movement disorder syndrome ORPHA:457260	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	EXOC8;ZBTB33
X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome ORPHA:482606	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	FZD2;ABHD16B
Young adult-onset distal hereditary motor neuropathy ORPHA:314485	2/101	0.999929792390071	0.9999961656375117	0	0	0.1562685680332739	1.0971627819039781E-5	ZNF865;ZNF358
Amyotrophic lateral sclerosis ORPHA:803	4/137	0.9999318342922199	0.9999961656375117	0	0	0.232395575934564	1.5841948863511336E-5	MORF4L2;ANG;ZNF664;UBQLN2
12q14 microdeletion syndrome ORPHA:94063	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	RBM12B;CHML
2p21 microdeletion syndrome without cystinuria ORPHA:369881	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	ZNF770;KBTBD6
3M syndrome ORPHA:2616	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	FZD7;CCDC8
9q33.3q34.11 microdeletion syndrome ORPHA:495818	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	CTXN1;CDK5R2
Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) ORPHA:402020	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	MORF4L2;PRR15
Acute necrotizing encephalopathy of childhood ORPHA:263524	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	RBM12B;ZNF518A
Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy ORPHA:329336	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	TRMT10C;PIGW
Aniridia-cerebellar ataxia-intellectual disability syndrome ORPHA:1065	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	TCEAL6;SLITRK5
Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis ORPHA:329173	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	ZNF865;ABHD16B
Autosomal recessive sideroblastic anemia ORPHA:260305	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	FEN1;TRMT10C
Autosomal recessive spastic paraplegia type 23 ORPHA:101003	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	PURA;KBTBD6
Branchiootic syndrome ORPHA:52429	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	FOXC1;TWIST1
CHARGE syndrome ORPHA:138	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	SOX2;FUT9
Chronic eosinophilic leukemia ORPHA:168940	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	FIBIN;CDR1
Cockayne syndrome type 1 ORPHA:90321	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	ZBED6;SOCS4
Congenital mesoblastic nephroma ORPHA:2665	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	CYSLTR1;POU5F2
Cushing disease ORPHA:96253	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	CYSLTR1;C5AR2
Dermatofibrosarcoma protuberans ORPHA:31112	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	FOXS1;SOD3
Epidermolysis bullosa simplex with pyloric atresia ORPHA:158684	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	GJB3;SFN
Familial isolated congenital asplenia ORPHA:101351	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	FEN1;C19ORF48
Familial porphyria cutanea tarda ORPHA:443062	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	OST4;C14ORF119
Fibrosarcoma ORPHA:2030	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	CYSLTR1;POU5F2
Generalized arterial calcification of infancy ORPHA:51608	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	RNASE4;CYP8B1
Hereditary combined deficiency of vitamin K-dependent clotting factors ORPHA:98434	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	ANG;CHST14
Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia ORPHA:313808	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	TIFAB;MPEG1
Hereditary retinoblastoma ORPHA:357027	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	ZNF260;SOCS4
Hydrolethalus ORPHA:2189	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	FEN1;HYLS1
Hypotonia-cystinuria syndrome ORPHA:163690	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	DIRAS2;GPR22
Intermediate osteopetrosis ORPHA:210110	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	RHOG;MGAT1
Intrauterine growth restriction-congenital multiple cafe-au-lait macules-increased sister chromatid exchange syndrome ORPHA:508512	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	FEN1;CDCA4
Joubert syndrome with hepatic defect ORPHA:1454	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	RAB40A;GPR135
Juvenile glaucoma ORPHA:98977	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	THBD;ISLR
Juvenile polyposis of infancy ORPHA:79076	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	TOR1AIP2;ZNF518A
Matthew-Wood syndrome ORPHA:2470	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	GJA1;FLRT3
Microlissencephaly ORPHA:1083	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	ZNF581;NUP62
Moyamoya disease ORPHA:2573	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	SAMD9L;LPAR6
Multiple benign circumferential skin creases on limbs ORPHA:2505	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	MLLT11;FEN1
Myxoid/round cell liposarcoma ORPHA:99967	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	NXT1;PCBP1
Non-hereditary retinoblastoma ORPHA:357034	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	ZNF260;SOCS4
Non-seminomatous germ cell tumor of testis ORPHA:363494	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	TPBG;CLDN12
Null pituitary adenoma ORPHA:314790	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	ZNHIT2;ZNF581
Paroxysmal exertion-induced dyskinesia ORPHA:98811	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	SOX12;CTXN1
Pediatric hepatocellular carcinoma ORPHA:33402	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	TPBG;CLDN12
Pituitary gigantism ORPHA:99725	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	ZNHIT2;ZNF581
Porokeratosis of Mibelli ORPHA:735	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	DPM3;POP7
Pseudoxanthoma elasticum ORPHA:758	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	RNASE4;CYP8B1
Punctate palmoplantar keratoderma type 1 ORPHA:79501	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	GJA1;MORF4L2
Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome ORPHA:71289	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	FOXC1;FOXL1
Rolandic epilepsy-speech dyspraxia syndrome ORPHA:163721	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	GJA1;FIBIN
Sclerosteosis ORPHA:3152	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	GJA1;FZD7
Silent pituitary adenoma ORPHA:314786	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	ZNHIT2;ZNF581
Spondylometaphyseal dysplasia, 'corner fracture' type ORPHA:93315	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	GJA1;FZD7
Wolfram syndrome ORPHA:3463	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	MORF4L2;CLDN12
Yunis-Varon syndrome ORPHA:3472	2/102	0.999936888922945	0.9999961656375117	0	0	0.1546971027216857	9.763408862924036E-6	ZNF319;HPS6
Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome ORPHA:86818	2/103	0.9999432339298634	0.9999961656375117	0	0	0.1531567555350794	8.694353901085576E-6	CDCA4;KCNE5
Anauxetic dysplasia ORPHA:93347	2/103	0.9999432339298634	0.9999961656375117	0	0	0.1531567555350794	8.694353901085576E-6	TRMT10C;FIGNL1
Brachydactyly type A1 ORPHA:93388	2/103	0.9999432339298634	0.9999961656375117	0	0	0.1531567555350794	8.694353901085576E-6	FLRT3;FIBIN
Chronic myeloid leukemia ORPHA:521	2/103	0.9999432339298634	0.9999961656375117	0	0	0.1531567555350794	8.694353901085576E-6	ZNF865;CENPB
Familial advanced sleep-phase syndrome ORPHA:164736	2/103	0.9999432339298634	0.9999961656375117	0	0	0.1531567555350794	8.694353901085576E-6	TOB2;AHDC1
Familial platelet disorder with associated myeloid malignancy ORPHA:71290	2/103	0.9999432339298634	0.9999961656375117	0	0	0.1531567555350794	8.694353901085576E-6	SAMD9L;SAMD9
Fundus albipunctatus ORPHA:227796	2/103	0.9999432339298634	0.9999961656375117	0	0	0.1531567555350794	8.694353901085576E-6	C3ORF18;NKAPL
Hennekam syndrome ORPHA:2136	2/103	0.9999432339298634	0.9999961656375117	0	0	0.1531567555350794	8.694353901085576E-6	GJA1;DSEL
Hereditary gingival fibromatosis ORPHA:2024	2/103	0.9999432339298634	0.9999961656375117	0	0	0.1531567555350794	8.694353901085576E-6	ZNF518A;ZBED6
Hereditary isolated aplastic anemia ORPHA:397692	2/103	0.9999432339298634	0.9999961656375117	0	0	0.1531567555350794	8.694353901085576E-6	INAFM1;RNF208
Inherited congenital spastic tetraplegia ORPHA:210141	2/103	0.9999432339298634	0.9999961656375117	0	0	0.1531567555350794	8.694353901085576E-6	KCNJ10;CDR1
Kearns-Sayre syndrome ORPHA:480	2/103	0.9999432339298634	0.9999961656375117	0	0	0.1531567555350794	8.694353901085576E-6	OR2C3;SMIM15
Late-onset nephronophthisis ORPHA:93589	2/103	0.9999432339298634	0.9999961656375117	0	0	0.1531567555350794	8.694353901085576E-6	ZNF891;ZNF70
Melanoma of soft tissue ORPHA:97338	2/103	0.9999432339298634	0.9999961656375117	0	0	0.1531567555350794	8.694353901085576E-6	MIS12;PNRC2
NON RARE IN EUROPE: Paget disease of bone ORPHA:280110	2/103	0.9999432339298634	0.9999961656375117	0	0	0.1531567555350794	8.694353901085576E-6	ZBTB42;MGAT1
Neonatal glycine encephalopathy ORPHA:289857	2/103	0.9999432339298634	0.9999961656375117	0	0	0.1531567555350794	8.694353901085576E-6	CLDN6;PAQR9
Osteogenesis imperfecta ORPHA:666	2/103	0.9999432339298634	0.9999961656375117	0	0	0.1531567555350794	8.694353901085576E-6	MORF4L2;CLDN12
Preeclampsia ORPHA:275555	2/103	0.9999432339298634	0.9999961656375117	0	0	0.1531567555350794	8.694353901085576E-6	PLN;GPR22
Treacher-Collins syndrome ORPHA:861	2/103	0.9999432339298634	0.9999961656375117	0	0	0.1531567555350794	8.694353901085576E-6	CDCA4;C19ORF48
Autosomal dominant hypohidrotic ectodermal dysplasia ORPHA:1810	2/104	0.9999489064867942	0.9999961656375117	0	0	0.151646611234485	7.748356080770099E-6	TMEM30B;KIAA0040
Autosomal recessive malignant osteopetrosis ORPHA:667	2/104	0.9999489064867942	0.9999961656375117	0	0	0.151646611234485	7.748356080770099E-6	RHOG;S1PR4
COFS syndrome ORPHA:1466	2/104	0.9999489064867942	0.9999961656375117	0	0	0.151646611234485	7.748356080770099E-6	SRRM5;ZNF526
Familial hemophagocytic lymphohistiocytosis ORPHA:540	2/104	0.9999489064867942	0.9999961656375117	0	0	0.151646611234485	7.748356080770099E-6	TNFAIP8L2;S1PR4
Primary Fanconi renotubular syndrome ORPHA:3337	2/104	0.9999489064867942	0.9999961656375117	0	0	0.151646611234485	7.748356080770099E-6	NAT8;CYP8B1
Shwachman-Diamond syndrome ORPHA:811	2/104	0.9999489064867942	0.9999961656375117	0	0	0.151646611234485	7.748356080770099E-6	SMIM15;TRMT10C
Xeroderma pigmentosum-Cockayne syndrome complex ORPHA:220295	2/104	0.9999489064867942	0.9999961656375117	0	0	0.151646611234485	7.748356080770099E-6	FIGNL1;HNRNPA1L2
Extraskeletal myxoid chondrosarcoma ORPHA:209916	2/105	0.9999539771186661	0.9999961656375117	0	0	0.15016579012419343	6.911221377682057E-6	MORF4L2;ZNF146
Nanophthalmos ORPHA:35612	2/105	0.9999539771186661	0.9999961656375117	0	0	0.15016579012419343	6.911221377682057E-6	SLITRK2;LRRC4C
Usher syndrome type 2 ORPHA:231178	2/105	0.9999539771186661	0.9999961656375117	0	0	0.15016579012419343	6.911221377682057E-6	KCNJ10;FUT9
Williams syndrome ORPHA:904	3/124	0.9999544913989666	0.9999961656375117	0	0	0.191628828711114	8.720958353116792E-6	CLDN4;CLDN3;DNAJC30
Atrial septal defect, ostium secundum type ORPHA:99103	2/106	0.9999585092132006	0.9999961656375117	0	0	0.1487134463429459	6.170365903969621E-6	PABPC4L;FZD8
Cervical spina bifida aperta ORPHA:268392	2/106	0.9999585092132006	0.9999961656375117	0	0	0.1487134463429459	6.170365903969621E-6	ZBTB12;SOX12
Cervical spina bifida cystica ORPHA:268762	2/106	0.9999585092132006	0.9999961656375117	0	0	0.1487134463429459	6.170365903969621E-6	ZBTB12;SOX12
Cervicothoracic spina bifida aperta ORPHA:268397	2/106	0.9999585092132006	0.9999961656375117	0	0	0.1487134463429459	6.170365903969621E-6	ZBTB12;SOX12
Cervicothoracic spina bifida cystica ORPHA:268766	2/106	0.9999585092132006	0.9999961656375117	0	0	0.1487134463429459	6.170365903969621E-6	ZBTB12;SOX12
Congenital muscular dystrophy with cerebellar involvement ORPHA:370959	2/106	0.9999585092132006	0.9999961656375117	0	0	0.1487134463429459	6.170365903969621E-6	TIGD5;FKRP
Lumbosacral spina bifida aperta ORPHA:268388	2/106	0.9999585092132006	0.9999961656375117	0	0	0.1487134463429459	6.170365903969621E-6	ZBTB12;SOX12
Lumbosacral spina bifida cystica ORPHA:268758	2/106	0.9999585092132006	0.9999961656375117	0	0	0.1487134463429459	6.170365903969621E-6	ZBTB12;SOX12
NON RARE IN EUROPE: Heterozygous familial hypercholesterolemia ORPHA:406	2/106	0.9999585092132006	0.9999961656375117	0	0	0.1487134463429459	6.170365903969621E-6	GJB1;ANG
Postaxial polydactyly type A ORPHA:93334	2/106	0.9999585092132006	0.9999961656375117	0	0	0.1487134463429459	6.170365903969621E-6	LRRC4;TIGD1
Thoracolumbosacral spina bifida aperta ORPHA:268384	2/106	0.9999585092132006	0.9999961656375117	0	0	0.1487134463429459	6.170365903969621E-6	ZBTB12;SOX12
Thoracolumbosacral spina bifida cystica ORPHA:268752	2/106	0.9999585092132006	0.9999961656375117	0	0	0.1487134463429459	6.170365903969621E-6	ZBTB12;SOX12
Total spina bifida aperta ORPHA:268377	2/106	0.9999585092132006	0.9999961656375117	0	0	0.1487134463429459	6.170365903969621E-6	ZBTB12;SOX12
Total spina bifida cystica ORPHA:268748	2/106	0.9999585092132006	0.9999961656375117	0	0	0.1487134463429459	6.170365903969621E-6	ZBTB12;SOX12
Upper thoracic spina bifida aperta ORPHA:268740	2/106	0.9999585092132006	0.9999961656375117	0	0	0.1487134463429459	6.170365903969621E-6	ZBTB12;SOX12
Upper thoracic spina bifida cystica ORPHA:268770	2/106	0.9999585092132006	0.9999961656375117	0	0	0.1487134463429459	6.170365903969621E-6	ZBTB12;SOX12
Achromatopsia ORPHA:49382	2/107	0.9999625593907061	0.9999961656375117	0	0	0.14728876625276976	5.514684387865449E-6	NEUROD4;OMG
Early-onset autosomal dominant Alzheimer disease ORPHA:1020	2/107	0.9999625593907061	0.9999961656375117	0	0	0.14728876625276976	5.514684387865449E-6	CEBPA;MGAT1
Isolated cytochrome C oxidase deficiency ORPHA:254905	2/107	0.9999625593907061	0.9999961656375117	0	0	0.14728876625276976	5.514684387865449E-6	COA4;COX14
Joubert syndrome with oculorenal defect ORPHA:2318	2/107	0.9999625593907061	0.9999961656375117	0	0	0.14728876625276976	5.514684387865449E-6	RAB40A;MORF4L2
Lennox-Gastaut syndrome ORPHA:2382	2/107	0.9999625593907061	0.9999961656375117	0	0	0.14728876625276976	5.514684387865449E-6	AMER3;FUT9
NON RARE IN EUROPE: Age-related macular degeneration ORPHA:279	2/107	0.9999625593907061	0.9999961656375117	0	0	0.14728876625276976	5.514684387865449E-6	ISLR;FIBIN
Pituitary stalk interruption syndrome ORPHA:95496	2/107	0.9999625593907061	0.9999961656375117	0	0	0.14728876625276976	5.514684387865449E-6	RAB40A;PCDHB15
Semantic dementia ORPHA:100069	2/107	0.9999625593907061	0.9999961656375117	0	0	0.14728876625276976	5.514684387865449E-6	MAFB;FPR3
Juvenile myoclonic epilepsy ORPHA:307	2/108	0.9999661784167341	0.9999961656375117	0	0	0.14589096691901204	4.93434692958082E-6	AMER3;FUT9
22q11.2 deletion syndrome ORPHA:567	2/109	0.9999694117208652	0.9999961656375117	0	0	0.14451929467560493	4.4206641365043186E-6	IRF2BP1;ZNF865
Congenital stationary night blindness ORPHA:215	2/109	0.9999694117208652	0.9999961656375117	0	0	0.14451929467560493	4.4206641365043186E-6	ZNF891;TAF1L
Meckel syndrome ORPHA:564	2/111	0.9999748801793601	0.9999961656375117	0	0	0.1418514550829232	3.5633278644586845E-6	RAB40A;TTC30A
Giant cell glioblastoma ORPHA:251579	2/112	0.9999771843153717	0.9999961656375117	0	0	0.14055391491739166	3.2068703796321474E-6	SOWAHC;MARVELD1
Gliosarcoma ORPHA:251576	2/112	0.9999771843153717	0.9999961656375117	0	0	0.14055391491739166	3.2068703796321474E-6	SOWAHC;MARVELD1
Tetralogy of Fallot ORPHA:3303	2/112	0.9999771843153717	0.9999961656375117	0	0	0.14055391491739166	3.2068703796321474E-6	GJA5;FZD8
Hereditary pheochromocytoma-paraganglioma ORPHA:29072	2/113	0.9999792417704643	0.9999961656375117	0	0	0.13927975385394173	2.891231108703885E-6	TMEM127;RPP25L
Idiopathic pulmonary fibrosis ORPHA:2032	2/113	0.9999792417704643	0.9999961656375117	0	0	0.13927975385394173	2.891231108703885E-6	CLDN3;TMEM125
Early-onset nuclear cataract ORPHA:98991	2/118	0.9999866533088562	0.9999961656375117	0	0	0.13323847294965335	1.7783046142027282E-6	GJA3;TRNP1
Non-specific syndromic intellectual disability ORPHA:528084	2/120	0.9999886200097121	0.9999961656375117	0	0	0.13096531301617537	1.4903924705159351E-6	RBM12B;CHML
Leber congenital amaurosis ORPHA:65	2/121	0.9999894467323257	0.9999961656375117	0	0	0.12985738632590876	1.3704269886359027E-6	ZNF891;TIGD1
Brugada syndrome ORPHA:130	2/122	0.9999901837348937	0.9999961656375117	0	0	0.12876792508047996	1.2640262937997012E-6	TMEM246;KCNE5
Cone rod dystrophy ORPHA:1872	2/122	0.9999901837348937	0.9999961656375117	0	0	0.12876792508047996	1.2640262937997012E-6	NEUROD4;OMG
Precursor T-cell acute lymphoblastic leukemia ORPHA:99861	2/123	0.9999908406446827	0.9999961656375117	0	0	0.12769647145894253	1.1696227113626143E-6	ZBTB39;ZBED4
Atypical hemolytic uremic syndrome with anti-factor H antibodies ORPHA:93581	1/100	0.9999912594313147	0.9999961656375117	0	0	0.07809999955677885	6.826413937871277E-7	CYP8B1
Autosomal dominant Alport syndrome ORPHA:88918	1/100	0.9999912594313147	0.9999961656375117	0	0	0.07809999955677885	6.826413937871277E-7	PLN
Autosomal dominant optic atrophy, classic form ORPHA:98673	1/100	0.9999912594313147	0.9999961656375117	0	0	0.07809999955677885	6.826413937871277E-7	CHML
Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis ORPHA:88924	1/100	0.9999912594313147	0.9999961656375117	0	0	0.07809999955677885	6.826413937871277E-7	ZNF865
Autosomal recessive Alport syndrome ORPHA:88919	1/100	0.9999912594313147	0.9999961656375117	0	0	0.07809999955677885	6.826413937871277E-7	PLN
C3 glomerulonephritis ORPHA:329931	1/100	0.9999912594313147	0.9999961656375117	0	0	0.07809999955677885	6.826413937871277E-7	CYP8B1
C3 glomerulopathy ORPHA:329918	1/100	0.9999912594313147	0.9999961656375117	0	0	0.07809999955677885	6.826413937871277E-7	CYP8B1
Cataract-intellectual disability-hypogonadism syndrome ORPHA:1387	1/100	0.9999912594313147	0.9999961656375117	0	0	0.07809999955677885	6.826413937871277E-7	ZBED6
Familial porencephaly ORPHA:99810	1/100	0.9999912594313147	0.9999961656375117	0	0	0.07809999955677885	6.826413937871277E-7	GJA1
Joubert syndrome with renal defect ORPHA:220497	1/100	0.9999912594313147	0.9999961656375117	0	0	0.07809999955677885	6.826413937871277E-7	RAB40A
Multiple osteochondromas ORPHA:321	1/100	0.9999912594313147	0.9999961656375117	0	0	0.07809999955677885	6.826413937871277E-7	TPBG
Noonan syndrome-like disorder with loose anagen hair ORPHA:2701	1/100	0.9999912594313147	0.9999961656375117	0	0	0.07809999955677885	6.826413937871277E-7	ABHD13
Propionic acidemia ORPHA:35	1/100	0.9999912594313147	0.9999961656375117	0	0	0.07809999955677885	6.826413937871277E-7	CLDN12
Saldino-Mainzer syndrome ORPHA:140969	1/100	0.9999912594313147	0.9999961656375117	0	0	0.07809999955677885	6.826413937871277E-7	ZNF664
Sitosterolemia ORPHA:2882	1/100	0.9999912594313147	0.9999961656375117	0	0	0.07809999955677885	6.826413937871277E-7	NAT8
15q11q13 microduplication syndrome ORPHA:238446	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF770
15q14 microdeletion syndrome ORPHA:261190	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FLRT3
15q24 microdeletion syndrome ORPHA:94065	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZBTB39
16q24.3 microdeletion syndrome ORPHA:261250	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	AHDC1
17q11 microdeletion syndrome ORPHA:97685	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZBED6
17q11.2 microduplication syndrome ORPHA:139474	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZBED6
2-methylbutyryl-CoA dehydrogenase deficiency ORPHA:79157	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CPN2
2q32q33 microdeletion syndrome ORPHA:251019	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	POU3F2
3-methylglutaconic aciduria type 9 ORPHA:505216	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	C19ORF48
3-phosphoglycerate dehydrogenase deficiency, infantile/juvenile form ORPHA:79351	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CTXN1
6-pyruvoyl-tetrahydropterin synthase deficiency ORPHA:13	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TAF9
6q terminal deletion syndrome ORPHA:75857	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	PEX2
8p23.1 microdeletion syndrome ORPHA:251071	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	PAQR9
ADNP syndrome ORPHA:404448	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF664
ALDH18A1-related De Barsy syndrome ORPHA:35664	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TMEM177
ALG12-CDG ORPHA:79324	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	SCO2
ALG8-CDG ORPHA:79325	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	PIGW
ALK-positive anaplastic large cell lymphoma ORPHA:300895	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FAM181B
ALK-positive large B-cell lymphoma ORPHA:364043	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FAM181B
ATP13A2-related juvenile neuronal ceroid lipofuscinosis ORPHA:314632	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	IRF2BP1
ATTRV122I amyloidosis ORPHA:85451	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GJB1
ATTRV30M amyloidosis ORPHA:85447	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GJB1
Aceruloplasminemia ORPHA:48818	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GJB1
Achondrogenesis type 1A ORPHA:93299	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZBED6
Achondroplasia ORPHA:15	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	SOWAHB
Acquired partial lipodystrophy ORPHA:79087	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	H2AFX
Acromegaloid facial appearance syndrome ORPHA:965	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	PLN
Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome ORPHA:466794	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	IRF2BP1
Acute infantile liver failure-multisystemic involvement syndrome ORPHA:370088	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF146
Acute inflammatory demyelinating polyradiculoneuropathy ORPHA:98916	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CDC42EP4
Acute neonatal citrullinemia type I ORPHA:247546	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CLDN12
Acyl-CoA dehydrogenase 9 deficiency ORPHA:99901	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	DOLK
Adult-onset cervical dystonia, DYT23 type ORPHA:420492	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF865
Adult-onset citrullinemia type I ORPHA:247573	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CLDN12
Adult-onset distal myopathy due to VCP mutation ORPHA:329478	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	DOLK
Alagille syndrome due to 20p12 microdeletion ORPHA:261600	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	SOCS6
Alagille syndrome due to a JAG1 point mutation ORPHA:261619	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	SOCS6
Alagille syndrome due to a NOTCH2 point mutation ORPHA:261629	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ITPRIPL2
Albers Schonberg osteopetrosis ORPHA:53	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ABHD16B
Alkaline ceramidase 3 deficiency ORPHA:502444	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TOR1AIP2
Anaplastic astrocytoma ORPHA:251589	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF672
Anaplastic oligoastrocytoma ORPHA:251663	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF672
Angelman syndrome due to a point mutation ORPHA:411511	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF770
Angelman syndrome due to paternal uniparental disomy of chromosome 15 ORPHA:98795	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF770
Argininosuccinic aciduria ORPHA:23	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	SCO2
Atrial septal defect, ostium primum type ORPHA:99106	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GJA1
Atypical pantothenate kinase-associated neurodegeneration ORPHA:216873	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CNR2
Autism-epilepsy syndrome due to branched chain ketoacid dehydrogenase kinase deficiency ORPHA:308410	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	LSM10
Autoimmune interstitial lung disease-arthritis syndrome ORPHA:444092	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	MORF4L2
Autosomal dominant Charcot-Marie-Tooth disease type 2 due to TFG mutation ORPHA:435819	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	MORF4L2
Autosomal dominant Charcot-Marie-Tooth disease type 2A1 ORPHA:99946	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CDR1
Autosomal dominant Charcot-Marie-Tooth disease type 2DD ORPHA:521414	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF664
Autosomal dominant Charcot-Marie-Tooth disease type 2L ORPHA:99945	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GJA1
Autosomal dominant Charcot-Marie-Tooth disease type 2U ORPHA:397735	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	C19ORF48
Autosomal dominant Charcot-Marie-Tooth disease type 2Y ORPHA:435387	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	DOLK
Autosomal dominant Charcot-Marie-Tooth disease type 2Z ORPHA:466768	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	SOX12
Autosomal dominant adult-onset proximal spinal muscular atrophy ORPHA:209335	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF664
Autosomal dominant aplasia and myelodysplasia ORPHA:314399	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TRMT10C
Autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome ORPHA:476093	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GJA1
Autosomal dominant multiple pterygium syndrome ORPHA:65743	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CRIPAK
Autosomal dominant slowed nerve conduction velocity ORPHA:140481	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GJA1
Autosomal dominant spastic paraplegia type 13 ORPHA:100994	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FEN1
Autosomal dominant spastic paraplegia type 31 ORPHA:101011	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	KCNJ4
Autosomal dominant spastic paraplegia type 42 ORPHA:171863	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TOR1AIP2
Autosomal dominant spastic paraplegia type 9A ORPHA:447753	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TMEM177
Autosomal dominant spastic paraplegia type 9B ORPHA:447757	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TMEM177
Autosomal dominant striatal neurodegeneration ORPHA:228169	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TCEAL6
Autosomal recessive brachyolmia ORPHA:448242	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ITPRIPL2
Autosomal recessive intermediate Charcot-Marie-Tooth disease type B ORPHA:254334	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	HNRNPF
Autosomal recessive spastic paraplegia type 45 ORPHA:320396	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CHMP1B
Autosomal recessive spastic paraplegia type 57 ORPHA:431329	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	MORF4L2
Autosomal recessive spastic paraplegia type 70 ORPHA:401835	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	C19ORF48
Autosomal recessive spastic paraplegia type 76 ORPHA:488594	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ABHD16B
Autosomal recessive spastic paraplegia type 78 ORPHA:513436	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	IRF2BP1
Autosomal recessive spastic paraplegia type 9B ORPHA:447760	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TMEM177
Autosomal spastic paraplegia type 58 ORPHA:397946	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	PHLDA3
B4GALT7-related spondylodysplastic Ehlers-Danlos syndrome ORPHA:75496	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNHIT2
Basel-Vanagaite-Smirin-Yosef syndrome ORPHA:464738	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF865
Benign recurrent intrahepatic cholestasis type 2 ORPHA:99961	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	NAT2
Beta-ketothiolase deficiency ORPHA:134	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ALDH1B1
Blepharophimosis-intellectual disability syndrome, MKB type ORPHA:293707	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF865
COASY protein-associated neurodegeneration ORPHA:397725	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	RNF26
CODAS syndrome ORPHA:1458	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	IRF2BP1
COG7-CDG ORPHA:79333	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	DOLK
COL4A1-related familial vascular leukoencephalopathy ORPHA:36383	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GJA1
Camptodactyly-arthropathy-coxa-vara-pericarditis syndrome ORPHA:2848	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	THRSP
Camptodactyly-tall stature-scoliosis-hearing loss syndrome ORPHA:85164	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	SOWAHB
Capillary malformation-arteriovenous malformation ORPHA:137667	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZBED6
Cardiomyopathy-hypotonia-lactic acidosis syndrome ORPHA:91130	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FEN1
Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome ORPHA:436174	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF146
Cerebellar-facial-dental syndrome ORPHA:444072	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	IRF2BP1
Charcot-Marie-Tooth disease type 1A ORPHA:101081	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CDC42EP4
Charcot-Marie-Tooth disease type 1E ORPHA:90658	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CDC42EP4
Charcot-Marie-Tooth disease type 4C ORPHA:99949	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	BLID
Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder ORPHA:500180	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	HNRNPA0
Choroideremia ORPHA:180	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZBED6
Christianson syndrome ORPHA:85278	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZBTB33
Chudley-McCullough syndrome ORPHA:314597	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FIGNL1
Citrullinemia type II ORPHA:247585	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FZD5
Classic pantothenate kinase-associated neurodegeneration ORPHA:216866	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CNR2
Cleft lip/palate-ectodermal dysplasia syndrome ORPHA:3253	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CDC42EP4
Cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome ORPHA:444077	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZBED6
Cohen syndrome ORPHA:193	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TAS2R30
Combined immunodeficiency due to LRBA deficiency ORPHA:445018	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZBED6
Combined immunodeficiency due to TFRC deficiency ORPHA:476113	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FIGNL1
Combined oxidative phosphorylation defect type 11 ORPHA:324535	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TRMT10C
Combined oxidative phosphorylation defect type 2 ORPHA:254920	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	COA4
Combined oxidative phosphorylation defect type 23 ORPHA:444013	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	C19ORF48
Combined oxidative phosphorylation defect type 27 ORPHA:477774	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	LTB4R
Combined oxidative phosphorylation defect type 39 ORPHA:565624	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	MORF4L2
Combined oxidative phosphorylation defect type 4 ORPHA:254925	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	POP7
Complement component 3 deficiency ORPHA:280133	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	RNASE1
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency ORPHA:95699	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNHIT2
Congenital analbuminemia ORPHA:86816	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	NAT8
Congenital cataract-hearing loss-severe developmental delay syndrome ORPHA:300313	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TOR1AIP2
Congenital factor XI deficiency ORPHA:329	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	NAT8
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type ORPHA:70472	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF146
Congenital prekallikrein deficiency ORPHA:749	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	NAT8
Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome ORPHA:508542	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF518A
Congenital thrombotic thrombocytopenic purpura ORPHA:93583	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF358
Crouzon syndrome-acanthosis nigricans syndrome ORPHA:93262	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	SOWAHB
Currarino syndrome ORPHA:1552	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TEX19
Cystathioninuria ORPHA:212	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ALDH1B1
D-glyceric aciduria ORPHA:941	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	SCO2
DNM1L-related encephalopathy due to mitochondrial and peroxisomal fission defect ORPHA:330050	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CHML
Denys-Drash syndrome ORPHA:220	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TEX19
Desmosterolosis ORPHA:35107	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CLDN12
Developmental delay-facial dysmorphism syndrome due to MED13L deficiency ORPHA:369891	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZBED6
Dihydropyrimidinuria ORPHA:38874	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	NAT8
Dilated cardiomyopathy with ataxia ORPHA:66634	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TRMT10C
Drug- or toxin-induced pulmonary arterial hypertension ORPHA:275786	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CDR1
Dubin-Johnson syndrome ORPHA:234	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CLDN2
Dyschromatosis universalis hereditaria ORPHA:241	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CTXN1
EVEN-plus syndrome ORPHA:496751	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FEN1
Early-onset epilepsy-intellectual disability-brain anomalies syndrome ORPHA:488635	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FAM156A
Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome ORPHA:319678	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TMEM177
Endosteal sclerosis-cerebellar hypoplasia syndrome ORPHA:85186	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FIGNL1
Enzalutamide toxicity ORPHA:529828	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	NAT8
Epidermolysis bullosa simplex due to BP230 deficiency ORPHA:412181	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GJA1
Erythrocyte galactose epimerase deficiency ORPHA:308473	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	PHLDA2
Exercise-induced hyperinsulinism ORPHA:165991	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ALDH1B1
FG syndrome type 1 ORPHA:93932	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF865
Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome ORPHA:412022	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CLDN12
Familial apolipoprotein A5 deficiency ORPHA:530849	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CYP8B1
Familial gastric type 1 neuroendocrine tumor ORPHA:464756	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	RPRML
Familial progressive hyper- and hypopigmentation ORPHA:280628	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TPBG
Familial progressive hyperpigmentation ORPHA:79146	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TPBG
Familial pseudohyperkalemia ORPHA:90044	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CTXN1
Familial schizencephaly ORPHA:481986	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GJA1
Fatal infantile lactic acidosis with methylmalonic aciduria ORPHA:17	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	COX14
Fibrillary astrocytoma ORPHA:251601	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF672
Fibronectin glomerulopathy ORPHA:84090	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GJA1
Formiminoglutamic aciduria ORPHA:51208	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	NAT8
Frank-Ter Haar syndrome ORPHA:137834	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FJX1
Frasier syndrome ORPHA:347	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TEX19
Fried syndrome ORPHA:85335	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CGGBP1
GAPO syndrome ORPHA:2067	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GJA1
GCGR-related hyperglucagonemia ORPHA:438274	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	NAT8
GMPPB-related  limb-girdle muscular dystrophy R19 ORPHA:363623	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNHIT2
Gamma-glutamyl transpeptidase deficiency ORPHA:33573	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	RHOG
Gemistocytic astrocytoma ORPHA:251604	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF672
Generalized galactose epimerase deficiency ORPHA:308487	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	PHLDA2
Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome ORPHA:544488	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FEN1
Global developmental delay-lung cysts-overgrowth-Wilms tumor syndrome ORPHA:404476	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF518A
Glycogen storage disease due to LAMP-2 deficiency ORPHA:34587	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	C1GALT1C1
Glycogen storage disease due to acid maltase deficiency, infantile onset ORPHA:308552	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF865
Glycogen storage disease due to acid maltase deficiency, late-onset ORPHA:420429	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF865
Glycogen storage disease due to glycogen debranching enzyme deficiency ORPHA:366	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF770
Glycogen storage disease due to liver and muscle phosphorylase kinase deficiency ORPHA:79240	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	UTP14C
Glycogen storage disease due to phosphoglycerate kinase 1 deficiency ORPHA:713	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	HNRNPF
Gray platelet syndrome ORPHA:721	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	LTB4R
Gynandroblastoma ORPHA:99914	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF518A
HANAC syndrome ORPHA:73229	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GJA1
Hajdu-Cheney syndrome ORPHA:955	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ITPRIPL2
Helicoid peripapillary chorioretinal degeneration ORPHA:86813	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CLDN12
Hemolytic anemia due to red cell pyruvate kinase deficiency ORPHA:766	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	NAT8
Hepatoerythropoietic porphyria ORPHA:95159	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	SF3B5
Hereditary motor and sensory neuropathy, Okinawa type ORPHA:90117	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	MORF4L2
Hereditary neuropathy with liability to pressure palsies ORPHA:640	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CDC42EP4
Hereditary orotic aciduria ORPHA:30	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	PIGW
Hereditary papillary renal cell carcinoma ORPHA:47044	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CLDN12
Hereditary sensory and autonomic neuropathy type 6 ORPHA:314381	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GJA1
Hereditary thrombophilia due to congenital antithrombin deficiency ORPHA:82	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	NAT8
Holocarboxylase synthetase deficiency ORPHA:79242	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF664
Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency ORPHA:209902	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CYP8B1
Hypertrichosis-acromegaloid facial appearance syndrome ORPHA:966	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	PLN
Hypertryptophanemia ORPHA:2224	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	NAT2
Hypochondroplasia ORPHA:429	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	SOWAHB
Hypomyelination with brain stem and spinal cord involvement and leg spasticity ORPHA:363412	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TRMT10C
Hypomyelination-congenital cataract syndrome ORPHA:85163	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GJC1
Infantile cerebellar-retinal degeneration ORPHA:313850	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	IRF2BP1
Infantile osteopetrosis with neuroaxonal dysplasia ORPHA:85179	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ABHD13
Infantile-onset ascending hereditary spastic paralysis ORPHA:293168	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GPRASP2
Infantile-onset mesial temporal lobe epilepsy with severe cognitive regression ORPHA:391316	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF865
Intellectual disability-autism-speech apraxia-craniofacial dysmorphism syndrome ORPHA:529965	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	EBLN2
Intellectual disability-craniofacial dysmorphism-cryptorchidism syndrome ORPHA:329224	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF865
Intellectual disability-hyperkinetic movement-truncal ataxia syndrome ORPHA:369847	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF518A
Isobutyryl-CoA dehydrogenase deficiency ORPHA:79159	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	MOAP1
Isolated hyperchlorhidrosis ORPHA:542657	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TPBG
Jalili syndrome ORPHA:1873	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	NRARP
Johanson-Blizzard syndrome ORPHA:2315	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZBED6
Juvenile Huntington disease ORPHA:248111	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	AMER1
Juvenile absence epilepsy ORPHA:1941	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TIGD1
KBG syndrome ORPHA:2332	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	AHDC1
Ketoacidosis due to monocarboxylate transporter-1 deficiency ORPHA:438075	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ALDH1B1
Kufor-Rakeb syndrome ORPHA:306674	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	IRF2BP1
Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency ORPHA:1900	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	MARVELD1
LAMA5-related multisystemic syndrome ORPHA:521450	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	PPP1R26
Larsen-like syndrome, B3GAT3 type ORPHA:284139	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNHIT2
Lethal ataxia with deafness and optic atrophy ORPHA:1187	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FEN1
Lethal hydranencephaly-diaphragmatic hernia syndrome ORPHA:480528	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GJA1
Lethal occipital encephalocele-skeletal dysplasia syndrome ORPHA:293925	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FOXC1
Lethal polymalformative syndrome, Boissel type ORPHA:210144	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF891
Letrozole toxicity ORPHA:529831	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	NAT8
Lipoic acid synthetase deficiency ORPHA:401859	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	LIPT1
Lissencephaly due to LIS1 mutation ORPHA:95232	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TSPYL4
Lymphedema-posterior choanal atresia syndrome ORPHA:99141	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GJC1
MEPAN syndrome ORPHA:508093	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TMEM177
MFF-related encephalopathy due to mitochondrial and peroxisomal fission defect ORPHA:485421	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TAF9
MITF-related melanoma and renal cell carcinoma predisposition syndrome ORPHA:293822	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ITPRIPL2
MPI-CDG ORPHA:79319	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TMEM177
Malignant Sertoli-Leydig cell tumor of the ovary ORPHA:99916	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF518A
Malonic aciduria ORPHA:943	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ACSF3
Meacham syndrome ORPHA:3097	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TEX19
Megaconial congenital muscular dystrophy ORPHA:280671	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	S1PR4
Metabolic myopathy due to lactate transporter defect ORPHA:171690	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ALDH1B1
Metachondromatosis ORPHA:2499	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF664
Microcephalic cortical malformations-short stature due to RTTN deficiency ORPHA:468631	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	RBM12B
Microphthalmia with brain and digit anomalies ORPHA:139471	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TPBG
Mild hemophilia B ORPHA:169799	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CYP8B1
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria ORPHA:1933	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	MORF4L2
Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome ORPHA:502423	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	C19ORF48
Mitochondrial pyruvate carrier deficiency ORPHA:447784	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	COX14
Moderately severe hemophilia B ORPHA:169796	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CYP8B1
Monosomy 9q22.3 ORPHA:77301	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	LRRTM1
Mucolipidosis type III gamma ORPHA:423470	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	MGAT1
Mucopolysaccharidosis type 6, rapidly progressing ORPHA:276212	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TMPPE
Mucopolysaccharidosis type 6, slowly progressing ORPHA:276223	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TMPPE
Muenke syndrome ORPHA:53271	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	SOWAHB
Mulibrey nanism ORPHA:2576	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	MORF4L2
Multiple paragangliomas associated with polycythemia ORPHA:324299	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CDC42EP4
Mutilating hereditary sensory neuropathy with spastic paraplegia ORPHA:139578	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FEN1
Myhre syndrome ORPHA:2588	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF660
Myopathic Ehlers-Danlos syndrome ORPHA:536516	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TPBG
NAD(P)HX dehydratase deficiency ORPHA:555402	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	IRF2BP1
NON RARE IN EUROPE: Benign familial hematuria ORPHA:97562	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GJA1
NON RARE IN EUROPE: Congenital isolated thyroxine-binding globulin deficiency ORPHA:209893	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	NAT8
NON RARE IN EUROPE: Familial dysalbuminemic hyperthyroxinemia ORPHA:276271	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	NAT8
NON RARE IN EUROPE: Pseudoarylsulfatase A deficiency ORPHA:751	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	MGAT1
NON RARE IN EUROPE: Specific language impairment ORPHA:458713	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	RBM12B
NPHP3-related Meckel-like syndrome ORPHA:3032	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF83
Nance-Horan syndrome ORPHA:627	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TPBG
Neonatal epileptic encephalopathy due to glutaminase deficiency ORPHA:557064	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	SLC5A3
Neonatal intrahepatic cholestasis due to citrin deficiency ORPHA:247598	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FZD5
Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion ORPHA:363700	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZBED6
Nicolaides-Baraitser syndrome ORPHA:3051	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	SAMD9L
Noonan syndrome-like disorder with juvenile myelomonocytic leukemia ORPHA:363972	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TMPPE
Ocular anomalies-axonal neuropathy-developmental delay syndrome ORPHA:496790	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	H2AFX
Odontochondrodysplasia ORPHA:166272	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZBED6
Ogden syndrome ORPHA:276432	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	POP7
Oligoastrocytoma ORPHA:251656	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF672
Oral-facial-digital syndrome with short stature and brachymesophalangy ORPHA:508501	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	EID1
Orofaciodigital syndrome type 1 ORPHA:2750	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GPR18
Osteofibrous dysplasia ORPHA:488265	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CLDN12
Otospondylomegaepiphyseal dysplasia ORPHA:1427	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZBTB12
PCNA-related progressive neurodegenerative photosensitivity syndrome ORPHA:438134	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FEN1
PEHO-like syndrome ORPHA:99807	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF660
PLAA-associated neurodevelopmental disorder ORPHA:521426	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TRMT10C
PLIN1-related familial partial lipodystrophy ORPHA:280356	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	THRSP
PYCR2-related microcephaly-progressive leukoencephalopathy ORPHA:481152	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	THAP11
Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome ORPHA:477993	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZBTB12
Pancreatic hypoplasia-diabetes-congenital heart disease syndrome ORPHA:2255	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FOXC1
Parkes Weber syndrome ORPHA:90307	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZBED6
Pelizaeus-Merzbacher-like disease due to HSPD1 mutation ORPHA:280288	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FEN1
Perlman syndrome ORPHA:2849	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ACSF3
Perry syndrome ORPHA:178509	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF358
Pleuropulmonary blastoma familial tumor susceptibility syndrome ORPHA:284343	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF518A
Polyendocrine-polyneuropathy syndrome ORPHA:453533	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF518A
Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome ORPHA:500533	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	LINGO3
Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome ORPHA:171848	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF358
Pontine autosomal dominant microangiopathy with leukoencephalopathy ORPHA:477749	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GJA1
Porphyria due to ALA dehydratase deficiency ORPHA:100924	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	IGIP
Porphyria variegata ORPHA:79473	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	NHLRC4
Postaxial acrofacial dysostosis ORPHA:246	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ACSF3
Primary hyperoxaluria type 2 ORPHA:93599	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ALDH1B1
Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency ORPHA:75391	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FEN1
Primary lateral sclerosis ORPHA:35689	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ACSF3
Progressive familial intrahepatic cholestasis type 2 ORPHA:79304	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	NAT2
Progressive myoclonic epilepsy type 9 ORPHA:457265	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	H2AFX
Progressive retinal dystrophy due to retinol transport defect ORPHA:352718	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GJB1
Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome ORPHA:228012	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CLDN12
Protoplasmic astrocytoma ORPHA:251598	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF672
Proximal myopathy with focal depletion of mitochondria ORPHA:521305	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	S1PR4
Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome ORPHA:505242	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CLDN12
Pulmonary capillary hemangiomatosis ORPHA:199241	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	RAB40A
Pyruvate carboxylase deficiency, benign type ORPHA:353320	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CDC42EP4
Pyruvate carboxylase deficiency, infantile type ORPHA:353308	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CDC42EP4
Pyruvate carboxylase deficiency, severe neonatal type ORPHA:353314	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CDC42EP4
Pyruvate dehydrogenase E3 deficiency ORPHA:2394	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TRMT10C
Pyruvate dehydrogenase E3-binding protein deficiency ORPHA:255182	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CLDN12
QRSL1-related combined oxidative phosphorylation defect ORPHA:570491	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	LIPT1
RARS-related autosomal recessive hypomyelinating leukodystrophy ORPHA:438114	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TRMT10C
RERE-related neurodevelopmental syndrome ORPHA:494344	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	AHDC1
Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta ORPHA:566243	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FAM84A
Reticular dysgenesis ORPHA:33355	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FEN1
Retinal arterial tortuosity ORPHA:75326	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GJA1
Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome ORPHA:436245	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	MORF4L2
S-adenosylhomocysteine hydrolase deficiency ORPHA:88618	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	C19ORF48
SATB2-associated syndrome due to a chromosomal rearrangement ORPHA:251028	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	POU3F2
SATB2-associated syndrome due to a pathogenic variant ORPHA:576283	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	POU3F2
SIN3A-related intellectual disability syndrome due to a point mutation ORPHA:500166	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZBTB39
SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome ORPHA:157965	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	MGAT1
SPONASTRIME dysplasia ORPHA:93357	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	C19ORF48
STAG1-related intellectual disability-facial dysmorphism-gastroesophageal reflux syndrome ORPHA:502434	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZBED6
STT3B-CDG ORPHA:370924	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF146
Sanfilippo syndrome type A ORPHA:79269	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	MGAT1
Schilbach-Rott syndrome ORPHA:2353	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	LRRTM1
Sensorineural deafness with dilated cardiomyopathy ORPHA:217622	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FOXC1
Severe achondroplasia-developmental delay-acanthosis nigricans syndrome ORPHA:85165	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	SOWAHB
Severe combined immunodeficiency due to CTPS1 deficiency ORPHA:420573	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FEN1
Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency ORPHA:440427	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	C19ORF48
Severe hemophilia B ORPHA:169793	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CYP8B1
Severe hereditary thrombophilia due to congenital protein C deficiency ORPHA:745	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	NAT8
Severe hereditary thrombophilia due to congenital protein S deficiency ORPHA:743	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TCEAL9
Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome ORPHA:369939	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TMEM187
Severe phosphoribosylpyrophosphate synthetase superactivity ORPHA:411543	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FEN1
Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome ORPHA:314394	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FEN1
Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome ORPHA:508533	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FKRP
Smith-Lemli-Opitz syndrome ORPHA:818	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TMEM177
Spastic ataxia-dysarthria due to glutaminase deficiency ORPHA:557056	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	SLC5A3
Spastic paraplegia type 7 ORPHA:99013	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ACSF3
Spastic paraplegia-Paget disease of bone syndrome ORPHA:329475	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	DOLK
Spastic paraplegia-severe developmental delay-epilepsy syndrome ORPHA:464282	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TIGD1
Spectrin-associated autosomal recessive cerebellar ataxia ORPHA:352403	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CTXN1
Spinal muscular atrophy with respiratory distress type 2 ORPHA:404521	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FEN1
Spinocerebellar ataxia type 1 ORPHA:98755	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	SAMD9L
Spinocerebellar ataxia type 10 ORPHA:98761	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	MORF4L2
Spinocerebellar ataxia type 13 ORPHA:98768	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF865
Spinocerebellar ataxia type 2 ORPHA:98756	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF70
Spinocerebellar ataxia type 4 ORPHA:98765	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	C19ORF48
Spinocerebellar ataxia type 5 ORPHA:98766	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CTXN1
Spondylo-ocular syndrome ORPHA:85194	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TIGD5
Spondyloepimetaphyseal dysplasia, PAPSS2 type ORPHA:93282	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ITPRIPL2
Spondyloepimetaphyseal dysplasia, Shohat type ORPHA:93352	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	MRPL41
Stuve-Wiedemann syndrome ORPHA:3206	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GJA1
Steel syndrome ORPHA:438117	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GJA1
Succinyl-CoA:3-oxoacid CoA transferase deficiency ORPHA:832	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	EID1
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A ORPHA:308386	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GPRASP2
Symptomatic form of hemophilia B in female carriers ORPHA:177929	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CYP8B1
Syndromic X-linked intellectual disability due to JARID1C mutation ORPHA:85279	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZBTB12
Syndromic multisystem autoimmune disease due to Itch deficiency ORPHA:228426	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	EXOC8
TBCK-related intellectual disability syndrome ORPHA:488632	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TIGD1
TMEM165-CDG ORPHA:314667	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ITPRIPL2
TMEM94-associated congenital heart defect-facial dysmorphism-developmental delay syndrome ORPHA:562569	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF865
TRAPPC11-related  limb-girdle muscular dystrophy R18 ORPHA:369840	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF518A
Tall stature-intellectual disability-renal anomalies syndrome ORPHA:500095	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	POP7
Tay-Sachs disease, B variant, adult form ORPHA:309192	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	MGAT1
Tay-Sachs disease, B variant, infantile form ORPHA:309178	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	MGAT1
Tay-Sachs disease, B variant, juvenile form ORPHA:309185	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	MGAT1
Tay-Sachs disease, B1 variant ORPHA:309239	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	MGAT1
Temtamy preaxial brachydactyly syndrome ORPHA:363417	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	SOCS4
Thanatophoric dysplasia type 1 ORPHA:1860	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	SOWAHB
Thanatophoric dysplasia type 2 ORPHA:93274	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	SOWAHB
Thrombocytopenia-absent radius syndrome ORPHA:3320	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TRMT10C
Tietz syndrome ORPHA:42665	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ITPRIPL2
Transketolase deficiency ORPHA:488618	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF581
Trehalase deficiency ORPHA:103909	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	GJB1
Tyrosinemia type 2 ORPHA:28378	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CYP8B1
Uveal coloboma-cleft lip and palate-intellectual disability ORPHA:1473	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TPBG
Vitamin B12-responsive methylmalonic acidemia type cblB ORPHA:79311	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	MRPL57
Vitamin B12-unresponsive methylmalonic acidemia type mut- ORPHA:79312	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CLDN12
Vitamin B12-unresponsive methylmalonic acidemia type mut0 ORPHA:289916	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CLDN12
WARS2-related combined oxidative phosphorylation defect ORPHA:572798	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TRMT10C
Warsaw breakage syndrome ORPHA:280558	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	C19ORF48
Werner syndrome ORPHA:902	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	RBM12B
Wilson disease ORPHA:905	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FZD5
Wolfram-like syndrome ORPHA:411590	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF358
Wrinkly skin syndrome ORPHA:2834	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF891
X-linked Charcot-Marie-Tooth disease type 5 ORPHA:99014	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FEN1
X-linked dystonia-parkinsonism ORPHA:53351	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	RBM12B
X-linked intellectual disability, Najm type ORPHA:163937	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FLRT3
X-linked intellectual disability, Snyder type ORPHA:3063	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FEN1
X-linked intellectual disability-Dandy-Walker malformation-basal ganglia disease-seizures syndrome ORPHA:1568	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CGGBP1
X-linked intellectual disability-cerebellar hypoplasia-spondylo-epiphyseal dysplasia syndrome ORPHA:459070	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF581
X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome ORPHA:480907	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	RBM12B
X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior syndrome ORPHA:85329	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CGGBP1
X-linked intellectual disability-limb spasticity-retinal dystrophy-diabetes insipidus syndrome ORPHA:423479	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	FEN1
X-linked microcephaly-growth retardation-prognathism-cryptorchidism syndrome ORPHA:435938	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	ZNF581
X-linked myopathy with excessive autophagy ORPHA:25980	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	CHML
X-linked osteoporosis with fractures ORPHA:391330	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TCEAL9
X-linked sideroblastic anemia and spinocerebellar ataxia ORPHA:2802	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	TRMT10C
XYLT1-CDG ORPHA:370930	1/101	0.9999918616566181	0.9999961656375117	0	0	0.07731461167178587	6.292154186099201E-7	KCNA3
Acquired idiopathic sideroblastic anemia ORPHA:75564	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	ZNF518A
Acrodysostosis ORPHA:950	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	B3GALT2
Acrodysostosis with multiple hormone resistance ORPHA:280651	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	B3GALT2
Acute myeloid leukemia with t(9;11)(p22;q23) ORPHA:402017	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	ZNF891
Angiocentric glioma ORPHA:251671	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	SPN
Bohring-Opitz syndrome ORPHA:97297	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	GJC1
CADDS ORPHA:369942	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	TMEM187
Cenani-Lenz syndrome ORPHA:3258	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	CDR1
Cerebral sinovenous thrombosis ORPHA:329217	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	NAT8
Cholesterol-ester transfer protein deficiency ORPHA:79506	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	NAT8
Cole-Carpenter syndrome ORPHA:2050	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	MGAT2
Congenital amegakaryocytic thrombocytopenia ORPHA:3319	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	NAT8
Constitutional mismatch repair deficiency syndrome ORPHA:252202	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	FIGNL1
Craniopharyngioma ORPHA:54595	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	ZBED6
Crouzon disease ORPHA:207	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	CDC42EP4
Dense deposit disease ORPHA:93571	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	CYP8B1
Early myoclonic encephalopathy ORPHA:1935	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	IRF2BP1
Frontometaphyseal dysplasia ORPHA:1826	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	ZNF146
Glycogen storage disease due to liver phosphorylase kinase deficiency ORPHA:264580	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	LTB4R
HELLP syndrome ORPHA:244242	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	RNASE4
Hartnup disease ORPHA:2116	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	RNF186
Hemimegalencephaly ORPHA:99802	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	B3GALT2
Hereditary motor and sensory neuropathy type 6 ORPHA:90120	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	ZHX1
Hypotonia-speech impairment-severe cognitive delay syndrome ORPHA:371364	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	AMER3
Immunoglobulin-mediated membranoproliferative glomerulonephritis ORPHA:329903	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	SAMD9L
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia ORPHA:52430	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	FEN1
MEDNIK syndrome ORPHA:171851	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	CENPB
Microphthalmia, Lenz type ORPHA:568	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	NUP62
Myelodysplastic syndrome ORPHA:52688	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	FOXC1
Neonatal inflammatory skin and bowel disease ORPHA:294023	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	TPBG
Niemann-Pick disease type C, adult neurologic onset ORPHA:216986	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	MGAT1
Niemann-Pick disease type C, juvenile neurologic onset ORPHA:216981	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	MGAT1
Niemann-Pick disease type C, late infantile neurologic onset ORPHA:216978	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	MGAT1
Niemann-Pick disease type C, severe early infantile neurologic onset ORPHA:216975	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	MGAT1
Niemann-Pick disease type C, severe perinatal form ORPHA:216972	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	MGAT1
Ochoa syndrome ORPHA:2704	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	ZNF891
Papillary renal cell carcinoma ORPHA:319298	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	ITPRIPL2
Parkinson-dementia complex of Guam ORPHA:90020	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	TRMT10C
Phakomatosis cesioflammea ORPHA:79483	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	CDC42EP4
Polymerase proofreading-related adenomatous polyposis ORPHA:447877	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	C19ORF48
Progressive myoclonic epilepsy type 5 ORPHA:402082	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	KLHL25
Senior-Boichis syndrome ORPHA:84081	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	KAAG1
Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency ORPHA:397593	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	MRPL57
Silver-Russell syndrome due to 11p15 microduplication ORPHA:231144	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	ISLR
Silver-Russell syndrome due to an imprinting defect of 11p15 ORPHA:231140	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	ISLR
Smith-McCort dysplasia ORPHA:178355	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	ZNF345
Synaptic congenital myasthenic syndromes ORPHA:98915	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	ZNF358
Wilson-Turner syndrome ORPHA:3459	1/102	0.9999923936041255	0.9999961656375117	0	0	0.07654477602213929	5.822320828954693E-7	FEN1
Adult-onset foveomacular vitelliform dystrophy ORPHA:99000	1/103	0.9999928632170606	0.9999961656375117	0	0	0.07579003518915245	5.408989602559003E-7	B3GALT2
Alopecia-intellectual disability syndrome ORPHA:2850	1/103	0.9999928632170606	0.9999961656375117	0	0	0.07579003518915245	5.408989602559003E-7	SOWAHB
Atypical hypotonia-cystinuria syndrome ORPHA:238523	1/103	0.9999928632170606	0.9999961656375117	0	0	0.07579003518915245	5.408989602559003E-7	GPR22
Auriculocondylar syndrome ORPHA:137888	1/103	0.9999928632170606	0.9999961656375117	0	0	0.07579003518915245	5.408989602559003E-7	TPBG
Autosomal dominant epilepsy with auditory features ORPHA:101046	1/103	0.9999928632170606	0.9999961656375117	0	0	0.07579003518915245	5.408989602559003E-7	AMER3
Beckwith-Wiedemann syndrome due to imprinting defect of 11p15 ORPHA:231117	1/103	0.9999928632170606	0.9999961656375117	0	0	0.07579003518915245	5.408989602559003E-7	ISLR
Gorlin syndrome ORPHA:377	1/103	0.9999928632170606	0.9999961656375117	0	0	0.07579003518915245	5.408989602559003E-7	AMER1
Hypomyelination neuropathy-arthrogryposis syndrome ORPHA:2680	1/103	0.9999928632170606	0.9999961656375117	0	0	0.07579003518915245	5.408989602559003E-7	PCDHB15
Hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome ORPHA:88637	1/103	0.9999928632170606	0.9999961656375117	0	0	0.07579003518915245	5.408989602559003E-7	PIGW
Isolated hemihyperplasia ORPHA:2128	1/103	0.9999928632170606	0.9999961656375117	0	0	0.07579003518915245	5.408989602559003E-7	ISLR
Isolated polycystic liver disease ORPHA:2924	1/103	0.9999928632170606	0.9999961656375117	0	0	0.07579003518915245	5.408989602559003E-7	ZBTB12
Keratosis follicularis spinulosa decalvans ORPHA:2340	1/103	0.9999928632170606	0.9999961656375117	0	0	0.07579003518915245	5.408989602559003E-7	RNASE4
Mantle cell lymphoma ORPHA:52416	1/103	0.9999928632170606	0.9999961656375117	0	0	0.07579003518915245	5.408989602559003E-7	ZBED6
Myxofibrosarcoma ORPHA:79105	1/103	0.9999928632170606	0.9999961656375117	0	0	0.07579003518915245	5.408989602559003E-7	CHST14
NON RARE IN EUROPE: Barrett esophagus ORPHA:1232	1/103	0.9999928632170606	0.9999961656375117	0	0	0.07579003518915245	5.408989602559003E-7	PLN
Noonan syndrome with multiple lentigines ORPHA:500	1/103	0.9999928632170606	0.9999961656375117	0	0	0.07579003518915245	5.408989602559003E-7	RBM12B
Ollier disease ORPHA:296	1/103	0.9999928632170606	0.9999961656375117	0	0	0.07579003518915245	5.408989602559003E-7	SOD3
Persistent hyperplastic primary vitreous ORPHA:91495	1/103	0.9999928632170606	0.9999961656375117	0	0	0.07579003518915245	5.408989602559003E-7	ATOH7
Pyridoxine-dependent epilepsy ORPHA:3006	1/103	0.9999928632170606	0.9999961656375117	0	0	0.07579003518915245	5.408989602559003E-7	CYP8B1
Triple A syndrome ORPHA:869	1/103	0.9999928632170606	0.9999961656375117	0	0	0.07579003518915245	5.408989602559003E-7	DOLK
Unverricht-Lundborg disease ORPHA:308	1/103	0.9999928632170606	0.9999961656375117	0	0	0.07579003518915245	5.408989602559003E-7	FZD1
2p21 microdeletion syndrome ORPHA:163693	1/104	0.9999932778422439	0.9999961656375117	0	0	0.07504994951797117	5.044992959110098E-7	GPR22
Aplasia cutis congenita ORPHA:1114	1/104	0.9999932778422439	0.9999961656375117	0	0	0.07504994951797117	5.044992959110098E-7	GJB3
Atypical glycine encephalopathy ORPHA:289863	1/104	0.9999932778422439	0.9999961656375117	0	0	0.07504994951797117	5.044992959110098E-7	CLDN6
Autosomal dominant Emery-Dreifuss muscular dystrophy ORPHA:98853	1/104	0.9999932778422439	0.9999961656375117	0	0	0.07504994951797117	5.044992959110098E-7	ITPRIPL2
Autosomal thrombocytopenia with normal platelets ORPHA:168629	1/104	0.9999932778422439	0.9999961656375117	0	0	0.07504994951797117	5.044992959110098E-7	FIGNL1
Chronic myelomonocytic leukemia ORPHA:98823	1/104	0.9999932778422439	0.9999961656375117	0	0	0.07504994951797117	5.044992959110098E-7	CHST14
Epidermodysplasia verruciformis ORPHA:302	1/104	0.9999932778422439	0.9999961656375117	0	0	0.07504994951797117	5.044992959110098E-7	S1PR4
Extraskeletal Ewing sarcoma ORPHA:370334	1/104	0.9999932778422439	0.9999961656375117	0	0	0.07504994951797117	5.044992959110098E-7	PNRC2
Familial progressive cardiac conduction defect ORPHA:871	1/104	0.9999932778422439	0.9999961656375117	0	0	0.07504994951797117	5.044992959110098E-7	ADRA2C
Hereditary sensory and autonomic neuropathy type 2 ORPHA:970	1/104	0.9999932778422439	0.9999961656375117	0	0	0.07504994951797117	5.044992959110098E-7	CDR1
Homozygous familial hypercholesterolemia ORPHA:391665	1/104	0.9999932778422439	0.9999961656375117	0	0	0.07504994951797117	5.044992959110098E-7	GJB1
Infantile glycine encephalopathy ORPHA:289860	1/104	0.9999932778422439	0.9999961656375117	0	0	0.07504994951797117	5.044992959110098E-7	CLDN6
Intrahepatic cholestasis of pregnancy ORPHA:69665	1/104	0.9999932778422439	0.9999961656375117	0	0	0.07504994951797117	5.044992959110098E-7	NAT2
Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type ORPHA:394529	1/104	0.9999932778422439	0.9999961656375117	0	0	0.07504994951797117	5.044992959110098E-7	COX14
NON RARE IN EUROPE: FG syndrome phenotypic spectrum ORPHA:323	1/104	0.9999932778422439	0.9999961656375117	0	0	0.07504994951797117	5.044992959110098E-7	CHML
Pontocerebellar hypoplasia type 1 ORPHA:2254	1/104	0.9999932778422439	0.9999961656375117	0	0	0.07504994951797117	5.044992959110098E-7	TRMT10C
Primary pigmented nodular adrenocortical disease ORPHA:189439	1/104	0.9999932778422439	0.9999961656375117	0	0	0.07504994951797117	5.044992959110098E-7	IGIP
Schwannomatosis ORPHA:93921	1/104	0.9999932778422439	0.9999961656375117	0	0	0.07504994951797117	5.044992959110098E-7	IRF2BP1
Severe early-childhood-onset retinal dystrophy ORPHA:364055	1/104	0.9999932778422439	0.9999961656375117	0	0	0.07504994951797117	5.044992959110098E-7	FLRT3
Severe intellectual disability and progressive spastic paraplegia ORPHA:280763	1/104	0.9999932778422439	0.9999961656375117	0	0	0.07504994951797117	5.044992959110098E-7	PGBD4
Systemic mastocytosis with associated hematologic neoplasm ORPHA:98849	1/104	0.9999932778422439	0.9999961656375117	0	0	0.07504994951797117	5.044992959110098E-7	EBLN2
Weaver syndrome ORPHA:3447	1/104	0.9999932778422439	0.9999961656375117	0	0	0.07504994951797117	5.044992959110098E-7	FIGNL1
Cornelia de Lange syndrome ORPHA:199	1/105	0.9999936436632149	0.9999961656375117	0	0	0.07432409626354339	4.7243048856751935E-7	RBM12B
Gastrointestinal stromal tumor ORPHA:44890	1/105	0.9999936436632149	0.9999961656375117	0	0	0.07432409626354339	4.7243048856751935E-7	ISLR
Hereditary hyperekplexia ORPHA:3197	1/105	0.9999936436632149	0.9999961656375117	0	0	0.07432409626354339	4.7243048856751935E-7	PNMA2
Multiple acyl-CoA dehydrogenase deficiency, mild type ORPHA:394532	1/105	0.9999936436632149	0.9999961656375117	0	0	0.07432409626354339	4.7243048856751935E-7	COA4
Waardenburg syndrome type 2 ORPHA:895	1/105	0.9999936436632149	0.9999961656375117	0	0	0.07432409626354339	4.7243048856751935E-7	GJA1
Adams-Oliver syndrome ORPHA:974	1/106	0.9999939663628596	0.9999961656375117	0	0	0.07361206878539042	4.4414985212290576E-7	CLEC14A
Clear cell sarcoma of kidney ORPHA:457246	1/106	0.9999939663628596	0.9999961656375117	0	0	0.07361206878539042	4.4414985212290576E-7	ZBTB12
Jeune syndrome ORPHA:474	1/106	0.9999939663628596	0.9999961656375117	0	0	0.07361206878539042	4.4414985212290576E-7	ZNF664
Muscle-eye-brain disease ORPHA:588	1/106	0.9999939663628596	0.9999961656375117	0	0	0.07361206878539042	4.4414985212290576E-7	FKRP
Sporadic pheochromocytoma/secreting paraganglioma ORPHA:276621	1/106	0.9999939663628596	0.9999961656375117	0	0	0.07361206878539042	4.4414985212290576E-7	SEPHS2
Wolf-Hirschhorn syndrome ORPHA:280	1/106	0.9999939663628596	0.9999961656375117	0	0	0.07361206878539042	4.4414985212290576E-7	IRF2BP1
Xeroderma pigmentosum ORPHA:910	1/106	0.9999939663628596	0.9999961656375117	0	0	0.07361206878539042	4.4414985212290576E-7	HNRNPA1L2
Infantile nephronophthisis ORPHA:93591	1/107	0.9999942508171702	0.9999961656375117	0	0	0.07291347578795732	4.191941080745523E-7	RBM12B
Pilomyxoid astrocytoma ORPHA:251615	1/107	0.9999942508171702	0.9999961656375117	0	0	0.07291347578795732	4.191941080745523E-7	CDR1
Hereditary breast cancer ORPHA:227535	1/108	0.9999945013996322	0.9999961656375117	0	0	0.07222794060356034	3.971536726641064E-7	KLLN
Heritable pulmonary arterial hypertension ORPHA:275777	1/108	0.9999945013996322	0.9999961656375117	0	0	0.07222794060356034	3.971536726641064E-7	ISLR
Hirschsprung disease ORPHA:388	1/108	0.9999945013996322	0.9999961656375117	0	0	0.07222794060356034	3.971536726641064E-7	GJA1
Orofaciodigital syndrome type 6 ORPHA:2754	1/108	0.9999945013996322	0.9999961656375117	0	0	0.07222794060356034	3.971536726641064E-7	ZNF146
Behavioral variant of frontotemporal dementia ORPHA:275864	1/109	0.999994721952901	0.9999961656375117	0	0	0.07155510051517072	3.7767218738259595E-7	UBC
Familial pancreatic carcinoma ORPHA:1333	1/109	0.999994721952901	0.9999961656375117	0	0	0.07155510051517072	3.7767218738259595E-7	FIGNL1
Isolated complex III deficiency ORPHA:1460	1/109	0.999994721952901	0.9999961656375117	0	0	0.07155510051517072	3.7767218738259595E-7	COA4
NON RARE IN EUROPE: Non rare thrombophilia ORPHA:64738	1/109	0.999994721952901	0.9999961656375117	0	0	0.07155510051517072	3.7767218738259595E-7	CYP8B1
Situs inversus totalis ORPHA:101063	1/109	0.999994721952901	0.9999961656375117	0	0	0.07155510051517072	3.7767218738259595E-7	APOBEC4
46,XY complete gonadal dysgenesis ORPHA:242	1/110	0.9999949161490681	0.9999961656375117	0	0	0.07089460611647633	3.6041852552954757E-7	SRY
Acute promyelocytic leukemia ORPHA:520	1/113	0.999995368167124	0.9999961656375117	0	0	0.0689838901773961	3.195225904278203E-7	GPR174
Autosomal recessive non-syndromic intellectual disability ORPHA:88616	2/140	0.9999954081724662	0.9999961656375117	0	0	0.11185759183621534	5.13631949309408E-7	PIGC;MORF4L2
Non-syndromic male infertility due to sperm motility disorder ORPHA:276234	1/114	0.9999954833502747	0.9999961656375117	0	0	0.06836953018518446	3.0880191710804533E-7	APOBEC4
Noonan syndrome ORPHA:648	1/114	0.9999954833502747	0.9999961656375117	0	0	0.06836953018518446	3.0880191710804533E-7	SOCS4
Fanconi anemia ORPHA:84	1/116	0.9999956722199956	0.9999961656375117	0	0	0.06717286376557224	2.907100057055109E-7	FANCF
Joubert syndrome ORPHA:475	1/116	0.9999956722199956	0.9999961656375117	0	0	0.06717286376557224	2.907100057055109E-7	HYLS1
Total early-onset cataract ORPHA:98994	1/116	0.9999956722199956	0.9999961656375117	0	0	0.06717286376557224	2.907100057055109E-7	PPP1R26
Isolated complex I deficiency ORPHA:2609	1/121	0.9999959673215156	0.9999961656375117	0	0	0.06435571156940179	2.595264166857016E-7	COX14
NON RARE IN EUROPE: Primary ovarian failure ORPHA:619	1/121	0.9999959673215156	0.9999961656375117	0	0	0.06435571156940179	2.595264166857016E-7	FOXL2
Leigh syndrome with leukodystrophy ORPHA:255241	1/122	0.9999960044838634	0.9999961656375117	0	0	0.06382021982963385	2.5499522759055946E-7	LIPT1
Primary ciliary dyskinesia ORPHA:244	1/136	0.9999961656375117	0.9999961656375117	0	0	0.05715632262363285	2.1915847960388227E-7	APOBEC4
